NZ735908B2 - System, method, and apparatus for infusing fluid - Google Patents
System, method, and apparatus for infusing fluid Download PDFInfo
- Publication number
- NZ735908B2 NZ735908B2 NZ735908A NZ73590812A NZ735908B2 NZ 735908 B2 NZ735908 B2 NZ 735908B2 NZ 735908 A NZ735908 A NZ 735908A NZ 73590812 A NZ73590812 A NZ 73590812A NZ 735908 B2 NZ735908 B2 NZ 735908B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- plunger
- fluid
- cam
- avs
- pump
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 482
- 230000002572 peristaltic Effects 0.000 claims abstract description 221
- 238000005086 pumping Methods 0.000 claims description 62
- 230000003068 static Effects 0.000 claims description 31
- 238000001802 infusion Methods 0.000 description 297
- 238000005259 measurement Methods 0.000 description 162
- 239000003570 air Substances 0.000 description 128
- 239000003814 drug Substances 0.000 description 101
- 239000012528 membrane Substances 0.000 description 97
- 239000007788 liquid Substances 0.000 description 77
- 238000000034 method Methods 0.000 description 72
- 230000003287 optical Effects 0.000 description 64
- 229940079593 drugs Drugs 0.000 description 62
- 210000004369 Blood Anatomy 0.000 description 50
- 239000008280 blood Substances 0.000 description 50
- 238000001764 infiltration Methods 0.000 description 49
- 238000001514 detection method Methods 0.000 description 45
- 238000010586 diagram Methods 0.000 description 44
- 238000004891 communication Methods 0.000 description 42
- 230000004044 response Effects 0.000 description 41
- 150000002500 ions Chemical class 0.000 description 36
- 239000000463 material Substances 0.000 description 33
- 239000010408 film Substances 0.000 description 23
- 239000011159 matrix material Substances 0.000 description 20
- 238000011144 upstream manufacturing Methods 0.000 description 17
- 210000004072 Lung Anatomy 0.000 description 16
- 238000007789 sealing Methods 0.000 description 15
- 230000002596 correlated Effects 0.000 description 14
- 239000004033 plastic Substances 0.000 description 14
- 229920003023 plastic Polymers 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 230000001419 dependent Effects 0.000 description 12
- 238000003708 edge detection Methods 0.000 description 12
- 238000003384 imaging method Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 230000000051 modifying Effects 0.000 description 12
- 230000000875 corresponding Effects 0.000 description 11
- 238000007599 discharging Methods 0.000 description 11
- 238000011068 load Methods 0.000 description 11
- 238000002560 therapeutic procedure Methods 0.000 description 11
- 206010053648 Vascular occlusion Diseases 0.000 description 10
- 210000003462 Veins Anatomy 0.000 description 10
- 230000000712 assembly Effects 0.000 description 10
- 239000000969 carrier Substances 0.000 description 10
- 230000001965 increased Effects 0.000 description 10
- 210000004027 cells Anatomy 0.000 description 9
- 238000006073 displacement reaction Methods 0.000 description 9
- 238000005286 illumination Methods 0.000 description 9
- 230000037250 Clearance Effects 0.000 description 8
- 230000005355 Hall effect Effects 0.000 description 8
- 241000229754 Iva xanthiifolia Species 0.000 description 8
- 239000012080 ambient air Substances 0.000 description 8
- 230000035512 clearance Effects 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 238000005070 sampling Methods 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 238000009530 blood pressure measurement Methods 0.000 description 7
- 238000007906 compression Methods 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 230000001960 triggered Effects 0.000 description 7
- 230000003542 behavioural Effects 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000000670 limiting Effects 0.000 description 6
- 230000000737 periodic Effects 0.000 description 6
- 238000010079 rubber tapping Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229960002897 Heparin Drugs 0.000 description 5
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 229920000669 heparin Polymers 0.000 description 5
- 229920001778 nylon Polymers 0.000 description 5
- 230000001360 synchronised Effects 0.000 description 5
- 238000004448 titration Methods 0.000 description 5
- 229920002574 CR-39 Polymers 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 229940035295 Ting Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000020639 clam Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000001809 detectable Effects 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 238000009499 grossing Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002985 plastic film Substances 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 230000002829 reduced Effects 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 230000001225 therapeutic Effects 0.000 description 4
- 206010067647 Delivery Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 210000002381 Plasma Anatomy 0.000 description 3
- 229910008801 WRe Inorganic materials 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- -1 e.g. Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003760 hair shine Effects 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000006011 modification reaction Methods 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000000284 resting Effects 0.000 description 3
- 230000003595 spectral Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 2
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 2
- SFLSHLFXELFNJZ-MRVPVSSYSA-N L-Noradrenaline Natural products NC[C@@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-MRVPVSSYSA-N 0.000 description 2
- 229960002748 Norepinephrine Drugs 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N VANCOMYCIN Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
- 229960003165 Vancomycin Drugs 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- ASCUXPQGEXGEMJ-GPLGTHOPSA-N [(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(4-methylanilino)oxan-2-yl]methoxy]oxan-2-yl]methyl acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](COC(=O)C)O[C@@H]1OC[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC=2C=CC(C)=CC=2)O1 ASCUXPQGEXGEMJ-GPLGTHOPSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive Effects 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000000903 blocking Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000000295 complement Effects 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000002209 hydrophobic Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000000977 initiatory Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 230000036961 partial Effects 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 230000000246 remedial Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000011031 topaz Substances 0.000 description 2
- 229910052853 topaz Inorganic materials 0.000 description 2
- 230000001052 transient Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N 5-flurouricil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 229920000122 Acrylonitrile butadiene styrene Polymers 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N Acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 210000004544 DC2 Anatomy 0.000 description 1
- 229960002949 Fluorouracil Drugs 0.000 description 1
- 230000036499 Half live Effects 0.000 description 1
- 102000006391 Ion Pumps Human genes 0.000 description 1
- 108010083687 Ion Pumps Proteins 0.000 description 1
- 241001527806 Iti Species 0.000 description 1
- 101700015817 LAT2 Proteins 0.000 description 1
- 101710034704 MCAM Proteins 0.000 description 1
- 241001237731 Microtia elva Species 0.000 description 1
- 208000010125 Myocardial Infarction Diseases 0.000 description 1
- 241001182492 Nes Species 0.000 description 1
- 206010063834 Oversensing Diseases 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920003031 Santoprene Polymers 0.000 description 1
- 206010040003 Sensation of pressure Diseases 0.000 description 1
- 229920002323 Silicone foam Polymers 0.000 description 1
- 229960001608 Teicoplanin Drugs 0.000 description 1
- 108010053950 Teicoplanin Proteins 0.000 description 1
- 102000003978 Tissue plasminogen activator Human genes 0.000 description 1
- 108090000373 Tissue plasminogen activator Proteins 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene (UHMWPE) Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000005534 acoustic noise Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 229960003318 alteplase Drugs 0.000 description 1
- 230000002238 attenuated Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000000701 chemical imaging Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001066 destructive Effects 0.000 description 1
- 229920005994 diacetyl cellulose Polymers 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001976 improved Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000002452 interceptive Effects 0.000 description 1
- 230000002530 ischemic preconditioning Effects 0.000 description 1
- 230000001795 light effect Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000000116 mitigating Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 230000005019 pattern of movement Effects 0.000 description 1
- 230000002085 persistent Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 229920002530 poly[4-(4-benzoylphenoxy)phenol] polymer Polymers 0.000 description 1
- 230000003252 repetitive Effects 0.000 description 1
- 230000002104 routine Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000001743 silencing Effects 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000001340 slower Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 238000007666 vacuum forming Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3375—Acoustical, e.g. ultrasonic, measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
- A61M5/14216—Reciprocating piston type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16809—Flow controllers by repeated filling and emptying of an intermediate volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M5/1684—Monitoring, detecting, signalling or eliminating infusion flow anomalies by detecting the amount of infusate remaining, e.g. signalling end of infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16886—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body for measuring fluid flow rate, i.e. flowmeters
- A61M5/1689—Drip counters
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01B—MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS
- G01B11/00—Measuring arrangements characterised by the use of optical techniques
- G01B11/02—Measuring arrangements characterised by the use of optical techniques for measuring length, width or thickness
- G01B11/026—Measuring arrangements characterised by the use of optical techniques for measuring length, width or thickness by measuring distance between sensor and object
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
- G01F22/00—Methods or apparatus for measuring volume of fluids or fluent solid material, not otherwise provided for
Abstract
peristaltic pump for infusing fluids. The peristaltic pump comprises a camshaft (705), a plunger (706), a tube receiver, a spring (710) and a position sensor (711). The camshaft includes a plunger cam (702) which is configured to engage or disengage from a plunger-cam follower (709). The plunger-cam follower is coupled to the plunger. The spring biases the plunger towards the tube receiver, to compress the tube (707) when a tube is placed in the receiver. The plunger cam engaging with the plunger-cam follower to urge the plunger away from the tube receiver. When the plunger-cam follower is not engaged by the plunger cam the plunger-cam follower does not follow the plunger cam. The position sensor is configured to determine a position of the plunger, when the plunger-cam follower is disengaged from the plunger cam and the spring compresses the plunger against the tube. A processor is coupled with the position sensor and is configured to estimate the fluid flow through the pump as indicated by the stroke of the plunger when the plunger-cam follower is disengaged and the spring applies the force through the plunger, against the tube. am follower is coupled to the plunger. The spring biases the plunger towards the tube receiver, to compress the tube (707) when a tube is placed in the receiver. The plunger cam engaging with the plunger-cam follower to urge the plunger away from the tube receiver. When the plunger-cam follower is not engaged by the plunger cam the plunger-cam follower does not follow the plunger cam. The position sensor is configured to determine a position of the plunger, when the plunger-cam follower is disengaged from the plunger cam and the spring compresses the plunger against the tube. A processor is coupled with the position sensor and is configured to estimate the fluid flow through the pump as indicated by the stroke of the plunger when the plunger-cam follower is disengaged and the spring applies the force through the plunger, against the tube.
Description
Patents Form No. 5
N.Z. No. 735908, itself divided
out of Appliction No. 724959,
itself divided out of Application
No. , itself divided out
of No. 626630
NEW ZEALAND
Patents Act 1953
COMPLETE SPECIFICATION
SYSTEM, METHOD, AND APPARATUS FOR INFUSING FLUID
We, Deka Products Limited Partnership, a company of the United States of America, of 340 Commercial
Street, Manchester, NH 03101, United States of America,
do hereby declare the invention, for which we pray that a patent may be granted to us, and the method
by which it is to be med, to be particularly bed in and by the following statement:-
(followed by page 1A)
The present application is a divisional application divided out from New Zealand Patent
Application No. 724959, itself divided from NZ , itself divided from NZ 626630,
and claims priority to and the benefit of the following:
Nonprovisional application for System, Method, and Apparatus for Clamping
(Attorney Docket No. J47, published as US 20130182381A1);
Nonprovisional application for , , and Apparatus for Dispensing
Oral Medications (Attorney Docket No. J74, published as US 20130197693A1);
PCT application for System, Method, and Apparatus for Dispensing Oral
tions (Attorney Docket No. J74WO, published as A1);
Nonprovisional application for System, Method, and Apparatus for Estimating
Liquid Delivery ney Docket No. J75, d as US 9,295,778B2);
Nonprovisional application for System, Method, and Apparatus for ng
Fluid (Attorney Docket No. J76, published as US 20130177455A1);
Nonprovisional application for , Method, and Apparatus for Electronic
Patient Care (Attorney Docket No. J77, published as US 20130297330A1);
Nonprovisional application for System, Method, and Apparatus for Electronic
Patient Care (Attorney Docket No. J78, published as US 20130317753A1);
Nonprovisional application for System, Method, and Apparatus for ring,
Regulating, or Controlling Fluid Flow (Attorney Docket No. J79, granted as
US 9,151,646B2);
PCT application for System, Method, and Apparatus for Monitoring,
Regulating, or Controlling Fluid Flow (Attorney Docket No. J79WO, published as
A1);
Nonprovisional application for System, Method, and Apparatus for Estimating
Liquid Delivery (Attorney Docket No. J81, published as US 20130204188A1);
PCT ation for System, Method, and Apparatus for Estimating Liquid
Delivery (Attorney Docket No. J81WO, published as WO 96713A1); and
Nonprovisional ation for System, Method, and Apparatus for Electronic
Patient Care (Attorney Docket No. J85, published as US 20130191513A1).
OUND
Relevant Field
[0001] The present disclosure relates to infusing fluid. More particularly, the
present disclosure relates to a system, method and apparatus for infusing fluid into a t,
e.g., using a pump.
Description of Related Art
Providing patient care in a hospital generally necessitates the interaction of
numerous professionals and caregivers (e.g., s, nurses, pharmacists, technicians, nurse
practitioners, etc.) and any number of medical devices/systems needed for treatment of a
given patient. Despite the existence of systems intended to facilitate the care process, such
as those incorporating onic medical records (“EMR”) and computerized provider order
entry (“CPOE”), the process of providing comprehensive care to patients including ordering
and delivering medical treatments, such as medications, is associated with a number of non—
trivial issues.
Peristaltic pumps are used in a variety of applications such as medical
applications, especially fluid transfer applications that would benefit from isolation of fluid
from the system and other fluids. Some peristaltic pumps work by compressing or
squeezing a length of flexible tubing. A mechanical mechanism pinches a portion of the
tubing and pushes any fluid trapped in the tubing in the direction of rotation. There are
rotary peristaltic pumps and finger peristaltic pumps.
Rotary peristaltic pumps typically move liquids h e tubing
placed in an arc—shaped raceway. Rotary peristaltic pumps are generally made of two to
four rollers placed on a roller carrier driven rotationally by a motor. A typical rotary
peristaltic pump has a rotor assembly with pinch rollers that apply pressure to the flexible
tubing at spaced locations to provide a squeezing action on the tubing against an occlusion
bed. The occlusion of the tubing creates increased pressure ahead of the squeezed area and
reduced pressure behind that area, thereby forcing a liquid through the tubing as the rotor
ly moves the pinch rollers along the tubing. In order to e, there must always be
an occlusion zone; in other words, at least one of the rollers is always pressing on the tube.
Finger peristaltic pumps are made of a series of fingers moving in cyclical
fashion to flatten a flexible tube against a counter surface. The fingers move essentially
vertically, in wave—like n, forming a zone of occlusion that moves from upstream to
downstream. The last finger--the furthest downstream——raises up when the first finger——the
furthest upstream--presses against the counter e. The most commonly used finger
pumps are linear, meaning that the r surface is flat and the s are parallel. In this
case, the fingers are controlled by a series of cams arranged one behind r, each cam
cooperating with a finger. These cams are placed helically offset on a shared shaft driven
onally by a motor. There are also rotary—finger peristaltic pumps, which attempt to
combine the advantages of roller pumps with those of finger pumps. In this type of pump,
the counter e is not flat, but arc—shaped, and the fingers are arranged radially inside
the counter surface. In this case, a shared cam with multiple knobs placed in the center of the
arc is used to activate the fingers.
SUMMARY
A peristaltic pump, and related system method are provided. The peristaltic
pump includes a cam shaft, first and second pinch-valve cams, first and second pinch-valve
cam followers, a plunger cam, a plunger-cam follower, a tube receiver, and a spring-biased
r. The first and second pinch-valve cams are coupled to the cam shaft. The first and
second pinch-valve cam followers each engage the first and second pinch-valve cams,
respectively. The plunger cam is coupled to the cam shaft. The r-cam follower engages
the plunger cam. The tube receiver is configured to receive a tube. The spring biased plunger
is coupled to the plunger-cam follower such that the expansion of the plunger cam along a
radial angle intersecting the plunger-cam follower as the cam shaft rotates pushes the plunger
cam er towards the plunger and thereby disengages the spring-biased plunger from the
tube. A spring coupled to the spring-biased r biases the spring-biased r to apply
the crushing force to the tube.
[0007a] In a particular embodiment, provided is a peristaltic pump, comprising: a cam
shaft having a plunger cam; a plunger-cam follower configured to engage the plunger cam to
follow the plunger cam and to disengage from the plunger cam, whereby the plunger-cam
follower does not follow the plunger cam when disengaged from the r cam; a tube
receiver configured to receive a tube; a spring-biased plunger coupled to the plunger-cam
er; a spring coupled to the spring-biased plunger, the spring configured to bias the springbiased
plunger toward the tube receiver; a position sensor operatively coupled to the springbiased
plunger, wherein the position sensor is configured to determine a position of the spring-
biased plunger when the plunger-cam follower is disengaged from the plunger cam and the
spring applies a force from the spring-biased plunger against the tube; and a processor d
to the position sensor to receive the position of the spring-biased plunger, n the sor
is configured to estimate fluid flow utilizing the position of the spring-biased plunger as
indicated by the position sensor when the plunger-cam follower is disengaged from the plunger
cam and the spring s the force from the spring-biased plunger against the tube.
In some embodiments, a slide occluder includes an RFID tag and the infusion
pump includes an RFID interrogator. A processor associated with (or in) the infusion pump
ogates the RFID tag to determine if the slide oclcuder is authorized for use. For example,
the RFID tag may have an tion key and/or ized identification value.
In some embodiments, a cam profile for an infusion pump may be shaped such
that rotation in any direction causes forward flow.
40 [0009] In some embodiments, an infusion pump may include a downstream e to
create a smooth fluid flow to the patient.
In some embodiments, the infusion pump may tically prime, e.g., the
tube may have an RFID tag and/or a barcode that may be read by the pump, which the pump
45 uses to estimate a priming volume of the downstream tube automatically (for fluid flow
estimation, etc.)
In some embodiments, an infusion pump includes a ive element that is
ssed against a tube. The infusion pump estimates the fluid pressure in accordance with
the resistance.
In some embodiments, the infusion pump includes a temperature sensor to
estimate the temperature of the fluid within the tube. The infusion pump may correct for the
temperature of the tube and/or fluid in its fluid flow calculation (e.g., the delta fluid
estimation described .
In some embodiments, a display on a pump UI will display instructions how
to install the slide occluder (e.g., when the ID in an RFID tag in an occluder is an
unauthorized ID, for e).
In some embodiments, an electronics module is attachable to an infusion
pump to control the pump. The electronics module may include an RF transceiver, a
battery, and a control component.
In some embodiment of the present disclosure, a peristaltic pump es a
cam shaft, first and second pinch—valve cams, first and second pinch—valve cam ers, a
plunger cam, a plunger—cam follower, a tube er, a spring—biased plunger, a position
sensor, and a processor. The first and second pinch—valve cams are operatively d to
the cam shaft. The first and second pinch—valve cam followers are configured to engage the
first and second pinch—valve cams. The plunger cam is coupled to the cam shaft. The
plunger—cam follower is configured to engage the plunger cam. The tube receiver is
configured to receive a tube. The spring—biased plunger is coupled to the plunger—cam
follower such that expansion of the plunger cam along a radial angle intersecting the
plunger—cam follower as the cam shaft rotates pushes the plunger cam to disengage the
spring—biased plunger from the tube. A spring is coupled to the spring—biased plunger to bias
the —biased plunger to apply the crushing force to the tube. The position sensor is
operatively coupled to the spring—biased plunger configured to determine a position of the
spring—biased plunger. The processor is coupled to the position sensor and is configured to
estimate fluid flow of fluid within the tube utilizing the position using the position sensor.
The pump may include an angle sensor operatively coupled to the cam shaft
ured to ine an angle of rotation of the cam shaft.
The processor ines the first static region by fying a peak
nt of the plunger as measured by the position sensor and identifies the second static
region to be after the identified peak. The processor may determine the first static region by
identifying the first static region within a predetermined range of angles as indicated by the
angle sensor. The processor may determine the second static region by identifying the
second static region within a second predetermined range of angles as indicated by the angle
sensor. The processor may determine the first and second static regions by measuring
position sensor at predetermined angles as indicated by the angle sensor.
The processor may compare a first static region measured by the position
sensor to a second static region measured by the position sensor to estimate the fluid flow.
The processor may determine the first static region by identifying a peak of the nt
of the position sensor and identifying the first static region after the identified peak. The
processor may determine the second static region by identifying an end of the first static
region.
In some embodiments, the pump also includes a balancer cam, a er-
cam follower, and a balancer spring configured to apply a force against the er—cam
follower and thereby apply a force from the balancer—cam follower to the balancer cam.
The er cam may be shaped to reduce a peak torque of the cam shaft as the cam shaft
rotates around its axis of rotation.
The pump may also include an electric motor operatively coupled to the cam
shaft to apply a rotational torque to the cam shaft. The electric motor may be a stepper
motor, a DC motor, a brushless DC motor, a brushed DC motor, an AC motor, a polyphase
induction motor, an ic motor with at least one permanent magnet coupled to a stator or
a rotor, and an induction motor.
In another embodiment of the present sure, a pump includes: a first
layer; and a second layer at least partially ed adjacent to the first layer ng an
inlet fluid path, a bubble chamber, and an outlet fluid path. The inlet fluid path is in fluid
communication with the bubble chamber and the outlet fluid path is in fluid communication
with the bubble chamber. The pump also includes an assembly having a variable—volume
chamber, a reference chamber, and an acoustic port in ive communication with the
variable—volume and reference chambers such that the variable—volume chamber includes an
opening disposed around the bubble chamber on at least one of the first and a second layers.
The pump may include a plunger positioned to engage the bubble chamber.
The pump may include source of pressure and a fluid port coupled to the
reference chamber such that the source of pressure is in fluid communication with the fluid
port to apply at least one of a negative pressure and a positive pressure thereto.
In some embodiments, the pump also includes: (1) a reference r
disposed within the reference chamber; a reference microphone disposed within the
reference chamber; and a variable—volume microphone disposed within the variable—volume
chamber.
The pump may include a processor in operative ication with the
reference speaker, and the reference and variable—volume microphones. The processor may
be ured to control the speaker to te a plurality of frequencies and sense the
frequencies through the reference and le—volume microphones to estimate a volume of
the variable volume using the sensed ncies from the reference and variable-volume
hones. The processor may be further configured to estimate a flow rate of the pump
using the estimated volume of the variable volume.
[0026] In another embodiment of the present disclosure, a flow rate meter includes:
(1) a first layer; (2) a second layer at least partially disposed adjacent to the first
layer defining an inlet fluid path, a bubble chamber, and an outlet fluid path, wherein the
inlet fluid path is in fluid communication with the bubble chamber and the outlet fluid path
is in fluid communication with the bubble chamber; (3) an assembly having a variable—
volume chamber, a reference chamber, and an acoustic port in operative communication
with the variable—volume and reference chambers, wherein the variable—volume chamber
includes an opening disposed around the bubble chamber on at least one of the first and a
second ; (4) a reference speaker disposed within the reference chamber; (5) a
reference hone disposed within the reference chamber; (6) a variable—volume
microphone disposed within the variable—volume chamber; and (7) a processor in operative
communication with the reference speaker, and the reference and variable—volume
microphones. The processor is configured to control the speaker to generate a plurality of
ncies and sense the frequencies through the reference and variable—volume
microphones. The processor is further ured to te a volume of the variable
volume using the sensed frequencies from the reference and variable—volume microphones.
The processor is further configured to estimate a flow rate using the estimated volume of the
variable volume.
In yet another embodiment of the present disclosure, a peristaltic pump
es a housing a motor, a cam shaft, a plunger, a pivot shaft, a plunger, a bias member,
a position sensor, and a processor. The cam shaft is operatively coupled to the motor such
that rotation of the motor s the cam shaft. The plunger cam is d to the cam shaft
for rotation therewith. The pivot shaft is operatively coupled to the housing. The plunger is
pivotally coupled to the pivot shaft, the plunger having a cam follower configured to engage
the plunger cam of the cam shaft. The plunger is configured to pivot to a first position to
compress a tube and to a second position away from the tube. The bias member is
configured to bias the plunger to the first position to compress the tube. The position sensor
coupled to the plunger to measure a position of the plunger. The processor is coupled to the
position sensor to estimate a volume of fluid discharged from the tube when the bias
member causes the plunger to move towards the first position.
The plunger and plunger cam may be configured to compress the tube using
only a force of the bias member. The plunger cam may be ured to only retract the
plunger to the second position. The plunger may be configured to engage the plunger cam
such that the plunger cam does not force the plunger against the tube. The plunger may be
any suitable shape, such as an L—shape or a U—shape, among other shapes.
The pump may further e an inlet valve and an outlet valve. The inlet
valve, the outlet valve, the plunger and the plunger cam may be configured to compress the
tube while the inlet and outlet valves are closed such that the processor can measure a first
position of the plunger using the position sensor. The inlet valve, the outlet valve, the
plunger and the r cam may be configured to open the outlet valve after the first
on of the plunger is measured to discharge fluid out of the tube through the outlet
valve. The processor may be configured to measure a second position of the r using
the position sensor after the outlet valve is opened. The processor may compare the first
measured position to the second ed position to determine an amount of fluid
discharged through the outlet valve. The inlet valve and the outlet value may be spring
biased against the tube.
The inlet valve may include an inlet—valve cam follower configured to
interface an valve cam coupled to the cam shaft. The outlet valve may include an
outlet—valve cam follower configured to interface an outlet—valve cam coupled to the cam
shaft.
In another embodiment of the present disclosure, a pump includes a housing,
a door, a carrier, and a lever. The g has a first slot. The door is pivotally coupled to
the housing and has a platen configured to receive a tube. The door is configured to have a
closed position and an open position. The door includes a second slot. The r has a
pivot defining first and second portions lly coupled together. The first n is
gly disposed within the first slot of the housing, and the second portion is slidingly
disposed within the second slot of door. The lever handle is pivotally coupled to the door
and is operatively coupled to the carrier.
In some embodiments, when the door is open, the first portion of the carrier
is disposed within the first slot and the second n of the carrier is disposed within the
second slot, and the first and second portions of the carrier are disposed orthogonal to each
other away from a pivot point when the door is open.
The peristaltic pump may be configured such that when the door is shut, the
first and second portions of the carrier are positioned adjacent to each other such that the
carrier is slidable within the first and second slots as the lever handle moves.
[0034] The second portion may be ured to e a slide occluder coupled to
the tube in the occluded position when the door is in the open position. The door and lever
handle may be configured such that when the door is in the closed position, movement of
the lever handle moves the first and second portions of the carrier towards the first slot to
thereby move the slide occluder into the unoccluded position.
[0035] In some embodiments, a r is configured to compress the tube in the
platen when the door is . The lever handle is operatively d to the r to lift
the plunger away from the tube when the lever handle is in an open position and to actuate
the plunger towards the tube when the lever handle is in a closed position.
The second portion may be configured to receive a slide occluder coupled to
the tube in the occluded position when the door is in the open position. In some
embodiments, the door may includes a leaf spring such that the door is configured to latch
onto the housing when the door is in the closed position and the lever handle is pivoted
against the door such that the leaf spring compresses the door against the housing.
In some onal embodiment, a pump includes: (1) a motor means for
rotating; (2) a cam means coupled to the motor means for rotating; (3) a plunger means for
compressing against a tube; and (4) a volume measurement means for estimating a volume
of fluid discharged through the tube.
BRIEF DESCRIPTION OF THE DRAWINGS
[0038] These and other s will become more apparent from the following
detailed description of the various embodiments of the present disclosure with nce to
the drawings wherein:
Fig. 1 shows block diagram of a system for infusing liquid in accordance
with an embodiment of the present disclosure;
Fig. 2 shows a block diagram of an on site monitor of the system of
Fig. l in accordance with an embodiment of the present sure;
Fig. 3 shows a block diagram of a pump for infusing liquid of the system of
Fig. 1 in accordance with an ment of the present disclosure;
Fig. 4 shows a drip-chamber holder receiving a drip chamber, and the drip-
chamber holder includes a flow meter and a free-flow detector in accordance with an
embodiment of the present disclosure;
[0043] Fig. 5 shows the drip—chamber holder of Fig. 4 with the door open in
accordance with an embodiment of the present disclosure;
Fig. 6 shows a block diagram of another drip—chamber holder in accordance
with another embodiment of the present disclosure;
Fig. 7 shows a ray diagram illustrating the diameter of a blur circle to
illustrate aspects of the cameras of the drip—chamber holder of Figs. 4 and 5 in accordance
with an ment of the present disclosure;
Fig. 8 is a graphic illustrating the blur circle as calculated for a y of
o—focal plane separations and lens—to—image separations for the cameras of the drip—
chamber holder of Figs. 4 and 5 in accordance with an embodiment of the t
sure;
Fig. 9 is a graphic illustrating the blur circle divided by pixel size when a 20
millimeter focal length lens of the cameras of the drip—chamber holder of Figs. 4 and 5 is
used in ance with an embodiment of the present disclosure;
Fig. 10 is a graphic illustrating the blur circle divided by pixel size when a
40 millimeter focal length lens of the cameras of the drip—chamber holder of Figs. 4 and 5 is
used in accordance with an embodiment of the present disclosure;
Fig. 11 shows a table illustrating the corresponding fields of view about the
optical axis for the comers of the two configurations of Figs. 9 and 10 in accordance with an
embodiment of the present disclosure;
[0050] Fig. 12 is a block diagram of an imaging system of the cameras of the drip—
r holder of Figs. 4 and 5 in accordance with an embodiment of the present
disclosure;
Fig. 13 is a graphic illustration of an image captured by the camera of the
system of Fig. 12 in accordance with an embodiment of the present disclosure;
Fig. 14 is a block diagram of an imaging system of the cameras of the drip—
chamber holder of Figs. 4 and 5 in accordance with an embodiment of the present
sure;
Fig. 15 is a graphic illustration of an image captured by the camera of Fig. 14
when a free flow condition exists in ance with an ment of the present
disclosure;
Fig. 16 is a graphic illustration of an image captured by the camera of Fig. 14
for use as a background image in accordance with an embodiment of the present disclosure;
Fig. 17 is a graphic illustration of an image ed by the camera when
drops are being formed within the drip chamber of Fig. 14 in accordance with an
ment of the present disclosure;
Fig. 18 is a graphic illustration of an image captured by the camera of Fig. 14
for use as a background image in accordance with an embodiment of the present disclosure;
Fig. 19 is a graphic ration of a difference between the images of Figs.
17 and 18 with additional processing in accordance with an embodiment of the present
disclosure;
Fig. 20 is a graphic representation of the image processing performed using
Figs. 17—19 to determine if a free flow condition exists in accordance with an embodiment
of the present disclosure;
Fig. 21 is a graphic illustration of an image captured by the camera when a
free flow condition exists thereby forming a stream within the drip chamber of Fig. 14 in
accordance with an embodiment of the present disclosure;
[0060] Fig. 22 is a graphic illustration of an image ed by the camera of Fig. 14
for use as a background image in accordance with an embodiment of the present sure;
Fig. 23 is a graphic illustration of a difference n the images of Figs.
and 21 with some additional processing for use in detecting a free flow condition in
accordance with an embodiment of the present disclosure;
[0062] Fig. 24 is a graphic representation of the image processing performed using
Figs. 21—23 to determine if a free flow condition exists in accordance with an embodiment
of the t disclosure;
Fig. 25 illustrates a template for pattern matching to determine if a free flow
condition exits using Figs. 17—19 or Figs. 21—23 in accordance with an embodiment of the
present disclosure;
Fig. 26 is a graphic illustration of a ence n a nce image and
an image containing a steam processed with edge detection and line detection for use in
detecting a free flow condition in accordance with an embodiment of the present disclosure;
Fig. 27 is a graphic illustration of an image captured by the camera when a
free flow condition exists thereby forming a stream within the drip chamber of Fig. 14 in
accordance with an embodiment of the present disclosure;
[0066] Fig. 28 is a block diagram of an g system for use with the drip—
chamber holder of Figs. 4—5 or Fig. 6 having a back pattern with stripes and a light source
shining on the stripes from an adjacent location to a camera in ance with an
embodiment of the present disclosure;
Fig. 29 is a block diagram of an imaging system for use with the drip—
chamber holder of Figs. 4—5 or Fig. 6 having a back pattern with stripes and a light source
shining on the stripes from behind the back pattern relative to an opposite end to a camera in
accordance with an embodiment of the t disclosure;
Fig. 30 shows an image from the camera of Fig. 29 when a drop distorts the
back pattern of Fig. 26 in accordance with an embodiment of the present disclosure;
[0069] Fig. 31 is a block diagram of an imaging system for use with the drip—
chamber holder of Figs. 4—5 or Fig. 6 having a back pattern with a checkerboard pattern and
a light source shining on the s from behind the back pattern relative to an opposite end
to a camera in accordance with an embodiment of the present disclosure;
Fig. 32 shows an image from the camera of Fig. 31 when a drop ts the
back pattern of Fig. 26 in accordance with an embodiment of the present disclosure;
Fig. 33 shows a block diagram of an air detector using a camera in
accordance with an embodiment of the present disclosure;
Fig. 34 shows a matching template for use in air detection in accordance with
an embodiment of the present disclosure;
[0073] Fig. 35 illustrates an image captured by the camera of system of Fig. 33 for
detecting that no tube is within a cavity in ance with an ment of the present
disclosure;
Fig. 36 illustrates an image ed by the camera of the system of Fig. 33
for detecting air s in accordance with an embodiment of the present disclosure;
Fig. 37 illustrates an image captured by the camera of the system of Fig. 33
for detecting blood in accordance with an ment of the present disclosure;
Fig. 38 illustrates the image of Fig. 37 that has undergone image processing
for detecting a threshold amount of red for detecting blood in accordance with an
embodiment of the present disclosure;
Fig. 39 shows an infiltration detector in accordance with an embodiment of
the present disclosure;
[0078] Fig. 40 shows a graphic illustrating the optical tion of oxygenated and
de—oxygenated obin in accordance with an embodiment of the present disclosure;
Fig. 41 shows another infiltration detector in accordance with another
embodiment of the present disclosure;
Fig. 42 shows a perspective view of an occluder in accordance to an
embodiment of the present disclosure;
Fig. 43 shows a side view of the occluder of Fig. 42 in accordance to an
embodiment of the present sure;
Fig. 44 shows a side view of the occluder of Fig. 42 in operation in
ance to an embodiment of the present disclosure;
[0083] Fig. 45 shows a side view of a valve for use in a cassette in accordance with
an embodiment of the present disclosure;
Fig. 46 shows a top view of the valve of Fig. 45 in accordance with an
embodiment of the present disclosure;
Fig. 47 shows another side view of the valve of Fig. 45 led within a
cassette in accordance with an embodiment of the present disclosure;
Fig. 48 shows a sliding valve having an inclined plane to e sealing in
accordance with an embodiment of the present disclosure;
Fig. 49 shows a side view of the sliding valve of Fig. 48 in accordance with
an embodiment of the present disclosure;
[0088] Fig. 50 shows the mount of the g valve of Figs. 48—49 in accordance
with an embodiment of the present disclosure;
Figs. 51—55 show a vent for a reservoir in accordance with an embodiment of
the present disclosure;
Figs. 56—58 illustrate the stages of a flow meter in accordance with an
embodiment of the t disclosure;
Fig. 59 shows a diagram of a able portion of a flow meter in
accordance with an embodiment of the present disclosure;
Figs. 60-62 show several views of a single—sided disposable portion of a flow
meter in accordance with an embodiment of the present disclosure;
Figs. 63-65 show several views of a double-sided disposable portion of a
flow meter in accordance with an embodiment of the present disclosure;
Figs. 66-68 show several views of a layer, opposite-sided, disposable
portion of a flow meter in accordance with an embodiment of the t sure;
Fig. 69 shows a top view of another disposable portion of a flow meter in
accordance with r embodiment of the present disclosure;
Fig. 70 shows a flow rate meter including a full acoustic volume sensing
(“AVS”) clam shell assembly and a single—sided disposable portion in accordance with an
embodiment of the present disclosure;
Fig. 71 shows a side view of flow rate meter including a double—sided AVS
assembly with integral perimeter seal valves in accordance with an embodiment of the
present sure;
Fig. 72 shows a side view of another flow rate meter including a single—sided
AVS assembly with surrounding AVS chambers in accordance with r embodiment of
the present disclosure;
Fig. 73 shows a side view of yet another flow rate meter ing two piston
valves in ance with another embodiment of the present disclosure;
Fig. 74 shows a flow rate meter having top and bottom AVS assemblies
which provide a semi-continuous flow in accordance with an embodiment of the present
sure;
Fig. 75 shows a flow rate meter having two in-line AVS assemblies in
accordance with an embodiment of the present disclosure;
Fig. 76 shows a membrane pump having a negative pressure source in
accordance with an embodiment of the present disclosure;
Fig. 77 shows a membrane pump having negative and positive pressure
sources in accordance with an embodiment of the present disclosure;
Fig. 78 shows a optical—sensor based flow rate meter in accordance with an
embodiment of the present disclosure;
Fig. 79 shows a pressure—controlled membrane pump in accordance with an
embodiment of the present disclosure;
] Figs. 80-82 show a diagram of a legend for use in conjunction with Figs. 79
and 83—98 in accordance with an embodiment of the present disclosure;
] Fig. 83 shows a flow-controlled membrane pump in accordance with an
embodiment of the present disclosure;
] Fig. 84 shows a state diagram of the operation of the flow-controlled
membrane pump of Fig. 83 in accordance with an embodiment of the present sure;
Fig. 85 shows the flow—controlled membrane pump of Fig. 83 illustrating the
operation of the valves when in the Idle state of the state diagram of Fig. 84 in accordance
with an embodiment of the present disclosure;
] Fig. 86 shows a more detailed View of the idle state of the state diagram of
Fig. 84 in accordance with an embodiment of the present disclosure;
Figs. 87—88 show the flow—controlled membrane pump of Fig. 83 in use
during the positive pressure valve leak test state of Fig. 84 in accordance with an
embodiment of the present sure;
Fig. 89 shows a more detailed view of the positive pressure valve leak test
state of Fig. 84 in accordance with an embodiment of the present disclosure;
Figs. 90—91 show the flow—controlled membrane pump of Fig. 83 in use
during the negative re valve leak test state of Fig. 84 in accordance with an
embodiment of the present disclosure;
Fig. 92 shows a more ed view of the ve pressure valve leak test
state of Fig. 84 in accordance with an embodiment of the present disclosure;
Fig. 93 shows the flow-controlled membrane pump of Fig. 83 in use during
the fill state of Fig. 84 in accordance with an embodiment of the present disclosure;
Fig. 94 shows a more detailed View of the fill state of Fig. 84 in accordance
with an embodiment of the present disclosure;
[00117] Fig. 95 shows the flow—controlled membrane pump of Fig. 83 in use during
an AVS measurement in accordance with an embodiment of the present disclosure;
Fig. 96 shows a more ed View of the AVS ement state of Fig. 84
in accordance with an embodiment of the present disclosure;
] Fig. 97 shows the flow—controlled membrane pump of Fig. 83 in use during
the emptying state of Fig. 84 in accordance with an embodiment of the present disclosure;
Fig. 98 shows a more ed view of the emptying state of Fig. 84 in
accordance with an embodiment of the present disclosure;
Fig. 99 shows a membrane pump having an elastic membrane that is flush
with a disposable portion and applies a force to a liquid in accordance with an embodiment
of the t disclosure;
Figs. 100-101 show two embodiments of lung pumps in accordance with
embodiments of the present disclosure;
[00123] Figs. 102—104 show several gaskets for sealing a lung pump in accordance
with onal embodiments of the present disclosure;
Fig. 105 shows another lung pump in accordance with r embodiment
of the present disclosure;
Figs. 106—112 illustrate the operation of a piston pump while performing
various checks in accordance with an embodiment of the present disclosure;
Figs. 113 and 114 illustrate a piston pump in accordance with another
embodiment of the t disclosure;
Figs. 115 and 116 show two views of a cassette having several membrane
pumps of Figs. 113 and 114 in accordance with an embodiment of the present disclosure;
[00128] Fig. 117 shows a cassette having a ne pump and volcano valves in
accordance with an embodiment of the present disclosure;
Fig. 118 shows a roller mechanism of a cassette—based pump in accordance
with an embodiment of the present disclosure;
Fig. 119 shows the fluid paths of a cassette—based pump for use with the
roller mechanism of Fig. 118 in accordance with an embodiment of the present disclosure;
Fig. 120 shows the fluid paths of a cassette-based pump for use with the
roller mechanism of Fig. 118 in ance with an embodiment of the present sure;
] Fig. 121 shows the stages of an infiltration test using a roller in ance
with an embodiment of the present disclosure;
[00133] Fig. 122 shows the stages of an infiltration test using a piston in accordance
with an embodiment of the present disclosure;
Figs. 123 and 124 show a cell—base reservoir in ance with an
embodiment of the present disclosure;
] Figs. 125 and 126 show a tube-based reservoir in accordance with an
embodiment of the present disclosure;
Fig. 127 shows several stages illustrating a method for ing a plunger
pump in conjunction with an AVS assembly in accordance with an embodiment of the
present sure;
Fig. 128 shows several stages illustrating a method for operating a plunger
pump in conjunction with an AVS assembly in accordance with another embodiment of the
present sure;
Fig. 129 shows several stages illustrating a method for using a plunger pump
having an AVS assembly in accordance with an embodiment of the present disclosure;
Fig. 130 shows several stages illustrating a method for using a plunger pump
having an AVS assembly in accordance with an embodiment of the present disclosure;
Fig. 131 shows several stages illustrating a method for using a plunger pump
having an AVS assembly in ance with an embodiment of the present disclosure;
[00141] Fig. 132 shows a plunger pump with an actuator inside the variable volume
for use with a standard IV set tubing in accordance with an embodiment of the present
disclosure;
Fig. 133 shows l views of a cam—driven linear altic pump having
pinch valves and a plunger inside a variable volume in accordance with an embodiment of
the present disclosure;
Fig. 134 shows a plunger pump for use within a standard IV set tubing with
an actuator outside of the variable volume in accordance with an embodiment of the present
disclosure;
Fig. 135 shows several views of a iven linear peristaltic pump having
pinch valves and a plunger inside a variable volume with a corresponding cam mechanism
outside of the variable volume in accordance with an embodiment of the present disclosure;
Fig. 136 shows a plunger pump having a plunger inside a variable volume
with an actuator outside of the variable volume in accordance with an embodiment of the
present disclosure;
[00146] Fig. 137 shows a cam—driven linear peristaltic pump having a r inside
a variable volume with a corresponding cam mechanism outside of the variable volume and
pinch valves on the housing of the variable volume in accordance with an embodiment of
the present disclosure;
Fig. 138 shows a plunger pump having a plunger inside a variable volume
and pinch valves outside of the variable volume in accordance with an embodiment of the
present disclosure;
Fig. 139 shows several views of a cam—driven linear peristaltic pump having
a plunger inside a variable volume with a corresponding cam mechanism and pinch valves
outside of the variable volume in accordance with an embodiment of the present disclosure;
Fig. 140 rates occlusion detection using a plunger pump having an AVS
assembly and a spring-biased pinching mechanism inside the variable volume in accordance
with an embodiment of the present disclosure;
[00150] Fig. 141 shows a pump with a spring—loaded plunger within a variable
volume of an AVS ly with an actuated plunger outside of the variable volume in
accordance with an embodiment of the present disclosure;
Fig. 142 shows a linear peristaltic pump with pinch valves and a cam shaft
disposed within a variable volume of an AVS assembly having spring—biased pinching
ism disposed therein, and a plunger and a pinch valve outside of the variable volume
in ance with an embodiment of the present sure;
Fig. 143 shows a linear peristaltic pump with pinch valves and a plunger
ed outside of a variable volume of an AVS assembly in ance with an
embodiment of the present disclosure;
] Fig. 144 shows a the stages of a plunger pump having a an optical sensor or
camera to measure the volume within a tube residing within a chamber in accordance with
an embodiment of the present disclosure ;
Fig. 145 shows a plunger pump having a r having an optical sensor to
estimate fluid volume of a tube having a spring—biased pinch mechanism around the tube
and a plunger and pinch valves in ance with an embodiment of the present disclosure;
Fig. 146 shows a plunger pump having a chamber with an l sensor to
estimate fluid volume of a tube having a spring-biased pinch mechanism around the tube
and a plunger and pinch valves outside the chamber in accordance with an embodiment of
the present disclosure;
[00156] Fig. 147 shows several views of a plunger pump having an AVS assembly
with pinch valve disposed within the variable volume of the AVS assembly, and a plunger
and pinch valve disposed outside the variable volume in accordance with an ment of
the present disclosure;
Fig. 148 shows an two cross—sectional views of the plunger pump of Fig. 147
in accordance with an embodiment of the present disclosure;
] Fig. 149 shows an alternative two cross—sectional views of the r pump
of Fig. 147 in accordance with an embodiment of the present sure;
Fig. 150 illustrates the stages during normal operation of a r pump
having a spring-biased r in accordance with an embodiment of the present disclosure;
Fig. 151 illustrates the stages for detecting an occlusion for a plunger pump
having a spring-biased plunger in accordance with an embodiment of the present disclosure;
Fig. 152 illustrates the stages for leakage detection for a plunger pump
having a spring—biased plunger in accordance with an embodiment of the present disclosure;
Fig. 153 illustrates the stages for detecting a failed valve and/or bubble
dection for a plunger pump having a spring—biased plunger in accordance with an
embodiment of the present disclosure;
Fig. 154 illustrates the stages for empty reservoir detection and/or upstream
occlusion detection for a plunger pump having a —biased plunger in accordance with
an embodiment of the present disclosure;
Fig. 155 illustrates the stages for ow prevention for a r pump
having a spring—biased plunger in accordance with an embodiment of the present disclosure;
Fig. 156 illustrates the stages for a negative pressure valve check for a
plunger pump having a spring—biased plunger in ance with an ment of the
present disclosure;
] Figs. 157—158 show views of a r pump having a cam shaft 671 that
traverses the variable volume of an AVS assembly in accordance with an ment of
the present disclosure;
[00167] Figs. 2 illustrate several cam profiles in accordance with several
embodiments of the present disclosure;
Fig. 163 illustrates a peristaltic pump having a plunger and a pinch valves
outside of an AVS chamber with two pinch valves on the interface of the ACS chamber in
accordance with an embodiment of the present disclosure;
[00169] Fig. 164 illustrates several stages of operation of the peristaltic pump of Fig.
163 in accordance with an embodiment of the present disclosure;
Fig. 165 illustrates a peristaltic pump having two plungers external to an
AVS chamber in accordance with an embodiment of the present disclosure;
Fig. 166 illustrate several stages of the peristaltic pump of Fig. 165 in
accordance with an embodiment of the present disclosure;
Fig. 167 illustrates a peristaltic pump having a plunger with a linear sensor in
accordance with an embodiment of the t disclosure;
Fig. 168 illustrates a graphic of data from the linear sensor of the peristaltic
pump of Fig. 167 in accordance with an embodiment of the present disclosure;
Fig. 169 illustrates the stages of the peristaltic pump of Fig. 169 in
accordance with an embodiment of the present disclosure;
Fig. 170 illustrates the detection of an ion condition vis-a-vis a non-
occluded condition in accordance with an embodiment of the present disclosure;
Fig. 171 illustrates the detection of a valve leak vis—a—vis a full—valve—sealing
ion in accordance with an embodiment of the present disclosure;
Fig. 172 illustrates the detection of a too much air in the tube or a valve fail
vis a proper operation in accordance with an embodiment of the present disclosure;
[00178] Fig. 173 shows a block diagram that illustrates the electronics of a peristaltic
pump in accordance with another embodiment of the present disclosure;
Fig. 174 shows a block diagram that illustrates the onics of a peristaltic
pump in accordance with another embodiment of the t disclosure;
Fig. 175 shows a perspective view of peristaltic pump in accordance with an
embodiment of the present disclosure;
Figs. 176—180 show data from several AVS sweeps in accordance with an
embodiment of the t disclosure;
Figs. 3 show several side views of a cam mechanism of the peristaltic
pump of Fig. 175 in accordance with an embodiment of the present disclosure;
[00183] Fig. 184 shows a nal view of the pinch valves and plunger of the
peristaltic pump of Fig. 175 in accordance with an embodiment of the present disclosure;
Fig. 185 show two views of a r with flexible fingers to grip a tube in
accordance with an embodiment of the present disclosure;
Fig. 186 shows an embodiment of a cam mechanism of a peristaltic pump in
accordance with an embodiment of the present disclosure;
Fig. 187 shows an embodiment of a cam ism of a altic pump in
accordance with an embodiment of the t disclosure;
Figs. 188—190 show several views of a peristaltic pump in accordance with
the present disclosure;
Figs. 5 show several views of a peristaltic pump in accordance with
an onal embodiment of the present sure;
Figs. 196A-196B illustrate torque on a cam shaft of a peristaltic pump in
accordance with an ment of the present disclosure;
Fig. 197 illustrates a cam e for several cams for a peristaltic pump in
accordance with an embodiment of the present disclosure;
Fig. 198 shows various feedback modes of a peristaltic pumps in accordance
with an ment of the present disclosure;
Fig. 199 shows a graph illustrating data of a linear sensor used to estimate
fluid flow in accordance with an embodiment of the present disclosure;
Figs. 6 show several perspective views of a peristaltic pump having a
angular members interfacing into a cam in accordance with an embodiment of the present
disclosure;
] Figs. 207—221 illustrate the operation of a slide occluder of the peristaltic
pump of Figs. 200—206 in accordance with an embodiment of the present disclosure;
Fig. 222—223 shows a two views of a peristaltic pump in accordance with an
embodiment of the present disclosure;
[00196] Figs. 224—238 shows several views of the peristaltic pump of Figs. 222—223
rating the operation of the slide occluder in accordance with an embodiment of the
present disclosure;
Figs. 239—245 show several view of the peristaltic pump of Figs. 222—238 in
accordance with an embodiment of the present disclosure;
[00198] Figs. 246-250 show several views of an integrated cam and motor in for use
in an peristaltic pump disclosed herein in accordance with another embodiment of the
t disclosure;
Figs. 251-254 illustrate a camera sensor for use for ing the position of
a plunger and pinch valves of a peristaltic pump in accordance with an embodiment of the
present disclosure;
Fig. 255 illustrates a peristaltic pump having L—shaped cam followers in an
exploded View of the mechanical elements from the top of the pump;
Fig. 256 illustrates the altic pump having L—shaped cam followers in an
exploded view of the mechanical elements from the bottom of the pump;
Fig. 257 illustrates the peristaltic pump having L—shaped cam followers with
a door open in an isometric view of the mechanical elements from the top of the pump;
Fig. 258 illustrates the peristaltic pump having L—shaped cam followers in an
exploded view showing the PCB, pump body, door, and a motor with a gear head;
Fig. 259 illustrates the slide occluder inserted into the open door of the
peristaltic pump having L-shaped cam ers;
Fig. 260 illustrates the peristaltic pump having L-shaped cam followers with
the door open and some elements removed to reveal the cam—shaft, pump and valves;
Fig. 261 illustrates the insertion of the slide er into the open door of
the peristaltic pump having L—shaped cam followers;
Figs. 262—263 shows an ative door with the door half of an alternative
split carriage;
[00208] Fig. 264 illustrates the door, a lever and a slide carriage of the peristaltic
pump having L—shaped cam followers in an exploded view;
Fig. 265 illustrates the peristaltic pump having L—shaped cam followers with
the door open in an isometric view of the mechanical elements from the bottom of the
pump;
[00210] Fig. 266 illustrates a cam—shaft of the peristaltic pump having L—shaped cam
ers in an isometric view;
] Fig. 267 illustrates the plunger cam follower of the peristaltic pump having
L—shaped cam followers in an isometric view from the front;
Fig. 268 illustrates the plunger cam follower of the peristaltic pump having
L—shaped cam followers in an isometric view from the back;
Fig. 269 illustrates the valve cam follower of the peristaltic pump having L-
shaped cam followers in an isometric view from a first side;
Fig. 270 illustrates the valve cam er of the peristaltic pump having L-
shaped cam followers in an isometric view from a second side;
[00215] Fig. 271 illustrates a outlet cam of the altic pump having L—shaped cam
followers in an orthographic view;
] Fig. 272 rates a pump cam of the peristaltic pump having L—shaped cam
followers in an orthographic view;
Fig. 273 illustrates a intake cam of the peristaltic pump having L—shaped cam
followers in an raphic view;
Fig. 274 illustrates the plunger and valve cam followers of the peristaltic
pump having L—shaped cam followers in an exploded View;
Fig. 275 illustrates retainers for the springs on the cam followers of the
peristaltic pump having L—shaped cam followers in an isometric view;
Fig. 276 shows a cross-section of the pump including sections of the cam,
plunger and platen;
Fig. 277 shows a cross-sectional View of the plunger ssing the
on tube against the platen;
Fig. 278 illustrates the housing, cam shaft and cam followers of the
peristaltic pump having ed cam followers in an exploded view;
Fig. 279 illustrates the upper and lower housing of the peristaltic pump
having L—shaped cam followers in an ric View;
[00224] Fig. 280 illustrates the assembled upper and lower housing of the peristaltic
pump having L—shaped cam followers in isometric views
Fig. 281 illustrates the assembled upper and lower housing of the peristaltic
pump having L—shaped cam followers in ric views
Fig. 282 illustrates the peristaltic pump having L—shaped cam followers with
PCB removed to reveal magnets on the plunger and corresponding sensors on PCB;
] Fig. 283 rates the insertion of the slide occluder into the open door of
the peristaltic pump having ed cam followers;
Figs. 284 illustrates the slide occluder inserted into the open door of the
peristaltic pump having L-shaped cam ers;
[00229] Figs. 285 illustrates the split—carriage in the open position;
] Figs. 286 illustrates the split-carriage in the closed position;
Fig. 287 illustrates the peristaltic pump having L-shaped cam followers with
the door partially closed and some elements removed to reveal the slide occluder in the
closed split—carriage;
[00232] Fig. 288 illustrates the multi—part link between the split carriage and the lever
in an isometric view;
Fig. 289 illustrates the peristaltic pump having L—shaped cam followers with
the door closed and some elements removed to reveal the slide occluder in the closed split—
carriage;
Figs. 290—293 illustrate four steps of closing the door of the peristaltic pump
having L—shaped cam followers;
Fig. 294 illustrates a lever on the door engaging a pin on the body of the
peristaltic pump having L—shaped cam followers;
Fig. 295 illustrates a spring t in the door of the peristaltic pump
having ed cam followers;
[00237] Fig. 296 illustrates two latch hooks of the lever on the door of the peristaltic
pump having ed cam ers;
Fig. 297 shows a vertical cross—sectional view of the peristaltic pump with L—
shaped cam followers;
Fig. 298 shows a ntal cross—sectional view of the peristaltic pump with
ed cam followers;
Fig. 299 illustrates a spring—pin engaging a detent on the lever latch hook in
the closed position within the door of the peristaltic pump having L—shaped cam followers;
Fig. 300 illustrates a spring—pin engaging a detent on the lever latch hook in
the open position within the door of the peristaltic pump having L—shaped cam followers;
[00242] Fig. 301 rates a slide—occluder detection lever displaced by the slide
occluder when the door is on the peristaltic pump having L—shaped cam followers;
] Fig. 302 illustrates a latch hook detection lever displaced by the latch hook
when the door is on the peristaltic pump having ed cam followers;
FIGS. 303-306 show l views of a patient bedside system in
accordance with an embodiment of the present disclosure;
7 shows a close—up view of a portion of an interface of a clamp that is
attachable to a pump shown in FIGS. 303-306 in accordance with an embodiment of the
present disclosure;
8 shows another close—up View of another portion of the interface
shown in 1 in accordance with an embodiment of the present sure;
9 shows a perspective view of a pump shown in FIGS. 303—306 in
accordance with an embodiment of the present disclosure;
0 shows a perspective view of a pump shown in FIGS. 303—306 in
accordance with an embodiment of the present disclosure;
1 shows a perspective view of a pump with the graphic user interface
shown on the screen in accordance with an embodiment of the t disclosure;
2 shows an example infusion programming screen of the graphic user
interface in accordance with an embodiment of the present disclosure;
3 shows an example infusion programming screen of the graphic user
interface in ance with an embodiment of the present disclosure;
4 shows an e on programming screen of the graphic user
ace in accordance with an embodiment of the present disclosure;
5 shows an example infusion programming screen of the graphic user
interface in accordance with an embodiment of the present disclosure;
] 6 shows an example infusion programming screen of the graphic user
interface in accordance with an embodiment of the present disclosure;
] 7 shows an infusion rate over time graphical representation of an
example infusion in accordance with an embodiment of the present disclosure;
8 shows an infusion rate over time graphical representation of an
example infusion in accordance with an embodiment of the present sure;
9 shows an infusion rate over time graphical representation of an
example infusion in ance with an embodiment of the present disclosure;
0 shows an infusion rate over time graphical representation of an
example infusion in accordance with an embodiment of the present disclosure;
1 shows an infusion rate over time graphical representation of an
e infusion in accordance with an ment of the present disclosure;
[00260] 2 shows an e drug administration library screen of the graphic
user interface in accordance with an embodiment of the present disclosure;
Fig. 323 shows a schematic of a battery powered draw speaker;
Fig. 324 illustrates an electrical block diagram of peristaltic pump in
accordance with an embodiment of the present sure;
[00263] Fig. 325A—325G illustrates a detailed ical block diagram of peristaltic
pump in accordance with an embodiment of the present disclosure;
Fig. 326 presents a linear encoder signal over cam angle graph in accordance
with an embodiment of the present disclosure;
Fig. 327 illustrates a volume over time graph in accordance with an
embodiment of the present sure;
Fig. 328 illustrates a cam shaft angle over volume graph in accordance with
an embodiment of the present disclosure;
Fig. 329 illustrates a possible measured pressure vs. time trace of a ry
line downstream of peristaltic pump in accordance with an embodiment of the present
disclosure;
Fig. 330 is a state diagram in accordance with an embodiment of the present
disclosure;
[00269] Fig. 331 is a software block diagram in ance with an ment of
the present disclosure;
Fig. 332 is a software block diagram in ance with an ment of
the present disclosure;
Fig. 333 shows a feedback based control loop to control a motor of an
infusion pump in accordance with an embodiment of the present disclosure;
Fig. 334 shows a process diagram to illustrate the software operation of an
infusion pump in accordance with an embodiment of the present disclosure; and
Figs. 335—336 shows two dual-band antennas for use with an infusion pump
in accordance with an ment of the present disclosure.
DETAILED DESCRIPTION
Fig. 1 shows a block m of a system 1 for ng fluid. System 1
includes fluid reservoirs 2, 3, and 4 for infusing the fluid contained therein into a patient 5.
The fluid reservoirs 2, 3, and 4 are gravity fed into drip chambers 7, 8, and 9, respectively.
The drip chambers 7, 8, and 8 are tively fed into flow meters 10, 11, and 12. From
the flow meters 10, 11, and 12, the fluid is fed into free—flow detectors 13, 14, and 15,
respectively.
System 1 also includes valves 16, 17, and 18 from a respective ow
detector of the free—flow detectors 13, 14, and 15. Pumps 19, 20, and 21 receive fluid from
valves 16, 17, and 18, and combine the fluid using a connector 22. The valves 16, 17, and
18 may be in wireless or wired communication with a respective pump 19, 20, and 21 to
control the flow rate and/or discharge profile. For example, the pump 19 may communicate
wirelessly with the valve 16 to adjust the opening and closing of the valve 16 to achieve a
target flow rate, for example, when the pump 19 runs at a predetermined speed; the valves
16 may be downstream from the pump 19 in some embodiments.
Fluid from the tor 22 is fed into an occlusion or 23 which is
fed into an air detector 24. The occlusion detector 23 can detect when an occlusion exists
within tubing of the system 1. The occlusion detector 23 may be a pressure sensor
compressed against the tube such that increases beyond a predetermined threshold is
indicative of an occlusion. The air detector 24 detects if air is present in the tubing, e. g.,
when flowing towards the patient 5. Prior to entering into an on site monitor 26, the
fluid passes through a valve 25.
[00278] The monitoring client 6, in some embodiments, monitors operation of the
system 1. For example, when an occlusion is detected by occlusion detector 23 and/or air is
ed by the air detector 24, the monitoring client 6 may wireles sly communicate a signal
to the valve 25 to shut—off fluid flow to the patient 5.
The monitoring client 6 may also remotely send a prescription to a
pharmacy. The prescription may be a prescription for ng a fluid using a fluid pump.
The pharmacy may include one or more computers connected to a network (e.g., the
intemet) to receive the iption and queue the prescription within the one or more
computers. The pharmacy may use the prescription to compound the drug (e. g., using an
automated compounding device coupled to the one or more computers or manually by a
pharmacist viewing the queue of the one or more computers), pre—fill a fluid reservoir
ated with an infusion pump, and/or m the infusion pump (e.g., a treatment
regime is programmed into the infusion pump 19) at the cy in accordance with the
prescription. The fluid reservoir 2 may be automatically filled by the automated
compounding device and/or the infusion pump 19 may be automatically programmed by the
automated nding device. The automated compounding device may generate a
barcode, RFID tag 29 and/or data. The information within the barcode, RFID tag 29, and/or
data may include the treatment regime, prescription, and/or patient ation. The
automated compounding device may: attach the barcode to the fluid reservoir 2 and/or the
infusion pump 19; attach the RFID tag 29 to the fluid reservoir 2 and/or the infusion pump
19; and/or program the RFID tag 29 or memory within the fluid reservoir 2 or the infusion
pump 19 with the information or data. The data or information may be sent to a database
(e.g., electronic medical records) that associates the iption with the fluid reservoir 2
and/or the infusion pump 19, e.g., using a serial number or other identifying information
within the barcode, RFID tag 29, or memory.
The infusion pump 19 may have a scanner, e.g., an RFID interrogator that
interrogates the RFID tag 29 or a e scanner that scans a barcode of the fluid reservoir
2, to determine that it is the correct fluid within the fluid oir 2, it is the correct fluid
reservoir 2, the treatment programmed into the infusion pump 19 corresponds to the fluid
within the fluid reservoir 2 and/or the fluid reservoir 2 and infusion pump 19 are correct for
the particular patient (e.g., as determined from a patient’s barcode, RFID 27, or other patient
identification). For example, the infusion pump 19 may scan the RFID tag 29 of the fluid
reservoir 2 and check if the serial number or fluid type encoded within the RFID tag 29 is
the same as indicated by the programmed ent within the infusion pump 19.
Additionally or alternatively, the infusion pump 19 may interrogate the RFID tag 29 of the
fluid reservoir 2 for a serial number and the RFID tag 27 of the patient 5 for a patient serial
, and also interrogate the onic medical records to determine if the serial
number of the fluid reservoir 19 within the RFID tag 29 matches a patient’s serial number
within the RFID tag 27 as indicated by the electronic medical records. Additionally or
alternatively, the monitoring client 6 may scan the RFID tag 29 of the fluid reservoir 2 and
an RFID tag of the infusion pump 19 to ine that it is the correct fluid within the fluid
reservoir 2, it is the correct fluid reservoir 2, the treatment programmed into the infusion
pump 19 corresponds to the fluid within the fluid oir 2, and/or the fluid reservoir 2
and infusion pump 19 are correct for the ular patient (e.g., as determined from a
patient’s barcode, RFID tag 27, electronic l records, or other patient identification or
information). Additionally or alternatively, the monitoring client 6 or the infusion pump 19
may interrogate an electronic medical records database and/or the pharmacy to verify the
prescription or download the prescription, e.g., using a barcode serial number on the
infusion pump 19 or fluid reservoir 2.
Additionally or atively, the flow from the pumps 19, 20, and 21 may be
red and/or controlled by the monitoring client 6 to ensure safe drug delivery. The
monitoring client 6 may scan a RFID tag 27 on a bracelet 28, and also RFID tags 29, 30,
and 31 on the fluid reservoirs, 2, 3, and 4, respectively. The monitoring client 6 may
download electronic medical records ) associated with the RFID tag 27 on the
patient’s 5 bracelet, and compare it to one or more prescriptions found in the EMR of the
patient 5. If the EMR indicates that the fluid reservoirs 2, 3, and 4 contain the correct
medication, a user can input into the monitoring client 6 a command to start pumping fluid
through pumps 19, 20, and/or 21 into the patient 5.
The infusion site monitor 26 monitors the site at which the fluid is fed into
the patient 5. The infusion site monitor 26 es the fluid through an input port 408 and
feeds the fluid to the patient 5 h an output port 409. As shown in Fig. 2, in some
embodiments the infusion site monitor 5 optionally includes an air detector 410, an
ration detector 32, a pressure sensor 33, a fluid-temperature sensor 34, and/or a patient
temperature sensor 35. In some embodiments, the infusion site monitor 26 optionally
includes an ambient air temperature sensor 35 and an RFID interrogator 41A.
[00283] The infusion site r 26 also includes a processor 37 and a memory 38.
The memory 38 may include processor executable ctions configured for execution on
the processor 37. The processor 37 is in operative communication with the air detector 410,
the infiltration detector 32, the pressure sensor 33, the emperature sensor, the patient
temperature sensor 35, the ambient air ature sensor 36, the RFID interrogator 41A,
the user input 39, and the buttons 40; for e, the processor 37 may be coupled to a
bus, a parallel communication link, a serial communication link, a wireless communication
link, and the like. Referring to Figs. 1 and 2, information from the various circuitry of 410,
32, 33, 34, 35, 36, 39, 40, and/or 41 may be communicated to the monitoring client 6 via a
wired or wireless communication link, e.g.,. WiFi, USB, serial, WiMax, oth, Zigbee,
and the like.
In Fig. 1, in each of the pumps 19, 20, and 21, or the fluid reservoirs 2, 3,
and 4 may include an am and/or downstream pressure ting source (e.g., an
occluder, speaker, etc) to generate a pressure "signature" that would travel along the line
and into the other devices, e. g., pumping, monitoring, or metering devices. These pressure
signatures may indicate the pressure in each of the lines, may be used to identify each line
and coordinate the flow rates of the lines, and/or may indicate what the measured flow rate
of the line should be. The pressure signature may be an ultrasonic signal generated by a
piezoelectric ceramic that is modulated to encode information such as digital data or an
analog signal, e.g., an acoustic carrier frequency with FM modulation, AM modulation,
digital modulation, analog modulation, or the like.
For example, each of the pumps 19, 20, and 21 may transmit sound pressure
down the IV line to the infusion site monitor 26 (which may include a transducer to detect
these pressure waves) indicating to the infusion site monitor 26 the expected total flow rate
therethrough. A flow rate meter 169 (see Fig. 2) may measure the liquid flow rate, and if
the measured liquid flow rate es by a predetermined amount, the infusion site monitor
26 may issue an alarm and/or alert, e.g., the alarm may signal the valves l6, 17, 18, and 25
to close, and/or the monitoring client 6 may use the information for logging purposes and/or
to cause the valves l6, l7, l8, and 25 to close.
Referring again to Fig. 2 and as previously mentioned, the processor 37 is in
operative communication with user input 39 and one or more buttons 40. The infusion site
monitor 26 may receive various user input 39 to signal the processor 37 to start monitoring
treatment of the patient 5. onally or alternatively, the infusion site monitor 26 may
interrogate the RFID 27 of the patient’s 5 bracelet (see Fig. 1) to ine if the infusion
site monitor 26 is coupled to the correct patient 5.
The air detector 410 is in operative communication with the processor 37.
The air detector 410 can measure, estimate, and/or determine the amount of air entering into
the infusion site monitor 26 via the input port 29. In some embodiments, when the
processor 37 determines that air within the tube exceeds a predetermined threshold, the
processor 37 communicates an alarm or alert to the ring client 6 (see Fig. l) which
can signal valve 25 to shut off fluid flow to the patient 5. Additionally or alternatively, the
processor 37 may communicate an alarm or an alert to the valve 25 or to one or more of the
pumps 19, 20, and 21 to stop fluid flow when the air within the tube exceeds the
predetermined threshold. The air detector 410 may be an ultrasonic air detector, an
impedance—based air detector, and the like.
] The infiltration detector 32 is in operative communication with the processor
37. The ration detector 32 can measure, estimate, and/or determine the amount of
blood entering into the infusion site monitor 26 via the output port 30 during an infiltration
test. In some embodiments, when the processor 37 determines that blood within the tube is
less than a predetermined old during an infiltration test, the processor 37
communicates an alarm or alert to the monitoring client 6 (see Fig. 1) which can signal the
valve 25 to shut off fluid flow to the patient 5. Additionally or alternatively, the processor
37 may communicate an alarm or an alert to the valve 25 or to one or more of the pumps 19,
20, and 21 to stop fluid flow when the infiltration tests determines that an ration has
occurred. The infiltration test may include reversing one or more of the pumps 19, 20,
and/or 21 to determine if blood does flow into the infusion site monitor 26. When an
infiltration has occurred, blood will not easily flow into the infusion site monitor 26. Thus,
when fluid is pulled from the patient 5, blood should enter into the tube 41 with a
predetermined minimum amount of backward pumping when no infiltration has occurred.
The infiltration or 32 may be CCD based, camera based, optical based, and the like.
The pressure sensor 33 is in operative communication with the processor 37.
The pressure sensor 33 can measure, estimate, and/or determine the amount of pressure
entering, exiting and/or flowing h the infusion site monitor 26 via the ports 29 and
. In some embodiments, when the processor 37 determines that pressure in the tube
exceeds a predetermined threshold and/or is below a predetermined threshold, the processor
37 communicates an alarm or alert to the monitoring client 6 (see Fig. 1) which can signal
valve 25 to shut off fluid flow to the patient 5. The pressure sensor 33 may be a resistive
element that s in resistance as a force is applied to the resistive t, the resistive
element is stretched, and/or the resistive element is pulled. The resistive element may be
wrapped around the tube 41 such that as the pressure of the fluid causes the tube 41 to
expand, the resistance of the resistive element is measured and is associated with a pressure
within the tube, e. g., the resistance may be measured and a look—up table may be used to
look up an estimated pressure within the tube 41. In some embodiments, when the
processor 37 determines that pressure within the tube is greater than a predetermined
maximum value or less than predetermined m value, the processor 37 communicates
an alarm or alert to the monitoring client 6 (see Fig. 1) which can signal the valve 25 to shut
off fluid flow to the patient 5. Additionally or alternatively, the sor 37 may
communicate an alarm or an alert to the valve 25 or to one or more of the pumps 19, 20, and
21 to stop fluid flow when the processor 37 receives from the pressure sensor 33 to a
measured re within the fluid line 41 greater than a predetermined maximum value or
less than predetermined m value.
[00290] The fluid-temperature sensor 34 is in operative ication with the
processor 37. The fluid-temperature sensor 34 can measure, estimate, and/or determine the
temperature of the fluid within the tube 41. In some embodiments, when the processor 37
determines that temperature of the fluid within the tube 41 exceeds a predetermined
threshold and/or is below a predetermined old, the processor 37 communicates an
alarm or alert to the monitoring client 6 (see Fig. l) which can signal valve 25 to shut off
fluid flow to the patient 5. In some embodiments, a user may de the alarm or alert,
e.g., using a touch screen of the monitoring client 6. Additionally or alternatively, the
processor 37 may communicate an alarm or an alert to the valve 25 or to one or more of the
pumps 19, 20, and 21 to stop fluid flow when the processor 37 receives a ted
temperature of the fluid within the tube 41 indicating the fluid is above a predetermined
old and/or is below a predetermined threshold. The fluid—temperature sensor 34 may
utilize a temperature sensitive material, a positive temperature—coefficient material, a
ve temperature—coefficient material, or other temperature sensor technology.
The patient ature sensor 35 is in operative communication with the
processor 37. The patient temperature sensor 35 can measure, estimate, and/or determine
the ature of the patient 5 (see Fig. 1). The temperature of the patient 5 may be used
to determine the condition of the t, compliance with a temperature affecting
medication, or effect of a temperature affecting medication. The temperature of the t
(a patient—condition parameter) may be icated to the monitoring client 6 (see Fig.
1). In some embodiments, when the processor 37 determines that the temperature of the
patient 3 exceeds a predetermined threshold or is below a predetermined threshold, the
processor 37 communicates an alarm or alert to the monitoring client 6 (see Fig. 1) which
can signal valve 25 to shut off fluid flow to the patient 5, send an alert to a remote
communicator, and/or notify a caregiver of the condition via an internal r 42 or
vibration motor 43 within the infusion site monitor 26. Additionally or alternatively, the
processor 37 may communicate an alarm or an alert to the valve 25 or to one or more of the
pumps 19, 20, and 21 to stop fluid flow when the processor 37 receives an estimated
temperature from the patient temperature sensor 35 that exceeds a predetermined threshold
or is below a predetermined threshold. The patient temperature sensor 35 may utilize a
temperature sensitive material, a positive temperature—coefficient material, a ve
temperature—coefficient material, or other temperature sensor technology.
] The ambient air temperature sensor 36 is in operative communication with
the processor 37. The t air temperature sensor 36 can measure, estimate, and/or
determine the temperature of the ambient air within the infusion site monitor 26, or in other
embodiments, the temperate of the air outside of the infusion site monitor 26. An ive
ambient air temperature may be an indication of an electronic component failure, in some
specific embodiments. In some embodiments, when the processor 37 determines that the
temperature from the ambient air temperature sensor 36 exceeds a predetermined old
or is below a predetermined threshold, the processor 37 communicates an alarm or alert to
the monitoring client 6 (see Fig. 1) which can signal valve 25 to shut off fluid flow to the
patient 5. Additionally or alternatively, the processor 37 may communicate an alarm or an
alert to the valve 25 or to one or more of the pumps 19, 20, and 21 to stop fluid flow when
the processor 37 receives an estimated ature from the ambient temperature sensor 36
that exceeds a predetermined threshold or is below a predetermined threshold. The ambient
air temperature sensor 36 may utilize a ature sensitive material, a ve
temperature—coefficient material, a negative temperature—coefficient material, or other
temperature sensor technology.
Referring to the drawings, Fig. 3 shows a block diagram of a pump for
ng liquid of the system of Fig. 1 in accordance with an ment of the present
disclosure. Although the pump 19 of Fig. 3 is described as being pump 19 of Fig. 1, the
pump 19 of Fig. 3 may be one or more of the pumps 19, 20, and 21 of Fig. l, or may be
included within any sufficient pump disclosed herein.
Pump 19 includes a processor 37 coupled to a memory 38. The processor 37
is in operative communication with the memory 38 to receive processor executable
instructions configured for ion on the processor 37. In some embodiments, the
processor 37 is, optionally, in operative communication with the user input 39, the air
detector 410, the fluid temperature sensor 34, valves 47, 49, 51 and 52, a flow meter 48, an
actuator 54, an air filter 50, a drain r 53, and/or a pressure sensor 33.
The pump includes an actuator 54 which operates on fluid contained within
tubing 56 flowing through the pump. The or 54 may directly operate on the tube 56,
or may actuate against one or more nes contained within the actuator 54. In some
embodiments, the valves 47 and 49 cooperate with the or 54 to pump fluid, e.g.,
liquid, from the input port 44 to the output port 45 through the tube 56. In some
embodiments of the present disclosure, the pump 19 contains no internal tubing and
interfaces to external tubing.
[00296] The air filter 50 filters out air from the tube 56. In alternative embodiments,
the air filter 50 is am from the air detector 410. Valve 52 can activate to allow air to
enter in from the tube 56 into a drain chamber 53 via a diversion tube 57.
Referring to the drawings, Figs. 4 and 5 show a drip-chamber holder 58
receiving a drip chamber 59. As described infra, the drip—chamber holder 58 includes a
free—flow detector in accordance with an embodiment of the present disclosure.
Additionally, alternatively, or optionally, the drip—chamber holder 58 may e a flow—
rate meter in accordance with some embodiments of the present disclosure. Fig. 4 shows
the drip chamber holder 58 with a shut door 62, and Fig. 5 shows the drip—chamber holder
58 with an open door 62. The drip chamber holder 58 may include the drip chamber 7, the
flow meter 10, and the freeflow detector 13 of Fig. 1 integrated together, or some
combination thereof. The drip chamber holder 58 includes a start button 60 and a stop
button 61. The drip—chamber holder may include a valve to stop fluid from flowing
therethrough or may signal another valve, e.g., valve 16 of Fig. l, to stop the fluid from
flowing.
The drip-chamber holder 58 optionally includes cameras 63 and 64 that can
estimate fluid flow and/or detect free flow conditions. Although the drip-chamber holder 58
includes two s (e. g., 63 and 64), only one of the cameras 64 and 64 may be used in
some embodiments. The cameras 63 and 64 can image a drop while being formed within
the drip chamber 59 and estimate its size. The size of the drop may be used to estimate
fluid flow through the drip chamber 59. For example, in some embodiments of the present
disclosure, the cameras 63 and 64 use an edge detection algorithm to estimate the outline of
the size of a drop formed within the drip chamber 59; a processor therein (see processor 90
of Figs. 12 of 14, for example) may assume the outline is uniform from every angle of the
drop and can estimate the drop’s size from the outline. In the ary embodiment
shown in Figs. 4 and 5, the two cameras 63 and 64 may average together the two outlines to
estimate the drop’s size. The s 63 and 64 may use a reference background pattern to
tate the recognition of the size of the drop as described .
[00299] In another embodiment of the present disclosure, the cameras 63 and 64
image the fluid to determine if a free flow condition exists. The s 63 and 64 may use
a background pattern to determine if the fluid is freely flowing (i.e., drops are not forming
and the fluid streams through the drip chamber 59). Although the drip—chamber holder 58
includes two s (e. g., 63 and 64), only one of the cameras 64 and 64 may be used in
some embodiments to determine if a free flow condition exists
onally or alternatively, in some embodiments of the present disclosure,
another camera 65 monitors the fluid line 66 to detect the presence of one or more s
within the fluid line. In alternative embodiments, other bubble detectors may be used in
place of the camera 65. In yet additional embodiments, no bubble detection is used in the
drip—chamber holder 58.
] Fig. 6 shows a block m of another drip—chamber holder 67 in
accordance with another embodiment of the t disclosure. The drip—chamber holder 67
includes an optical drip counter 68 that receives fluid from an IV bag 69. In alternative
embodiments, the l drip counter 68 is a camera, is a pair of cameras, is a capacitive
drip counter, and the like. The drip—chamber holder 67 is coupled to a tube 70 coupled to a
holder clamp 71 that is controlled by a motor 72. The motor 72 may be coupled to a lead
screw mechanism 73 to control a roller clamp 74.
] The motor 72 may be a servo—motor and may be used to adjust the flow rate
through the tube 70. That is, the drip—chamber holder 67 may also function as a flow meter
and regulator. For example, a processor 75 within the drip-chamber holder 67 may adjust
the motor 72 such that a desired flow rate is achieved as ed by the optical drip
counter 68. The processor 75 may implement a l thm using the optical drip
counter 68 as feedback, e.g., a proportional—integral—derivative (“PID”) control loop with the
output being to the motor 72 and the feedback being received from the optical drip counter
In alternative embodiments, the motor 72, the lead screw mechanism 73, and
the roller clamp 74 may be replaced and/or supplemented by an actuator that squeezes the
tube 70 (e.g., using a cam mechanism or linkage driven by a motor) or may be replaced by
any sufficient roller, screw, or slider driven by a motor.
] The drip—chamber holder 67 may also include a display, e.g., the display 76
as shown on the drip—chamber holder 58 of Figs. 4 and 5. The display may be used to set
the target flow rate, display the current flow rate, and/or may provide a button, e.g., a touch
screen button, to stop the flow rate (or a button 61 as shown in Figs. 4 and 5 may be used to
stop fluid flow).
Referring again to Fig. 4, in some specific embodiments of the present
disclosure, the cameras 63 and/or 64 may be a camera cube manufactured by OmniVision of
4275 Burton Drive, Santa Clara, California 95054; for example, the camera cube may be
one ctured for phone camera applications. In some embodiments of the present
disclosure, the cameras 63 and/or 64 may use a fixed focus and have a depth of field
) from 15 centimeters to infinity.
The s 63 and 64 may each have the blur circle of a point imaged in
the range of one of the cameras 63 and/or 64 ly contained within the area of a single
pixel. In an exemplary embodiment, the focal length of the camera lenses of cameras 63 and
64 may be 1.15 millimeters, the F# may be 3.0, and the aperture of the lenses of cameras 63
and 64 may be 0.3833 millimeter. A first order approximation to the optical system of one
or more of the cameras 63 and 64 may be made using matrix equations, where every ray, r,
is ented as the vector described in Equation (1) as follows:
r = g (1).
In Equation (1) above, h is the height of the ray at the entrance to the camera
system of s 63 and/or 64, and 0 is the angle of the ray. Referring to Fig. 7, when
imaging a hypothetical point at a distance dim from the lens of one of the cameras 63 or 64
(which has focal length f) and the lens is a distance dfp from the focal plane, the
corresponding matrix, Mcam ,describing the camera (e.g., one or both of the cameras 63
and/or 64) is described by Equation (2) as follows:
1 df 1 0 1 d.
' _% ’
[00309] Mcamz 0 1p 1 0 11m (2).
To find the place on the focal plane, fp, where the ray strikes, a matrix
lication as described in Equation (3) as s may be used:
h h.
fP zm
: M .
9 cam a (3).
f1? W
As illustrated in Fig. 7, the diameter of the blur circle, Dblur, is shown as
approximately the distance between the two points illustrated in Fig. 7. This distance is
found by tracing rays from the point dim away from the lens on the optical axis to the edges
of the lens and then to the focal plane. These rays are given by the vectors shown in (4) as
follows:
+ tan—1%
— (4)
2 * d. '
[00314] As shown in Fig. 8, the blur circle, Dblur, is calculated and shown for a
y of lens—to—focal plane separations and lens—to—image separations. A contour map 77
is also shown in Fig. 8. The x—axis shows the distance in microns between the focal plane
and a point located a focal length away from the lens of one of the s 63 and/or 64.
The y—axis shows the distance in meters between the lens and the point being imaged. The
values creating the contour map 77 is the blur size divided by the pixel size; therefore
anything about 1 or less is ient for g. As shown in Fig. 8, the focal plane is
located a focal length and an additional 5 micrometers away from the lens.
The cameras 63 and/or 64 may utilize a second lens. For example, one or
more of the cameras 63 and/or 64 may utilize a second lens to create a relatively larger
depth of field and a relatively larger field of View. The depth of field utilizing two lenses
can be ated using the same analysis as above, but with the optical matrix modified to
accommodate for the second lens and the onal distances, which is shown in Equation
(5) as follows:
11 0 11 0
1 d 1 1 d.
f dl
S375 0 1 f 0 l f O 1
cam lens
(5).
Figs. 9 and 10 illustrate the field changes with the separation between the
lens and the camera and the corresponding change in the focus of the camera. Figs. 9 and
show the blur circle divided by the pixel size. Fig. 9 shows the blur circle divided by
pixel size when a 20 millimeter focal length lens is used. Fig. 10 shows the blur circle
divided by pixel size when a 40 millimeter focal length lens is used. The corresponding
fields of views about the optical axis for the corners of the two configurations of Figs. 9 and
are shown in the table in Fig. 11.
] As shown in Fig. 11, in some embodiments, the cameras 63 and 64 of Figs. 4
and 5 may utilize a 40mm to 60mm focal length lens; this uration may include
placing one or more of the cameras 43 and 64 about 2 inches from the focus. In other
embodiments of the present disclosure, other configurations may be used including those
not shown in Fig. 11.
For example, the following analysis shows how the depth of field can be set
for one or more of the cameras 63 and 65: using a lens of focal length, f, a distance, 2, from
the focal plane, and a distance, d, from a point in space; a matrix of the system is shown in
Equation (6) as s:
M—1Z_ 110-161 6
‘01_'—71 0'
Equation (6) reduces to Equation (7) as follows:
1z 1 d
M: . 1 d
1_ (7).
f f
Equation (7) reduces to Equation (8) as follows:
1—i d + z —@
M = If f
(8).
f f
Considering the on-axis points, all of the heights will be zero. The point on
the focal plane where different rays will strike is given by (9) as follows:
[d + Z ——]9dz [00326] (9).
As shown above in (9), 0 is the angle of the ray. The point in perfect focus is
given by the lens maker's equation given in Equation (10) as follows:
1_1+1
f Z d (10),
] Equation (10) may be rearranged to derive Equation (11) as follows:
01—1 fz
] i_1 (11).
Z _ f
f z
Inserting d from Equation (1 1) into (9) to show the striking point results in
Equation (12) as follows:
fz z—f
+ _ 6_f2z+fz2—f2z—fz26_0
Z ——_— (12).
_ f z f f(z f)
[00333] All rays leaving this point strike the focal plane at the optical axis. As shown
in on (13), the ion when the cameras 63 and/or 65 are shifted by a distance 6
from the focus is described as follows:
fz iz—f+z 5]
+6+z— Z9 = f2z+fz6—f26+fz2—f2z—fz2—6z2+f6z9
z — f f f(z — f)
(2:—f)2
_ fz-f2—z2+fz§
—_ 59
f(z — f) f(z — f)
f — z
= 549 (13).
Equation (13) shows that by properly positioning the lens of the cameras 63
and 64 with respect to the focal plane, we can change the depth of field. Additionally, the
spot size s upon the magnitude of the angle 0. This angle depends linearly on the
aperture of the Vision system created by the cameras 63 and/or 64.
] Additionally or alternatively, in accordance with some embodiments of the
present disclosure, cameras 63 and 64 may be implemented by adjusting for various
parameters, including: the ce to the focus as it affects compactness, alignment, and
sensitivity of the Vision system to the environment; the field of View of the system; and the
lens—focal plane separation as it affects the nces on alignment of the system and the
sensitivity of the system to the environment.
[00339] Fig. 12 is a block diagram of an imaging system 78 of the cameras of the
drip—chamber holder of Figs. 4 and 5 in ance with an embodiment of the t
disclosure. gh the camera 63 of Figs. 4 and 5 will described with reference to Fig.
12, camera 64 may also utilize the configuration described in Fig. 12.
Fig. 12 shows an imaging system 78 including a camera 63, a uniform back
light 70 to shine light at least partially through the drip chamber 59, and an ed (“IR”)
filter 80 that receives the light from the uniform back light 79. System 78 also includes a
processor 90 that may be operatively coupled to the camera 63 and/or the uniform back light
The uniform back light 79 may be an array of light-emitting diodes (“LEDs”)
having the same or ent colors, a light bulb, a window to receive ambient light, an
incandescent light, and the like. In alternative embodiments, the uniform back light 79 may
be replaced by one or more point—source lights.
The processor 90 may modulate the uniform back light 79 with the camera
63. For example, the processor 90 may activate the uniform back light 79 for a
predetermined amount of time and signal the camera 63 to capture at least one image, and
thereafter signal the uniform back light 79 to turn off. The one or more images from the
camera 63 may be processed by the microprocessor to estimate the flow rate and/or detect
free flow conditions. For example, in one embodiment of the t sure, system 78
monitors the size of the drops being formed within the drip r 59, and counts the
number of drops that flow through the drip chamber 59 within a predetermined amount of
time; the sor 90 may average the periodic flow from the individual drops over a
period of time to estimate the flow rate. For example, if X drops each having a volume Y
flow through the drip chamber in a time Z, the flow rate may be calculated as (X*Y)/Z.
] Additionally or alternatively, the system 78 may determine when the IV fluid
is streaming through the drip chamber 59 (i.e. during a free flow condition). The uniform
back light 79 shines through the drip chamber 59 to provide an image of the drip chamber
59 to the camera 63. The camera 59 can capture one or more images of the drip chamber
Other orientations of the system 78 may be used to account for the sensitivity
and/or orientation of the uniform back light 79, the camera 63, the characteristics of the
light from the uniform back light 79, and the ambient light. In some embodiments of the
present disclosure, the processor 90 implements an thm that utilizes a uniformity of
the images collected by the camera 63 facilitated by the uniform back light 79. For
example, consistent uniform images may be captured by the camera 63 when a uniform
back light 79 is utilized.
t lighting may cause inconsistencies in the images received from the
camera 63, such as that caused by direct solar illumination. ore, in some
embodiments of the present disclosure, an IR filter 80 is optionally used to filter out some of
the ambient light effects. For example, the IR filter 80 may be a narrow-band infrared light
filter placed in front of the camera 63; and the uniform back light 79 may emit light that is
about the same wavelength as the center frequency of the passband of the filter 80. The IR
filter 80 and the uniform back light 79 may have a center ncy of about 850
ters. In alternative embodiments, other optical frequencies, bandwidths, center
frequencies, or filter types may be utilized in the system 78.
Fig. 13 is a graphic illustration of an image 81 captured by the camera 63 of
the system of Fig. 12, in accordance with an embodiment of the present disclosure. The
image 81 shows condensation 82 and a stream 83 caused by a free flow condition. Using
edge detection may be used to ine the position of the stream 83 and/or the
condensation 82, in some embodiments. Additionally or alternatively, a background image
or pattern may be used as described infra.
] Fig. 14 is a block diagram of an imaging system 84 of the cameras of the
drip-chamber holder of Figs. 4 and 5 in accordance with an embodiment of the present
disclosure. Although the camera 63 of Figs. 4 and 5 will described with reference to Fig.
14, camera 64 may also utilize the configuration described in Fig. 14.
System 84 includes an array of lines 85 that are opaque behind the drip
r 59. The array of lines 85 may be used in the ion of a free flow condition of
the system 84. The free flow ion algorithm may use the presence or absence of drops
for determining whether or not a streaming condition, (e.g., a free flow condition) exists.
Referring now to Fig. 15, a graphic illustration of an image 86 is shown as captured by the
camera 63 of Fig. 14 when a free flow ion exists in the drip chamber 59 in accordance
with an embodiment of the present sure.
The image 86 rates the condition in which the drip chamber 59
experiences a free flow condition and shows that the stream of fluid 87 acts as a positive
cylindrical lens. That is, as shown in Fig. 15, the array of lines 85 as captured in an image
by the camera 63 show a reversed line pattern 88 from the array of lines 85 as compared to a
non—free—flow condition.
In some embodiments of the present disclosure, an illumination of about 850
nanometers of optical wavelength may be used to create the image 86. Some materials may
be opaque in the visible spectrum and transparent in the near IR at about 850 nanometers
and therefore may be used to create the array of lines 85. The array of lines 85 may be
created using various rapid prototyping cs. For example, the array of lines 85 may be
created using a rapid prototype ure printed with an infrared opaque ink or coated with
a metal for making the array of lines 85. Additionally or alternatively, in some
embodiments of the present disclosure, another method of creating the array of lines 85 is to
create a t board with the lines laid down in copper. In another embodiment, the array
of lines 85 is created by laying a piece of ribbon cable on the uniform back light 79; the
wires in the ribbon cable are opaque to the infrared spectrum, but the insulation is
transparent and the spacing of the wires may be used for the imagining by the camera 63
(see Fig. 14). In yet additional ments, a piece of thin electric discharge machined
metal may be utilized. Metal is opaque and the spaces of the material may very finely
controlled during manufacturer to allow the IR light to pass h the spaces.
The processor 90 ents an algorithm to determine when a free flow
condition exists. The processor 90 may be in operative communication with a computer
readable medium 91 (e.g., a non-transitory computer le medium) to receive one or
more instructions to implement the algorithm to determine if a free flow condition exists.
The one or more instructions from the computer readable medium 91 are configured for
execution by the processor 90.
Referring again to Fig. 14, blood may be used by the system 84. For
example, system 84 may determine when a free flow condition of blood exists when
utilizing the camera 63, the IR filter 80, and the uniform back light 79 configured, for
example, for use using optical light having a wavelength of 850 nanometers or 780
ters, e.g., when using bovine blood. The blood may appear opaque compared to the
imagery taken using water as the fluid.
The following algorithm implemented by the processor 90 and received from
the computer readable medium 91 may be used to determine when a free flow condition
exists: (1) establish a background image 89 (see Fig. 16); and (2) subtract the background
image 89 from the current image. Additional processing may be performed on the resulting
image.
In some embodiments of the t disclosure, the background image 89 of
Fig. 16 may be dynamically generated by the processor 90. The dynamic background
image may be used to account for changing conditions, e.g. condensation or es 82 on
the surface of the drip chamber (see Fig. 13). For example, in one specific embodiment, for
each new image ed by the camera (e.g., 63 of Fig. 14), the background image has
each pixel lied by .96 and the current image (e.g., the most ly captured image)
has a respective pixel multiplied by .04, after which the two values are added together to
create a new value for a new ound image for that respective pixel; this process may
be repeated for all of the pixels. In yet another example, in one specific ment, if a
pixel of the new image is at a row, x, and at a column, y, the new background image at row,
x, and column, y, is the value of the previous background image at row, x, and column, y,
multiplied by .96, which is added to the value of the pixel at row, x, and column, y of the
new image multiplied by .04.
When the system 84 has no water flowing through the drip chamber 59 (see
Fig. 14), the ing subtraction should be almost completely black, i.e., low pixel
magnitudes, thereby facilitating the algorithm to determine that the drip chamber 59 has no
water flowing therethrough.
Fig. 17 shows an image 92 from the camera 63 when there is a drop within
the drip r 59 (see Fig. 14). Fig. 18 shows a ound image 93 used by the
system 84. When the system 83 has a drop as shown in image 92 of Fig. 17, the system 84
of Fig. 14 has a few high contrast—spots where the image of the array of lines is warped by
the lensing of the droplet as illustrated by an image 94 of Fig. 19. Image 94 of Fig. 19 is
generated by taking, for each respective pixel, the absolute value of the subtraction of the
image 92 of Fig. 92 from image 93 of Fig. 18, and converting each respective pixel to a
white pixel if the value is above a predetermined threshold or otherwise converts the pixel
to a black pixel when the value is below the predetermined threshold. Each white pixel
within the image 94 of Fig. 19 is a result of there being a difference for that pixel location
between the images 92 and 93 that is greater than a predetermined old.
For example, consider three tive pixels of Figs. 17, 18, and 19 having a
location of row, x, and column, y. To ine the pixel of row x and column y for the
image 94 of Fig. 19, the pixel at row x and column y of image 92 of Fig. 17 is subtracted
from the pixel at row x and column y of image 92 of Fig. 18, then the absolute value of the
result of the subtraction is taken; and if the absolute value of the result is above a
predetermined threshold (e. g., above a grayscale value of 128, for example), the pixel at the
location of row x and column y of image 94 of Fig. 19 is white, otherwise the pixel at the
location of row x and column y of image 94 of Fig. 19 is black.
When it is determined that a few high contrast-spot exists within image 94 of
Fig. 19, the processor 90 of system 84 (see Fig. 14) determines that drops are being formed
within the drip chamber 59 and no free flow condition exists. The images of the drops may
be utilized to ine their size to estimate a flow rate as described herein.
[00359] Fig. 20 is a graphic representation of some image processing that may be
performed using Figs. 17—19 to determine if a free flow condition exists in accordance with
an embodiment of the present disclosure. Referring to Figs. 20 and 19, all of the white
pixels for each row are summed er, and are illustrated in Fig. 20 as results 183. The
y—axis represents the row number, and the x-axis represents the number of white pixels
determined for each respective row.
Referring now to only Fig. 20, as previously mentioned, the number of white
pixels for each row is summed together and is illustrated as results 183, which are used to
determine if or when a free flow condition exists. In some specific embodiments, the
processor 90 of system 84 (see Fig. 14) determines that a free flow condition exists when a
predetermined number of contiguous values of the summed rows of the results 183 exist
above a threshold 184. For e, within the s 183, a plurality of rows ented
generally by 185 have a total value above the threshold 184. When greater than a
predetermined number of contiguous summed rows are determined to exist within the
results 183, a free flow condition is determined to exist by the processor 90 of Fig. 14. For
example, as shown in Fig. 20, the plurality of contiguous rows 185 are below the
predetermined number of contiguous summed rows and ore a free flow condition is
determined to not exist.
[00361] Fig. 21 shows an image 95 showing a stream as captured by the camera 63 of
Fig 14 when a free flow condition exists. Fig. 22 shows a background image 96. Fig. 23
shows an image 97 formed by the absolute value of the difference between the image 96 of
Fig. 22 and the image 95 from Fig. 21 when the absolute value is converted either to a white
pixel (when the absolute value of the difference is above a old) or to a black pixel
(when the absolute value of the difference is below the threshold). As shown in Fig. 23,
high—contrast spots caused by the reverse orientation of the lines in the stream run from top
to bottom are detectable by the processor 90. The processor 90 of Fig. 14 can use the image
97 to ine if a free flow condition exists using the algorithm described above.
That is, as shown in Fig. 24, results 186 are shown having a contiguous
range 187 of the results 186 that are above a threshold 188. Because the contiguous range
187 of summed rows is greater than a predetermined threshold number of contiguous values
above the threshold 188, a free flow ion is ined to exist by the processor 90
(see Fig. 14). That is, the contiguous range of the results 186 above the threshold 188 is
greater than a predetermined threshold range of contiguous values; therefore, the processor
90 determines that a free flow condition exists when using the s 186 of Fig. 24.
In yet an additional embodiment of the present sure, the ity, the
intensity squared, or other function may be used to produce the results 183 and and/or 186.
In yet an additional embodiment, one or more data smoothing functions may be used to
smooth the results 183 and/or 186, such as a spline function, cubic spline function, B—spline
function, Bezier spline on, polynomial interpolation, moving averages, or other data
smoothing functions.
For example, an image of the camera 63 of Fig. 14, e. g., image 95 of Fig. 21,
may be subtracted from a background image, e.g., the image 96 of Fig. 22, to obtain
intensity . For example, a pixel of row x and column y of Fig. 21 may be cted
from a pixel of row x and column y of the image 96 of Fig. 22 to create an intensity value at
row x and column y; this may be repeated for all pixel locations to obtain all of the intensity
values. The intensity values of each row may be summed together to obtain the results 183
and/or 186, such that the processor 90 may determine that a free flow condition exists when
the summed rows of the intensity values has a contiguous range of summed rows above a
threshold. In some embodiments, the intensity values are converted to an absolute value of
the intensity values, and the summed rows of the te values of the intensity values are
used to determine if a contiguous range of summed rows of the absolute values is above a
threshold range of contiguous values. Additionally or alternatively, the intensity may be
squared and then the processor 90 may sum the squared intensity rows and ine if a
contiguous range of summed rows of the intensity squared values exists beyond a threshold
range of contiguous values to determine if a free flow condition exists. In some
embodiments, a predetermined range of contiguous values above a threshold (e.g., min and
max ranges) of the summed rows of intensity values or intensity squared values may be
used by the processor 90 to determine if a drop of liquid is within the image. For the rows
of the intensity values (or the intensity d values) may be summed together and a
range of the summed values may be above a threshold number; if the range of uous
values is between a minimum range and a maximum range, the processor 90 may determine
that the range of contiguous values above a ermined threshold is from a drop within
the field of View of the camera 63. In some embodiments of the present disclosure the
summed rows of intensity values or intensity squared values may be normalized, e.g.,
ized to have a value between 0 and 1.
The following bes a smoothing function similar to the cubic spline
(i.e., the spline—type function) that may be used on the summed rows of intensity
values or the summed rows of the intensity values square prior to the determination by the
processor 90 to determine if a free flow condition exits. The cubic—spline—type function may
be used to identify blocks as described below which may facilitate the processor’s 90
identification of free flow ions, in some ic embodiments.
The cubic—spline—type function is an analog to the cubic spline, but smoothes
a data set rather than ully mimicking a given function. Having data sampled on the
interval from. [ ]
(e. g., the summatlon along a row of 1ntens1ty squared or 1ntens1ty that is. . . . . .
normalized) the processor 90 may find the best fit set of cubic functions on the intervals
[x,x,x,x0 1] [ 1 2] ,...,x_,x[ = =
N 1 N] 0
w1th. x0 and x” 1where the total function. . .
is continuous
with continuous derivatives and continuous curvature.
The standard cubic spline definition is illustrated in Equation (14) as follows:
Z(x):Ai(x)yi+Bi(x)yi+l+Ci(x)yi”+Di(x)yi:l
xi S'xg'xifl (14),
with the functions A5 ’85 ’Ci’ Di d as in the set of Equations (15):
Ai(x)=xi+1_x=xi+l_x, x_xi
Bi: :x_xi
xi+l _ xi Ai xi+l _ x; Ai
—" A?(X)-Ai(X)A? > , D. =—" 33(16)-Bi(X)AR >
6 6 (15).
Equations (14) and (15) guaranty continuity and curvature continuity. The
only values which can be freely chosen are the yi, yo and yN
. Please note that Equation
(16) is chosen as follows:
yo : yl : O
(16),
i.e., the function is flat at 0 and 1. The remaining yi must satisfy the
following set of Equations (17):
y]yo MAO y2_y1 ylAl Y2A1
A0 3 A1 3 6
Y2—yl ylAl y2A1 _ y3—y2 y2A2 y3A2
+ +
A16 3_A2_3_6
ys-yz yé’Az y§A2 y4—y3 y3A3 y4A3
+ +
A2 6 3 A3_3_6
yN—zYN—3 yN—3AN—3 yN—2AN—3 yN—1_yN—2 yN—ZAN—Z yN—IAN—Z
+ + _ _
AN_3 6 3 AN_2 3 6
yN—lYN—2 —Z yN—IAN—Z 1 yN—IAN—l
+ + = _
6 3 3
AN_2 AN_1
(17).
The set of Equations (17) can be rewritten as the set of Equations (18) as
follows:
[00376]
(18).
In turn, this becomes the matrix Equation (19):
s 0 0 0 yr
—1 13 2 f 0 0 0 y:
o — o o o y:
0 0 0 AN74:AN73 A12 3 0 yg/I—B
0 0 0 AAé—3 AN 3:AN 2 A122 y§_2
0 0 0 0 AIé—Z AN 2:AN 1 y}:_1
_ — yo
f0 mfg—fl f 0 0 0
0 l l l 0 0 0
AT —A—[ — A—z 3’2
0 0 f2 0 0 0
O O 0 A; 0 0 yN_3
0 O 0 —AN‘ — A572 0 yN—Z
3 A572
0 0 0 All — A54 — Air Air “‘1
_ _
YN (19)
The set of Equations (19) may be rewritten as the set of Equations (20):
Fydd = Gy
ydd ‘ F Gy ‘ Hy_ _
(20).
Choosing the values in the vector y using a least squares criterion on the
collected data is shown in Equation (21) as follows:
_ ik ()ygk _Bik (it ) yik+1 _ Cik (41))”; — Dik (5k ) yi: :|2
(21).
That is, Equation (21) is the minimum deviation between the data and the
, i.e., an error function. The y values are chosen to minimize the error as d in
Equation 21; The vector of predicted values can be written as illustrated in Equation (22) as
follows:
y(A{k} +300)” +(C{k} +D{k})ydd
(AW B{k})y+(c{k}+ D{k})Hy
[A{k}+B{k+C{k}H+D{k}H]y
(22),
The elements of the matrix in brackets of Equation (22) depend upon the xvalue
ponding to each data point, but this is a fixed matrix. Thus the final equation
can be determined using the pseudo—inverse. In turn, the pseudo-inverse only depends upon
the x—locations of the data set and the ons where the breaks in the cubic spline are set.
The implication of this is that once the geometry of the spline and the size of the image are
selected, the best choice for the y given a set of measured values ym is illustrated in
Equation (23) as follows:
y=(ATA)‘1A.ym
(23).
[00386] The cubic spline through the sum intensity—squared function of the image
will then be given by Equation (24):
yes y
(24).
Because we will want to find the maximum values of the cubic spline, we
will also need the derivative of the spline. The cubic spline derivative is given by Equation
(25) as follows:
) :Ai; (xk)yik +8; (xk)yik+l+Cikx(xk)yi: +Di(xk)yi:+1
:_:lk +):+1_A A AA11:63)” (3A: (xk)_1)+? A»1k:1:+1(3B:(-xk)_1)»
1} 5k (25).
on (25) can be n as Equation (26):
y; = (A0} +130} )y +(Cik} +130} )Yaa
—[A{k} +B{kH+CkH +D{k}H]y
2 Ay
(26)-
Once the current values of y are found, the cubic , yes, and its
derivative, y’cs can be calculated. The cubic spline data may include “blocks” of data that
includes values above a predetermined threshold. A pipe block is formed by the liquid
flowing out of the tube into the drip chamber 59 and a pool block is formed as the liquid
collects at the gravity end of the drip chamber 59 (see Fig. 14).
] The following algorithm may be applied to the cubic spline data: (1)
determine the local maxima of the cubic spline data using the derivative information; (2)
determine the block surrounding each local maxima by including all points where the cubic
spline value is above a threshold value; (3) merge all blocks which intersect; (4) ate
information about the block of data ing the center of mass (intensity), the second
moment of the mass (intensity), the lower x—value of the block, the upper x—value of the
block, the mean value of the original sum of intensity squared data in the block, the rd
deviation of the original sum of ity squared data in the block, and the mean intensity
of a high—pass filtered image set in the block; and (5) interpret the collected data to obtain
information about when drops occur and when the system is streaming.
The mean intensity of a high—pass filtered image set in the block is used to
determine if the block d by each contiguous range of spline data is a result of a high
frequency artifact (e.g., a drop) or a low frequency artifact. This will act as a second
background filter which tends to remove artifacts such as condensation from the image.
That is, all previous images in an image memory buffer (e.g., 30 previous frames, for
example) are used to determine if the data is a result of high frequency movement between
frames. If the block is a result of low frequency changes, the block is removed, or if it is a
result high ncy changes, the block is kept for further analysis. A finite impulse
response filter or an infinite impulse response filter may be used.
[00395] Each block is plotted over its al extent with height equal to the mean
value of the data within the block. If a block has a mean value of the ass filter image
less than the threshold, it is an indication that it has been around for several images and thus
may be removed.
Free flow conditions may be determined by the processor 90 to exist using
the blocks when the pipe block extends nearly to the pool block, the pipe block and the pool
block merge together, and/or the summed range of widths of the pool and pipe blocks (or all
blocks) is greater than a predetermined threshold, e.g., the total extent of the blocks exceeds
380 pixels in width. The processor 90 may detect a drop when the transition of the pipe
block from a larger width to a shorter width occurs as a result of a drop formation in the
tube and as the drop leaves the pipe (i.e., tube) opening of the drip chamber 59. The
sor 90 may detect this by looking at the ratio of the t pipe block width to the
previous image’s pipe block width, e.g., an image where the ratio is less than 0.9 while
simultaneously is a local minima is may be considered by the processor 90 to be an image
formed immediately after a drop has .
Various filtering algorithms may be used to detect sation or other low
frequency ratification, such as: If a block has a low mean value in the high-pass filter image,
then it may be condensation. This artifact can be removed from consideration. Additionally
or alternatively, long blocks (e. g., greater than a predetermined threshold) with a low high—
pass mean value are possibly streams, since stream images tend to remain ging.
The processor 90 may, in some specific embodiments use the block data to
count the drops y using the system 84 as a drop counter. The processor 90 may also
use width changes in the pool block as a drop disturbs the water to determine if a bubble
formed with the drop hit the pool. For e, the processor 90 may determines that a
block forms below the pool block, then the processor 90 may determine that a bubble
formed when a drop hit the water. The bubble may be filtered out by the processor 90 to
determine if a predetermined value of total block ranges indicates that a free flow condition
exists.
[00399] In some embodiments of the present disclosure, the depth of field of the
system 84 may have a narrow depth of field to make the system 84 less sensitive to
sation and droplets on the chamber walls. In some embodiments, a near focus
system may be used.
Referring now to Fig. 25, in another embodiment of the present disclosure a
template 189 is used to determine if a free flow condition exists. The template 189 is used
by the processor 90 of Fig. 14 to determine a pattern match score 190. The image 94 of Fig.
19 may be compared against the pattern 189 (e.g., a difference between a background image
and an image captured by the camera 63 of Fig. 14 which is then converted to either a black
pixel if the difference is below a threshold value or a white pixel if the difference is above a
threshold value). If the pattern match score 190 is above a predetermined threshold, a free
flow condition is determined to exist. The template ng may utilize a template
matching algorithm as found in Open Source Computer Vision (“OpenCV”) library. For
example, the template 189 may be used with the matchTemplate() function call of the
OpenCV library using the CV_TM_CCOEFF method or the method of
CV_TM_CCOEFF_NORMED. The CV_TM_CCOEFF method uses the pattern matching
algorithm illustrated in Equation (27) as follows:
REIIIIIJ : :JI’EII’I y“) . III I Iii-I + 953-1"
1‘ ‘IEJ "‘ ,(27) where:
T’IIZ I: J I IEiIf’I‘y J — II II] - E, III”, 19",]
; The I denotes the image, the T denotes the template, and the R denotes the results. The
summation is done over the template and/or the image patch, such that: x'= 0...w—1 and
y' = 0...h — 1.
The results R can be used to determine how much the template T is matched
at a particular location within the image I as determined by the algorithm. The OpenCV
template match method of CV_TM_CCOEFF_NORMED uses the pattern matching
algorithm illustrated in on (28) as follows:
I "53"] ~ III: —-— I II —-— III]
fofli] I }
"II-IE XVIII" PEXZHT ‘ Ema I’ij. T Eh I} *5" 1.5"? (28)
In another embodiment of the present disclosure, the template matching
algorithm uses a Fast Fourier Transform ). In some embodiments, any of the
methods of the emplate() function of OpenCV may be used, e. g., CV_TM_SQDIFF,
CV_TM_SQDIFF_NORMED, CV_TM_CCORR, and/or CV_TM_CCORR_NORMED.
The CV_TM_SQDIFF uses the pattern matching algorithm illustrated in
Equation (29) as follows:
II If} I EINI If"?! - HI: I II’I II I :III’TII3
[00407] if 5%: (29).
CV_TM_SQDIFF_NORMED uses the pattern ng thm illustrated
in Equation (30) as follows:
‘3'”: ' I" "
.J- —» fix: -I-c :33’, y,.‘ I .. is
.- , «U {19, I; -I- If}!
RITEI-‘I III I
, I{$",,I- I TEE", If}?
, ‘55,.-
$4.3; If:: -I'-- :I:-‘, I; I {£373
\(I at“), R} -- z 3}} .
. w I I. w .- (30).
CV_TM_CCORR uses the pattern ng algorithm illustrated in Equation
(31) as follows:
HiII-s If] I Em: I) ~ HI I I”! II I ”£le.
:M H
in? (31).
CCORR_NORMED uses the pattern ng algorithm illustrated
in Equation (32) as follows:
‘17“ I! II") . HI I II! II I If?!)
Effie :Il I—.”if“:
_. , ..
. Elf
. '31:! #(‘Ti}1f~‘?3;’j" I[1’ I :17", y I— gflg‘
In yet another embodiment of the present disclosure, a template of a
grayscale image of a free flow condition is compared to an image taken by the camera 63 of
Fig. 14 to determine if a free flow condition exists. In some embodiments, the template
matching on within the OpenCV library may be utilized.
Refer now to Figs. 26 and 27; in yet an onal embodiment of the present
disclosure, the algorithm to determine when a free flow condition exists being executed on
the processor 90 of Fig. 14 may utilize an algorithm to determine if a template pattern
matches an array of pixels utilizing edge detecting followed by line detection. As shown in
Fig. 26, an image 98 is formed from an image 99 of Fig. 27, by using edge detected
followed by line detection. The resulting lines may be ed by the processor 90 to
determine that a free flow condition exists. As shown in Fig. 26, the e which shows
up after this processing by the processor 90 are lines that have a different slope than the
ed 450 slope of the background reference image. The lines having the angle of the
background image may be filtered out of Fig. 26, in some embodiments. The lines may be
detected as edges using a Canny algorithm as found in the OpenCV y with the Hough
algorithm to ine the slope of the lines also found in the OpenCV library.
Figs. 28-32 illustrate various background patterns that may be used to detect
a free flow condition or estimate the size of a drop of liquid. When used with the back
patterns of Figs. 28-32, the cameras 102 mentioned for use in Figs. 28-32 may be the
cameras 63 or 64 of Figs. 4 or 5, the camera of Fig 6, the camera 63 of Fig. 14 each of
which may be coupled to a respective processor for processing the images from the camera,
such as processor 75 of Fig. 6 or the processor 90 of Fig. 14.
Fig. 28 is a block diagram of an imaging system 100 for use with the drip—
chamber 104 (e. g., a drip chamber as found in the drip-chamber holder of Figs. 4—5 or Fig.
6) having a back pattern 101 with stripes and a light source 102 shining on the stripes from
an adjacent location to a camera 103 in accordance with an embodiment of the present
disclosure. Any drops or free flow streams within the drip r 104 distorts the image
taken by the camera 103. A processor coupled to the camera 103 (e. g., processor 75 of Fig.
6) can use the distortions of the back pattern 101 as captured by the camera 103 to estimate
flow rate and/or detect free flow conditions.
Fig. 29 is a block diagram of an imaging system 105 for use with the drip—
chamber 104 having a back n 101 with stripes and a light source 102 shining on the
stripes from behind the back pattern 101 relative to an opposite end to a camera 103 in
accordance with an embodiment of the present disclosure. Fig. 30 shows an image from the
camera 103 of Fig. 29 when a drop distorts the back pattern 101 of Fig. 29 in accordance
with an embodiment of the present disclosure. Note that as shown in Fig. 30, the back
pattern’s 101 stripes are distorted by a drop (or will be distorted by a free flow stream) from
the drip chamber 104 as captured in images by the camera 103. This distortion may be used
to estimate the drop size, to calculate the flow rate through a fluid—chamber holder, or to
determine if a free flow condition exists.
[00419] Fig. 31 is a block diagram of an imaging system for use with the drip—
chamber holder of Figs. 4—5 or Fig. 6 having a back pattern with a rboard pattern and
a light source shining on the stripes from behind the back pattern ve to an opposite end
to a camera in accordance with an ment of the present disclosure. Fig. 32 shows an
image from the camera of Fig. 31 when a drop distorts the back pattern 107 of Fig. 26 in
accordance with an embodiment of the present sure. In yet r embodiment, the
ound may be formed using a plurality of random dots and/or circles.
Referring to Figs. 28—32, the Lensing of a drop (i.e., the distortion of the
back n from the view of a camera) may be used to measure the radius of the drop. The
radius of the drop is related to the effect it has on the light passing through it. By measuring
the change to the calibration grid as seen through the drop, the radius and hence the volume
of the drop can be calculated. For example, the magnification of a test grid of known size
as seen through the drop could be measured optically and the radius inferred from this
measurement. The relationship between the radius and the drop may be calculated and/or
may be determined using a lookup table that has been generated empirically.
] Fig. 33 shows a block diagram of an air detector 108 using a camera 109 in
accordance with an embodiment of the present disclosure. The air detector 108 may be the
air detector 24 of Fig. 1, the air detector 410 of Fig. 2 or Fig. 3, or the air detector 65 of Fig.
. Additionally or alternatively, in some specific embodiments, the air detector 108 may be
formed within the drip—chamber holder 58 and the camera 109 may be the camera 65 of the
drip—chamber holder 58 (see Figs. 4 and 5).
The air detector 108 includes the camera 109, a backlight 110, a processor
584, and a memory 585. The backlight 110 shines light through the tube 111. The camera
may optionally include an IR filter on its lens and/or the backlight may be tuned to an
ed wavelength or bandwidth, e.g., to correspond to the IR filter.
The camera 109 may be operatively coupled to one or more sors 584
that are in operative communication with a computer readable memory 585, e.g., RAM,
ROM, disk, hard disk, memory, etc. The computer readable memory585 may e one
or more ive instructions configuration for execution by the one or more sor.
The one or more ive instructions may implement an algorithm to detect or determine
the present of air within the tube 111; for example, by determining or detecting the ce
of one or more bubbles within the tube 111.
onally or alternatively, the system 108 can be used to detect the status
of the tube 111 designed to transport fluid, e.g., in this example IV tubing. The camera 109
may be a digital camera that captures images of the tube 111 that is back—lit with a diffuse
light from a ght 110. The backlight 110 may consist of a clear plastic material edge—lit
with a set of LEDs (e. g., as is used on a liquid crystal display). The camera 109 may capture
one or more images so that the one or more processors can detect or determine the
following: (1) if the tube 111 has been installed in the device; (2) if the tube 111 has been
primed (i.e., is full of liquid); (3) if there are bubbles in the tube; and/or (4) the color and
opacity of the fluid in the tube.
Referring now to Figs. 34, 35, and 36 for a description of an exemplary use
of the system 108 of Fig. 33. The detection algorithm residing within the memory 585 and
executed by the processor 584 (see Fig. 33) uses three template images: one representing no
tube installed; another representing a tube installed with clear liquid therein; and another
representing a thin vertical slice of a bubble as shown in Fig. 34. The algorithm quantifies
how closely each section of the tube 111 matches the bubble template of Fig. 34, the no tube
template, or the tube template with liquid therein. The matching algorithm may utilize the
OpenCV pattern matching function, matchTemplate(), bed in on (14) or
Equation (15) above, or an FFT pattern matching algorithm. In yet additional embodiment
any of the methods for pattern ng of the matchTemplate() of openCV may be used,
such as, for example, CV_TM_SQDIFF, CV_TM_SQDIFF_NORMED, CV_TM_CCORR,
and/or CV_TM_CCORR_NORMED.
] The pattern matching algorithm may scan from one side to the other side,
e. g., from left to right. As the processor 584 scans across the image, the pattern matching
algorithm tries to match each template to one of the scanned section. If a template matches,
and several scans later, no template is matched and finally another template is matched, the
sor may interpolate that the later template is the most likely one that should have been
matched. For example, when scanning from left to right, in region 191, the te of a
tube with liquid n matches. When transitioning from a side of the bubble 112 from the
left, a region 194 on the left side of the bubble within the box 112 may not match any
template, and finally, within the box 112, the bubble may match to the air template in region
193; the processor 584 may assume the reason the pattern matching algorithm could not
match the intermediate region of 194 with a template is e the bubble’s image started
to change the camera’s View. Therefore, in this example, the region 194 in which no
template was determined to match, the processor 584 may assume that the bubble was
present. Also note that interpolation may be used in region 195.
If there is a close match (including the interpolation as described above) a
bubble can be identified as is shown in the box 112. The size of the bubble in the box 112
can be estimated based on the tube’s 111 diameter (either known in advanced or measured
by the camera 109 of Fig. 33) and the bubble length found in the template matching
algorithm, e.g., as determined by the box 112. The box 112 may model the bubble as a
cylinder having the diameter of the tube 111. The bubble information can be compared
frame to frame to keep track of how many bubbles have moved through the field of view
and their sizes (and thus the total amount of air delivered to a t may be tracked). The
processor 584 may issue an alert or alarm if any bubble exceeds a given size, if the total
amount of air passing through the tube 111 exceeds a predetermined old, or if the total
amount of air passing through the tube 111 exceeds a predetermined threshold within a
predetermined amount of time. In some embodiments, the color of the fluid may be used to
estimate and/or determine the amount of air dissolved within the liquid within the tube 111.
] In some ments, the bubble of Fig. 36 may have its shape estimated.
For example, edge detection may be used to identify the left and right edges of the bubble to
te its volume, e. g., Canny edge detection, a order edge detection algorithm, a
second—order edge detection algorithm, a phase congruency—based edge detection algorithm,
and the like. The edge detection algorithm may utilize one found in OpenCV. Additionally
or alternatively, the edge detection algorithm may e 5 previous pixels from a side
(e. g., the left side) and compare that to an average of the next 5 pixels (e. g., the right side),
and when the change exceeds a predetermined threshold, the edge of the bubble may be
determined to be present.
Additionally or alternatively, the camera 109 can capture an image with a
threshold amount of red liquid within the tube 111 such that the one or more processors 584
determines that blood is t within the tube 111. For example, the system 108 having
the camera 109 of Fig. 33 may be used to form the infiltration or 32 of Fig. 2. One or
more of the pumps, e.g., pumps 19, 20, and 21, may be used to create a backpressure to
determine if the catheter is properly in the vein. That is, if the catheter is properly within
the vein, then a small amount of negative pressure within the tube should draw blood into
the tube. As shown in Fig. 37, blood 113 may be captured within an image taken by the
camera 109 of Fig. 33, which is then processed to ine that a threshold of red exists.
Fig. 38 shows a region 114 determined by the one or more processors, e. g., processor 37 of
Fig. 2, that a threshold amount of red color exists. The white pixels depicts that a threshold
amount of red has been detected and a black pixel depicts that a threshold amount of red has
not been detected for that pixel.
In another embodiment, the pixels are converted to grayscale and then a
threshold amount of a dark color may be used to ine that blood exists at each
individual pixel. For example, if the pixel is determined to be below a threshold (e.g.,
closer to black beyond a threshold), that pixel may be determined to be blood and is thereby
converted to white while the ing pixels are converted to black (or in other
embodiments, vice versa). For example, the image taken may be in RGB format which is
then ted to a grayscale image using the void cvtColor() function of the OpenCV
library using the CV_RGB2GRAY color space conversion code. The threshold amount
may be 50, 128, or may be dynamically adjusted.
The processor 37 may determine that infiltration has occurred when the
infusion site monitor 26 of Fig. 2 receives no blood or less than a ermined amount of
blood within the tube when a predetermined amount of negative re is present within
the tube, e.g., when running an infusion pump in reverse. The amount of blood may be
ined by summing the white pixels within the region 114. The tube may include
fiducials to help locate the tube and/or the tube’s holder. Additionally or alternatively,
fiducials may be used to indicate distance, e.g., the volume of blood in the tube may be
correlated with the length of the blood within the tube using the fiducials, for example, to
prevent g back too much blood during an infiltration test.
Fig. 39 shows an infiltration detector 115 in accordance with an embodiment
of the present disclosure. The ration detector 115 of Fig. 39 may be the infiltration
or 32 of Fig. 2. The infiltration detector 115 includes a photodiode coupled to a T—
connector 117. The T-connector connects the tube 118 to the tube 119 that feeds liquid into
the view 120 via an internal portion of the er 121. The infiltration detector 115 also
includes an LED 122 that shines light into the skin 124. The photodiode 116 and the LED
122 may be coupled to a sor that implements an algorithm to determine when
infiltration has occurred, e.g., processor 37 of the infusion site monitor 26 of Fig. 2. The
algorithm may be implemented by an operative set of processor executable instructions
(e.g., as stored on a memory 38) ured for execution by the processor (e.g., the
processor 37).
[00433] Blood entering into the tube 119 and found around the catheter has
significant light absorbing properties at specific wavelengths that would minimize the
passage of light from the LED 122 through a light path that passes through soft tissue, the
vein wall, venous blood, and the fluid in the IV catheter and tubing 119. When infiltration
has occurred, fluid should surround the internal portion of the catheter 121 (e.g., 18 Gauge),
and the amount of light from the LED 122 to the photodiode 116 is reduced from optical
absorption caused by the blood. This is in contrast to an rated state where IV fluid
nding the catheter 121 minimally absorbs or attenuates the same light wavelength
absorbed by venous blood and therefore allows a larger intensity of light to pass from the
LED 122, through the soft , extravasated fluid, and then into the catheter 121 and IV
tubing 119 to the light detector, e.g., the photodiode 116.
The photodiode 116 may be disposed such that it could receive any light
passing through a catheter 121 and the tube 119. The T-connector 117 is configured to
allow fluid to simultaneously pass into the catheter 121 from tube 118 via tube 119, and
allow light from the tube 119 to be diverted into the photodiode 116.
[00435] The LED 122 emits light at a wavelength that is attenuated by the
hemoglobin in the blood and is positioned to illuminate the surface of the skin 124 near the
open end of the catheter 121. When the catheter 121 is ly placed within the vein 126,
the attenuation of the nation from the LED 122 by blood reduces the amount of light
that reaches the photodiode 116. Additionally, when the catheter 121 is no longer
positioned within the vein 126 (e. g., which occurs when an infiltration ), the
illumination from the LED 122 passes into the catheter 121 and through the tube 119 to be
detected by the photodiode 116.
Fig. 40 shows a graphic 127 illustrating the optical tion of ated
and de—oxygenated obin in accordance with an embodiment of the present
sure. The graphic 127 shows that both oxygenated and de-oxygenated hemoglobin
have strong absorption in the 0 nanometer range and the 400-450 nanometer range.
Referring again to Fig. 39, in some embodiments of the present disclosure, the LED 122 and
the photodiode 116 may be configured to emit and absorb, respectively, 405 nanometers,
470 nanometers, 530 nanometers, 590 nanometers and 625 nanometers optical wavelengths.
In some ments, the photodiode 116 may be a silicon photo—detector with measurable
response from 400 nanometers to 1000 ters.
Referring now to Fig. 41, r infiltration detector 128 in accordance with
another embodiment of the present disclosure is shown. The infiltration or 128
includes a laser 129 to further illuminate the vein 126. The photodiode 116 is placed at the
end of a syringe 130, which includes a wrapping of copper tape to minimize stray light. The
LED 122, the laser 129 (e. g., a laser pointer), or both may be used to illuminate the end of
the catheter 121. The LED 122 may emit light having ngths about 625 nanometers,
and the laser 129 may emit light red wavelengths.
In some embodiments of the present disclosure, the catheter 121 and/or the
tube 119 includes a stainless steel needle (e.g., 18 gauge) having connectors wrapped in
aluminum foil. In yet additional embodiments of the present disclosure, the LED 122
and/or the laser 129 may be modulated to enhance detection by the photodiode 116.
[00439] The syringe 130 may be used to apply a negative pressure to the tube 119.
The processor 37 of Fig. 2 may be d to the photodiode 116 and a position sensor of
the syringe 130 to determine if an infiltration has occurred. If, after the syringe 130 (either
manually of via an automatic actuator) is pulled back as sufficient amount of distance and
no blood is detected by the photodiode 116 (e.g., from spectral absorption by the blood), the
processor 37 may issue an alert and/or alarm to indicate that an infiltration has ed.
In another embodiment, a small fiber optic disposed through the catheter 121
or needle illuminates the area at the tip of the catheter 121, e. g., the LED 122 is coupled to
the fiber optic cable to guide light into the vein 126. Additionally or alternatively, a pulse
oximeter over the IV site may be used to automatically measure a baseline profile of
absorption to detect changes caused by an infiltration, e. g., using the processor 37.
It yet additional embodiments, a cent coating is optionally applied to
the tip of the needle of the catheter 121 that is excitable by light in a wavelength
icantly absorbed by venous blood. For example, colored light which is absorbed by
obin would not be detectable when the catheter 121 is properly located in the vein.
When the catheter 121 was d outside of the vein, this light would not be absorbed and
would become detectable by the photodiode 116. The fluorescent g will emit less
when the exciting light is absorbed by the hemoglobin, and the emitted light may also be
absorbed by the hemoglobin.
For example, the emitted light from the fluorescent coating may be different
than the exciting light, e. g., from the LED 122, and the photodiode 116 may include a filter
to filter out the exciting light from the LED 122 and to receive the light being emitted from
the excited fluorescent coating. In some embodiments, the cent coating may
fluoresce when a black light is applied. Additionally or alternatively, the LED 122 may be
modulated.
Fig. 42 shows a perspective view of an occluder 131 in ance with an
embodiment of the present disclosure. Fig. 43 shows a side View of the occluder 131, and
Fig. 44 shows a side View of the occluder 131 in operation. Referring now to all of Figs.
42, 43, and 44, the occluder 131 includes occluder edges 132 and a pivot 133. The occluder
131 may e a spring (not shown) to force the occlude edges 132 against a tube 135.
onally or atively, the occluder 131 may include an actuator 134 to actuate the
occluder 131 against the tube 134.
The occluder 131 may be used within a peristaltic pump such that when a
door is opened for positioning the tube 135, the occluder 131 is opened for placing the tube
135 within the region of the occluder edges 132. When the door is opened again, the
occluder 131 may transition from an open to a relaxed state by action of the actuator 134 to
occlude the tube 135.
] Fig. 45 shows a side view of a valve 136 for use in a cassette in accordance
3O with an embodiment of the t disclosure; Fig. 46 shows a top View of the valve 136;
and Fig. 47 shows another side view of the valve 136 installed within a cassette in
accordance with an embodiment of the present disclosure. As is easily seen in Fig. 45, a
path 137 illustrates the flow of fluid. In Fig. 46, the exit orifice 138 and reentry orifice 139
are visible. Fig. 47 shows a membrane 140 when the valve 136 is installed in a cassette.
The membrane 140 may be set to compress again the valve 136 and may be 0.032 inches
thick. The membrane 140 may use an ed adhesive. The membrane 140 ts the
fluid from flowing in the wrong direction, e.g., opposite to that of the path 137 as shown in
Fig. 45. When the fluid attempts to flow in the wrong direction, the suction force presses
the membrane 140 against the exit orifice 138 preventing fluid from flowing from the
reentry orifice 139 to the exit orifice 138. Additionally or alternatively, a plunger coupled
to an actuator may be used to compress the membrane 140 to further close the valve 136. In
yet an additional embodiment of the t disclosure, a positive or negative pressure may
be applied to the top of the membrane 140 to control the valve 136.
Fig. 48 shows a g valve 141 having an inclined plane to provide sealing
in accordance with an embodiment of the present disclosure. The sliding valve 141 includes
a sealing surface 142 and a ng surface 143. As seen from Fig. 49 which shows a side
view of the sliding valve 141, the sliding valve 141 includes spring arches 144, and a wedge
145 to create a downward force to seal the port 146 of the mount 147 as shown in Fig. 50.
A downward force on the spring arches 144 causes the sliding valve 141 to
slide away from the mounting es 143 exposing the valve port 146. When released, the
spring arches 144 force the sealing arm 148 towards the mounting surfaces 143, and the
downward force wedges 145 make contact with a molded counterpart in the mount 147 and
force the sealing surface 142 onto the valve sealing surface port 146.
Figs. 51—55 show a vent 149 for a reservoir 150 in accordance with an
embodiment of the t disclosure. The vent 149 may be used on the fluid reservoirs 2,
3, or 4 in Fig. 1, may be used on the air filter 50 or with the drain chamber 53 of the pump
19 as shown in Fig. 3. The vent includes a septum 151, an air permeable filter 151, and a
tube 153. In some embodiments of the present disclosure, a reservoir 150 of an te is
rigid, e. g., a rigid IV bag or other fluid reservoir for a fluid pumping device. The oir
150 may include a vent 149 to allow fluid flow out of a rigid reservoir 150 while venting the
fluid reservoir 150 with an air permeable filter 152. In some embodiments, the vent 152
may not be impermeable to water vapor. However, by placing an oil plug 154 inline
n the fluid reservoir 150 and the air filter 152, infusate 155 losses are reduced
because the oil 154 ts the te from evaporating through the oil plug 154.
The oil plug 154 is created by placing the septum 151 upstream of the
reservoir 150 in a relatively narrow cross—sectioned section of the reservoir 150 as shown in
Figs. 51, 52, 53, 54, and 55. As shown in Fig. 52, oil 154 is injected through the septum
151 through a filing needle 156 before ing the infusate 155 (as shown sequentially in
Figs. 53 and 54). An amount of oil 154 is left in between the air filter 152 and the infusate
155 at the end of the fill. As air is drawn into the oir 150 through the air filter 152, as
shown in Fig. 55, the oil 154 advances with the infusate 155 preventing evaporative losses.
Additionally or atively, in some embodiments, the oil plug 154 is pre—
loaded into the tube 153 in between the septum 156 and the air filter 152; for example, as
would be the case if the fill procedure began as shown in Fig. 52.
Figs. 56-58 illustrate the stages of a flow meter 157 in accordance with an
embodiment of the present disclosure. Fig. 56 illustrates a first stage, Fig. 57 illustrates a
second stage, and Fig. 58 rates a third stage. The stages of Figs. 56—58 may be
implemented as a method in accordance with an embodiment of the present disclosure. A
pump disclosed herein may be coupled upstream via the input port 162 and/or an infusion
pump may be coupled to the output port 163 downstream to create a fluid from the input
port 162 through the flow meter 157 to the output port 163.
The flow meter 157 includes a chamber 158 divided by a membrane 159.
The ne 159 divides the chamber 158 into a first section 160 and a second section
161. The flow meter 157 includes an input port 162 and an output port 163. The flow
meter 157 includes first 164, second 167, third 166, and fourth 165 valves. The input port
162 is in fluid communication with the first section 160 via the first valve 164 and the
second section 161 via the fourth valve 165. The output port 163 is in fluid communication
with the first section 160 via the third valve 166 and the second section 161 via the second
valve 167. The r 158 may be spherically shaped or cylindrically shaped. The
chamber 158 may be rigid, e.g., the chamber 158 may be made out of a plastic, metal, or
other rigid or semi-rigid material.
The flow from the input port 162 to the output port 163 may be red by
use of the flexible membrane 159. The passage of fluid may be controlled via actuation of
the first valve 164, the second valve 167, the third valve 166, and the fourth valve 165. To
fill the second section 161 of the chamber 158 and empty the first section 160 of the
chamber 158, the first valve 164 and the second valve 167 are closed while the third valve
166 and the fourth valve 165 are . This pushes the diaphragm or membrane 159 to
the top side of the chamber 159 as shown in Fig. 57. As illustrated in Fig. 58, this process
can be reversed to fill the first n 160 and empty the second section 161 by opening the
first valve 164 and second valve 167 while closing the third valve 166 and fourth valve 165.
Because the volume of the chamber 158 is known, the volume of fluid flowing through the
input port 162 to the output port 163 can be estimated by the movement of the membrane
e it is expected that the membrane 159 will become flush against the inner e of
the chamber 15 8.
To determine when the membrane 159 (i.e., diaphragm) has reached the top
or bottom of the chamber 158, a pressure sensor could be added to the input valve 162.
When the membrane 159 reaches the end of the travel, the flow from the input port 162 will
be occluded and the re will increase. At this point, the valves can be switched (as
shown in Fig. 58) and the process ued on the te chamber.
In some embodiments of the present disclosure, the valves 164, 165, 166,
and 167 may be ically toggled. The input port 162 pressure could potentially be used
to mechanically toggle a switch that alternately opens and closes the two pair of valves in
each state as illustrated by Figs. 56—57, or Fig. 58. For e, the inlet pressure could
expand a spring—loaded diaphragm which pushes on a latching mechanism that controls the
valves 164, 165, 166, and 167.
Additionally or alternately, in some embodiments, the chamber 158 may be
made of a clear material (polycarbonate, topaz, etc.) and the diaphragm 159 out of an
opaque material, and a camera may be used to observe the chamber 15 8 and detect when the
diaphragm 159 has reached the end of its . In yet another embodiment, a ”target”
image may be placed on the diaphragm 159 and a pair of stereo cameras (not shown) could
detect when this target has reached the chamber 158 housing edge and is viewable. For
example, there may be a camera to view the first section 160 from the outside and r
camera to view the second section 161 from the e.
[00457] Fig. 59 shows a diagram of a disposable portion 168 of a flow rate meter in
accordance with an embodiment of the present disclosure. The disposable portion 168 may
be part of the flow meter 10, 11, or 12 of Fig. 1, the flow meter 169 of Fig. 2 for use within
the infusion site monitor 26, or may be the flow meter 48 of Fig. 3 for use with the pump 19
(in some embodiments, the flow meter 48 is coupled to the tube 56). In yet additional
embodiments, the disposable portion 168 is part of an integrated flow rate meter and
membrane pump. The disposable portion 168 may interface with an upper clam—shell
Acoustic Volume Sensing (AVS) assembly and a lower clam—shell AVS assembly (e. g., the
upper clam—shell AVS assembly 192 and the lower hell AVS assembly 193 of Fig. 70
as described below). Acoustic volume sensing is described in greater depth in the section of
the detailed description tilted “ACOUSTIC VOLUME SENSING”
] The disposable portion 168 includes inlet tubing 170, an inlet occlude release
collar 171, an inlet Duck—bill occluding valve 172, a disposable body 173, fluid tracks 174
and 181, an AVS chamber 175 (described below), an air purge and spectral analysis
window 176, and an outlet assembly 177. The outlet assembly 177 includes an occluding
valve 178, a release collar 179, and an outlet tubing 180.
The duck-bill valves 172 and 178 may be ed open by deforming the
duck-bill (pinching the slot) when AVS hells (see Fig. 70) are closed over the AVS
fluid chamber 175, and/or there may be separate components on the tubing set to open the
valves 172 and 178 manually (e.g. sliding an oval ring over the duck bill to open it, etc.).
The AVS chamber 175 may be utilized to measure the fluid flowing through
the disposable portion 168. That is, the AVS system described below can measured the
volume of fluid within the AVS r 175. The flow rate may be communicated by a
processor to the monitoring client 6, e.g., Via a wired or ss connection. The
measurement taken from the AVS chamber 175 may be operatively communicated to a
processor, e. g., the processor 37 of the infusion site monitor 26 of Fig. 2 or the processor 38
of the pump 19 of Fig. 3 to l the ement of fluid flowing through the AVS
chamber 175.
] Referring to Figs. 1 and 59, the disposable portion 168 may be used (with the
full clam—shell AVS assembly bed below) to control the flow of the pumps 19, 20,
and/or 21 (directly or via a control system within the monitoring client 6) or may be used to
indicate when a predetermined amount of fluid has been fed into the patient 5, in which case
a signal is sent to the pumps 19, 20, and/or 21 to stop fluid flow (directly or via a control
system within the monitoring client 6). In some embodiments, the disposable portion 168,
when used as a flow meter with the full clam-shell AVS assembly, can be used to run a
pump in a fixed volume mode with a variable fill and/or empty time, can be used to run in a
variable volume with a fixed and/or variable fill or empty time, or can be run in a fixed
measurement interval, etc. Additionally or atively, the disposable portion 168 may
detect error conditions or run—away conditions (e. g., fluid is flowing beyond a
ermined threshold), which may cause the flow rate meter using the disposable portion
168 to issue an alarm or alert, e.g., directly or to the monitoring client 6. The alarm or alert
may be used to cause one or more of the valves 16, 17, 18, and/or 25 to prevent additional
fluid flow.
] Referring again to Fig. 59, the disposable portion 168 may be formed by two
or more sheets of barrier film or layers of barrier film and a rigid plastic sheet that are heat
sealed together. The disposable portion 168 may be used with (or is part of) the disposable
portion 194 of Figs. 60-62, the able n 201 of Figs. 63—65, the disposable portion
208 of Figs. 66-68, and the disposable n 220 of Fig. 69. The fluid tracks may be
incorporated into the film and/or the rigid plastic (e.g. they may be thermally formed or
simply an area of the film that is not heat sealed). For example, the rigid portion may define
the fluid tracks 174 and 181, and the AVS chamber 175; and a flexible layer may be placed
over the rigid sheet such that the flexible layer is generally flat when in an unpressured state
over the rigid layer.
For example, the disposable portion 168 may be formed from three layers
using a rigid plastic sheet with a barrier film/membrane on either side that contains fluid
tracks routed on one (or both) sides connected by through hole(s) in the rigid plastic sheet
(e.g., a ”Via”).
The AVS chamber 175 may be incorporated into the film and/or the rigid
plastic (e. g. thermally formed or simply an area of the film that is not heat sealed; that is, the
chamber expands with the elastomeric potential when filled). The fluid may be routed into
the AVS chamber 175 via fluid tracks in the film/membrane, e.g., when using the three
layer design. For example, the AVS chamber 175 may be fed by holes in the AVS chamber
175 with the fluid tracks 174 and 181 on the te side. In some embodiments, these
holes are part of a valving system that works on the fluid tracks on the opposite side. The
tubes 170 and 180 may interface into the fluid tracks 174. The tubes 170 and 180 include
normally closed occluding valves 172 and 178, respectively. Additionally or alternatively,
in some embodiments of the present disclosure, the occluding valves 172 and/or 178 may be
one-way valves.
The air purge and al is window 176 may be transparent for
spectral imaging and/or analysis of the composition of the fluid contained therein. For
example, the al analysis window 176 may be used by a camera to detect blood therein
or to determine the spectral absorption or reflection of the al therein which is
compared to a database to determine the likely composition of the fluid and/or a
concentration of a material.
The air purge 176 may include a micorporous hydrophobic membrane that
has one side in contact with the infused fluid and the other side is exposed to here
air. The micorporous hydrophobic membrane may be located, in some specific
embodiments, in a pressurized section of the flow path. The air purge and spectral analysis
window 176 may include an integral air bubble trap to prevent free flow of bubbles and/or
re may drives trapped s across the membrane while fluid passes past the trap,
etc.
The disposable portion 168 may optionally include several alignment
features 182, which may be ink markers, holes, indentations, or other alignment feature(s).
The disposable portion 168 may be constructed using stamping, vacuum forming and heat
sealing, and can use materials known to be compatible with infusion fluids (e.g. IV bag
materials, polycarbonates, Topaz, etc.).
Figs. 60—62 show several views of a single—sided disposable portion 194 of a
flow meter in accordance with an embodiment of the present disclosure. Fig. 60 shows a
side view of the disposable portion 194 of a flow meter, Fig. 61 shows a top view of the
disposable n 194 of the flow meter, and Fig. 62 shows an end view of the disposable
portion 194 of the flow meter.
The disposable n 194 includes a one or more film layers 195 that
define a fluid space 196 with a bottom film 197 that may be rigid (in some embodiments the
bottom film 197 is semi—rigid or flexible). As is easily seen in Fig. 61, the film 195 also
forms an AVS chamber 198. As seen in Fig. 62, the AVS chamber 198 is oned to
e the fluid flowing into and out of the AVS r 198 via the fluid track 199. The
fluid track 199 interfaces with the AVS chamber 198 allowing it to expand as fluid enters
into the AVS chamber 198 from the fluid track 199. The fluid track 199 may hold a volume
of, in some specific embodiments, .025 cc allowing for 300 milliliters per hour maximum
flow rate. The layers 195 are head bonded along length 200.
As shown in Fig. 62, the fluid track 199 formed by the layer 195 is visible
and the AVS chamber 198 is also visible; however, the layer 195, in some embodiments,
transitions from the fluid track 199 to the AVS r 199 when transitioning from the
left side of the disposable portion 194 to the right side as shown in Fig. 61. For example, in
Fig. 62, the fluid track layer 199 is relatively proximal (along a length 284 of Fig. 61) to the
AVS chamber 198 (which is along a length 285 of Fig. 62), which is distal in the view
shown in Fig. 62.
Figs. 63—65 show several views of a double—sided disposable portion 201 of a
flow meter in accordance with an embodiment of the present disclosure. The disposable
portion 201 includes one or more top films 202 with one or more bottom films 203 that
er define a fluid space 204. Either one of the films 202 and/or 203 may be rigid,
semi—rigid, flexible, or c. In additional ic embodiments, a rigid, planar layer may
be positioned between the layers 202 and 203 (not depicted) with the layers 202 and 203
being flexible.
As is easily seen in Fig. 64, the films 202 and 203 form an AVS r
205. As is easily seen Fig. 65, the AVS chamber 205 can measure fluid received from a
fluid track 206. Also, fluid may leave the AVS chamber 205 via the fluid track 206. As
also shown in Fig. 65, the heat sealed and/or bonded interface 207 is shown. As mentioned,
in some embodiments, a rigid member (not shown) may be placed in the center of the layers
202 and 203 thereby ng two AVS chambers 205 and two fluid tracks 206; in this
specific embodiment, a small hole may exists between the two fluid tracks 206 and/or the
two AVS chambers 206 to provide pressure equalization therebetween. Any common mode
compliance of the fluid track 206 would be accounted for by one of the AVS chambers 205
thereby providing a self balancing of the AVS measurements.
Figs. 66—68 show several views of a three—layer, opposite—sided, disposable
portion 208 of a flow meter in accordance with an embodiment of the t disclosure.
The disposable portion 208 is formed by a top layer 209 and a bottom layer 212 having a
rigid c layer 210 therebetween. The rigid plastic layer 210 has two holes 217 and 218
that allow fluid to pass between a fluid space 211 and the AVS r 213.
The fluid passes from the fluid track 215 through the holes 217 and 218 to
transgress through the AVS chamber 213. Also, the disposable portion 208 includes a heat
bonded n 219.
Fig. 69 shows a top view of another disposable portion 220 of a flow meter
in accordance with another embodiment of the t disclosure. The disposable portion
220 includes one or more layers bonded to a rigid body 259. The rigid body 259 includes a
cut—out portion 260. The AVS r 261 may protrude out of both side of the rigid body
259 allowing an AVS assembly (not shown) to surrounding the AVS chamber 261 to
estimate the volume of the AVS chamber 261. Air may completely transgress through the
cut—out portion 260 such that a variable volume may be positioned completely (or
substantially) around the AVS chamber 261. The disposable portion 220 may be formed
from one or more elastic layers sealed to the rigid body 259. The disposable portion 220
includes fluid tracks 262 and 263 enabling fluid to ress and egress through the AVS
chamber 261.
Fig. 70 shows a flow meter 221 including a full AVS clam shell assembly
and a single—sided disposable portion (e.g., the disposable portion 194 of Fig. 62) in
accordance with an embodiment of the present disclosure. The flow meter 221 may fill .025
cc of liquid for up to 300 milliliters per hour.
] The AVS clam shell assembly includes the upper clam-shell AVS ly
192 and the lower clam-shell AVS assembly 193. The lower clam-shell AVS assembly 192
may be slightly biased for proper seating in the lower backing 233 and/or it may include a
rigid plastic sheet or ner to compliment the vents 224. The upper and lower clam—shell
AVS assemblies 192 and 193 may circumferentially surround the AVS fluid volume 224,
e.g., just outside the heat seal using a trough/protrusion “pinch”; and an o—ring may
optionally also be used to seal the AVS fluid volume 224. The flow meter 221 may
optionally include an air sensor as described herein, e.g., ultrasonic— and/or camera—based
air sensor, to determine if air beyond a threshold is being red to a patient; an alarm or
alert may be issued in response to the air exceeding the threshold. Additionally or
alternatively, the air may be cted from the volume of liquid estimated as flowing
through the flow meter 221.
[00478] The flow meter 221 includes an AVS reference chamber 222, a reference
microphone 223, a resonance port 224, an integral ter seal or valve 225 (shown in the
open state), another al perimeter seal or valve 230 (shown in the sealed state), a
variable volume microphone 226, a speaker 227, and a variable volume 228. The flow
meter 221 also includes a spring disk 229. The spring disk 229 may include a small hole for
pressure equalization. The spring disk 229 may be formed, in some embodiments, out of an
elastomeric film or layer. In some embodiments, the spring disk 229 is used to bring in
fluid into the AVS fluid volume 224. The spring disk 229 may provide a spring via pre-
forming and/or the variable volume 228 may have a negative or positive pressure relative to
either the ambient air and/or the fluid flowing through the AVS fluid volume 224.
[00479] The valves 225 and 230 slide along the body of the upper clam—shell AVS
assembly 192 to permit or occlude fluid from enter or leaving the AVS fluid volume 224.
The valves 225 and 230 are coupled to an or (e.g., linear servo, linear stepper motor, a
cam follower d to a rotating cam, etc.) to control the valve states of the valves 225
and 230. The valves 225 and/or 230 may: be normally closed; actuated open (e.g., using a
solenoid and/or Nitinol); include a position sensor; cone—shaped (e.g., a cone shaped plunger
from the fluid track side pushes through the elastomer into the AVS chamber inlet/outlet
holes to form a seal); and may include an opposing re seal to determine if the valve is
applying sufficient pressure. The actuators may be coupled to a processor disclosed herein
(e.g., the processor 37 of Figs. 2 or 3). The valves 225 and/or 230 may both close in an
error condition to prevent fluid from being sent to a patient, e.g., when the processor 37 of
Figs. 2 or 3 and/or the monitoring client 6 determines that an error condition exists that
requires the stoppage of the fluid flow to the patient. The sor may coordinate
operation of the valve 225 and 230 such that the AVS volume 226 is filled when, for
example, a pulsing pump pumps liquid ream. The flow rate meter 221 may
coordinate its operation with a pump, e.g., via wireless ation received from the pump,
such as a flow rate, pulse times, pulse durations, pulse s, pulse frequency, etc.
The speaker 227 emits one or more acoustic frequencies which are received
by the reference microphone 223 and the variable volume microphone 226. The acoustic
gain between the microphones 223 and 226 may be correlated with the volume of the
variable volume 228 to determine the volume through the flow rate meter 221. Additionally
or alternatively, the phase shift between the microphones 223 and 226 may be correlated
with the volume of the variable volume 228. The r 227 and the microphones 223 and
226 may be in operative communication with one or more processors to implement an
thm to determine the volume using AVS, e.g., the processor 37 of Figs. 2 or 3.
Additional details related to the operation of AVS are described infra in the section entitled
“ACOUSTIC VOLUME SENSING.”
The films 231 and 233 define a fluid space 232. As the fluid varies within
the AVS fluid volume 224 by entering and leaving via the fluid space 232, the ence in
volume is calculated to determine the flow rate via the flow meter 221. That is, the variable
volume 228 has an acoustic se that may be used to determine the AVS fluid volume
224. The flow meter 221 also includes ventilation paths 225 to prevent air from building up
under the film 233 that defines the AVS fluid volume 224.
[00482] In yet an additional embodiment of the present disclosure, the flow rate
meter 221 may be utilized as part of a membrane pump. For example, an actuator (not
shown) may interface with the spring disk 229 (or the film 231) to providing a pumping
action with the AVS fluid volume 224; the actuator may exists within the variable volume
or may interface with the spring disk 229 via a shaft that transgresses through the upper
clam shell assembly 192 (with an riate acoustic seal). The shaft’s volume may be
accounted for in the AVS ement and/or the entire actuator may be in the variable
volume.
Fig. 71 shows a side view of a flow rate meter 234 including a top AVS
assembly 236 and bottom AVS assembly 238 with integral ter seal valves 239 and
340 in accordance with an embodiment of the t disclosure. The flow rate meter 234
may include the disposable portion 201 of Figs. 63-65. The flow rate meter 234 may allow
for flows of up to 0.25 cc per fill for up to 300 milliliters per hour, in some specific
embodiments, e. g., 0.125 cc for each side for 150 millimeters per hour on each side.
The top AVS ly 236 measures the acoustic response of the top
variable volume 241 and the bottom AVS assembly 238 measures the acoustic response of
the bottom variable volume 242. The measurements of the ic response of the top and
bottom variable volumes 241 and 242 may be ated to the top and bottom variable
volumes 241 and 242. The volume of the AVS fluid chamber 243 may be estimated by
subtracting a predetermined total volume from the volumes of the AVS chambers 241 and
242. A processor disclosed herein (e.g., processor 37 of Figs. 2 or 3) may estimate the
volume of the AVS fluid chamber 243.
In yet an additional embodiment of the present disclosure, the flow rate
meter 234 may be utilized as part of a membrane pump. For example, one or more actuator
(not shown) may interface with the spring disks 235 and/or 237 (or the AVS fluid chamber
243) to provide a pumping action with the AVS fluid volume 243; the actuator may exists
within the variable s 243 and/or 242 or may interface with the spring disks 235
and/or 237 via a shaft that transgresses through the AVS assemblies 236 and/or 238 (with an
riate acoustic seal). The shaft’s volume may be accounted for in the AVS
measurement and/or the entire actuator may be in the variable volume.
] Fig. 72 shows a side view of another flow rate meter 244 including a single-
sided AVS assembly 245 with surrounding variable volumes 246 and 247 in accordance
with another embodiment of the present disclosure. The flow rate meter 244 may use the
disposable portion 220 of Fig. 69. The variable volumes 246 and 247 may be in fluid
communication with each other around the edges of the AVS fluid chamber 248. The AVS
assembly 245 measures the acoustic response of the chambers 246 and 247 to correlate the
volume of the AVS chambers 246 and 247. The total volume of the AVS chambers 246 and
247 is subtracted from the predetermined total volume to estimate the volume of the fluid
within the AVS fluid volume 248.
In yet an onal embodiment of the present disclosure, the flow rate
meter 244 may be utilized as part of a membrane pump. For example, one or more
actuators (not shown) may interface with the spring disks 286 and/or 287 (or the AVS fluid
chamber 248) to provide a pumping action with the AVS fluid volume 248; the actuator
may exist within the variable s 246 and/or 247 or may interface with the spring disks
286 and/or 287 via a shaft that traverses through the AVS ly 245 (with an
appropriate acoustic seal). The shaft’s volume may be accounted for in the AVS
measurement and/or the entire actuator may be in the variable volume.
Fig. 73 shows a side view of yet another flow rate meter 249 including two
piston valves 250 and 251 in accordance with another embodiment of the present disclosure.
The piston valves 250 and 251 may be coupled to actuators which are, in turn, coupled to a
processor, e.g., the processor 37 of Figs. 2 or 3. The flow rate meter 249 includes a top
AVS clam—shell assembly 252 and a bottom AVS claim—shell assembly 253. The fluid
flows from the fluid track 254, through a hole 255 and into the AVS fluid chamber 256.
Thereafter, the fluid can flow through the hole 257 (when the valve 251 is in the open state,
through the fluid track 258) and finally out of the flow rate meter 249. The piston valves
250 and/or 251 may alternatively open and close such one of the piston valves is open while
the other one is closed. The spring disk 229 may assist in the intake of the fluid or the
expelling of the fluid out of the AVS fluid chamber 256.
] In yet an additional embodiment of the present disclosure, the flow rate
meter 249 may be utilized as part of a membrane pump. For example, one or more
actuators (not shown) may interface with the spring disk 288 (or the AVS fluid chamber
257) to provide a pumping action with the AVS fluid volume 257; the actuator may exist
within the variable volume 289 or may interface with the spring disk 289 Via a shaft that
resses through the AVS assembly 252 (with an appropriate acoustic seal). The s
volume may be accounted for in the AVS measurement and/or the entire actuator may be in
the variable volume.
[00490] Fig. 74 shows a flow rate meter 259 having top and bottom AVS assemblies
(262 and 263, respectively) which provide a semi—continuous flow in accordance with an
ment of the present disclosure. The flow rate meter 259 es valves 260, 261,
264, and 265. The valves 260, 261, 264, and 265 may e together to fill an AVS fluid
volume 266 and 267 in a sequential, but opposite, manner. For example, the valves 260,
261, 264, and 265 may operate to fill the AVS fluid volume 266 while discharging the other
AVS fluid volume 267, and vice versa. That is, when an AVS fluid volume is being filled,
the other AVS fluid volume may have an AVS ement taken by the respective AVS
assembly.
The flow rate meter 259 also includes a small reservoir 268 to buffer to fluid
flowing from a pump and a le er 269 that may be coupled to a processor. The
variable occluder 269 may be varied such that the discharge of the AVS fluid volumes 266
and 267 are “smoothed” out to produce a semi-continuous flow to the patient (e. g., the AVS
fluid volumes 266 and 267 may be spring loaded, such as with a disk spring, to force out the
fluid). The processor may use the feedback from the AVS assemblies 262 and 263 to adjust
the variable occlude 269 to achieve a target flow rate to a patient.
In one specific embodiment, the flow rate meter 259: measures flow over a
range of 0.1 to 300 ml/hr; allows for non—metered flow rates of greater than 300 ml/hr to
2000 ml/hr; the flow resistance does not exceed 1 PSI across a flow range of 0.1 to 2000
ml/hr; the active volume accumulation does not exceed 2 eters; has a hold up volume
of less than 0.5 ml; has a size of less than 1 inch, by 3 , by 1 inch for the disposable;
may be battery or wired powered and may run at a rate of 100 ml/hr for 8 hours on the
battery power; and may include a user interface that communicates with all of the valves,
sensors, and component wirelessly.
Fig. 75 shows a flow rate meter 276 having two in—line AVS assemblies 270
and 271 with several valves 272, 273, 274, 275, and 277 to control to fluid flowing
therethrough in accordance with an embodiment of the present sure. The valve 275
allows the least amount of fluid flow into the AVS volume 279 from the AVS volume 278,
the valve 274 allows more fluid to flow into the AVS volume 279 from the AVS volume
278, and the valve 273 allow the most amount of fluid to flow into the AVS volume 279
from the AVS volume 278. The valves 273, 274, and 275 may be controlled to l the
flow from the pump to the patient.
The two AVS assemblies 270 and 271 may each take measurements of the
AVS fluid volumes 278 and 279, respectively. The AVS fluid volumes 278 and 279 may be
different because of a pressure differences caused by the valves 273, 274, and 275 as the
fluid flow from the pump to the patient. The continuous fluid flow causes a difference in
pres sure based upon the Bernoulli principle.
A continuous flow sensor may utilize the Bernoulli ple. For example, a
fixed orifice or other restriction in a flow path of a fluid (e.g., one caused by an orifice
plate) may be used to measure a pressure drop across the orifice to determine the flow rate
based on the Bernoulli principle illustrated in Equation (33) as follows:
Q =Cd ’flL2 (33).
p A,
1_ _
Where Q is the volumetric flow rate, Cd is the discharge coefficient which
relates to turbulence of flow, p is the density of the fluid, A1 is the cross-sectional area just
in front of the restriction, A2 is the sectional area of the restriction, and Ap is the
pressure drop across the ction. Equation (33) may be simplified to Equation (34) as
follows:
Q = CA —1’ (34).
A0 is the area of the orifice, and Cf is a constant related to the turbulence and
flow geometry specific to the restrictor design (Cf lly has a value n 0.6 and 0.9
that is derived empirically). Therefore, the estimated flow rate is related to the area of the
orifice and the square root of the measured pressure drop. The ted flow rate is also
related to the density of the fluid being measured and the orifice geometry.
Therefore, the valves 273, 274, and 275 of the flow meter 276 may be
considered a restrictor (e.g., serving as an orifice plate in a continuous flow rate meter) to
produce a measurable pressure difference n the AVS volumes 278 and 279. The
AVS volumes 278 and 279 may be correlated with respective pressures e the
respective membranes forming the AVS chambers 278 and 279 will stretch based upon the
pressure therein.
For example, the valves 272 and 277 may be opened thereby allowing fluid
to continuously flow from the pump to the patient. The AVS volumes 278 and 279 will
have a difference in pressure caused by the total restriction from one or more of the valves
273, 274, and 275 (which may, in some embodiments, be modeled as an orifice).
The differential AVS volume measurements n the AVS chambers 278
and 279 are proportional to flow rate (the pressure difference may be correlated with flow
rate empirically). Any common—mode, down—stream pressure change would result in a
volume increase in both of the AVS rs 278 and 279 thereby subtracting out the
increase in the AVS chambers 278 and 279. Additionally, a predetermined positive change
in the AVS volume ements may be considered an indication of an ion, and a
predetermined change in the flow rate may trigger an alarm and/or alert.
The valves 273, 274, and 275 allow a range of flow rates from the pump to
the patient to be used and also change the measurement range of the flow rate meter 276. A
processor can actuate one or more valves 273, 274, and 275 and can determine the total
restriction of occlusion caused by the valves 273, 274, and 275. That is, the configuration
of the valves 273, 274, and 275 may be correlated with a model, e. g., a cross-sectional area
of a restriction using Equation (33) or (34), for determining the flow rate. The processor
may vary the valves 273, 274, and 275 to determine the flow rate within a desired
measurement flow rate range.
The AVS assemblies 270 and 271 perform a measurement within a
ermined amount of time by sweeping acoustic ncies (as described herein), e.g.,
for one—half a second or 1/20 of a second. In some embodiments, the AVS assemblies 270
and 271 may perform two types of frequency sweeps, e. g., a shorter frequency sweep (e.g.,
med in less time) and/or a full frequency sweep, e. g., to do other error checking such
as, for example, to check for acoustic leak(s). The flow rate meter 276 may, in some
ments, coordinate with a pump to introduce a periodic disturbance to calibrate the
flow meter 276 and/or for error checking. Additionally or atively, small reservoirs
400 and 401 may provide fluid dampening to "smooth" the flow in some embodiments. The
fluid reservoirs 400 and 401 may be formed from an elastic material that defines a bubble—
type flexible r.
The valves 272 and 277 may have their operation coordinated to check for
error conditions. For example, the valve 272 may be closed while the valve 277 remains
open to determine if the fluid is being discharged to the patient for error checking (e. g., to
check for occlusions, etc.).
In some embodiments, the valves 272, 273, 274, 275, and 277 are used so
that the AVS volumes 278 and 279 are operated such that one of the AVS volumes is filled
with a liquid while the other AVS volume is discharges the liquid thereby ing a piece—
wise continuous flow ements using the AVS volumes 278 and 270. Additionally or
alternatively, the valves 272, 273, 274, 275, and 277 may also be used to do a “flow to zero”
test to do a "flow zero" correction (e .g. correct for volume drift of the AVS volume
measurements).
In one specific embodiment, the flow rate meter 276: may measure
continuous flow over a range of 0.1 to 300 ml/hr (in some embodiments up to 2000 ;
has an accuracy of measurement of +/— 0.02 m1/hr from 0.1 to 2.5 m1/hr, or 5% otherwise;
measures fast enough to be insensitive to flow disturbances of a 10% change in flow in 1
second; measures with head height pressure changes of +/— 2PSI; does not add flow
resistance exceeding 1 PSI across a flow range of 0.1 to 2000 ml/hr; has a size of less than 1
inch, by 3 inches, by 1 inch for the disposable; may be battery or wired powered and may
run at a rate of 100 ml/hr for 8 hours on battery power; and may include a user interface that
communicates with all of the valves, sensors, and components wirelessly.
[00508] Fig. 76 shows a membrane pump 280 having a negative pressure source 281
in accordance with an ment of the t disclosure. The membrane pump 280
es valves 282 and 283 that can alternate between applying a negative re to the
variable volume 290 and apply atmospheric pressure to the variable volume 290. The
valves 282 and 283 are fluidly connected to the AVS reference volume 402 via a port 403
that is of a sufficiently small size that does not introduce ic artifacts, e. g., .020 inches
in some ic embodiments. A processor, e.g., processor 37 of Fig. 3, may control the
valves 282 and/or 283 to achieve a target pressure within the reference volume 402 as
measured by a pressure sensor 404. The processor, e.g., processor 37 of Fig. 37 of Fig. 3,
may be in operative communication with the valves 282 and 283, and with the pressure
sensor 404.
The valve 282 may be closed and the valve 283 may be opened thereby
putting the variable volume 290 in fluid communication with the ve pressure source
281. Thereafter, the valve 283 may be closed and the valves 282 opened to put the variable
volume 2190 in fluid communication with atmospheric air. This may be ually
repeated to repeatedly oscillate the pressure within the variable volume 290. In some
ic embodiments AVS measurements are made when the variable volume 402 is placed
in a static re state (e.g., set to ambient pressure, the static negative pressure, or by
closing the valves 282 and 283), and the AVS fluid volume 293 is placed in a static pressure
state (e. g., the piston valves 291 and 292 are closed).
[00510] As previously mentioned, a negative source 281 may be applied to the
variable volume 290 by opening the valve 283 and closing the valve 282. When the
negative pressure is applied to the variable volume 290, the piston valve 291 may be opened
and the piston valve 292 closed to draw fluid into the AVS fluid volume 293. Thereafter,
the valve 283 and the piston valve 291 are closed so that an AVS measurement may be
taken by the AVS assembly 249 (the AVS assembly 294 includes a lower AVS hell
assembly 296). Optionally, the piston valves 291 and 292 may be closed prior to or during
the AVS measurement. Thereafter, the valve 282 and the piston valve 292 are opened to
allow fluid to flow into the fluid channel 295 from the AVS chamber 293. Next, the piston
valve 292 and the valve 282 are closed, and another AVS measurement is taken from the
AVS chamber 293. The difference in these AVS measurements may be correlated to the
amount of fluid pumped for each tive pumping cycle. That is, each pulse of liquid to
the patient may be estimated by subtracting one AVS measurement from another AVS
measurement. In some specific embodiments the AVS measurements are each taken at the
same pressures of the AVS volume 290 (e.g., at atmospheric pressure or a static negative
pressure, as may be ined by the pressure sensor 404) to account for the effects of
positive and negative pressures on air—bubble volume thereby mitigating the effect that an
air bubble has on the fluid volume flow measurements.
[00511] Fig. 77 shows a membrane pump 300 having a negative—pressure source 296
and a positive—pressure source 297 coupled to valves 298 and 299, respectively, in
ance with an ment of the present disclosure. The negative—pressure source
296 may be in fluid communication with the variable volume 301 when drawing fluid into
the AVS r 302. Likewise, the positive—pressure source 297 may be in fluid
communication with the variable volume 301 when discharging fluid out of the AVS
chamber 302. The variable volume may be coupled to atmospheric re 303 via a valve
304 when an AVS measurement is taken.
Note that no disk spring is used in the embodiment shown in Fig. 77. The
AVS fluid volume 302 is formed by a flaccid material that generates little or no pressure
within the le volume 301. In some embodiments of the present disclosure, the pump
300 takes AVS measurements all at the same pressure to account for the pressure effects on
bubble size; for example: the AVS volume measurement may be taken as follows: (1) close
the piston valve 405, open the piston valve 406, open the valve 298, close the valve 299,
and close the valve 304 thereby causing fluid to be drawn into the AVS chamber 302 with
the negative pressure from the negative—pressure source 296; (2) close the piston valve 406
and close the valve 298; (3) open the valve 304 thereby causing the pressure of the variable
volume 301 to reach heric pressure 303; (4) close the valve 304; (5) take an AVS
measurement; (6), open the valve 299 and open the piston valve 405 thereby discharging the
fluid out of the AVS volume 302; (7) close the piston valve 405 and close the valve 299; (8)
open the valve 304 to ze the variable volume pressure to atmosphere 303; (9) close
the valve 304; (10) take an AVS measurement; (11) and compare the AVS volumes
measurements to determine the volume discharged, e.g., to estimate flow rate. The
previous example may be ed to take one or more AVS measurements in positive
pressure, ve pressure, atmospheric pressure, or in some combination thereof.
In yet an additional embodiment, the positive pressure source 297 is used to
take AVS measurements when the variable volume 301 is under a positive pressure. For
example, in some embodiments of the present disclosure, the pump 300 takes AVS
measurements all at a ve pressure to account for the pressure effects on bubble size;
for example: the AVS volume measurement may be taken as follows: (1) close the piston
valve 405, open the piston valve 406, open the valve 298, close the valve 299, and close the
valve 304 thereby causing fluid to be drawn into the AVS chamber 302 with the negative
pressure from the negative—pressure source 296; (2) close the piston valve 406 and close the
valve 298; (3) open the valve 299 thereby causing the pressure of the variable volume 301
to reach a ermined positive pressure as indicated by the pressure sensor 407; (4) close
the valve 299; (5) take an AVS measurement; (6) open the valve 304 and open the piston
valve 405 thereby discharging the fluid out of the AVS volume 302; (7) close the piston
valve 405 and close the valve 304; (8) open the valve 299 thereby causing the pressure of
the variable volume 301 to reach a predetermined ve re as indicated by the
pressure sensor 407; (9) close the valve 299; (10) take an AVS measurement; (11) and
e the AVS volumes measurements to determine the volume discharged, e.g., to
estimate flow rate. The us example may be modified to take one or more AVS
measurements in ve pressure, negative pressure, atmospheric re, or some
combination thereof.
The pump 300 may also, in some embodiments, determine if there is
compliance in the system, such as compliance caused by air, by taking AVS volume
measurements at two different pressures. For example, two AVS measurements may be
taken during the fill phase at two different pressures (e. g., negative pressure and ambient
pressure, or some other combination) and/or during the discharge phase at two difference
pressures (e. g., negative pressure and ambient re, or some other combination). The
change in volume at the two pressures may be correlated with compliance of the AVS
volume 302, such as if there was an air bubble in the fluid. If a predetermined amount of
AVS volume 302 variation is determined to exists, a processor may determine an error
condition exists and issue an alarm or alert. In yet another embodiment, the flow rate
measurement may be corrected for the air volume ement taken; For example, a
processor may determine the volume of air that was delivered to the patient instead of a
drug, such as insulin, and compensate the delivery of the insulin to ensure that the
prescribed does of insulin is delivered. For example, consider the following additional
embodiments.
In some embodiments of the present sure, ance may be
estimated in the pump 300 by taking at least two AVS measurements at different pressures
to account for air s; for example: the AVS volume measurements may be taken as
follows: (1) close the piston valve 405, open the piston valve 406, open the valve 298, close
the valve 299, and close the valve 304 thereby causing fluid to be drawn into the AVS
chamber 302 with the negative re from the negative—pressure source 296; (2) close the
piston valve 406 and close the valve 298; (3) take an AVS measurement while the reference
volume 301 remains under negative pressure; (3) open the valve 304 y causing the
pressure of the le volume 301 to reach atmospheric pressure 303; (4) close the valve
304; (5) take an AVS measurement while the reference volume 301 remains at atmospheric
pressure; (6) compare the two AVS measurements from (3) and (5) to determine compliance
of the AVS volume 302; (7) open the valve 299 and open the piston valve 405 y
discharging the fluid out of the AVS volume 302; (8) close the piston valve 405 and close
the valve 299; (9) take an AVS measurement while the variable volume 301 remains under
positive pressure; (10) open the valve 304 to equalize the variable volume pressure to
atmosphere 303; (11) close the valve 304; (12) take an AVS measurement while the
variable volume 302 remains under atmospheric pressure; (13) compare the two AVS
measurements from (9) and (12) to determine compliance of the AVS volume 302; (14) and
compare at least two AVS volume measurements to determine the volume discharged, e. g.,
to estimate flow rate. The above example may be modified in various ways such that the
two AVS measurements having two ent pressures and may occur during the filling
stage, the discharging stage, any other stage of the pumping, using one or more of a positive
pressure measurement, a negative re measurement, an atmospheric pressure
ement, or some ation thereof.
Consider yet another embodiment: the AVS volume measurement and
pumping action may occur as follows: (1) close the piston valve 405, open the piston valve
406, open the valve 298, close the valve 299, and close the valve 304 thereby causing fluid
to be drawn into the AVS chamber 302 with the negative pressure from the negative—
pressure source 296; (2) close the piston valve 406 and close the valve 299; (3) take an AVS
measurement when the variable volume 301 remains at a negative pressure; (4) open the
valve 299 y causing the pressure of the variable volume 301 to reach a predetermined
positive pressure as indicated by the pressure sensor 407; (5) close the valve 299; (6) take
an AVS measurement when the le volume 301 is at a positive pressure; (7) compare
the two AVS measurement from (3) and (6) to determine ance of the AVS volume
302; (8) open the valve 304 and open the piston valve 405 thereby discharging the fluid out
of the AVS volume 302; (9) close the piston valve 405 and close the valve 304; (10) take an
AVS measurement while the le volume 301 is at an atmospheric pressure (in another
embodiment, the AVS volume measurement is taken at a negative pressure); (11) open the
valve 299 y causing the pressure of the le volume 301 to reach a predetermined
positive pressure as indicated by the pressure sensor 407; (12) close the valve 299; (13) take
an AVS measurement; (14) and compare at two AVS volume measurements to determine
the volume discharged and/or the compliance of the variable volume, e. g., to estimate flow
rate. The above example may be modified in various ways such that the two AVS
measurements having two different pressures may occur during the filling stage, the
discharging stage, any other stage of the pumping, using one or more of a positive pressure
measurement, a negative pressure measurement, an atmospheric pressure measurement, or
some combination thereof.
In one specific ment, the membrane pump 300: has a flow rate target
of 0.1 to 2000 ml/hr; can generate at least a maximum of 3 PSI and up to 10PSI; can draw
fluid from a reservoir of a maximum of negative re of at least —2PSI; may be battery
powered; may be powered by a cable; and may have a user interface that wirelessly
communicates with a sor coupled to all actuators, valves, pressure sensors, and other
devices.
Fig. 78 shows an optical-sensor based flow rate meter 305 in accordance
with an embodiment of the present disclosure. The flow rate meter 305 includes an IR
source 306 that reflects light off a flexible membrane 307. The reflected IR light is ed
by a sensor 308. The sensor formed by the IR source 306 and the IR sensor 308 may be a
sensor with the part : GP2S60 manufactured by Sharp Corporation. The light
reflected off of the membrane 307 may be ated to a volume 309. With an upstream or
downstream pump (not shown) used in conjunction with input and outlet valves (not shown)
the flow rate me be calculated by measuring the light as it reflects off the membrane 307.
Since a change in fluid pressure in the line results in a displacement of the mer
membrane 309, the distance between the sensor 308 varies as a on of the pressure in
the fluid line; therefore the output of the sensor is proportional to the pressure in the fluid
line and may be correlated with pressure and/or volume.
The flow rate meter 305 may be used by a membrane pump disclosed herein
to facilitate positive and/or negative pressure measurements. The re sensitivity may
be tuned by selecting the meric properties of the membrane and the area of fluid
contact with the membrane forming the AVS volume 309. The reflective property of the
elastomeric membrane may be enhanced with metal, plastic, film, or other reflective
material. A temperature sensor may be added to account for the thermal s of the
material that forms the AVS volume 309. A heat sink and/or thermal controller around the
elastomer AVS chamber 309 may be used to mitigate thermal effects, in some specific
embodiments.
The IR source 306 may be pulsed and/or multiplexing may be used with
le IR sources 306 and multiple sensors 307 to inhibit cross—talk error. An l
reading may be used as an offset null, and the change in sensor output may be correlated
with changes in pressure in the AVS volume 308. Focusing optics may be used with the
disposable portion, e.g., the membranes, to facilitate the ranging and aligning of the IR
source 306 and the IR sensor 308. In alternative embodiments, an ultrasonic proximity
sensor is used d of the IR source 306 and the IR sensor 308.
In one specific ment, the flow rate meter 305 may: have a sensitivity
to line pressure over a range of —2 to +10 PSI; may measure a line pressure to within +/—
20% over a range of 1 to 10 PSI; have a resolution of at least 10 bits; and may be low
power.
Fig. 79 shows a pressure-controlled membrane pump 322 in accordance with
an ment of the present disclosure. Figs. 80-82 show a legend for reference herein;
that is, refer to Fig. 80—82 for the legend of s for Figs. 83, 85, 87, 88, 90, 91, 93, 95,
and 97. Referring again to Fig. 79, the membrane pump 322 includes an AVS assembly
323 having a reference volume 324 and a variable volume 325. The reference volume 324
includes a speaker 326 for ting an acoustic signal in the reference chamber 324 which
travels through a port 357 to the variable volume 325. The acoustic signal is received by a
reference microphone 327 and a variable—volume microphone 328. The signals from the
microphones 327 and 328 are compared to determine an acoustic response to measure the
volume of the AVS chamber 335. An optional optical sensor 329 may be used to reflect
light off of a membrane forming the AVS chamber 335. The l sensor 329 may be
used to facilitate the estimation of the volume of the AVS chamber 335. In some
embodiments multiple l sensors 329 may be used.
The pump 353 may be a diaphragm pump, such as one having the part
number: T3CP-1HEISNB, manufactured by Parker Hannifin Corporation located at
6035 Parkland Boulevard, Cleveland, Ohio 44124-4141; additionally or alternatively, other
pump types and/or pumps manufactured by any other manufacturer may be utilized.
A variable voltage applied to the pump 353 (see Fig. 79) may be adjusted in
real time to reach a desired pressure as measured by the re sensor 340. The pump 353
can have a flow rate of several liters per minute. The variable volume 325 may have an air
volume of 0.5cc, and may be pressure limited to between 1—10 PSI. In some embodiments,
the pump 353 has a fill and empty cycle time of 1 Hz and a fluid chamber of 0.5cc resulting
in a maX flow rate of 1800 cc/hr, for example. In additional embodiments, variable pressure
may be controlled in bursts that last in the tens of econds and siX ts may be
delivered over an hour interval to achieve a flow rate of 0.1 cc/hr. In additional
embodiments, an alternative tic flow path (not shown) having a pneumatic flow
restriction may be used to lower the working pressure on the variable volume 324 thereby
facilitating low and high volumetric flow .
A fluid reservoir 331 is d through a fluid path to a one—way valve 332.
The valve 332 may be a pinch valve. An optical sensor 333 es when the valve is
closed, e. g., an optical beam may be broken when the pinch valve 332 is open or the optical
beam is broken when the pinch valve 332 is closed.
The fluid travels into the AVS volume 335 through a fluid line 334. The
fluid may be discharged through a fluid path to a one-way valve 336 that is also measured
using an optical sensor 337. y, the fluid enters into a patient 338.
The nce chamber 324 and the variable volume chamber 325 are in
fluid communication with a line 339. A pressure sensor 340 es the pressure of the
line and hence the chambers 324 and 325. Additionally or alternatively, the pump 322
includes a temperature sensor 330. The pressure from the pressure sensor 340 and/or the
temperature from the temperature sensor 330 may be used for to se the accuracy of
AVS measurements.
The valve 341 ts the tube 339 to the ambient pressure 342. A pressure
sensor 343 measures ambient pressure. The valve 341 is also d to a valve 344 which,
in turn, is connected to a negative re source 347 and a positive pressure source 345.
The positive pressure source 345 is coupled to a pressure sensor 346, and the negative
re source 347 is d to another pressure sensor 348. In some ic
embodiments, the positive re source 345 and ve pressure source 347 may be
accumulators where predetermined pressures are set therein and vented into the nce
volume 324 (via the valves 344, 341, 350, and 349) to develop specific pressures.
A variable flow/pressure pump 353 is coupled to both of the valves 349 and
350 to keep the positive pressure reservoir 345 at a positive pressure and the negative
re reservoir 347 at a sufficiently lower pressure. The valves 350 and 349 are also
d to atmospheric vents 354 and 351, respectively. The variable flow/pressure pump
353 is fed a signal at 356, which may be fed back to an output pin for verification by a
processor, e.g., processor 37 of Fig 2. Also, a switch 355 may enable and/or disable the
pump 353.
In some embodiments, the one or more optical sensors 329 may be used as
part of an inner portion of a control loop that has a target aliquot volume to deliver. For
example, the one or more optical sensors 320 may provide a controller within the processor
37 of Fig. 2 (e. g., a PID controller) with an estimate of fill or discharge volume based on the
deflection of the AVS Chamber’s 335 membrane as measured by the one or more optical
s 329. The feedback from the one or more optical sensors 329 may be used to control
the pressure flow or the timing of the pneumatics in the AVS pump chamber, e.g., the
valves 231, 344, 349, and 350.
Multiple optical sensors 329 may be used to triangulate the AVS Chamber’s
335 membrane position; additionally or alternatively, the membrane may have reflective
features disposed surface of the membrane of the AVS chamber 335 to provide a reflective
surface for the optical sensors 329. In some specific embodiments, an outer portion of the
control loop can target the trajectory delivery volume delivered to the patient to tune the
individual aliquot volume. For example, the optical volume sensing functionality performed
by the one or more optical sensors 329 may provide an independent volume measurement
that is used as a check on the AVS—based volume measurements and/or to calculate errors in
volume estimation. In additional embodiments, only optical volume measurements are
performed, i.e., in this specific exemplary embodiment, no AVS is used).
Fig. 83 shows a flow—controlled membrane pump 358 in accordance with an
embodiment of the present disclosure. The flow—controlled membrane pump 358 is similar
to the pressure controlled pump 322 of Fig. 79; however, the flow—controlled membrane
pump 358 does not have the reservoirs 345 and 347 as shown in Fig. 79.
Fig. 84 shows a state diagram 359 of the ion of the ontrolled
membrane pump 358 of Fig. 83 in accordance with an embodiment of the present
sure. The state diagram 359 includes states 360-368. The states 360-368 are
illustrated by Figs. 85—98.
Referring now to Figs. 84, 85, and 86, an idle state 360 is depicted in Figs.
84 and 86 with Fig. 86 g more details. The idle state 360 includes substates 370—
371. In substate 370, several variables are set. After a predetermined amount of time after
substate 370 sets the variables, the substate 371 measures several values which are checked
against predetermined ranges.
Fig. 85 shows the flow—controlled membrane pump 358 of Fig. 79
illustrating the operation of the valves when in the idle state 360 of the state diagram of Fig.
84 in accordance with an embodiment of the present sure. In the idle state 360, the
valve 341 couples the reference volume 324 to the atmospheric pressure source 342. Note
that, as shown in Fig. 85 which illustrates the idle state 360, the ne forming the
AVS volume 335 is deflated.
As shown in Fig. 86, the substate 370 sets the variables PCadj, PCenbl,
PCenb2, PCvl, PCv2, PCv3, HCvl, and HCv2; e.g., via applying an input voltage into an
appropriate input (see Fig. 83). Referring to Figs. 85 and 86, the variable PCadj sets the
pump 353, the variable PCenbl enables the input to the pump 353, the le PCenb2
enables the switch 355, the variable PCvl controls the valve 350, the variable PCv2
controls the valve 349, the le PCv3 controls the valve 341, the variable HCvl controls
the valve 332, and the variable HCv2 controls the valve 336.
Also as shown in Fig. 86, after the parameters are set in substate 370, the
te 371 takes several ements. In substate 371, the PSavs, PSatm,
PCmon,OPTvar, OPThvl, , and Tavs values are taken and compared to
predetermined ranges. If any of the measured values are outside a predetermined range,
e.g., as shown in the ed column 373 in Fig. 86, an error ion 372 is determined
to exist; in response to the error condition 372, an alert or alarm may be .
The PSavs is a value determined from the pressure sensor 340, PSatm is a
value determined from the pressure sensor 343, PCmon is a value determined from the
sensor 369 to determine if the pump is receiving the correct voltage from the input voltage
356, OPTvar is a measurement from the l sensor 329, OPThvl is the measurement
from the optical sensor 333 to determine if the valve 332 is closed or open, OPThc2 is the
measurement from the optical sensor 337 to determine if the valve 336 is open or closed,
and Tavs is the measurement of the temperature from the temperature sensor 330.
[00539] Referring again to Fig. 84, after the idle state 360, the state diagram 359
continues to the positive valve leak test state 361. Figs. 87—88 show the flow—controlled
membrane pump 358 of Fig. 83 in use during the positive pressure valve leak test state of
Fig. 84 in ance with an embodiment of the present disclosure. Note that there is a
change in the valve 349 to allow the pumping of pressure into the reference volume 324
from as shown in Fig. 87. Fig. 88 shows where the valve 349 is switched again and the
reference volume 324 is isolated from the fluid sources.
Fig. 89 shows a more detailed View of the positive pressure valve leak test
state 361 of Fig. 84 in accordance with an embodiment of the present disclosure. Fig. 89
may also represent state 364 of Fig. 84. The positive pressure valve leak test state 361
includes substates 374—380.
te 374 turns on the pump 353 and sets the valves 350, 249, and 341
such that positive pressure is applied to the reference volume 324. The valves 222 and 337
remain closed. In substate 374, measurements are taken. If the measured values are outside
predetermined acceptable ranges, a substate 379 determines an error condition occurs. If
the average pressure Target Pmax is not reached, state 361 continues to the substate 378 to
wait for a predetermined amount of time. This process is depicted in Fig. 87. tes
374, 375, and 378 may repeat until a predetermined number of t 378 occurs or a
predetermined amount of time is reached at which time an error 379 is substate determines
an error condition .
[00542] State 361 may optionally wait a ermined amount of time when
tioning from substate 375 to 376. In substate 376, the pump 353 is turned off and the
valves 350 and 349 disconnect the variable volume 324 from the pump 353 (as depicted in
Fig. 88). State 361 may optionally wait a predetermined amount of time when transitioning
from substate 376 to 377. In substate 377, various measurements are taken, such as an AVS
measurement using, for example, the AVS system having the speaker 326, and the
microphones 327 and 328 which measure the volume of the variable volume 325 (using an
acoustic response) to determine if the AVS volume 335 is changing y indicating a
leak condition. Additionally or alternatively, the optical sensor 330 may detect if a
predetermined movement of the membrane 335 occurs to determine if a leak condition
exists. If these measurements are outside of a predetermined range and/or beyond a
predetermined old, then an error condition is determined to exist in te 280.
Referring again to Fig. 84, after the positive leak valve test state 361 occurs,
a negative leak valve test state 362 occurs. Refer to Figs. 90, 91, and 92 for a description of
the positive leak valve test state 362. Figs. 90—91 show the flow—controlled membrane
pump 358 of Fig. 83 in use during the negative pressure valve leak test state of Fig. 84, and
Fig. 92 shows a more detailed View of the negative pressure valve leak test state 362 of Fig.
84 in accordance with an embodiment of the present disclosure. As shown in Fig. 92, state
362 es substates 381—387. Fig. 92 may also be used to illustrate state 365 of Fig. 84.
te 381 turns on the pump 353 and sets the valves 350, 249, and 341
such that negative pressure is applied to the reference volume 324. The valves 222 and 337
remain closed. In substate 382, measurements are taken. If the measured values are outside
predetermined acceptable ranges, a substate 382 determines an error condition occurs and
continues to state 385. If the average pressure Target Pmin is not d, state 382
continues to the substate 386 to wait for a predetermined amount of time. This process is
depicted in Fig. 90. Substates 381, 382, and 386 may repeat until a predetermined number
of substates 378 occurs or a predetermined amount of time is reached at which time substate
385 determines an error condition exists.
[00545] State 362 may optionally wait a predetermined amount of time when
transitioning from substate 382 to 383. In substate 383, the pump 353 is turned off and the
valves 350 and 349 disconnect the variable volume 324 from the pump 353 (as depicted in
Fig. 91). State 362 may optionally wait a predetermined amount of time when tioning
from substate 383 to 384. In substate 383, various measurements are taken. For example,
the AVS system using the r 326, and the hones 327 and 328 to measure the
volume of the variable volume 325 (using an acoustic response) to determine if the AVS
volume 335 is changing thereby indicating a leak condition. Additionally or alternatively,
the l sensor 330 may detect if a predetermined nt of the membrane 335
occurs to determine if a leak condition exists. If these measurements are outside of a
predetermined range and/or beyond a predetermined threshold, then an error ion is
determined to exist in substate 387.
] Fig. 93 shows the flow—controlled membrane pump 358 of Fig. 83 in use
during the fill state 363 of Fig. 84 in accordance with an ment of the present
disclosure. Fig. 94 shows a more detailed view of the fill state 363 of Fig. 84 in accordance
with an embodiment of the present disclosure.
State 363 includes substates 388-391. Substate 288 sets the valves 350 and
351, and the pump 353 to apply a negative pressure to the variable volume 324. The valve
332 is also opened and the AVS volume 335 fills with a fluid from the fluid reservoir 331.
State 389 takes several measurements, ing an optical measurement from the optical
sensor 330, to ine if the membrane defining the AVS volume 335 is filling. If it
hasn’t filled, substate 391 waits a predetermined amount of time. Thereafter, substates 288,
289, and 391 may be repeated for at least a predetermined number of cycles and/or until a
predetermined amount of time has passed, after which substate 390 ines that an error
condition , e.g., because the reservoir 331 is empty and/or a valve is stuck, for
example, valve 332 may be stuck closed, etc. Additionally or alternatively, if the
measurement taken during the substate 389 is outside of a predetermined range and/or is
beyond a predetermined threshold, the te 390 may determine an error condition exists.
[00548] Referring again to Fig. 84, after state 363 is performed, another positive
valve leak test is performed during state 364 and another negative valve leak test is
performed in state 365.
State 366 takes an AVS measurement to determine the volume of the AVS
chamber 355 (see Fig. 95). Referring now to Figs. 95 and 96: Fig. 95 shows the flow—
controlled membrane pump 358 of Fig. 83 in use during an AVS measurement state 366,
and Fig. 96 shows a more detailed view of the AVS measurement state 366 of Fig. 84.
State 366 includes substates 392 and 395. Substate 392 causes the speaker
329 to emit one or more acoustic frequencies, and substate 393 takes measurements from
the microphones 327 and 328 to determine an acoustic response. The acoustic response is
correlated with a volume of the AVS r 335 and is thus also correlated with the fluid
in the AVS chamber 335. The acoustic response and other measurements are taken during
substate 393. Substates 392 and 393 may optionally repeated, e.g., shown as the te
395. If one or more measurements from the substate 392 are outside of a predetermined
range and/or is beyond a predetermined threshold, the substate 394 may determine that an
error state exists.
Referring again to Fig. 84, after the AVS measurements are taken in state
366, the emptying state 367 empties the AVS volume 335. Fig. 97 shows the flow—
lled ne pump 358 of Fig. 83 in use during the emptying state 367 of Fig. 84,
and Fig. 98 shows a more detailed view of the emptying state of Fig. 84.
As shown in Fig. 98, the emptying state 367 includes substates 396-399.
Substate 396 sets the valves 350 and 349, and the pump 353 to apply a positive pressure to
the nce volume 324. Substate 396 also open the valve 336 to allow fluid to flow to the
patient 338. During substate 387, several measurements are taken, and substate 397
ues to substate 399 to wait a predetermined amount of time. The substates 396, 397,
and 399 repeat until the optical sensor 329 determines that the AVS volume is below a
predetermined amount. If the measurements taken during substate 397 are outside of a
predetermined range and/or a measurement exceeds a predetermined threshold (i.e., above
or below the threshold) the substate 398 determines an error condition exists. If the te
399 repeats a predetermined number of times and/or operates for a predetermined amount of
time, the substate 398 may ine that an error condition exists, e. g., a stuck valve such
as valve 336 and/or a downstream occlusion may be preventing the AVS volume from
discharging the liquid to the patient 338, for example.
] ing again to Fig. 84, after state 367, state 368 takes an AVS
measurement. The AVS measurement 368 may be compared to the AVS measurement 366
to determine an amount of fluid delivered to a patient 338. For example, in the emptying
state 367, some of the fluid may remain in the AVS volume 335. By comparing the
difference between the AVS measurements, the amount of fluid discharged down the line to
the patient 338 may be estimated.
Fig. 99 shows a membrane pump 411 having an elastic membrane 412 that is
flush with a disposable portion 413 and applies force to a liquid in ance with an
embodiment of the present disclosure. That is, the action of the membrane 412 provides an
actuation to move fluid through the membrane pump 411. The membrane pump 411
es an AVS assembly 417 that couples to a disposable portion 418. The AVS
assembly 417 may be snap—fitted, may screw onto, or may include latches to attach to the
disposable portion 418. The membrane pump 411 includes a pneumatic fill port 414. The
pneumatic fill port 414 may be connected to any air pump as described herein. In yet
additional embodiments, the pneumatic fill port 414 may be connected to a liquid pump,
e. g., a syringe pump, or other liquid pump. In some embodiments, alternative positive and
negative pressures are applied to the pneumatic fill port 414, which is used in ction
with valves 415 and 416 to pump fluid. In some embodiments, a negative pressure is
applied to the pneumatic fill port 414 and the elastic property of the membrane 412 is used
to suck in liquid through the valve 416. In some embodiments, a positive pressure is
applied to the pneumatic fill port 414 and the elastic property of the membrane 412 is used
to expel in liquid through the valve 415.
Figs. 100-101 show two ments of lung pumps in accordance with
ments of the present disclosure. Fig. 100 shows a lung pump 419, and Fig. 101
shows a lung pump 420.
The lung pump 419 of Fig. 100 includes a rigid body 421 having an AVS or
FMS port 425 for measuring the volume of a reservoir 425 that is flexible. FMS is
described in the United States Patents Nos. 4,808,161; 4,826,482; 4,976,162; 5,088,515;
5,193,990; and 5,350,357. In some embodiments, ve and/or negative re is
applied to the port 425 to facilitate the pumping action of the lung pump 419. The reservoir
424 is in fluid communication with the valves 422 and 423. The oir 424 may be
molded or bonded to the tube 431, or is vacuum formed from the tube 431, e.g., a blister.
The rigid body 421 may fully seal around the tube 431 as it passes through the rigid body
and connects to the reservoir 424. By applying a positive or negative pressure via the port
425, the fluid may be drawn into and out of the oir 424. This positive and negative
pressure may be ed by a manifold which also contains a reference chamber allowing
for FMS measurements via the port 425. Additionally or alternatively, the rigid body 421
may include hardware, such as, for example, a processor to control the valves 422 and 425,
an AVS assembly coupled to the port 425, etc. The liquid is drawn from the valve 422 and
leaves Via the valve 423. The valves 422 and 423 may be pinch valves. The valves 422 and
423 may be atively closed and open, relative to each other and synchronized with any
ve and/or negative pressure applied via the port 425. For e, a pumping
sequence may occur as follows: (1) close the valve 413 and open the valve 422; (2) apply a
negative pressure to the port 425; (3) close the valve 422; (4) estimate the volume of fluid in
the reservoir 425 (e. g., using AVS or FMS); (5) repeat steps (1)—(4) until a predetermined
volume is within the reservoir; (6) open the valve 425; (7) apply a positive pressure to the
valve 425; (8) close the valve 423; (9) estimate the volume of fluid in the reservoir; (10)
compare the volumes measured during steps (9) and (4) to determine an amount of liquid
discharged; (11) and repeat (1)—(10) until a ermined amount of liquid has been
The lung pump 420 of Fig. 101 includes a rigid body 426 having an AVS or
FMS port 430 for measuring the volume of a reservoir 429 that is flexible. In some
embodiments, positive and/or negative pressure is applied to the port 430 for facilitating the
pumping action of the lung pump 420. The reservoir 429 is in fluid communication with
valves 427 and 428. The lung pump 420 may be r to the lung pump 419 of Fig. 99;
however, the valve 427 is opened and the valve 428 is closed to pump fluid into the
reservoir; and the valve 428 is opened and the valve 427 is closed to pump fluid out of the
reservoir.
Figs. 102—104 show several gaskets for sealing a lung pump in accordance
with additional embodiments of the present disclosure. Fig. 102 shows a tube 432 that may
be sealed by sections 433 and 434 of the rigid body of the lung pump (e. g., rigid body 421
of Fig. 99 or rigid body 426 of Fig. 100). In other embodiments, 422 and 424 may be part of
a housing, ng, or dooring mechanisms. Fig. 103 shows a tube 425 that includes a
gasket seal 426. The gasket seal 426 may push to the left and right causing a better seal
where the two sides of the sealing surfaces meet (i.e., 422 and/or 424). Fig. 104 shows
another way of sealing a tube 432 in including a gasket 427 that seals by being ssed
in between a valley structure 427 and a compressing plate 429.
Fig. 105 shows another lung pump 430 in accordance with another
embodiment of the present disclosure. The lung pump 430 includes a rigid piece 431
bonded around a tube 432 that creates a face—sealing gasket that seals against a ring
structure 433 when a pressure is applied to the rigid piece 431. The rigid piece 431 may be
a circular structure, e. g., a ring structure similar to a washer.
Figs. 106-112 illustrate the operation of a piston pump while performing
various checks in ance with an embodiment of the present disclosure. The checks
described in conjunction with the piston pump of Figs. 106-112 may also be used with a
altic pump having a spring—biased plunger as bed herein. Fig. 106 shows a
pump 434 ing a piston 435, a diaphragm 436, an inlet valve 437, an outlet valve 438,
and a pump chamber 439. The piston 435 may be coupled to a linear actuator 54 (not shown
in Figs. 106—112) that is coupled to a processor 37 for control (see Fig. 3).
The opening of the valves 437 and 438 may be timed with the movement of
the piston 435 to allow the integrity of the valves to be checked periodically during the
pump ion. The piston 435 applies a re or vacuum to check the valves 437 and
438 to verify that one or both are not leaking before opening the other valve. This s
may be used to safeguard against free—flow conditions; if one valve is not sealing properly
the other valve is not opened. The same configuration can be used to check for air in the
pumping chamber, upstream occlusions, and downstream occlusions.
In some embodiments, the piston 435 and valves 437 and 438 may be driven
by a set of cams driven by a single motor. Additionally, in some embodiments, the piston
435 is spring loaded such that the cam lifts the piston 435 and the spring returns the piston
435 to the down position; this specific embodiment may have a relatively constant delivery
In some embodiments of the present disclosure, the position of the piston
435 and/or the position of the diaphragm 436 may be determined using a sensor. In some
embodiments, the position of the piston 435 may be determined using an encoder, a
magnetic sensor, a potentiometer, or rotational sensors on a camshaft, etc. In additional
embodiments, the position of the piston 435 is measured directly by using an optical sensor,
a LVDT (linear variable ential transformer)sensor, a hall—effect sensor, or other linear
sensor. The position of the diaphragm 436 may be sensed using an AVS assembly as
described elsewhere herein (e. g., the AVS ly 417 of Fig. 98 may be used to
determine the position of the diaphragm 436). In some additional embodiments, no piston
is used and the diaphragm is moved using pneumatic pressure as described herein.
Figs. 107—112 illustrate various stages of the piston pump of Fig. 106. Fig.
107 illustrates an air check and inlet valve 437 leak check. The piston 435 applies a
downward force while the valves 43? and 438 are closed. If the piston 435 moves a
predetermined distance and/or beyond a predetermined speed, the processor 37 may
determine that excessive air exists within the pump chamber 439. If the piston 435
compresses an amount and slowly continues to move towards the bottom of the pump
chamber 439, the processor may determine that one of the valves 437 and/or 438 is leaking.
For example, if a valve 437 and/or 438 is leaking, the volume with the pump chamber 439
will continuously decrease. The movement (or speed) cause by ive air in the pump
chamber 439 may be at a different speed than the nt caused by a leak; and, in some
specific embodiments, the sor 37 may guish between excessive air in the pump
chamber 439 and/or a leak in one of the valves 437 and 438. For example, the piston 435
may move downwards at a first speed and quickly approaches a very slow speed; if the slow
speed continues, then it may be ined that the continued slow movement after the
abrupt ve acceleration is an indication of a leak in one of the valves 437 and 438.
Fig. 108 shows a stage in which a downstream occlusion check is performed.
The outlet valve 438 is opened and the fluid in the pump chamber 439 is delivered to the
patient. If the volume does not change, there may be a downstream occlusion. Additionally
or alternatively, if the piston 435 moves slower than a threshold and/or moves more slowly
than the previous fluid discharge by a predetermined , the processor 37 (see Fig. 3)
may determine that a downstream occlusion has occurred. Additionally or alternatively, if
the piston 435 stops moving less than a predetermined amount of movement (e.g., with a
predetermined force is applied to the piston 435) then the processor 37 may determine that a
downstream occlusion has occurred.
Fig. 109 illustrates the stages in which the outlet valve 438 is closed. Fig.
110 illustrates the stage in which the piston 435 is pulled up. The outlet valve 438 remains
closed. The stretch of the diaphragm 436 results in vacuum in the pump chamber 439. If
one of the valves 437 and 438 is g, the fluid in the pumping chamber 439 will
se. If the diaphragm 436 moves by a predetermined amount, the processor 37 may
determine that a valve is leaking and issue an alert and/or alarm.
[00567] Fig. 111 illustrates a stage where the pump chamber 438 is filled, and an
upstream occlusion check is performed. The inlet valve 437 is opened and the pump
chamber fills 438 with liquid. If the pump chamber fails to fill by a predetermined amount,
then the processor may determine that an am occlusion exists or the IV bag is empty.
Additionally or alternatively, if the chamber fills 438 too , or slower than the
previous fill by a ermined amount, the processor 37 may determine that an upstream
occlusion exists. Fig. 112 illustrates the stage in which the inlet valve 437 is closed. The
stages illustrated in Figs. 107-112 may be ed until a predetermined amount of fluid is
delivered to a patient.
Figs. 113 and 114 illustrate a piston pump 441 in accordance with another
3O embodiment of the present disclosure. As shown in Fig. 113, piston pump 441 includes a
disposable cassette 442 including a preformed ne 440 and a cassette body 445. The
preformed membrane 440 may be one or more of a PVC elastomeric such as, Sarlink,
Pebax, Kraton, a Santoprene, etc. The preformed membrane 440 may be attached to the
cassette body 445 using any method, including heat bonding, laser welding, using a t
or adhesive bonding, ultrasonic welding or attachment, RF welding, or over molding. When
the preformed membrane 440 is compressed, as shown in Fig. 114, the membrane will
return to its original shape as shown in Fig. 113 after the piston 443 is withdrawn. Fig. 115
and 116 show two views of a cassette 444 having several membrane pumps 441. The
cassette 444 may be formed by a rigid body defining the cassette body with two elastic
layers disposed around the rigid body. The rigid body may form the reservoir such that the
elastic layer forms the preformed membrane as illustrated in Figs. 113 and 114.
Fig. 117 shows an ly 446 having a cassette 447 that includes a
ne pump 451 and volcano valves 449 and 450 in accordance with an embodiment of
the present disclosure. The ne pump 451 includes a pump r 452 that
interfaces with an membrane 451. As the plunger 451 reciprocates, fluid is draw from the
fluid path 454 and out the fluid path 456. The volcano valve 449 is a one way valve that
allows fluid into the fluid volume 455 from the volcano valve 449, but not in reverse. An
actuator may press again the membrane 456 in some embodiments to help the one—way
action of the volcano valve 449.
The volcano valve 450 is a one—way valve that allows fluid out of the fluid
valve 455 through the fluid path 455 and the volcano valve 450 (but not in reverse). An
actuator may press again the membrane 457 in some ments to help the one—way
action of the volcano valve 450.
The assembly 446 also includes an AVS assembly 448. The AVS ly
es a nce volume 458 having a speaker 459 and a microphone 460. The le
volume 461 includes a microphone 462. The speaker 459 and the microphones 460 and 462
are coupled to a processor 37 to measure the volume of the fluid volume 455 and coordinate
the operation of the plunger 452 as described herein.
] The plunger 452 may interface with one or more acoustic seals coupled to
the AVS assembly 448. The processor 37 may be in operative communication with a
position sensor (e.g., one coupled to a linear actuator of the plunger) to determine the
position of the plunger 452. The processor 37 may account for the amount of volume the
plunger 37 displaces as it reciprocates in and out of the variable volume 461; this volume
correction may be done by directly measuring the plunger’s (452) displacement or by
ing the a drive shaft angle coupled to a cam that moves the plunger 452.
Fig. 118 shows a roller mechanism 463 of a cassette—based pump in
accordance with an embodiment of the present disclosure. The roller mechanism 463
includes rollers 464, 465, and 466. The rollers 464, 465, and 466 move in a circular
direction and apply a downward pressure again a cassette 467 having a cassette body 468
and a membrane 469. The rollers 464, 465, and 466 may be on a rail and may be spaced
such that at least one roller s the cassette 467. The roller ism 463 may be
controlled by a stepper motor. The roller mechanism 463 may help pump liquid at a rat of,
for example, 0.1 ml/hr.
The roller mechanism 463 may be used to estimate fluid flow based upon the
speed of its movement, for example. The rollers 464, 465 , and 466 may be disengaged from
the te 467 to facilitate non—occluded flow and/or to create a desired free—flow
ion.
Fig. 119 shows the fluid paths 470 of a cassette—based pump for use with the
roller mechanism of Fig. 118 in accordance with an embodiment of the present disclosure.
The fluid paths 470 include a roller interaction area 471 having a path 472 and a bypass path
473. The fluid paths 470 may ed a vacuum formed film bonded to a ridged back to
form raised flexible features. The path 470 es ers 474 and 475. The occluders
474 and 475 may be independently occluded. The paths 472 and 473 may have the same or
different cross—sectional areas. The roller mechanism 463 may interact with the roller
interaction area 472 to create different flow rates based on the rate of nt of the
roller mechanism 463 and the total cross sectional area of all channels that are un—occluded
(e.g., which of the occlude features 474 and 475 are engaged. The occluder features 474
and 475 may be volcano valves with a plunger that may be applied on the membrane of the
volcano valve to stop fluid from flowing in any direction. In other embodiments, the
occluders 474 and 475 may be a pinch valves coupled to an actuator, such as a id.
The fluid paths 470 may include a fluid capacitor 476 to buffer the flow of
liquid (e.g., smooth the liquid). Additionally or alternatively, an AVS assembly may be
coupled to the fluid capacitor 476 to measure fluid flowing therethrough.
In another embodiment, one or more of the fluid paths 472 or 473 include a
flat flexible film boded to a ridged back with the features molded into the rigid backing
(cassette body). In this embodiment, the roller 463 has a e that recesses into the
channel 478 in order to pinch off the channel 478. This embodiment may also have
molded—in features that allows a ball—head piston to variably restrict the flow through the
channel 478 (e.g., the occlude features 474 and 475). The geometry of the features that
recess into the channels and the piston head may be adjusted to allow different flow profiles
based on the linear engagement of the piston. In one embodiment, the disposable has one
l 472 for the roller mechanism 463 and a second channel 473 that acts as a bypass
from the roller area. The two channels 472 and 473 in conjunction with the occluders 474
and 475 allow the cassette (which may be disposable) to be used in a bypass mode or a
pump mode. In some embodiments, the roller mechanism 463 of Fig. 119 is always engaged
above the channel 478 but not over the bypass channel 473.
In one embodiment, the roller mechanism 463 may be used for high flow
rates and the bypass 474 may be used for low flow rates. For example, in some specific
embodiments, when the fluid paths 472 and 473 have a cross sectional area of 0.4 cm2, the
flow rates may be from 100 ml/hr to 1000 ml/hr by using a stepper motor to actuate the
linear travel of the rollers from 250 cm/hr to 2500 cm/hr; the bypass 473 is used to achieve
flow rates under 100 cm/hour.
[00579] Fig. 120 shows the fluid paths 478 of a cassette—based pump for use with the
roller mechanism of Fig. 118 in accordance with an embodiment of the present sure.
The fluid paths 478 e two paths 479 and 480, and a bypass path 481 The roller
mechanism 470 of Fig. 118 aces with the fluid paths 470 and 480. The fluid paths 478
are also coupled to occluders 482, 483, and 484.
[00580] Fig. 121 shows the stages 310, 311, and 312 of an infiltration test in
accordance with an embodiment of the present disclosure. The infiltration test illustrated by
Fig. 121 includes an occluder roller 313 that is pressed against a tube 314 (as shown in stage
311) which is then drawn back through a rolling motion (shown in stage 314). The er
roller 313 may be in the pumps 19, 20, and/or 21 (see Fig. 1) or in the infusion site monitor
26 (See Fig. 2). The monitoring client 6 can instruct the occluder roller 313 to perform an
infiltration test. For example, the monitoring client 6 may ct a stepper motor coupled
to the roller occluder 313 to pull liquid out of the patient 5 (See Fig. 1). The monitoring
client 6 may then receive an estimate of the amount of blood that enters into the infusion
site monitor 26 (see Fig. 1) from the infiltration detector 32 (see Fig. 2). The ration
detector 32 determines if the proper amount of blood is pulled into the infusion site monitor
26 during the stages of the ration test, or alternatively, the monitoring client 6 may
receive raw data from the ration detector 32 to determine if the proper amount of blood
is pulled into the infusion site monitor 26 (See Figs. 1 and 2).
As previously mentioned, the infiltration detector 32 of Fig. 2 may be a
camera—based infiltration detector 32 as described above in relation to the system 108 of
Fig. 33 when used to capture images illustrated by Figs. 37 and 38. Figs. 37 and 38
illustrate the images taken by the camera 109 of the system 108 of Fig. 33 for estimating
blood that enters into the infusion site monitor 26 of Fig. 2 during an infiltration test. That
is, the system 108 of Fig. 33 may be within the infiltration detector 32 of the on site
monitor 26 (see Fig. 2) for detecting blood when the roller occluder 313 of Fig. 121 actuates
to draw blood into the infusion site r 26 of Fig. 2.
During stage 312, a drawback volume 315 thereby is pulled from a patient 5.
A camera 109 of Fig. 33 at an infusion site monitor 26 (e. g., within the infiltration detector
32) may ine if blood is drawn back from the patient as shown in Figs. 37 and 38. If
no blood is pulled into the tube within the infusion site monitor 26 (see Fig. 2), it may be an
indication that an infiltration has occurred. Additionally or alternatively, the camera 109 of
Fig. 33, in conjunction with a pressure sensor 33 and/or volume sensor 169, may be used to
determine what amount of pressure causes the blood to be pulled back into the tube 41.
In some embodiments, the fluid is returned to the patient 5 by actuating the
rolling occluder 313 in the opposite direction, or by lifting the occluder 313 off of the tube
314. In an onal embodiment, a compliant upstream reservoir may be included which
holds the drawback fluid (valves may direct the reverse fluid into the complaint upstream
reservoir). The am reservoir may be coupled to an AVS chamber as described herein
or is a separate chamber. The AVS chamber may have the drawback fluid volume measured
by a sor coupled o and/or communicated to the monitoring client 6.
Additionally or alternatively, the pumps 19, 20, and 21 are stopped during an infiltration test
or may assist in draw back fluid, in ction with the rolling occluder 313 or in lieu of
the rolling occluder 313.
] In additional embodiments, a compliant chamber is used between the roller
occluder 313 and the patient 5. The displacement volume of the chamber ne during
the ck is monitored using, for example, AVS or an optical sensor. The deflection of
the chamber membrane is proportional to the pressure in the fluid line 314, the amount of
the deflection of the membrane is tional to the effort to draw blood into the tubing. A
threshold amount of drawback pressure needed to draw blood out of the patient 5 is used to
determine if an infiltration exists. In addition, if a old amount of time is required to
drawback, this may be used as an indication that a downstream occlusion exists or an
ration exists. Therefore, the chamber membrane could be monitored over time and
detect a rate in pressure change that is an indication of the ck effort (as ined
by the processor 37 of Fig. 2).
Fig. 122 shows stages of an infiltration test 316 and 318 in accordance with
an embodiment of the present disclosure. A piston 319 may be disposed anywhere along the
fluid line or in a pump 19, 20 or 21 of Fig. 2, or the piston 319 may be disposed in the
infusion site monitor 26 of Fig. 2. In stage 316, a valve 318 remains open and the piston
319 is press against a membrane 320, but fluid continues to flow to the t. In stage
317, the valve 318 is closed, and the piston 319 is lifted up, after which the resiliency of the
membrane 320 pulls back and draws fluid backwards. The drawn back fluid returns to the
patient when the piston actuates back to the resting state as shown in stage 316. A camera
109 of Fig. 33 at an infusion site monitor 26 in the infiltration detector 32 (see Fig. 2) may
determine if blood is drawn back from the patient 5 as described above. If no blood is
pulled into the tube within the on site monitor 26 (see Fig. 2), it may be an tion
that an infiltration has occurred.
In some embodiments, the elastomer surface area and elastomer properties
are selected in combination with the chamber volume such that there is a maximum
determined fluid pressure that is applied during the drawback, e.g., the properties may be
chosen such that there is ient drawback pressure to draw back blood into the
monitoring area, however, there would be icient pressure to draw back the blood into
the monitoring when an infiltration has occurred. Additionally or alternatively, the blood
must be drawn back within a predetermined amount of time; otherwise, an infiltration
condition may be determined to exist. The amount of time allowed for the drawback can be
used with predetermined criteria to determine if an infiltration has occurred (i.e., allow the
drawback r to persist with ck for a predetermined amount of time while
looking for the indication of blood using the camera 109, and determining that an
infiltration has occurred if no blood is detected by the infiltration sensor 32 (see Figs. 2 and
33), e. g., a camera 109, before the predetermined amount of time has passed).
Figs. 123 and 124 show a cell—based reservoir 485 in accordance with an
embodiment of the present disclosure. The cell—based reservoir 485 may be the reservoirs 2,
3, or 4 of Fig. 1. The cell—based reservoir 485 includes cell foam 486 capable of absorbing
liquid ucted of a compatible material to dampen the motion of an infusate. The cell
foam 486 may e a membrane 487. The reservoir base 488 may be constructed using a
in a rigid, semi—rigid, or non—rigid fluid oir to increase infusate stability in the
presence of fluid shear.
For example, when using a semi—rigid base 488, the cell foam 486 may
include an open—cell silicone foam to fill the normally empty oir cavity. The cell foam
486 may help prevent sloshing of the reservoir contents to help ve the stability of the
infusate in some embodiments. By choosing a foam with a high degree of compressibility
relative to both the collapsible ne’s 487 spring rate and the pumping mechanism,
the residual volume of the cell foam 486 may be minimal in some ments.
Figs. 125 and 126 show a tube-based reservoir 489 in accordance with an
embodiment of the present sure. The cell—based reservoir 489 may be the reservoirs 2,
3, or 4 of Fig. 1. The tube—based reservoir 489 includes a tubing reservoir 490 that can
house a liquid. The tube—based reservoir 489 may be vented through a filter 491. The filter
491 may be part of the vent of Figs. 51—55. For example, a pumping mechanism (e.g., a
pump as described herein but not shown in Figs. 125 and 126) may draw fluid from the
tubing reservoir 490 stored in a rigid reservoir cavity 492 (the base 492 may be flexible,
rigid, semi—rigid, and/or part of a cassette in some embodiments). The tubing oir 490
can help prevent sloshing of the reservoir contents thereby helping ve infusate
stability in some embodiments.
Fig. 127 shows stages 1—8 rating a method for operating a plunger pump
493 in conjunction with an AVS assembly 494 in accordance with an embodiment of the
present disclosure. A fluid path 495 includes valves 496, 497, and 498.
Stage 1 shows the valve 498 closed with valves 496 and 497 open. The
valve 497 may be closed while the plunger 499 withdraws to check if the valves 498 and
497 are leaking. For example, a constant force may be applied to the plunger 499 drawing
the plunger up (e. g., from a spring) and either valves 496 and/or 497 may be closed. If the
plunger 499 moves upwards beyond a predetermined amount or more quickly than
predetermined speed, the processor 37 (see Fig. 2) may ine that a leak has ed.
Additionally or alternatively, the valve 496 may be closed, and the plunger 499 applies an
upwards force by a predetermined amount of time and then applies a downward force. The
AVS assembly 494 may then perform an AVS sweep. If the fluid within the AVS assembly
(e. g., measured by the volume of the fluid volume) is beyond a predetermined amount) then
the processor may determine that one of the valves 496 and 498 may be leaking.
Stage 2 shows the fluid being drawn into the plunger pump 493. Stage 3
ms an AVS sweep. Between stages 3 and 4, a leak check may be performed, e. g., the
valves 497 and 498 may remain closed while the plunger 493 applies a downwards force. If
there is movement beyond a predetermined amount, the one or both of the valves 497 and
498 may be determined to be leaking by the processor. In Stage 4, the volume of fluid from
the plunger pump 493 is transferred to the membrane of the AVS assembly 494. Stage 5
there is an AVS sweep to determine the fluid in the AVS ly 494. In stage 6, the
valve 497 is opened, and the volume of fluid is erred from the AVS assembly 494 to
the plunger pump 493. Between stages 5 and 6, the valve 497 may temporarily be left
closed to perform another valve leak check.
In stage 7, the valve 497 is closed. In stage 8, the fluid in the plunger
pump 493 is discharged. Between stages 7 and 8, the valve 498 may initially remain closed
to determine if one or both of the valves 497 and 498 is leaking.
Fig. 128 shows several stages illustrating a method for operating a plunger
pump in conjunction with an AVS assembly in accordance with another embodiment of the
present disclosure. Between stages 1 and 2, a leak test may be performed by g the
valve 500 temporarily closed while an upwards force is applied to the plunger 499. In stage
2, fluid is drawn into the plunger pump 493. Also during stage 2 an AVS sweep may be
performed by the AVS assembly 494. In stage 3, the fluid is transferred to the AVS
assembly 494. Also during stage 2 an AVS sweep may be performed by the AVS assembly
494. A leak test may be performed between stages 2 and 3 (e. g., by g the valve 501
closed while applying a downward force on the plunger 499. In stage 4, the fluid is drawn
from the AVS assembly 494 into the plunger 493. Also during stage 2 an AVS sweep may
be performed by the AVS assembly 494. Between stages 3 and 4, a leak test may be
performed by keeping the valve 501 temporarily closed while an upwards force is applied to
the plunger 499. In stage 5, the fluid is discharged from the plunger 493 to the patient (i.e.,
past the AVS assembly 494). A leak test may be performed between stages 4 and 5, by
keeping the valve 501 temporarily closed and/or to check for backflow. A leak test may
also be performed during stage 5 to check for backflow.
] Fig. 129 shows l stages rating a method for using a plunger pump
503 having an AVS ly 504 in accordance with an embodiment of the present
disclosure. In stage 1, an AVS sweep is performed. In stage 2, fluid is drawn into the
variable volume 506. In stage 2, after fluid is drawn into the le volume 453, another
AVS sweep is performed. In stage 3, the fluid is discharged. In stage 3, after the fluid has
discharged, an AVS sweep may be med. Note that the actuator 507 is within the
variable volume 506. Therefore, the movement of the actuator 507 does not affect the
volume of the variable volume 506.
Fig. 130 shows several stages illustrating a method for using a plunger pump
508 having an AVS assembly 509 in accordance with an embodiment of the present
disclosure. The actuator 507 is located outside of the variable volume 509. The plunger
pump 508 uses a standard IV set 510 such that the compliance of the tubing 510 draws
liquid in during stage 4. Stage 2 discharges the . The stages 1-4 may be repeated.
] Stage 1, an AVS sweep is performed by the AVS assembly 509 and a
downward force may be applied to the plunger 512 with both of the pinch valves 513 and
514. In stage 2, the fluid volume is discharged. In stage 3, the plunger 512 is retracted, after
which an AVS sweep may be performed to determine if the valves 513 and 514 are leaking
(e.g., the compliance of the tubing 455 may provide a negative pressure within the tubing
5 10.
Fig. 131 shows several stages 1—5 rating a method for using a plunger
pump 515 having an AVS assembly 516 in accordance with an embodiment of the t
disclosure. The plunger pump 515 draws fluid into and out of the variable volume 517 via a
tic actuator 518. During stage 1, a positive and/or negative pressure may be applied
to the variable volume 518 with both of the valves 519 and 520 closed. During stage one,
one or more AVS sweeps may be performed by the AVS assembly 516. If the volume
estimated by the AVS assembly 516 changes when both of the valves 519 and/or 520, then
the processor 37 may determine that a leak in one or both of the valves 519 and/or 520
exists.
[00599] During stage 3, a positive and/or ve pressure may be applied to the
variable volume 518 with both of the valves 519 and 520 closed. During stage one, one or
more AVS sweeps may be performed by the AVS ly 516. If the volume ted
by the AVS assembly 516 changes when both of the valves 519 and/or 520, then the
processor 37 may determine that a leak in one or both of the valves 519 and/or 520 exists.
[00600] Fig. 132 shows a plunger pump 521 with an actuator 522 inside the variable
volume 523 for use with a standard IV set tubing 524 in accordance with an embodiment of
the present disclosure.
Fig. 133 shows several views of a cam—driven linear peristaltic pump 522
having pinch valves 523 and 524 and a plunger 525 inside a variable volume 536 in
accordance with an embodiment of the present disclosure. The cross—sectional Views 527
and 528 show two different standard IV set tubing 529 configurations below the plunger
525.
Fig. 134 shows a plunger pump 530 for use within a standard IV 531 set
tubing with an actuator 532 outside of the variable volume 533 in accordance with an
embodiment of the present disclosure. Fig. 135 shows several views of a cam-driven linear
peristaltic pump 534 having pinch valves 535 and 536 a plunger 537 inside a variable
volume 538 with a corresponding cam mechanism 539 outside of the variable volume 538
in ance with an embodiment of the t disclosure. As the cam followers 540,
541, and 542 move in and out of the variable volume 535, the processor 37 of Fig. 2 may
adjust the measured volume to account for the changes in volume the cam followers 540,
541, and 542 affect the variable volume. section Views 543 and 544 show two
different configuration of the standard IV set tubing 545 for the plunger 537 to interface
with.
Fig. 136 shows a plunger pump 546 having a plunger 547 inside a variable
volume 548 with an actuator 549 outside of the variable volume 548 in accordance with an
embodiment of the present disclosure. The processor 37 is coupled to a position sensor of
Fig. 2 to account for the volume of the shaft of the r 547 as it moves in and out of the
variable volume 548.
Fig. 137 shows a cam—driven linear peristaltic pump 550 having a plunger
551 inside a variable volume 552 with a ponding cam mechanism 553 outside of the
variable volume 552 and pinch valves 554 and 555 on the housing of the le volume
552 in accordance with an embodiment of the present disclosure. The pinch valves 554 and
555 may also form the acoustic seal for interface of the variable volume 552 and the
standard IV set tubing 556. Two cross-sectional views 557 and 558 are shown to illustrate
the configuration of the interface of the r 551 with the standard IV set tubing 556.
Fig. 138 shows a plunger pump 559 having a plunger 560 inside a variable
volume 561 and pinch valves 562 and 563 outside of the variable volume 561 in accordance
with an ment of the present disclosure. The actuator 564 (e. g., a cam mechanism,
linear motor, linear actuator, etc.) is d outside of the variable volume 561. The
processor 37 of Fig. 2 can compensate for the shaft of the plunger 560 as it enters and exits
the variable volume 561.
Fig. 139 shows several views of a cam—driven linear peristaltic pump 562
having a plunger 563 inside a variable volume 564 with a ponding cam mechanism
565 and pinch valves 566 and 56? outside of the variable volume 564 in accordance with an
embodiment of the present disclosure. Views 569 and 570 shows two different
configuration of the standard IV set tubing 568. The standard IV set tubing 568 may be
positioned by a raceway (e. g., d below, above, and/or around the tubing 568).
Fig. 140 illustrates the stages 1-5 of occlusion detection using a plunger
pump 571 having an AVS assembly 572 and a -biased pinching mechanism 573
inside the variable volume 574 in accordance with an embodiment of the t disclosure.
The plunger pump 571 includes pinch valves 575, 576, and 577.
In stage 1, the pinch valves 575, 576, and 577 are closed. The variable
volume 574 may be measured as the spring—biased pinching mechanism 573 compresses the
tube 578. If the volume of the variable volume increases (e. g., the tube diameter within the
variable volume 574 decreases) then the processor 37 of Fig. 2 may determine that one or
both of the valves 576 and 577 are leaking. Additionally or atively, the spring—biased
ng mechanism 573 may include a sensor to estimate the volume of the liquid within
the tube 573 within the variable volume 574. The sensor may be, for example, a linear hall
effect sensor. If the sensor indicates that the pinching mechanism 573 is slowly g
despite that the pinch valves 575, 576, and 577 are , the processor 37 may determine
that an error condition exists (see Fig. 2).
In stage 2, the valve 576 is opened and the actuator 579 compresses against
the tube 573 y filling the tube within the variable volume with a liquid. In stage 3, the
valve 576 is closed. In stage 4, the valve 577 is opened. If there is no occlusion the liquid
within the spring-biased pinching mechanism 573 will discharge the liquid. In Fig. 137, the
stage 4 shows a View 580 where there is no occlusion and the spring-biased pinching
mechanism 573 discharges the liquid, and stage 4 also shows a view 581 where the spring-
biased pinching mechanism 573 does not rge (or does not fully discharge) the liquid.
In some embodiments of the present disclosure, the on of then spring—biased pinching
mechanism 573 during stage 4 is used to determine if an occlusion condition downstream
exists (e.g., the processor 37 may determine that an occlusion exists). Stage 5 shows two
views 582 and 583. View 582 of stage 5 shows when no downstream occlusion exists and
view 583 shows stage 5 when a downstream occlusion exists) note the difference volumes
of the spring—biased pinching mechanism 573 in the two views 582 and 583). An AVS
sweep and/or the position sensor of the spring—biased pinching mechanism 573 may be used
in stage 5 to determine if the volume of the liquid within the variable volume 573 exceeds a
predetermined threshold such that the processor 37 of Fig. 2 determines that a downstream
occlusion exists.
Fig. 141 shows a pump 600 with a spring-loaded plunger 604 within a
variable volume 605 of an AVS assembly 606 with actuated plunger 604 outside of the
variable volume 605 in accordance with an embodiment of the present disclosure. The
valve 602 may be closed and the valve 601 opened with the plunger 604 retracted to allow
the tube 607 to pull fluid in under the r 604.
The valves 601 and 603 are closed and the valve 602 opened while the
plunger 604 presses against the tube 607 to force fluid into the tube 607 region disposed
within the variable volume 605; this causes the spring—loaded (or spring—biased) plunger 604
actuate to increase the amount of energy stored in its spring. The valve 602 is closed and an
AVS measurement is taken. Thereafter, the pinch valve 603 is opened which forces fluid
within the variable volume 605 out of the tube 607 and towards the t. fter, the
valve 602 is closed and another AVS sweep is performed. The AVS volume measurements
are ed to determine the amount of fluid discharged through the pump 600. The
spring biased r 604 may be a single plunger with a spring attached to a shaft to apply
a downward force on the tube 607.
Fig. 142 shows a linear peristaltic pump 608 with pinch valves 609 and 610
and a cam shaft 611 disposed within a variable volume 612 of an AVS assembly 613 having
spring—biased ng mechanism 614 (see view 615) disposed therein, and a plunger 616
and a pinch valve 617 outside of the variable volume 612 in ance with an
embodiment of the present sure. The manner of operation may be the same as the
pump 600 of Fig. 141 (e. g., the plunger 616 force fluid to expand the pinching-mechanism
614 and load the associated s).
Fig. 143 shows a linear altic pump 618 with pinch valves 619, 620,
and 621 and a plunger 622 disposed outside of a variable volume 623 of an AVS assembly
624 in accordance with an embodiment of the present disclosure. The manner of operation
may be the same as in pump 600 of Fig. 141.
Fig. 144 shows a the stages 1-5 of a plunger pump 625 having an optical
sensor or camera 626 to measure the volume within a tube 627 residing within a chamber
628 in accordance with an embodiment of the present disclosure. The plunger pump 625
includes a spring—biased pinching mechanism 629. An actuator 634 applies a pumping
force to force fluid into the region of the tube 627 within the r 628 in the manner
similar to the pump 600 of Fig. 141.
In stage 1, the valves 630, 631, and 632 are closed. The optical sensor or
camera 626 estimates the volume within the region of the tube 627 disposed within the
chamber 628. The plunger 633 may compress the tube 627 to determine if the plunger 633
moves beyond a predetermined amount to perform a check of the valves 630 and 631. That
is, if the plunger 633 moved beyond a threshold amount, a sor 37 may determine that
one of the valves 630 and 631 is leaking.
] In stage 2, the valve 631 is opened, and fluid is forced into the chamber 628
by actuation of the plunger 633. In stage 3, another optical volume estimate is made after
both valves 631 and 632 are closed. In stage 4, the the valves 632 is opened. If an
occlusion exists, the spring— biased pinching mechanism 629 cannot discharge all of the
fluid out of the tube 627 within the chamber 628. If no ion exists, then the spring—
biased pinching mechanism 629 can discharge the fluid out. During stage 5 a volume
measurement is made to determine if the fluid has been discharged beyond a old. If
fluid has not been discharged beyond a threshold, the processor 37 of Fig. 3 determines that
an occlusion exists
Fig. 145 shows a plunger pump 635 having a chamber 636 having an optical
sensor 637 to estimate fluid volume of a tube 638 having a spring—biased pinch ism
639 around the tube 638 and a r 640 and pinch valves 641, 642, and 643 in
accordance with an embodiment of the present disclosure. The optical sensor 637 may be
an LED time-of—flight device or a camera. The manner of operation of the plunger pump
635 may be the same as the plunger pump 625 of Fig. 144.
Fig. 146 shows a plunger pump 644 having a chamber 645 with an optical
sensor 646 to estimate fluid volume of a tube 647 having a spring-biased pinch mechanism
648 around the tube 647 and a plunger 649 and pinch valves 650, 651, and 652 outside the
chamber 645 in accordance with an embodiment of the present sure. The r
pump 644 may operate in the same manner of operation of the pump 625 of Fig. 144.
Figs. 147 show several views of a plunger pump 653 having an AVS
ly 655 with pinch valve disposed 656 and 657 within the variable volume 658 of the
AVS assembly 659, and a plunger 660 and pinch valve 661 disposed e the variable
volume 658 in accordance with an embodiment of the present disclosure. Note that the
pinch valves 656 and 657 wholly traverse through the variable volume 658. Fig. 148 shows
an two cross—sectional views of the plunger pump of Fig. 147 in accordance with an
embodiment of the present disclosure. Fig. 149 shows an alternative two cross-sectional
views of the plunger pump of Fig. 147 in accordance with an embodiment of the present
sure. Note in the two views of Fig. 148, the pinch valve is disposed around the tube
and in Fig. 149 the pinch valve is disposed on one side of the tube.
Fig. 150 rates the stages 1—4 during normal operation of a plunger pump
662 having a spring—biased plunger 663 in ance with an embodiment of the present
disclosure. In stage 1, the plunger 663 is pulled away from the tube 664 and the pinch valve
665 is opened. An AVS measurement is taken. In stage 2, the pinch valves 665 is closed
and the plunger 663 compresses the tube 664. Another AVS measurement is taken. In
stage 3, the pinch valve 666 is opened and the plunger 663 pushes fluid out of the tube 664.
An AVS sweep is performed to estimate the volume of fluid delivered. In some
embodiments, the plunger 663 includes a linear hall effect sensor which correlates the
movement of the plunger between stages 2 and 3 to estimate the amount of fluid discharged.
[00621] Fig. 151 illustrates the stages for detecting an ion for the r pump
622 of Fig. 150 in ance with an embodiment of the present disclosure. Stage 3
compares the AVS measurements when an occlusion occurs vs. a normal fluid delivery.
The processor 37 of Fig. 3 can detect when not enough fluid is delivered thereby indicating
to the processor than an occlusion has occurred.
[00622] Fig. 152 illustrates stages 1—2 for leakage ion for the plunger pump 622
of Fig. 150 in accordance with an embodiment of the present disclosure. In stage 1, the
pinch valve 665 is opened and the plunger 663 is opened thereby drawing fluid into the tube
664. In stage 2, after the pinch valve 665 is compressed against the tube 664, the plunger
applies a force against the tube 664. If one of the valves 665 and 666 is leaking, in stage 2,
the AVS measurement would te a leakage of fluid (i.e., the variable volume would
increase.
Fig. 153 illustrates the stages 1—2 for ing a failed valve and/or bubble
detection for the plunger pump 602 in accordance with an embodiment of the present
disclosure. As shown in stage 2, if the variable volume increases beyond a predetermined
threshold and does not continue to se, the processor 37 of Fig. 3 may determine that a
bubble exists in the tube 664.
Fig. 154 illustrates the stages for empty reservoir detection and/or upstream
occlusion detection for a plunger pump 662 in ance with an embodiment of the
present disclosure. As shown in stage 2, if the AVS sweeps indicate that fluid is not being
drawn into the tube 664, then the processor 37 of Fig. 3 may determine that the upstream
reservoir is empty.
Fig. 155 illustrates the stage for free flow prevention for a plunger pump 662
in accordance with an embodiment of the present disclosure. That is, when a free flow
condition is detected, the plunger 663 may ss against the tube 664 to stop the free
flow.
Fig. 156 illustrates the stages for a negative pressure valve check for the
plunger pump 662 in accordance with an embodiment of the present disclosure. Stage 1, the
plunger 663 is ssed against the tube 664, and both valves 665 and 665 are . In
stage 2, the plunger 663 is lifted from the tube 665. If there is a leak, the compliance of the
tube 664 will pull in fluid which is detected by the AVS sweeps. As shown in Stage 3, the
valves 665 and 665 are opened.
Figs. 157—158 show views of a plunger pump 670 having a cam shaft 671
that traverses the variable volume 672 of an AVS assembly 673 in ance with an
embodiment of the present disclosure;
Figs. 159—162 illustrate several cam profiles in ance with several
ments of the present disclosure. The cam profiles of Figs. 159—162 may be used
with the peristaltic pump 662 of Figs. 150—158, or any sufficient pump disclosed herein.
[00629] Fig. 159 shows a cam profile that uses the integrity check described in Figs.
150-158 except for a negative pressure valve check, and can be used for forward pumping
and backward pumping. The backward pumping may be used during an infiltration test as
described herein. Fig. 160 shows a cam profile which uses the integrity checks described in
Figs. 150—158 without the negative pressure check. on of the cam in a back and forth
manner causes fluid flow in the cam e of Fig. 160 when the cam is rocked from 0 to
155 degrees. Back pumping is accomplished in the cam profile of Fig. 160 by rotating the
cam shaft back and forth from 315 s to 160 degrees. In Fig. 161 a cam profile is
shown that uses the integrity check described in Figs. 8 except for a negative
pressure valve check. The cam e in Fig. 161 can be used to provide forward fluid flow
of the pump. Fig. 161 shows a cam profile that pulses fluid when rotated continuously in
one direction with a zero total fluid flow. The chart in the bottom right hand comer of Fig.
162 shows the movement to achieve forward, backwards, and swishing fluid movement.
Fig. 163 illustrates a peristaltic pump 675 having a plunger 676 and a pinch
valve 677 outside of an AVS variable volume 678 with two pinch valves 679 and 680 on
the interface of the AVS variable volume 678 in accordance with an embodiment of the
t disclosure. Fig. 164 illustrates stages 1-5 of operation of the altic pump of Fig.
163 (in simplified version) in accordance with an embodiment of the present disclosure.
[00631] Fig. 165 illustrates a peristaltic pump 681 having two plungers 682 and 683
external to an AVS variable volume 684 in accordance with an embodiment of the present
disclosure. Fig. 166 illustrates several stages 1—6 of the peristaltic pump 681 of Fig. 165 in
accordance with an embodiment of the present disclosure;
Fig. 167 illustrates a peristaltic pump 685 having a plunger 686 with a linear
sensor 687 in ance with an embodiment of the present disclosure. Fig. 168 illustrates
a graphic of data from the linear sensor 687 of the altic pump 685 of Fig. 167 in
accordance with an embodiment of the present disclosure. As shown in Fig. 168, the
amount of movement of the plunger 686 between the pressurized stage (e. g., both pinch
valves closed 688 and 689 and the plunger’s 686 spring applying a force again the tube 690)
and the ry stage (e.g., the outlet pinch valve 689 is opened) is correlated with the
amount of fluid discharged. The correlation between the amounts of fluid discharged with
the delta output from the sensor 687 may be determined empirically. The plunger 686 may
be spring loaded against the tube 690 such that the cam only comes into contact with a cam
follower coupled to the plunger 686 in order to lift the plunger 686 away from the tube 690.
[00633] Fig. 169 illustrates the stages of the peristaltic pump of Fig. 167 in
accordance with an embodiment of the present disclosure. Fig. 170 illustrates the ion
of an ion ion vis-a-vis a non-occluded condition in accordance with an
embodiment of the present disclosure. That is, the r position data is shown for the
normal vs. occluded conditions. Note that when there is an occlusion, fluid does not
discharge and thus the r position does not move as much. This may be detected by
the processor 37 of Fig. 3. Fig. 171 illustrates the detection of a valve leak vis—a—vis a full—
sealing condition. Fig. 172 illustrates the detection of a too much air in the tube or a
valve fail vis—a—vis a proper operation.
Fig. 173 shows a block diagram that illustrates the electronics of a peristaltic
pump in accordance with r embodiment of the present disclosure. That is, Fig. 173
shows the onics of one of pumps l6, l7, and 18 of Fig. l in one specific embodiment.
Fig. 174 shows a block diagram that illustrates the onics of another embodiment of the
peristaltic pump of one of the pumps l6, l7, and 18 in Fig. 1.
Fig. 175 shows a perspective view of peristaltic pump 700 in ance
with an embodiment of the present disclosure. The peristaltic pump includes an AVS
chamber (see the AVS chamber 714 of Fig. 184). The peristaltic pump 700 includes cams
701, 702, and 703 that rotate along with a cam shaft 704 coupled to a motor via a gear 705.
The cam 702 control an inlet pinch valve, the cam 702 controls a plunger, and the cam 703
controls an outlet pinch valve.
The cams 701—703 may be shaped to provide a peristaltic—pumping action
along the tube 707. The cams 701—703 may be shaped to provide a three stage pumping
action or a four stage pumping action.
[00637] The three stage g action includes stages 1, 2, and 3. In stage 1, the
outlet valve is closed, the inlet valve is opened, and the plunger is lifted off of the tube. In
one embodiment, the outlet valve is substantially closed before the inlet valve is
substantially open. In stage 2, the inlet valve is , and the spring—biased plunger is
allowed by the cam to apply a compression force against the tube 707. In stage 3, the outlet
valve is opened such that the compressive force of the spring’s plunger compresses out the
fluid towards the patient. A linear sensor (e.g., optical or hall—effect) es the position
of the plunger. A processor coupled to a motor to l the cam shaft 704 and coupled to
the linear sensor may compare the difference of the plunger’s position in stage 2 when the
plunger stops movement and fully compresses against the tube 707 and at the end of stage 3
(all fluid has been forced out towards the patient and the plunger stops moving because no
additional fluid may be compressed out of the tube). In another embodiment, the processor,
d to the processor coupled to a motor to control the cam shaft 704 and coupled to the
linear sensor, may compare the difference of the plunger’s position in stage 2 when the
plunger rate of movement drops below a defined old and during stage 3 when the
plunger rate of nt drops below a given threshold or the plunger position drops
below a defined value. The thresholds for the rate of nt and position of the plunger
are determined by calibration experiments. The processor uses the measured differences
between the displacements between these two positions to correlate the difference to a
volume of fluid pumped (e. g., by comparing the delta value (the difference between the two
measurements) to values in a look—up table). Optionally, in stage 3, the opening of the
outlet valve is controlled by the rotation of the cam 704 to achieve a target fluid discharge—
rate profile, e. g., the delta is used between the measurement of stage 2 and in real—time as
the outlet valve is opened in stage 3 (e.g., the delta is continuously calculated).
] During stage 2, if the plunger moves beyond a predetermined threshold
and/or beyond a predetermined slope, one of the inlet valve and the outlet valve may be
leaking. For e, if the r quickly moves to compress the tube and continues to
move (e.g., beyond a predetermined slope), the processor may determine that one of the
inlet and outlet valves are leaking. The processor (the processor 37 of Fig. 3) is coupled to
the linear sensor may issue an alarm and/or alert.
During stage 2, if the plunger moves beyond a predetermined threshold when
the cams allows the compression of the spring to compress the tube or the movement slows
as the plunger hits the tube and then moves more beyond a predetermined threshold (as the
bubble is compressed), it may indicate that a bubble exists within the tube. For e, if
the plunger moves as the cam follower moves the spring—biased plunger towards the tube,
then momentarily stops, and then moves again, the processor may determine that air within
the tube has been compressed. In some embodiments, nt beyond a predetermined
threshold may suggest that air exists within the tube. The processor coupled to the linear
sensor may issue an alarm and/or alert. In some embodiments, to distinguish n a
leaking valve and a bubble, a downstream bubble sensor (not shown) may be used by the
sor to distinguish n the two error conditions.
In some ments, if the spring—biased plunger in stage 2 moves towards
the tube and does not engage the tube until after a predetermined threshold has been
crossed, the processor may determine that an upstream occlusion exists and the tube did not
fill up with fluid during stage 1.
] In some embodiments, if the spring-biased plunger in stage 3 does not move
beyond a predetermined threshold, the processor may determine that a downstream
occlusion exists (e. g., the tube cannot discharge fluid downstream). Additionally or
alternatively, the processor may determine that a ream occlusion exists when each
cycles of the stages l—3, less and less fluid is discharged to a patient (i.e., the compliance is
increasing taking in fluid downstream).
In some embodiments of the present disclosure, the cams 701, 702, and 703
may be shaped to have a four stage pumping action.
In stage 1, the outlet valve is closed, the inlet valve is opened, and the
plunger is lifted off of the tube. In stage 2, the inlet valve is closed, and the —biased
plunger is allowed by the cam to apply a compression force against the tube 707. In stage 3,
the plunger is lifted off of the tube and the outlet valve is opened. In stage 4, the cam 702
allows the plunger to apply the compressive force of the spring’s plunger to compress out
the fluid s the patient. A linear sensor (e.g., optical or hall-effect) measures the
position of the plunger. A processor coupled to a motor to control the cam shaft 704 and
d to the linear sensor may compare the difference of the plunger’s position in stage 2
when the plunger stops movement and fully compresses against the tube 707 and at the end
of stage 4 (all fluid has been forced out towards the patient and the plunger stops moving
because no onal fluid may be compressed out of the tube). The processor uses the
measured differences between the displacements between these two positions to ate
the difference to a volume of fluid pumped (e.g., by comparing the delta value (the
difference between the two measurements) to values in a look—up table). Optionally, in
stage 4, the nt of the plunger to compress the tube using the plunger’s compressive
force (as allowed by the cam 702) is controlled by the rotation of the cam 704 to e a
target fluid discharge—rate profile, e.g., the delta is used between the measurement of stage 2
when the plunger fully compresses the tube and the movement of the plunger in real—time as
the plunger is allowed to compress the tube 707 (e.g., the delta is continuously ated).
In some embodiments, a downstream occluder may be adjusted to smooth
the flowing of the fluid to the patient.
In some embodiments AVS may be used instead of the linear position
sensor. In some ments, only the linear position sensor is used. In yet additional
embodiments, both of the AVS and the linear position sensor are used.
Figs. 0 show data from several AVS sweeps in accordance with an
embodiment of the present disclosure. The AVS sweeps of Figs. 176-180 are for the
peristaltic pump 700 of Fig. 175.
[00647] Fig. 176 shows data, including a magnitude and phase response, of a variable
volume around the tube 707 of the peristaltic pump 700 of Fig. 175 relative to a reference
volume. That is, the data as shown in Fig. 176 is correlated to the volume of air around the
tube 707 (see Figs. 175) within an acoustically sealed region as shown in Fig. 184 (i.e., a
variable volume chamber).
Fig. 177 illustrates several AVS sweeps performed using the peristaltic pump
700 of Fig. 175. Note that, although the plunger is —loaded against the tube 707 in
Sweep 3 and the outlet valve is opened by the cam 703, the fluid is not discharged
downstream towards the patient. The processor 37 of Fig. 3 may determine that a
downstream occlusion exists in this circumstance.
Fig. 178 shows several AVS sweeps using the pump 700 of Fig. 175. In
sweeps 2 and 3 of Figs. 178, the cam 702 allows the plunger’s spring to compress against
the tube 707, but the cams 701 and 703 force the pinch valves closed. In sweep 3, the inlet
and outlet valves have remained closed, however, the variable volume is increasing which
thereby tes that the fluid is being discharged out of one of the inlet and outlet .
The processor 37 of Fig. 3 may determine that one of the inlet and outlet valves are leaking
when the sweeps data s as in sweeps 2 and 3 despite that the inlet and outlet valves
have remained closed.
Fig. 179 shows several AVS sweeps using the pump 700 of Fig. 175. In
sweep 1, the cams 701 and 703 close the valves, and the cam 702 allow the plunger’s spring
the compress against the tube 707. In sweep 2, the cams 701 and 703 have kept the valves
closed, however, the plunger’s spring has moved the plunger beyond an ermined
amount. The processor 37 may determine that the movement of the plunger is e air is
within the tube under the plunger. A downstream air detector 24 (see Fig. 1) may be used to
distinguish between movements caused by the compressibility of air when air is within the
tube 707 below the r vs. a leaking inlet or outlet pinch valve.
Fig. 180 illustrates the AVS sweep performed during multiple (full cycles) of
fluid rge towards the patient using the pump 700 of Fig. 175 when there is a
downstream occlusion. That is, each sweep may be performed after the plunger is expected
to discharge fluid towards the patient. As shown in sweep 4, the pump 700 is not
discharging the fluid. For example, the pump 700 may slowly fill the downstream
compliance of the tube 707 until the tube can no longer expand, in which case, the pump
700 has difficultly pumping additional liquid ream because the spring of the plunger
cannot apply sufficient force to pump additional liquid downstream. The processor 37 (see
Fig. 3) may determine that the decreased liquid delivery during each cycle of the pump 700
indicates that a downstream occlusion exists.
Figs. 181—183 show several side views of a cam mechanism of the peristaltic
pump of Fig. 175 in accordance with an embodiment of the present sure. Fig. 181
shows a side sectional—view of the plunger 706. The movement of the plunger 706 and cam
follower 709 is red by an l cam follower on sensor 711.
There are various devices that may be used to sense the position of the
pump plunger 706 and pinch valves of the pump of Fig. 175. These include, but are not
limited to one or more of the following: onic, l (reflective, laser interferometer,
camera, etc), linear caliper, magnetic, mechanical contact switch, infrared light
measurement, etc. In one embodiment, a small reflective optical sensor assembly
(hereinafter al sensor”) that fits into the ary embodiments of the peristaltic
pump 175, as shown and described, for example, herein, may be used. The optical sensor
in the various embodiments has a sensing range that odates the components for
which the optical sensor may be sensing, e.g., in some embodiments, the plunger 706. In the
ary embodiment any optical sensor may be used, including, but not limited to a
Sharp GP2S60, manufactured by Sharp Electronics Corporation, which is a US subsidiary
of Sharp Corporation of Osaka, Japan.
In various embodiments, the pumping apparatus may be based on the
principle of indirect compression of a flexible tube segment through the application of a
ing force against the tubing segment by a spring—based apparatus. As shown in Fig.
181, a cam lobe or element 702 may be eccentrically disposed on a shaft 705 to cause cam
follower 709 to move in a reciprocating fashion as the cam t 702 rotates. Plunger
spring 710 in this illustration is biased to urge a plunger 706 to compress the flexible tube
segment 707 situated within the peristaltic pump 700. Thus, in this arrangement, a spring
constant may be selected for spring 710 to cause the plunger to compress flexible tube
segment 707 to the extent necessary to deform the wall of the tube segment when liquid
having a pre-selected range of ities is present within it, and for a pre-determined flow
resistance of the fluid column to the end of a catheter or cannula attached to the terminal
end of the flexible tube. In this way, the distance and speed with which plunger 706 moves
to compress tubing segment 707 can provide information about the state of the tubing distal
to tubing segment 707, such as whether there is a complete or partial occlusion involving
the tube or an ed catheter, or whether the catheter has been dislodged out of a blood
vessel or body cavity and into an extravascular tissue space. The movement of the spring or
attached elements (such as the plunger) may be monitored by one or more sensors, the data
being transmitted to a controller (e.g., the processor 37 of Fig. 3) for analysis of the rate and
pattern of movement as the tube segment is compressed. Examples of suitable sensors for
this purpose may include, for example, Hall Effect s, potentiometers, or optical
sensors including LED—based, laser—based or —based sensing systems that are capable
of transmitting data to a controller employing various forms of pattem—recognition software.
The action of peristaltic pump 700 of Fig. 175 is illustrated in Fig. 182. Fig.
182a shows the cam lobe or element 704 contacting cam follower 709, compressing spring
710, and moving the plunger 706 away from tube segment 707. Fig. 182b shows cam lobe
704 having rotated about cam shaft 705 away from cam follower 709, allowing spring 710
to extend, and the r 706 to begin compressing tube segment 707. In Fig. 182c, cam
lobe 704 has rotated sufficiently to completely release cam follower 709 to allow spring 710
to extend sufficiently to allow the plunger 706 to completely compress tube segment 707.
Assuming that an inlet valve acting on tube segment 707 entering pump 700 is closed, and
an outlet valve acting on tube t 707 leaving pump 700 is open, a volume of liquid
within tube segment 707 will be propelled distally out of the tube segment 707. Although
the side—view shown in Fig. 182 is of a plunger, the ion of the inlet and outlet valve
may be similar and/or the same.
Fig. 183 rates a scenario in which the resistance to flow of the liquid
column within tube t 707 is increased beyond the pre—determined functional range of
the spring selected for pump 700. As cam lobe 704 moves from a spring compressing
position in Fig. 183a to a spring de—compressing on in Fig. 183b, the spring force is
insufficient to compress tube segment 707 quickly, and may only be able to compress tube
segment 707 partially, as shown in Fig. 183C. The rate of movement and end position of a
ent the plunger—spring-cam follower assembly may be detected by one more sensors
appropriate for this task (e. g., camera—based sensor), which may, for example, be mounted
near or adjacent to plunger 706. This information may be transmitted to a controller, which
can be programmed to interpret the signal pattern in light of stored data that has previously
been determined empirically. The n of volume-change vs. time of a compressed tube
segment such as that shown in Fig. 180 may in some cases mirror the pattern to be expected
of movement vs. time when the relative position of a component of the plunger—spring—cam
er ly is tracked.
Fig. 184 shows a sectional view of the pinch valves 715 and 716 and plunger
718 of the peristaltic pump of Fig. 175 in ance with an embodiment of the present
sure. In various embodiments, the tube segment within the pumping apparatus is held
against an anvil plate during compression by a r. The tube segment may be held in
position by being secured in a form—following raceway having sufficient space to allow for
the lateral displacement of the tube segment walls as it is being compressed. However, this
may allow for some lateral movement of the tube segment in an uncompressed state. Fig.
185 shows an alternative arrangement in which the tube segment may be held in position by
flexible side arms or fingers that can elastically spread apart to accommodate the spreading
sides of the tube segment as it is compressed. Fig. 185 shows a plunger comprising e
side arms or fingers to grip a tube segment to keep it relatively immobilized in both a non-
compressed and ssed state. In an uncompressed or ched’ state, the flexible
fingers fit snugly against the sides of the tube segment, preventing lateral movement of the
tube within the pumping apparatus. In a compressed or ‘pinched’ state, the flexible fingers
elastically spread apart to odate the lateral displacement of the tube segment walls
as it is compressed, maintaining the overall position of the tube segment within the pumping
apparatus.
Fig. 186 shows an embodiment of a cam mechanism of a peristaltic pump
719 in accordance with an embodiment of the present disclosure. A cam 720 ls a
pinch valve 721. A Cam 722 controls plungers 723, 724, and 725. A cam 726 controls
another pinch valve 727. A latching mechanism (e.g., a magnetic latch) may prevent the
plungers 723 and 725 from moving to compress the tube 728 as shown in Fig. 187.
Figs. 188, 189, and 190A show several views of a peristaltic pump 729 in
accordance with the t disclosure. The peristaltic pump 729 es a cam shaft 730
coupled to cams 731, 732, 733, and 734 that engage the cam followers 735, 736, 737, and
738, respectively. The cam follower 735 is coupled to a first pinch valve 739, the cam
ers 736 and 737 are coupled to a plunger 740, and the cam follower 738 is coupled to
another pinch valve 741. As shown in Figs. 190B-190C, the plunger 740 includes a pincher
744 that engages fingers 743 g a y.
Figs. 5 show several views of a peristaltic pump 745 in accordance
with an additional embodiment of the present disclosure. The peristaltic pump 745 of Figs.
190—195 is similar to the peristaltic pump 729 of Figs. 188—190C, except that the peristaltic
pump 745 of Figs. 190—195 includes a torque balancing cam 746 coupled to a cam follower
747 that operate together to smooth the rotational torque of the camshaft 748.
Fig. 196A rates the torque profile of a rotating cam shaft of the
altic pumps of Figs. 188—190C and of Figs. 191—195 in accordance with an
embodiment of the present disclosure. The torque profile 749 shows the torque of the
peristaltic pumps of Figs. 188-190C. torque 750 shows the torque ed by the torque
balancing cam 746 of the peristaltic pump of Figs. 191—195. The torque profile 751 shows
the resulting net torque on the camshaft 748 caused by the smoothing operation of the
torque balancing cam 746 (also see Fig. 196B).
Fig. 197 illustrates a cam profile for several cams for a peristaltic pump in
accordance with an embodiment of the present sure. The cam profile describes the
four stage pumping action bed above. The solid lines describe the linear position of
the cams. The dashed lines plot the position of the plunger and valves. The Pump cam and
plunger position over time are plotted in 1300. The inlet valve cam and inlet valve position
are plotted in 1302. The outlet valve cam and outlet valve position are plotted in 1304. In
stage 1, the outlet valve closes at 1306. The inlet valve opens at 1308. The plunger is lifted
off the tube at 1310, which allows fluid to enter the tube under the plunger. In stage 2, the
inlet valve closes at 1312, while the r remains lifted off the tube. In stage 3, the
plunger is allowed to compress the tube. The position of the plunger 1314 departs from the
cam position due to the presence of fluid in the tube. The ller may execute a number
of diagnostic tests including but not limited to leak tests, air in the line, occlusions based on
the measured position and movement of the plunger during stage 3. In stage 4, the outlet
valve is opened at 1316 first. After the outlet valve is opened, the plunger is allowed to
compress the tube forcing liquid out of the pump. The plunger force is supplied by springs
acting on the plunger or springs acting on the plunger cam followers. The cam may be
formed to limit the descent of the plunger during stage 4. The actual position of the plunger
may be further limited by the fluid flow out of the tube. The processor on the pump may
ly control the plunger position by controlling the cam rotation based on the measured
location of the plunger. This closed loop l of the motor may provide low flow rates
(Fig. 198). In other embodiments at higher flows, the cam and/or motor will be lled
in an open loop.
Fig. 198 shows various feedback modes of a peristaltic pump in accordance
with an embodiment of the t disclosure. In a closed loop mode, feedback from the
AVS measurements and/or the linear sensor is used to control the speed of the camshaft. In
open loop mode, the speed of rotation is selected by reference to a lookup table in response
to a target fluid flow rate.
Fig. 199 shows a graph illustrating data of a linear sensor used to estimate
fluid flow in accordance with an embodiment of the present sure; The delta value
from the plateau 752 caused by both inlet and outlet valves being closed in a peristaltic
pump with the plunger fully compressing t a fluid filled tube and the plateau 753
cause after the outlet valve is opened and all of the fluid is expelled out of the peristaltic
pump and the plunger is fully compressing against the tube by the force from its spring.
Figs. 200-206 show an alternate embodiment of a peristaltic pump 1200
wherein a motor 1204 may drive a cam shaft 1206 Via a gear train 1208. The cams may
actuate one or more valves 1226, 1228 and a plunger 1222 Via levers that rotate about a
common axis. The tube 1202 is held in place by a door 1212. The peristaltic pump 1200
may include a receptacle for a slide occluder 1200 and mechanisms that prevent a free—flow
condition on the tube during installation of the tube in the peristaltic pump 1200.
[00666] The cam shaft 1206 may include l cams 1232A—E. The cams 1232A—E
may control the position of several items that may include but are not limited to the
following: inlet pinch valve 1224, plunger 1222, outlet pinch valve 1226, and a torque
balancer. The cams 1232A—E may be contacted by wheels 1214A—E on the cam followers
1216A—E. The cam ers 1214A—E may e magnets 1218A—E. The position of
each magnet may be detected by an array of sensors 1220. The pump controller may
calculate the position of a pump plunger 1222 and valves 1226, 1228 from the sensor
signals generated by the magnets 1218A—E. The peristaltic pump 1200 may e an
ultrasonic sensor 1228 to detect the presence of the air bubbles in the fluid exiting the pump.
The ultrasonic sensor 1228 may communicate with the pump ller.
] The cam followers 1214A—E may have an L shape and may pivot about a
central axis at 1230. The cam followers are held against the cams E by springs
1234A-E. Spring 1234C may provide a torque balancing load. The springs 1234B and
1234D may provide the force to urge the plunger toward the anvil plate 1236. The springs
1234A and 1234E may provide the force to close the pinch valves 1226, 1228 t the
anvil plate 1236.
Fig 207 illustrates the installing tube with the slide occluder in the altic
pump 1200. In step 1, the door 1212 is open. In step 2, the tube 1202 and slide occluder
1210 are placed in position in the peristaltic pump 1200. In step 3, the slide occluder 1210
is slid into the altic pump 1200 and displaces slide 1242 and lever 1240 away from the
door and displaces button 1248 d. The tube 1202 is held near the front peristaltic
pump 1200 as the slide occluder 1210 so that the tube 1202 is in the narrow part of the slot
and pinched closed. In step 4 the door is closed. In step 5, the slide occluder 1210 pushed
out by the movement of button 1248 toward the back of the peristaltic pump 1200. The
button 1248 moves lever 1240, which draws slide 1242 forward. The forward movement of
the slide occluder 1210 releases the pinch on the tube 1202 by the slide occluder 1202.
Figs 210-212 illustrates features to prevent the user from installing a tube
without the correct slide occluder. A tab 1250 ts a slide occluder 1210 from being
installed that does not have a matching slot 1252. A shutter 1254 prevents the door 1212
from closing. The r 1254 is displaced by the slide occluder 1210 in step 3 of Fig. 207.
Figs 213—220 illustrate how the peristaltic pump 1200 ts a free flow
condition when the tube 1202 is loaded and/or removed. The door 1212 easily opens to an
angular position 900 from the front of the peristaltic pump 1200. A small force may be
applied to further rotate the door 1212, which forces the plunger 1222 and the pinch valves
1224, 1226 into the open position. The movement of the door 1212 pulls the L shaped cam
followers 1218A—E toward the front and y lifts the plunger 1222 and the pinch valves
1224, 1226 off the tube 1202.
Fig. 221 illustrates the ultrasonic air sensor 1228 that may detect air bubbles
of a certain size in the fluid downstream of the pinch valve 1266 pump. The pressure sensor
1260 may measure the static pressure in the fluid downstream of the pump. The pressure
sensor 1260 and air sensor 1228 may communicate with the pump controller.
Fig. 222—223 shows two views of a peristaltic pump 754 in accordance with
an embodiment of the present disclosure. The peristaltic pump 754 includes a door lever
755 and a door 756. Fig. 224 shows the slide occluder 757 in an open position against the
tube 758. The slide occluder 754 is carried in the slide occluder carriage 1312. The slide
occluder ge 760 engages a pin 761 that is in mechanical ication with the
plunger lift lever 759 in Fig. 225. Fig. 225 illustrates that as the door lever 755 is opened
(see Fig. 244), a plunger lift lever 759 is not lifting the plunger 1310 and pinch valves. Fig.
226 shows how as the door lever 755 is opened, the carriage 760 moves d toward the
door and moves the slide occluder 757 passed the tube 758 so that the tube 758 is closed as
it passes into the narrow section of the slide er 757. At approximately the same time
that the tube 758 is pinched closed by the slide occluder 757 the forward motion of the
carriage 760 rotates the pin 761 which moves the r lift level 759 to lift the plungers
1310 and pinch valve off the tube 758 as shown in Fig. 227. In Fig. 228, the door lever 755
is fully opened and the carriage 760 stops moving. As shown in Fig. 229, the plunger lift
lever 759 is in a stable over center position that will keep the plunger 1310 off the tube 758
when the door lever 755 is fully opened.
Figs 230-233 illustrate an interlock that may t the slide er
carriage 760 from moving and closing the rs 1310 and valves 1312 without the door
756 being closed first. Fig. 230 shows the door 756 open and the release tab 1316 exposed.
The interlock pin 1318 is shown in the interlocked position that prevents the slide er
carriage 760 from moving. A spring 1320 pushes the interlock pin 1318 toward the slid
occluder ge 760 and engages the interlock pin in a matching hole when the slide
er carriage 760 is in position.
Figs 231—233 show the sequence of the door 756 opening and releasing the
interlock pin 1316 by awing the release tab 1316. As the tab is withdrawn the
interlock pin 1318 is pushed toward the slide er carriage 760.
Fig. 234 shows the door 756 open and the slide occluder 757 being lifted out
of the slide occluder carriage 760. The tube 758 is in the narrow section of the slide
occluder 757 that pinches the tube 758 closed. Fig. 235 illustrates placing the tube 758 into
the pump between the anvil plate 1324 and the plunger 1310 and valves 1312. Fig. 236
shows the slide occluder 757 and tube 758 fully installed in the pump 754, where the slide
occluder 757 is pinching the tube 758 closed. Fig. 237 shows the door 756 and the door
lever 755 being shut which slid the slide occluder carriage 760 toward the rear of the pump
754. The movement of the slide occluder carriage 760 pushed the slide occluder 757 past
the tube 75 8 so that the tube is open and rotated the pin 761 that in turn rotated the plunger
lift lever 759 that released the plungers 1310 and valves 1312 to descend and close the tube
758. Fig. 238 shows a front view of the door 756 being shut.
Figs. 239-245 show several views of the peristaltic pump of Figs. 222-238 in
accordance with an embodiment of the present disclosure. A motor 2001 rotates gears
which in turn rotates a camshaft 772. As the camshaft 772 rotates, the cams 2003, 2004,
2005, 2006, and 2007 rotate with the camshaft 772. The cam 2003 engages a cam follower
769, which pivots along a pivot 763 to move a pinch valve 770. The cams 2004 and 2006
engage cam follows 766 and 765, which pivot along the pivot 763 to move a plunger 767.
The cam 2007 engages the cam follower 762 to move the pinch valve 764. Additionally,
the cam 2005 engages a cam follower 768. The cam 2005 is shaped such that the
engagement with the cam follower 768 at least partially balances the torque (e. g., to reduce
the peak toque). In some embodiments, the cam 2005 and the cam er 768 are
optional. The inlet valve 770 (which is a pinch valve), the plunger 767, and the outlet valve
764 (which is a pinch valve) may engage the tube 771 using the three or four stages of
pumping action as described above. A bubble sensor 2008 may be used to distinguish
between a bubble and a leaking valve 764 or 770 (e.g., pinch valves) as described above.
The rotation of the cam shaft 772 may be controlled by the motor 2001 such
that while fluid is ssed by the plunger 767, the outlet valve 764 is opened by a PID
control loop to achieve a target discharge rate profile (e. g., smoothed out discharge rate) as
measured by the plunger position sensor. In some embodiments, a range of angles only
moves the outlet valve (e. g., outlet pinch valve). In yet additional embodiments, in the four
stage pumping action described above, the movement of the plunger 767 is closed after the
outlet valve 764 opens to achieve a target discharge rate profile (e. g., ed out
discharge rate) as measured by the plunger’s 767 position sensor.
As is easily seen in Fig. 241, the cams 2002, 2003, 2004, 2005, and 2006 are
shows as engaging the cam followers 769, 766, 768, 765, and 762, respectively. Fig. 242
shows a front View of the peristaltic pump including the r 767, and the pinch valves
764 and 770 positioned to engage the tube 771.
] A standard tubing pump 1000 with an optical monitoring system is shown in
1 and 252. The optical monitoring system is comprised of a camera 1010 with a
field of view that may include part or all of the plunger 1004, one pinch valve 1002, a
portion of the tube 1006, fiducial marks on the pinch valve 1014, al marks on the
plunger 1016, al marks on the backstop 1018, a light source (not shown) and a light
guide 1012 to nate the surfaces facing the camera 1010. The optical monitoring
system may further additional s 1010 with fields of view that include or all of the
plunger 1004, additional pinch valves 1002, a portion of the tube 1006, al marks on
the pinch valve 1014, fiducial marks on the plunger 1016, fiducial marks on the backstop
1018, a light source (not shown) and a light guide 1012 to illuminate the surfaces facing the
camera 1010. The optical monitoring system may further comprising one or more rear light
sources 1102, rear light guides 1104 and a transparent plunger 1006 to illuminate the back
side of the tube 1006 ve to the camera 1010. The camera 1010 and lights may operate
in a range of spectrums from ultraviolet to infrared.
The optical system may further be comprised of a processor, memory and
software that may allow the images to be interpreted to provide a range of information on
the status of the pump, tubing and flow that includes but is not limited to plunger position
relative to the op 1005, the pinch valve position relative to the backstop 1005, the
speed and direction of the plunger 1004 and pinch valve 1002, the presence of the tube
1006, the presence of liquid or gas in the tube 1006, the presence of gas s in the tube
1006, the presence deformations in the tube 1006. The processor may further interpret the
information on plunger and valve position to determine fluid flow rate, presence of an
occlusion in the line, presence of a leak in the ,
The l monitoring system recognizes and es the positions of the
plunger 1004 and valves 1002 relative to the anvil plate 1005. The anvil plate 1005 is the
stationary part of the pump and elsewhere may be referred to as the counter surface or
occlusion bed. The pump controller may command the optical monitoring system may take
an image using the camera 1010 and front or rear light sources. A processor located in the
camera or elsewhere may s the image using software to identify the relative ce
and orientation of the plunger 1004 and valves 1002 relative to the anvil plate 1005. In one
embodiment, the machine vision software may identify the elements 1002, 1004 and 1005
and their location within its field of view through an edge detection algorithm as described
above. The detected edges may be e ed to each element 1002, 1004 and 1005 based
the edge location within the field of view. By way of an example, an edge detected in the
up third of the field of view may be assigned as the anvil plate 1005, while an edge detected
in the lower left quadrant may be assigned as the pinch valve 1002 if the camera 1010 is the
on the left hand side as shown in Fig. 251.
In another embodiment, the machine vision software may identify the pinch
valve 1002, plunger 1004 and anvil plate 1005 and their location within its field of View
with al marks located on each of the elements 1002, 1004 and 1005. Each element
may include one or more al marks that are located within the field of View of the
camera 1010. Fiducial marks will be assigned to each element 1002, 1004, 1005 based on
the region in the field of view that it is detected. Considering the left hand camera 1010 in
1 by way of example, fiducial marks in the lower left region may be assigned as the
pinch valve 1002, while fiducial marks in the lower right region may be assigned as the
plunger 1004 and fiducial marks in the upper region may be assigned to as the anvil plate
1005. A single fiducial mark may allow the optical monitoring system to measure the
relative movement of the pinch valve 1002, and plunger 1004 to the anvil plate 1006. More
than one al mark on a single element may allow the optical monitoring system to
identify elements that rotated in their plane of motion. The processor may signal a warning
or an alarm if one or more of the elements 1002, 1004 and/or 1005 have rotated beyond an
d amount. A significant rotation may indicate a mechanical break in the pinch valve
1002 or plunger 1004 or that the camera has rotated within its mounting on the camera door
1020.
[00683] The machine Vision software may fy the fiducial elements by matching
a stored template to the image. The vision software may be an off—the—shelf product such as
Open Source er Vision referred to as OpenCV and available for download from the
intemet. The vision software may use the function or module TemplateMatching to identify
the fiducial marks from a stored template.
[00684] The machine vision software may then calculate the relative position and
orientation of elements 1002, 1004 and 1005 from observed location within the camera’s
field of view and stored geometric data of the pinch valve 1002, plunger 1004 and anvil
plate 1005. The locations and orientations determined by the machine vision software may
then be passed to algorithms to identify specific conditions which include, but are not
limited to the following: pinch valve opening, pinch valve closing, plunger at m
, r at minimum stroke. Other algorithms may process the machine vision
determined locations and orientation data to determine parameters that include but are not
limited to the following, plunger speed, fluid flow rate, occlusion in the line, air in the line,
external leaks. These conditions and parameters are ined in the same way as they are
ined from hall effect sensors measuring the location of the plunger 1004 and pinch
valves 1002, which is described above.
In other embodiments, the machine vision re may identify the
conditions and determine the parameters described above. In other embodiments, the
relative on and orientation of the pinch valve 1002, plunger 1004 and anvil plate 1006
may be calculated by thms outside the e vision software.
The machine vision software or algorithms that process the output of the
machine vision software may recognize a number of conditions including but not limited to
the following: tubing is not present, tubing is not correctly placed, tubing is empty of fluid,
tubing is full of fluid, tubing is deformed, and a gas bubble is present in the liquid.
The optical monitoring system may calculate the volume of the tube with
fewer tions with data from an additional camera 1011 mounted at a substantial angle
to camera 1010 as shown in Fig. 252. The back light 1102, light guide 1104 may supply
infrared illumination to the back of the plunger 1004. The plunger 1004 may be nylon or
similar material that is transparent to infrared radiation. The plunger is uncoated in the
field of View of camera 1011 to e a clear View of the tube through the plunger 1004 in
the infrared spectrum. A machine vision software package may determine the profiles of
the tube 1006 from camera 1010 and the profile from camera 1011. An thm may
calculate a first thickness of the tube as seen by camera 1010 and a second distance as seen
by camera 1011. The volume of the tube may then be calculated from the two distances and
the known circumference of the tube. A comparison of the two distances and the tube
circumference may identify buckling in the tube shape that would significantly change the
volume of liquid in the tube.
The volume of fluid in the tube 1006 may depend on the shape taken by the
filled—tube when the pinch valves 1002 are closed. The shape of the tube 1006 near the
pinch valves 1002 may change after the pump is ated due to a number of factors
including but not limited to changes in the tubing materials, changes in manufacturing,
changes in humidity and temperature. The camera 1010 may observe the shape of the tube
1006 near the pinch valve 1002. The tube may be illuminated with visible or infrared light
from the front or back. In a preferred embodiment, the tube may be illuminated from
behind with infrared light. Here illuminating from behind refers to placing the source of the
nation on the opposite side of the tube 1006 from the camera 1010.
[00689] In one embodiment, the machine vision software may detect the tube shape
using edge detection. An algorithm may compare the observed tube shape to a shape stored
in the memory. In one embodiment the algorithm may correct the volume of fluid per
stroke to t for the changed tube shape. In r ment, the algorithm
evaluating the tube shape may signal a warming or alarm to a higher level algorithm. In
another embodiment, the machine vision software may confirm an acceptable tube shape by
attempting to match a template of the accepted tube shape to the image. The machine vision
software or the next higher level of re control may signal a g or alarm if an
acceptable tube shape is not identified.
The cameras 1010, 1011 may include either CCD (charge coupled device) or
CMOS (Complementary Metal Oxide Semiconductor) chips to convert light into electrical
signals that can be processes to generate an image. One example of a camera is HM0357—
ATC—00MA31 by Himax Imaging, Inc. of Irvine California USA. The cameras 1010, 1011
and lights 1012 may be powered on only when taking measurements in order to reduce
power consumption.
The pinch valve 1002, plunger 1004, tube 1006 and anvil plate 1005 may be
illuminated from the front. Front illumination refers to a light source that is on the same
side of the object of interest as the camera 1010 and supplies illumination to the camera
1010 by reflection from the object of st. One embodiment to supply front
nation is comprised of a light bar 1012 that transmits light from LED’s mounted in the
camera door 1020. One embodiment of the light bar 1012 is shown in 3. Light is
supplied to the end surfaces 1032 of the light bar from LED’s or other light sources
d in the camera door 1020. The front e 1030 and back surface (not shown) are
d with a material that reflects the supplied light. In one embodiment, the front and
back surfaces are covered with an aluminized tape. Holes 1036 provide a clear field of view
for the cameras 1010. The light bar may include a surface around each hole 1036 that is
roughened to provide a diffuse light that illuminates the front of the pinch valve 1002,
plunger 1004, tube 1006 and anvil plate 1005. The area around the holes 1036 may be
recessed and then roughened to provide more diffuse light.
It may be advantageous to provide backlighting or illumination from the
opposite side of the tube 1006 relative to the camera 1010. ghting may allow clearer
visualization of the tube shape and or the shape of the volume inside the tube 1006. One
embodiment places the rear light source on the back of the pump 1000. The rear light
source 1102 may be an LED or other light providing illumination in the ultraviolet, visible
and or infrared range. A light guide 1104 may direct the light to the back of the plunger
1004. The plunger may be made from a material that is transparent to the spectrum of light
emitted by the light source 1102. In one ment, the r is made from nylon and
the light source 1102 provides infrared illumination, which the camera 1010 can sense. In
some embodiments, the backlight may be a plurality of light sources. The plurality of light
sources may be controlled and/or modulated such that only ic lights are on that are
ary to illuminate a pixel being exposed. For example, the camera may have a region
of interest, and only the lights needed to illuminate the region of interest are turned on
during the exposure time of pixels within the region of interest. In some embodiments, the
lights may be rows and/or columns of lights and/or pixels of lights (e.g., an array of LED
lights).
The spectrum of the rear light source 1102 and camera 1010 may be selected
to maximize the visibility of the fluid in the tube. In one embodiment, the spectrum may be
broad to provide the maximum light to visualize the tube. In another ment, a set of
filters in front of the rear light source 1102 emits a narrow range of the ed um
that passes through the light guide 1104, plunger 1004 and tube 1006, but is absorbed by the
liquid in the tube. The light source 1102 may also emit a narrow range of the infrared
spectrum that passes h the light guide 1104. In another embodiment, the filters to
allow only the desired band of infrared are in front of the camera 1010.
ACOUSTIC VOLUME SENSING
] The follow discussion describes acoustic volume sensing that may be
med by a processor disclosed herein with a speaker and two microphones (e.g., a
reference microphone and a variable—volume microphone) of a peristaltic pump, e.g., a
peristaltic pump disclosed herein; AVS may be used to estimate liquid within a reservoir
disclosed herein, to estimate an amount of liquid discharged from a reservoir disclosed
herein, and/or to estimate a liquid discharge rate of a reservoir disclosed herein. Table 1
shows the definition of various terms as follows:
Pressure
Pressure Perturbation
Volume
Volume Perturbation
Specific Heat Ratio
Specific Gas Constant
Density
Impedance
Flow friction
Cross nal Area
Length
Frequency
Damping ratio
Volume Ratio
Subscripts
0 Speaker Volume
l Reference Volume
2 Variable Volume
k Speaker
Resonant Port
Zero
Pole
Table 1.
The acoustic volume sensor (“AVS”) measures the fluid volume displaced
by the non-liquid side of a oir in the AVS chamber, e. g., an acoustic housing or within
a reservoir, etc. The sensor does not directly measure the fluid volume, but instead
measures the variable volume of air, V2, within the AVS chamber; if the total volume of
AVS chamber remains nt, the change in the V2 will be the direct te of the
change in the fluid volume. The AVS chamber is the volume of air in fluid communication
with a variable—volume microphone beyond the acoustic port.
The volume of air, V2, is measured using an acoustic resonance. A time—
lO g pressure is established in the fixed volume of the reference chamber, Vl, using a
speaker. This pressure perturbation causes cyclic airflow in the acoustic port connecting the
two volumes, which in turn causes a pressure perturbation in the variable volume. The
system dynamics are similar to those of a Helmholtz oscillator; the two volumes act
together as a g” and the air in the port connecting the s as a resonant mass.
The natural frequency of this resonance is a function of the port geometry, the speed of
sound, and the variable volume. The port geometry is fixed and the speed of sound can be
found by measuring the temperature; therefore, given these two parameters, the variable
volume can be found from the natural frequency. In some embodiments of the present
disclosure, a ature sensor is used within the acoustic housing and/or within the non-
liquid side of a reservoir. In some embodiments, the temperature is ered to be a
predetermined fixed value, e.g., is assumed to be room temperature, etc.
The natural frequency of the system is estimated by ing the relative
response of the pressures in the two s to different frequency perturbations d by
the speaker. A typical AVS measurement will consist of taking an l measurement.
The liquid is then released from the liquid side of one or more reservoirs and delivered to
the patient (after which a second volume measurement is taken). The difference between
these measurements will be the volume of liquid delivered to the patient. In some
embodiments a measurement will be taken before filling the liquid side of the one or more
reservoirs and/or prior to discharging the liquid, e.g., when the syringe pump is preloaded,
to detect any failures of the fluidic system.
An AVS measurement may occur in accordance with the following acts: (I)
the processor will turn on power to the AVS electronics, enable the ADC of the processor,
and initialize an AVS algorithm; (2) an AVS measurement consists of collecting data at a
number of different frequencies; (3) optionally measuring the temperature; and (4) then
g an estimation routine based on the collected data to te the volume of liquid in
the liquid side of a reservoir.
] To collect data at each frequency, the speaker is driven sinusoidally at the
target frequency and measurements are taken from the two microphones over an integer
number of wavelengths, e.g., the reference microphone and the variable volume hone
(as described above). Once the data has been ted, the processor disclosed herein
performs a discrete Fourier transform algorithm on the data to turn the time—series data from
the microphones into a single complex amplitude. Integrity checks are run on the data from
the microphones to determine if the data is valid, e. g., the response is within a
predetermined phase and/or amplitude range of the acoustic ncy.
The frequency measurements are taken at a number of ent frequencies.
This sine—sweep is then used by the estimation routine to estimate the variable volume.
After the estimation is complete, other integrity checks is may be performed on the whole
sine sweep, including a secondary check by a processor disclosed .
In some embodiments, after the a processor disclosed herein verifies the
measurement integrity, the volume estimates are finalized and the sensor is powered off.
AVS Resonance Model
[00703] The governing equations for the AVS system can be found from first—
principles given a few simplifying assumptions. The system is modeled as two linearized
acoustic volumes connected by an idealized acoustic port.
] Modeling the ic s
The pressure and volume of an ideal adiabatic gas can be related by Equation
(35) as s:
PV7=K (35),
where K is a constant defined by the initial conditions of the system.
Equation 1 can be n in terms of a mean pressure, P, and volume, V, and a small time—
p (t) v(t)
dependent perturbation on top of those pressures, as illustrated in Equation (36)
as follows:
(P+p(t))(V+v(t)) —Ky _ ] (36).
Differentiating Equation (36) results in Equation (37) as follows:
. 7 7—1 .
] p(t)(V +v(t)) + 9/(V +v(t)) (P+ p(t))v(t) = 0 (37).
Equation (37) simplifies to Equation (38) as follows:
P+ [9 t
. .
[00712] P(‘)+7Tv((t))v(‘)=0 (38).
If the ic pressure levels are much less than the ambient pressure the
Equation(38) can be further simplified to Equation (39) as follows:
1'9 (I) +—\> (I) =
V (39).
Using the adiabatic relation, Equation (40) can be shown as follows:
5:[P+p(t)]£1’+p(t)]_7V WV“) P
(40).
Thus, the error assumption is shown in Equation 41 as follows:
L-l-l
error :1_£P+—p(t)]
(41).
A very loud ic signal (e.g., 120 dB) would correspond to re sine
wave with amplitude of roughly 20 Pascal. Assuming air at atmospheric conditions has the
7:1'4
parameters of and P =101325Pa the resulting error is 0.03%. The conversion
from dB to Pa is shown in Equation (42) as follows:
flzZOlogw£ m] pref pm“ : 154102"
or (42),
where pref = 20W“.
P = pRT
[00722] Applying the ideal gas law, and substituting in for pressure gives
the result as shown in Equation (43) as follows:
p<r>+7RTpv(r)=o
V (43).
This can be written in terms of the speed of sound in Equation (44) as
follows:
0 =47”
] (44).
And, substituting in on (44) in Equation (43) results in Equation (45)
as follows:
p(r)+pa v(r)=0
V (45).
Acoustic nce for a volume is defined in Equation 46 as follows:
p< >__I 1
z. z
v‘(t)
E V 2 [00729] p“ )3 (46).
Modeling the Acoustic Port
The acoustic port is modeled assuming that all of the fluid in the port
essentially moves as a rigid cylinder reciprocating in the axial direction. All of the fluid in
the channel is assumed to travel at the same velocity, the channel is assumed to be of
constant cross n, and the end s resulting from the fluid entering and g the
channel are neglected.
: fpf/
If we assume laminar flow friction of the form AP the friction force
F _ pr x2-_
acting on the mass of fluid in the channel can be written: . A second order
differential equation can then be written for the dynamics of the fluid in the channel as
shown in Equation (47) as follows:
PLAx - APA ' fPA x (47),.. 2 .
or, in terms of volume flow rate as shown in Equation (48) as follows:
'v' = —flv' + ApA
[00735] PL (48).
The acoustic impedance of the channel can then be written as shown in
Equation (49):
Z =fl — p_L [s +fl]
p A
] V L
(49).
System Transfer Functions
[00739] Using the volume and port dynamics define above, the AVS system can be
described by the following system of Equations 50—5 3:
. a .
P0 _ pV VI: = 0
0 (50),
. a .
121+ Q 0, —v,) =0
1 (5 1),
122+ v, = 0
V2 (52), and
A A
vr = —fTvr +—L(p2 _pl)
[00743] P (53).
One equation can be eliminated if p0 is treated as the input substituting
. VO .
vk — 2 p0
in pa as shown in Equations 54—56:
pwfipo—p“2 v; =0
V1 V1 (54),
V2 (55), and
.. fA A A
vr : —Tvr +—Lp2 ——Lpl
P P (56).
The relationship between the two s on each side of the ic port is
referred to as the Cross Port transfer function. This relationship is rated in Equation
(57) as follows:
& _—“’n
1’1 52 ”WSW:
(57),
a2Ai
(02 =
n g =i
where V2 and 21w”
This relationship has the advantage that the poles are only dependent on the
variable volume and not on the reference volume. Note that the resonant peak is actually
due to the inversion of the zero in the response of the nce volume pressure. This
means that that pressure measurement in the reference r will have a low amplitude
in the vicinity of the resonance which may influence the noise in the measurement.
] Resonance Q Factor and Peak Response
] The quality of the resonance is the ratio of the energy stored to the power
loss multiplied by the resonant frequency. For a pure second—order system the quality factor
can be expressed as a function of the damping ratio illustrated in Equation (58):
Q = 2—
f (58).
The ratio of the peak response to the low—frequency response can also be
written as a function of the damping ratio shown in Equation (59):
lGla, =—
[00756] “5‘49" (60).
= a)" 1_ g,
This will occur at the damped natural frequency (001 .
Electrical and Mechanical analogies
The acoustic resonator is analogous to either a spring—mass—damper system
or a LRC circuit, e.g., a resistor, inductor and capacitor coupled together in series, for
example.
Computing the complex response
To implement AVS, the system must get the relative response of the two
microphones to the acoustic wave set up by the speaker. This is accomplished by driving
the speaker with a sinusoidal output at a known frequency; the complex response of each
microphone is then found at that driving frequency. Finally, the relative responses of the
two microphones are found and corrected for alternating sampling of the analog—to—digital
converter coupled to the a sor disclosed herein.
In addition, the total signal variance is computed and compared to the
ce of pure tone extracted using the discrete Fourier transform ). This gives a
measure of how much of the signal power comes from noise sources or tion. In some
embodiments of the present disclosure, this value can be used to reject and repeat bad
measurements.
] Computing the Discrete Fourier Transform
The signal from each microphone is sampled synchronously with the output
to the speaker such that a fixed number of points, N, are taken per wavelength. The
measured signal at each point in the wavelength is summed over an integer number of
wavelengths, M, and stored in an array x by an interrupt service routine (“ISR”) in the a
processor disclosed herein after all the data for that frequency has been collected.
A discrete Fourier orm is done on the data at the integer value
corresponding to the driven frequency of the speaker. The general expression for the first
harmonic of a DFT is as follows in Equation (61):
xk =— xne
MN "=0
(61).
] The t MN is the total number of points and the factor of 2 is added
such that the resulting real and imaginary ns of the answer match the amplitude of the
sine wave illustrated in Equation (62):
x" = re(xk ) cos [lemjfl'muk ) sin [2—71-1021
N N
[00768] (62).
This real part of this expression is illustrated in on (63):
2 AH
re(x) —— x” cos —n
MN n=o [27:N [00770] ] (63).
We can take advantage of the symmetry of the cosine function to reduce the
number of ations needed to compute the DFT. The expression above is equivalent to
Equation (64) as follows:
"=1 — (
64).
Similarly, the imaginary portion of the equation is rated in Equation
(65) as follows:
zm(x) = —iN—Ixn sin [Z—fln]
MN "=0 N
(65), which may be sed as on
(66):
4N lsin [2%er
zm(x) = —M—21V[(X‘I‘N —X%N )+ :(xn —x%N+ )+ ()qu —xN_n)
"=1 ] (6
The variance of the signal at that driven frequency is illustrated in Equation
(67) as follows:
in, = l(re()c)2 +im(x)2)
2 (67).
The tone variance is proportional to the acoustic power at the driven
frequency. The maximum possible value of the real and imaginary portions of x is 211; this
corresponds to half the A/D range. The maximum value of the tone variance is 221; half the
square of the AD range.
] Computing the total signal variance
A good measure of the integrity of a measurement is the ratio of the acoustic
power at the driven frequency relative to the total acoustic power at all frequencies. The
total signal variance is given by the expression in on (68):
MN—l MN—l MN—l
atotal=fizpn_p =W2pn_{fi2pnj2 2 _2 2
[00781] "=0 "=0 "=0 (68).
However, in some specific embodiments, the summations are performed in
the A/D upt service routine (ISR) where there are time constraints and/or all of the
microphone data must be stored for post—processing. In some embodiments, to increase
ency, a pseudo—variance is calculated based on a single averaged wavelength. The
pseudo—variance of the signal is calculated using the following relation illustrated in
Equation (69) as follows:
N—l N—l
2 2
_ 1 1
0-fold] — NM2 Z X” _ N2M2 Z xn
"=0 "=0 j (69).
The result is in the units of AD counts squared. The summation will be on
2x2 224)H
the order of ”=0 for a 12—bit ADC. If N < 27 2128 and M < 26 = 64 then
the summation will be less than 243 and can be stored in a 64—bit integer. The maximum
le value of the variance would result if the ADC oscillated between a value of 0 and
1(212 )2 = 222
212 on each consecutive sample. This would result in a peak variance of 4 so
the result can be stored at a maximum of a Q9 resolution in a signed 32—bit r.
Computing the relative microphone response
The relative response of the two microphones, G, is then computed from the
complex response of the individual microphones illustrated in ons 70—72:
xvar xvar xref
G _ _
xref xref xref (70).
RMW— 2
R6094) “111(19qu2 (71).
1mm)—Rem>Im<xm>—Re<x..)1m<x..>‘fi
134%) +1m(xmf) (72).
The denominator of either expression can be expressed in terms of the
reference tone variance ed in the previous section, illustrated as s in Equation
Re(xref )2 + Im(xmf )2 = 20'2W
(73).
Correcting for AD Skew
The speaker output may be d at a fixed 32 times per sample. For
example, as the driving frequency is changed, the speaker output frequency is also updated
to maintain the fixed 32 cycles. The two hones are sampled synchronous with the
speaker output so the sampling frequency remains at a fixed interval of the driving
frequency. The microphone A/D measurements, however, are not sampled simultaneously;
the A/D ISR alternates between the two microphones, taking a total of N s per
wavelength for each microphone. The result will be a phase offset between the two
microphones of N .
To correct for this phase offset, a complex rotation is applied to the
relative frequency response computed in the us section.
To rotate a complex number an angle N it is multiplied by
e : COS (7) +1 sm (7).
The result is illustrated in Equation (74) as follows:
Grotated = (Re(G)COS (fi) —Im(G)sin (%)) + (Im(G)COS (%) + Re(G)sin (%))i
(74).
Time Delays
In some embodiments, one of the assumptions when deriving the AVS
ons is that the pressure is uniform in the acoustic volumes. This assumption is true if
the acoustic wavelength is large compared to the dimensions of the AVS r. The
wavelength of a sound wave at a given frequency can be computed with the following
Equation (75):
A = —
] f (75).
For example, the wavelength at 1 kHz is roughly 246 mm and at 5 kHz is
roughly 49.2 mm. The AVS chamber may have a diameter such that the time delay
associated with acoustic waves traveling through the volumes has a small but measurable
effect. The effect can be modeled as a time delay (or time advance, ing on
microphone orientation). The Laplace transform of a pure time delay, d, is illustrated in
Equation (76) as follows:
[00800] G = 6‘“ (76).
The phase is influenced by the time delay, but not the magnitude of system
se. To correct for the time , the frequency response data may be corrected in
advance by applying a model fit algorithm. The x amplitude may be rotated as a
function of frequency according the time delay equation above. The time delay may be
assumed to be fixed, so the rotation is only a function of frequency.
The time delay may be determined by running an optimization routine to find
the time delay to minimize the model fit error. Additionally or alternatively, there may be
an nt “time advance” in the data. For example, the reference microphone may
experience a pressure perturbation slightly in advance of the acoustic port and the variable
microphone may experience a pressure perturbation slightly behind the acoustic port. These
“advances” and s” may be the effects of the propagation of the pressure waves and
are in addition to “resonant” dynamics of the , e.g., these effects may be accounted
for.
Amplitude ng
The amplitude of the pressure measurements for a given speaker drive signal
may vary from device-to-device and also as a function of the driven frequency. The device-
to-device variations result from part-to-part differences in microphone and speaker
sensitivities (e. g., roughly on the order of +/— 3 dB). The frequency-based dependencies
result from variations in speaker ivity over frequency as well as from the expected
dynamics of the acoustic resonance.
To compensate, in some embodiments, the speaker gain is automatically
tuned during the AVS measurement. The speaker gains are stored in an array with one
entry for each of the sine—sweep frequencies, e.g., within the memory 22 of Fig. 2. The
amplitude of the microphone signal (from either the variable or reference microphone) may
be checked t the target ude. If it is either too large or too small a binary search
routine may be employed to update the speaker gain at that frequency.
Checking individual measurement integrity
] It is le for component errors, failures, or external disturbances to result
in an erroneous measurement. Component failures might include a distorted speaker output
or failed microphone. External disturbances might include mechanical shock to the pump
housing or an extremely loud al noise. These types of es can be detected using
two ent integrity checks: microphone tion and out—of—band variance.
[00808] The microphone saturation check looks at the maximum and minimum
values of the wavelength averaged signal for each microphone. If these values are close to
the limits of the A/D then a flag within the a processor disclosed herein is set indicating that
the measurement amplitude was out of range.
The out—of—band variance check es the tone variance to the total
signal variance for each microphone. In the ideal case the ratio of these signals will be 1—
all of the acoustic power will be at the driven frequency. In the event of shock or an
extremely loud external acoustic noise, more power will be present at other frequencies and
this value will be lower than unity. In some embodiments, normal operation may be
considered to have a ratio greater than 0.99.
In some ments, if an individual data point fails either of these
integrity , it may be repeated or excluded without having to repeat the entire sine—
sweep to help facilitate AVS robustness. Other integrity checks may be done based on the
complete sine—sweep and are described later.
Volume Estimation using Swept Sine-Generalized Solution
The resonant frequency of the system may be estimated using swept-sine
system identification. In this method the se of the system to a sinusoidal re
variation may be found at a number of different frequencies. This frequency response data
may be then used to estimate the system transfer function using linear regression.
The transfer function for the system can be expressed as a rational function
of s. The general case is sed below for a transfer on with an nth order numerator
and an mm order denominator. N and D are the coefficients for the numerator and
denominator respectively. The on has been normalized such that the g
coefficient in the denominator is l, as illustrated in Equations (77) and (78):
an11 +Nn_ls 11—1 +...+ NO
G (s) =
S ms ,Hs 0 (77)
Nksk
G(s) = k=°m_1
Sm + Dksk
k=0 (78).
[00817] This equation can be re—written in the form of Equation 79 as follows:
Gsm = :Nksk —G§Dksk
k=0 k=0 (79).
Equation (80) shows this summation in matrix notation:
as": s: sf —Gls:"“ —Glsf 190
GkS1:n_ SI: 51:) _GkSk—l _Gksic) 2H
(80).
Where k is the number of data points collected in the swept sine. To
fy the notation this equation can be summarized using the vectors y illustrated in
Equation (81).
Y = X0 (81).
Where )2 is k by l, x is k by (m+n—l) and c is (m+n—l) by l. The coefficients
can then be found using a least square approach. The error function can be n as
shown in Equation (82):
e = y ' X0 (82).
The function to be minimized is the ed square of the error function; W
is a k X k diagonal matrix, as rated in Equations 83-84.
eTWe=(y—XC)TW(y—Xc)
(83)-
T T T T T T
e We = y Wy — (y WXC) — y W c+c x WX Xc
(84).
The center two terms are scalars so the ose can be neglected, as
illustrated in Equations 85—87:
T T T T T
[00829] e We — y Wy—2y WXc+c x WXC (85),
ae WT
= —2XTWy + 2X TWXc = 0
ac (86), and
( ) —1 C = XTWX XTWy
(87).
In some embodiments, the complex transpose in all of these cases is utilized.
This approach can result in complex coefficients, but the process can be modified to ensure
that all the coefficients are real. The least—square minimization can be modified to give only
real coefficients if the error function is changed to Equation (88).
eTWe =Re(y—XC)TWRe(y—Xc)+lm(y—XC)TWIm(y—Xc)
(88),
Then the coefficients can be found with the Equation (89):
c = (Re(X)T W Re(X)+ Im(X)T W 1(Re(X)T WRe(y)+ 1m(X)T WIm(y))
(89).
Volume Estimation using Swept Sine-Solution for a 2nd Order System
For a system with a 0th order numerator and a second order denominator as
shown in the transfer function illustrated in Equation (90).
S +D1S+Do (91).
The coefficients in this transfer function can be found based on the
sion found in the previous section as follows Equation (92):
c=(Re(X)TWRe(X)+Im(X)TWIm(X))_l(Re(X)TWRe(y)+Im(X)TWIm(y))
(92).
Where Equation (93) is as follows:
01s? 1 —Glsl —Gl NO
y = Z X = 3 3 3 c = D1
Gksk2 1 ‘Gksk ‘Gk D0
, , (93).
To simplify the algorithm we can combine some of terms as illustrated in
Equations 94-96:
[00844] C = 19—11? (94),
where
D—Re(X) WRe(X)+Im(X) WIm(X)T T
(95), and
b—Re(X) WRe(y)+Im(X) WIm(y)T T
(96).
To find an expression for D in terms of the complex response vector G and
the natural frequency S : jw we first split X into its real and imaginary parts as illustrated
in Equations (97) and (98), respectively, as s:
1 wkhn(Gl) _Re(Gl)—
Re(X)= 2 ' '
1 wk 1mm» ‘Remk )—
(97), and
0 _wk Re(Gl) _Im(G1)
Im(X)= 5 I I
0 _wk Re(Gk) _In1(Gk)
(98).
The real and imaginary ns of the expression for D above then become
ons (99) and (100), respectively:
2 wt. Im(Gi )wi —i wi Re(Gi)
i=1 i=1
k k
Re(X)TWRe(X)= Zwilm(Gi)60i 2k: wi Im(Gl.)2 603 —2 wi Im(Gi) Re(Gi)a)i
k k k
—Zw Re(Gi) —Zw Im(Gi) Re(Gi )wi Zw 2
i=1 i=1 i=1
(99), and
0 0 0
k k
Im(X)TWIm(X)=0 ZwiRawaf Zwi Im<Gi> wi
i:l i=1
0 :wi Im(Gl.) a)i iwi Im(Gi)2
i=1 i=1
(100).
Combining these terms gives the final expression for the D matrix. This
matrix will contain only real values, as shown in Equation (101) as follows:
k k k
Zwi Zwi Im(Gi)a)i —Z wi Re(Gi)
i=1 i=1 i=1
D: iwiIm(Gi)a)i :wi(Re(Gi)2+Im(Gi)2)a)f 0
i=1 i=1
k k
—2 WI. Re(Gl) 0 Zwi (Racy)2 +Im(Gi)2)
i=1 i=1
(101).
The same approach can be taken to find an expression for the b vector in
terms of G and a). The real and imaginary parts of y are illustrated in Equation 102—103.
-R6(G1)af -Im(Gl)af
Re ( y) = 3 Im( y) = 5
'Rele )‘0‘3 'ImleW
(102), and (103).
Combining these two gives the sion for the [9 vector illustrated in
Equation 104 as follows:
—Z w, Racing?
b=Re(X)TWRe(y)+Im(X)TWIm(y)= 0
in}, (Re(Gi)2 + 2 ) a);
— (104).
The next step is to invert the D matrix. The matrix is symmetric and
positive-definite so the number of computations needed to find the inverse will be reduced
from the general 3X3
case. The general expression for a matrix inverse is shown in
Equation (105) as:
D‘1 = adj(D)
If D is expressed as in Equation (106):
—dll d12 dl3
D = d12 £122 0
_d13 O d33
(106),
then the te matrix can be written as in Equation (107) as follows:
d22 0 6112 0 d12 d22
0 d33 d13 d33 d13 0
d12 dl3 dll dl3 dll d12
adj(D)= _
0 d33 dl3 d33 d13 0
d12 dl3 dll d13 dll £112
d22 0 d12 0 d12 £122
[00862] (107).
Due to symmetry, only the upper diagonal matrix needs to be calculated.
The Determinant can then be computed in terms of the adjugate matrix values, taking
advantage of the zero elements in the original array as illustrated in Equation (108) as
det (D) = and12 + 022d”
[00864] (108).
y, the inverse of D can be written in the form shown in Equation (109):
D‘1 = am)
det(D) (109).
In some ments, we may solve the value in Equation (110):
c=D_1b= adj(D)b
(191(1)) (1 10);
So that Equation (111) is used:
all an an 191 _a11b1 +5113]?3
1 1
c = a12 an a:23 0 = 012191 + 5123173
det(D) det(D)
a13 5232 5233 I?3
_al3bl + 033193 (111),
To get a quantitative assessment of how well the data fits the model, the
original expression for the error as shown in on (112) is utilized:
eTWe =Re(y—Xc)TWRe(y—Xc)+1m(y—XC)TWIm(y—Xc)
(112).
This can be expressed in terms of the D matrix and the b and c vectors
illustrated in Equation (113):
eTWe = h — 26% + CTDC (113),
[00875] where:
h = R6(y )W 6U”T R Im(y )W mmT I
(114), and
h = Z w, )2 +Im(Gi)2 ) a):
i=1 (1 15).
In some embodiments, to compare the errors from different sine sweeps, the
fit error is normalized by the square of the weighted by matrix as follows in Equation (116),
where h is a scalar:
eTWelf1 = (h — ZCTI) + cTDc)h_l
(1 16).
Volume Estimation using Swept stimating volume
] The model fit may be used such that the resonant frequency of the port may
be extracted from the sine sweep data. The delivered volume may be related to this value.
The ideal relationship between the two can be sed by the relation illustrated in
Equation (117):
2 a2A 1
(0n = —
V2 (117).
The speed of sound will vary with the temperature, so it is useful to split out
the temperature effects as shown in Equation (118):
2_7RA1
V2 (118).
The volume can then be expressed as a function of the measured resonant
frequency and the temperature, illustrated in Equation (119) as follows:
V, = Cl,
”n (119).
] Where C is the calibration constant illustrated in Equation (120) as follows:
C = —7RA
L (120).
Volume Estimation using Swept Sine-Volume estimation integrity
checks
In some embodiments, a second set of integrity check can be performed out
of the output of the mode fit and volume estimation routines (the first set of checks is done
at the FFT level). Checks may be done either h redundancy or h range
checking for l values, such as: (1) model fit error, (2) estimated damping ratio, (3)
estimated transfer function gain, (4) estimated l frequency, (5) estimated variable
volume, and (6) AVS sensor temperature.
[00891] In addition, ns of the AVS calculations may be done redundantly on
the a processor disclosed herein using an independent temperature sensor and an
independent copy of the calibration parameters to guard against RAM failures, in some
specific embodiments.
Volume Estimation using Swept Sine-Disposable Detection
[00893] The presence of the disposable, e.g., cartridges or reservoirs that are
attachable, may be detected using a magnetic switch and mechanical interlock, in some
specific embodiments. However, a second detection method may be used to 1) differentiate
between the pump being attached to a disposable and a charger, and 2) provide a backup to
the y detection methods.
[00894] If the able is not present, the variable volume, V2, is effectively very
large. As a result, there will be a normal signal from the reference microphone, but there
will be very little signal on the variable microphones. If the mean amplitude of the
reference microphone during a sine sweep is normal (this verifies that the speaker is
working) and the mean amplitude of the variable microphone is small, a flag is set in the a
sor disclosed herein indicating that the disposable is not present.
Implementation Details-Sizing V1 ve to V2
Sizing V1 may include trading off acoustic volume with the relative position
of the poles and zeros in the transfer function. The transfer function for both V1 and V2 are
shown below relative to the volume displacement of the speaker as illustrated in Equations
121—124, as follows:
p2 _ pa2 603
1:V1 52+ 2509+“:
(121), and
p1 _ pa2 s2+2fwns+awf
E:V1 “+2505”: (122)
where
(ojzazAi {2i
L 251% (123) and a=£1+£jV1 [00900] V2
, (124).
[00901] As V1 is increased the gain ses and the speaker must be driven at a
higher amplitude to get the same sound pressure level. However, increasing V1 has the
benefit of moving the x zeros in the [)1 transfer on toward the complex poles.
In the limiting case where V1 _) 0° then a —)1 and you have pole—zero cancellation and a
flat response. Increasing V1, therefore, has the reduces both the resonance and the notch in
the p1 transfer function, and moves the 192 poles toward a)"
; the result is a lower sensitivity
to measurement error when calculating the pg/pl transfer function.
Implementation Details-Aliasing
Higher frequencies can alias down to the frequency of interest. The aliased
frequency can be expressed in Equation (125) as s:
fn—ns
[009041 (125).
Where 1: is the sampling frequency, f'1 is the frequency of the noise source,
12 is a positive integer, and f is the aliased frequency of the noise source.
The demodulation routine may filter out noise except at the specific
ncy of the demodulation. If the sample frequency is set cally to be a fixed
multiple of the demodulation frequency, then the frequency of the noise that can alias down
to the demodulation frequency will be a fixed set of ics of that fundamental
frequency.
For example, if the sampling frequency is 8 times the demodulation
frequency then the noise frequencies that can alias down to that frequency are
£_ 1 1
] f /3—1 {111111}7’9’15’17’23’25"" (126)
where f (12?). For ’8 _ we would have the series
17 31 33
£_{i L i if 15 } (127).
Sources of Avs Measurement Error-AVS Chamber Movement
] In some embodiments, one of the assumptions of the AVS measurement is
that the total AVS volume (V2 plus the volume taken up the by the other components) is
constant. However, if the AVS housing flexes the total volume of the AVS chamber may
change slightly and affect the differential volume measurement. In some embodiments, to
keep the bution of the volume error is kept to be less than 1.0% of the fluid delivery.
Sources of Avs Measurement Error-External Noise
In some embodiments, external noise sources may be filtered out.
Sources of Avs Measurement Error-Mechanical Shock
] Mechanical shock to the pump housing during an AVS measurement will
affect the microphone measurements and may result in an error in the frequency response
data. This error, however, is detectable using the out—of—band variance check in the
demodulation routine by the a processor disclosed herein. If such an error is detected, the
data point can be repeated (e. g., another sample is taken) resulting in little or no effect on
the resulting AVS ement.
] Sources of Avs Measurement Error-Air in the AVS Chamber
] A mechanism for an air bubble to affect the AVS measurement is through a
ary resonance. This secondary resonance will make the system 4Lh order and,
depending on the frequency and magnitude of the secondary resonance, can cause some
error if the estimation is using a 2nd order model.
Sources of Avs Measurement Error-Electrical Component e
In general, failure an electrical component will result in no signal or in
increased harmonic distortion. In either case the fault would be detected by AVS integrity
checks and the measurement invalidated.
The one exception that has been identified is a failure of the oscillator used
to l the DAC and ADC. If this oscillator were to drift out of tolerance it would
introduce a measurement error that would not be detected by the low—level integrity check
(it would be detected in an extreme case by the volume integrity checks described above).
To guard against these failures, in some embodiments, the oscillator is checked against an
independent clock er an AVS measurement is initiated.
ed Cam Follower Peristaltic Pump
Figs. 255-302 show another embodiment of a peristaltic pump 2990.
Fig. 255 illustrates a peristaltic pump 2990 comprising a pumping
mechanism 3000, display 2994, buttons 2996, s 2992, and clamp 2998. The chassis
2992 includes an extension 2992A above the pumping mechanism 3000 that deflects liquid
away from the inside of the mechanism.
Figs. 256A—B illustrate a peristaltic pumping mechanism 3000 having L—
shaped cam followers 3090, 3101, 3110 (see Fig. 274) in an exploded View. A housing,
composed optionally of two halves, 3005, 3010 provides a mounting for a cam shaft 3080, a
main PCB 3002, a cam—follower shaft 3120, a gear head ly 3070, and hinge points
3010A to mount a door 3020. The two halves 3005, 3010 may be an upper half 3010 and a
lower half 3005. The sensor housing 3015 may mount to the housing halves 3005, 3010 and
provide an attachment point to a sensor mount 3060 and a on sensor board 3130 (Fig.
257). An —line detector 3066 (see Fig. 257) and a pressure sensor 3068 (Fig. 257) may
be attached to the sensor mount 3060.
Fig. 257 rates the pumping mechanism 3000 having L—shaped cam
followers 3090, 3101, 3110 (see Fig. 274) with the door assembly 3021 fully open and the
infusion line 3210 and slide occluder 3200 mounted in the door 3020. The door ly
3021 is mounted to the housing halves 3010, 3005 via two hinges 3010A and a hinge pin
3012 (Fig. 258). In the open position, the door assembly 3021 may provide convenient
receiving elements, which may serve to locate an infusion line 3210 on the door assembly
3021. The receiving elements may locate the on line 3210 so that it properly
interfaces or lines up with the sensors and active elements of the peristaltic pump 2990. The
sensors may, for example, include a pressure sensor 3068 (Fig. 257) and/or an air—in—line
sensor 3066 (Fig. 257). The active elements may include, for example, the plunger 3091,
inlet valve 3101 and outlet valve 3111 (Fig. 260). The receiving elements in the door 3020
may include one or more of the following: grooves in the door 3020K (see Fig. 259), clips
3062A (Fig. 257), clip inserts 3024 (Fig. 257), platen 3022 (Fig. 257, 259). The clips
3062A (Fig. 257) and 3024 (Fig. 257) may be fabricated out of any suitable, non—
able, non or minimally compliant material. The clips 3062A are preferably molded
from plastic such as nylon, but many other materials ing ABS plastic, aluminum, steel
or ceramics may be used.
The door assembly 3021 (Fig. 257) may include a receiving element for the
slide occluder 3200. The slide occluder 3200 receiving ts in the door assembly 3021
may hold the slide occluder 3200 in position so that the slide occluder 3200 enters a
receiving opening in the pump body 3001 (Fig. 265). Some of the slide occluder 3200
receiving elements may e features that prevent the infusion set from being loaded
incorrectly. In one embodiment, door split carriage 3040 includes a slot to receive the slide
occluder 3200 and hold it perpendicular to the infusion line 3210 as the door assembly 3021
is closed against the pump body 3001. The slide occlude 3200 may include tabs 3040C
(9) that allow the slide occluder 3200 to only be inserted such that cutouts 3200A
(Fig. 261) line up with tabs 3040C (1). In another embodiment, the door 3020 may
include tabs 3020F (Fig. 262, 263) that allow the slide occluder 3200 to only be inserted
such that cutouts 3200A (1) line up with tabs 3020F (2). The door 3020
(7) may include tabs 3020D (Fig. 259) that prevent the slide occluder 3200 (Fig.
257) from being inserted with the tab 3200B (Fig. 261) toward the door assembly 3021
(7). The tabs 3020F located on the door 3020 and/or on the door—split—carriage 3040
(7) may allow the slide occluder 3200 to be inserted in only one orientation and
thereby force the correct orientation between the infusion set and the pumping ism
3000. The platen 3022 (Fig. 257) receives the infusion line 3210 and provides a general
“U” shape to constrain the infusion line 3210 as a plunger 3091 deforms the infusion line
3210 during g.
Fig. 264 illustrates, in an exploded view, the door assembly 3021 including
the lever 3025 and the split carriage 3041 of the peristaltic pumping mechanism 3000 (7) having L—shaped cam followers 3090, 3101, 3110 (see Fig. 274). Infusion line 3210
receiving elements 3062, 3022 (Fig. 260) 3024 (Fig. 257) may be mounted respectively in
recesses 3020A, 3020B, 3020B of the door 3020. The door ly 3021 may include a
door split ge 3040 that is connected to the lever 3025 via link 3035. The door
ly 3021 may also e a flat spring 3032 that is a sheet of ent material such
as —steel. The flat spring 3032 may be pressed against the door 3020 by the latch pin
3034 as the lever 3025 grips the body pins 3011 (Fig. 297) on the pump body 3001 and
draws the latch pin 3034 toward the pump body 3001. The latch pin 3034 moves along slot
3020C in the door 3020 as the latch hooks 3025C engage the body pins 3011.
Fig. 265 illustrates the peristaltic pump 2990 (Fig. 255) having L—shaped
cam followers 3090, 3101, 3110 (see Fig. 274) with the door assembly 3021 open and the
lever 3025 retracted. The main PCB 3002, which includes the l processors and some
sensors is shown attached to the top of the upper housing 3010. A motor 3072 and gear
head 3070 are shown in on at one end of the upper housing 3010. The rotation sensor
assembly 3130 may be mounted on the lower housing half 3005. The pump body 3001 may
comprise housing halves 3005, 3010, the rotating, and reciprocating mechanisms inside the
housing halves 3005, 3010, the motor 3072 and gearbox 3070, the sensors and the structure
in which the above mount.
Fig. 260 illustrates the peristaltic pump 2990 (Fig. 255) having L—shaped
cam followers 3090, 3101 ,3110 (see Fig. 274) with the door 3020 open and the upper
housing 3010 and other elements removed to reveal the cam—shaft 3080, the plunger 3091
and valves 3101, 3111. The motor 3072 drives the cam shaft 3080 through the gearbox
3070. The motor 3072 may have a drive shaft whose the speed and/or position can be
controlled. In one embodiment the motor 3072 is a brushless DC servo—motor 3072
controlled by a motor ller 3430 (see 5B) that may be mounted on the main
PCB 3002. In alternative embodiments, the motor 3072 may be a r motor 3072, a DC
brushed motor 3072 or an AC motor 3072 with the appropriate controller.
The motor 3072 may be fixedly coupled to the gearbox 3070 allowing the
motor/gearbox unit to be ed as a unit to the cam shaft 3080 and upper housing 3010.
The gear reduction of the gearbox 3070 increases the torque, while increasing the number of
motor 3072 rotations per rotation of the cam shaft 3080 (Fig. 260). In one embodiment, the
gearbox 3070 has a reduction ratio of 19:1. The gear reduction allows reasonable resolution
on the cam shaft 3080 (Fig. 260) position with a relatively few number of hall s in the
motor 3072. In one embodiment, three hall sensors and eight gs produce —four
crossings per revolution. The twenty—four crossings combined with a 19:1 gear ratio
provides better than 0.80 angular resolution on the cam shaft 3080 (Fig. 260) rotation.
The rotation of the cam shaft 3080 (Fig. 260) may be directly measured with
a on sensor 3130 (Fig 257) that detects the position of the magnet 3125 on the end of
the cam shaft 3080 (Fig. 260). In one embodiment, the sensor is a single—chip magnetic
rotary encoder IC that employs 4 integrated Hall elements that detect the position of the
magnet 3125 (Fig. 260), a high resolution analog to digital converter and a smart power
management controller. The angle on, alarm bits and magnetic field ation may
be transmitted over a standard 3—wire or 4—wire SPI interface to a host controller. One
example of a rotary encoder is model A85055 manufactured by Austriamicrosystems of
Austria that provides 4096 ents per rotation.
The movements of the valve 3101, 3110, and the plunger 3090 are controlled
by the rotation of the cam shaft 3080 that turns dual cams 3083, 3084, 3082 (FIG
266), which in turn deflects a roller end 3092, 3102, 3112 (Fig. 274) of the L—shaped
followers 3090, 3100, 3110 (Fig. 274) downward. The L-shaped cam followers 3090, 3100,
3110 (Fig. 274) rotate about the cam—follower shaft 3120, so downward movement of the
roller end 3092, 3102, 3112causes the active end to pull away from the infusion line 3210
(Fig. 276). Torsional s 3094, 3104, 3114 (4) on each of the L—shaped cam
followers 3090, 3100, 3110 (Fig. 274) urge the rollers 3092, 3102, 3112 upward against the
cams 3082, 3083, 3084 (Fig. 276) and urge the active ends 3091. 3101, 3111 toward the
infusion line 3210.
The es of the outlet valve cam 3084, plunger cam 3083, and inlet valve
cam 3082 are pictured in FIGS. 271—273. These profiles e a valve sequence similar
to that plotted in 7. The cams 3084, 3083, 3082 may be connected to the cam shaft
3080 in any of the standard methods including adhesive, press fit, keyed shaft. In some
embodiments, the cams 3084, 3083, 3082 may be physically integrated into the cam shaft
3080 as a single piece. In one embodiment, the cams 3084, 3083, 3082 have a key slot
3082A, 3083A, 3084A and are pressed onto the cam shaft 3080 against a shoulder (not
shown) with a key (not shown) to rotationally locate the cams 3084, 3083, 3082 on the cam
shaft 3080 and a circle clip 3085 to hold the cams 3084, 3083, 3082 in on along the
axis of the cam shaft 3080. The cam shaft 3080 is mounted in the upper and lower housings
3005, 3010 by bearings 3086. In one embodiment, the bearings 3086 are sealed roller
bearings.
[00934] Fig. 274 illustrates the plunger L—shaped follower 3090, valve L—shaped cam
followers 3101, 3110 and cam—follower shaft 3120 in an exploded view. The L—shaped cam
followers 3090, 3100, 3110 mount on the cam—follower shaft 3120 and rotate freely on the
cam—follower shaft 3120. The rotation of the L—shaped cam followers 3090, 3100, 3110 on
the cam—follower shaft 3120 may be facilitated by bearings. In one embodiment, the
bearings are solid flanged bushings 3095, 3105, 3115 pressed into the bodies 3093, 3103,
3113 of the L—shaped cam followers 3090, 3100, 3110. The bearings may be any low
friction bushing including bronze, brass, plastic, nylon, polyacetal, polytetrafluoroethylene
(PTFE), ultra—high—molecular-weight polyethylene (UHMWPE), rulon, PEEK, urethane,
and vespel. The flanges on the bushings 3095, 3105, 3115 may serve as axial bearing
surfaces between adjacent L—shaped cam followers 3090, 3100, 3110 and between the valve
L-shaped cam followers 3101, 3110 and the housing halves 3005, 3010 (Fig. 265). The
flanges on the bushings 3095, 3105, 3115 (Fig. 274) may also serve to ly space the
active ends 3091, 3101, 3111 (Fig. 274) of the L—shaped cam followers 3090, 3100, 3110
(Fig. 274) relative to platen 3022 (Fig. 257) on the door assembly 3021 (Fig. 257).
] The cam—follower shaft 3120 (Fig. 274) may include end sections 3120A
(Fig. 274) that are eccentric relative to the center section 3120B (Fig. 274) of the cam—
follower shaft 3120 (Fig. 274). The on of the cam—follower shaft 3120 (Fig. 274)
relative to the cam—shaft 3080 (Fig. 260) and/or platen 3022 (Fig. 260) may be finely
adjusted by turning the eccentric end 3120A. Turning the eccentric end 3120A allows
adjustment of the lash between rollers 3092, 3102, 3112 and the cams 3084, 3083, 3082
(Figs. 271—273) on the cam shaft 3080 (Fig. 260).
The end section 3120A of the cam—follower shaft 3120 (Fig. 274) may
include a feature 3120C to receive a tool such as a screw , heX key or other tool
capable of applying a torque to the cam—follower shaft 3120 (Fig. 274). In one embodiment,
the feature is a slot sized to accept a eaded screw driver. The eccentric ends 3120A fit
in holes formed by cut—outs 3005D, 3010D (see Fig. 278) in the housing halves 3005, 3010
respectively. In one embodiment, the holes formed by cutouts 3005D, 3010D (Fig. 278) do
not bind the cam-follower shaft 3120 (Fig. 274) in order to allow adjustment. A clamping
element may be added to secure the rotary position of the cam-follower shaft 3120 (Fig.
274). In one embodiment, the clamping element is a set screw in threaded hole 3120A.
The L-shaped cam followers 3090, 3100, 3110 (Fig. 274) or actuators
comprise rollers 3092, 3102, 3112 that touch the cams 3084, 3083, 3082 (Figs. 271—273),
an c t 3094, 3104, 3114 that urges the contacting element toward the cam
surface, and an L—shaped structure 3093, 3103, 3113 that es a bore, which mounts on
the cam—follower shaft 3120 and ts the rollers 3092, 3102, 3112 to the active element
3091, 3101, 3111 that in turn touches the on line 3210. The L—shaped cam followers
3090, 3100, 3110 (Fig. 274) additionally include flanged gs 3095, 3105, 3115
mounted in the bore of the ure 3093, 3103, 3113 (Fig. 274).
In one embodiment, the rollers 3092, 3102, 3112 rotate about a shaft 3096,
3106, 3116 that is mounted in the structures 3093, 3103, 3113 (Fig. 274). Rollers are
preferred as the contacting element in order to reduce the load on the motor 3072 and
improve peristaltic pump 2990 ability. In other embodiments a different type of
contacting element may be used.
In one embodiment, the active ts, or inlet valve 3101, plunger 3091,
an outlet valve 3111, are formed as part of the L-shaped cam followers 3090, 3100, 3110
(Fig. 274). In one embodiment, the active elements, 3091, 3101, 3111 are removably
attached to the structure of each ed cam follower 3090, 3100, 3110 (Fig. 274). In
one embodiment, the active elements 3091, 3101, 3111 (Fig. 274) may be mechanically
ed with screws. In other embodiments, the active elements 3091, 3101, 3111 (Fig.
274) may include studs that pass through holes in the structures 3093, 3103, 3113 (Fig. 274)
and are held in place with nuts, or the active elements 3091, 3101, 3111 (Fig. 274) may
include plastic studs that snap into receiving elements in the structures 3093, 3103, 3113
(Fig. 274).
The elastic elements 3094, 3104, 3114 urge the L—shaped cam followers
3090, 3100, 3110 (Fig. 274) against the cam surfaces of the cams 3084, 3083, 3082 (Figs.
271—273) and toward the platen 3022 (Fig. 260) and infusion line 3210. In one
embodiment, the c elements 3094, 3104, 3114 (Fig. 274) are coiled torsion springs that
wrap around the section of the structures 3093, 3103, 3113 (Fig. 274) that includes the bore.
One end of the torsion springs press against the L— shaped cam follower structures 3090,
3100, 3110 (Fig. 274) between the bore and the rollers 3092, 3102 and 3112. The other
end of the spring contacts the fixed structure of the altic pump 2990. In one
embodiment the other end of each spring contacts a spring retainer 3140 (Figs 275, 276)
that may include a slot 3140A to capture the spring end. A retainer set screw 3142 (Fig.
275) can be turned to move the spring retainer 3140 within the upper housing 3010 and
apply a load against the elastic elements 3094, 3104, 3114. At some cam 3084, 3083, 3082
(Figs. 271—273) rotary positions, the load applied to the spring will in turn be applied by the
active ends 3091, 3101, 3111 to the infusion line 3210. The compressive load of each
active ends 3091, 3101, 3111 (Fig. 274) on the infusion line 3210 may be adjusted by
turning the corresponding retainer set screw 3142.
In r embodiment, the elastic elements 3094, 3104, 3114 (Fig. 274) are
helical springs that are located between the L—shaped cam followers 3090, 3100, 3110 (Fig.
274) and the structure of the pump body 3001. The helical springs are located such that
they urge the follower—end or roller—end of the L—shaped cam ers 3090, 3100, 3110
(Fig. 274) toward the cams 3082, 3083, 3084 (Fig. 271—273). The helical springs may also
urge the active end of the L—shaped cam followers 3090, 3100, 3110 (Fig. 274) toward the
platen 3022 (Fig. 260). One arrangement of helical springs and L-shaped cam followers
3090, 3100, 3110 is shown in Figs. 205, 206, 219, 220.
Fig. 276 shows a cross-section of the pump mechanism 3000 including
sections of the plunger cam 3083, plunger 3091 and platen 3022. The cam shaft 3080 turns
the plunger cam 3083 which is keyed to the shaft at 3084A. The cam 3083 displaces the
cam ting element or cam roller 3092, which is part of the plunger 3091 L—shaped cam
follower 3090. The plunger 3091 L—shaped cam follower 3090 rotates about the cam—
follower shaft 3120. The plunger 3091 L—shaped cam follower 3090 is held t the
plunger cam 3083 by the elastic element 3094. One end of the c element 3094A
contacts the structure 3093, while the free end of the elastic t 3094B contacts the
spring retainer 3140. The r 3091 compresses the infusion line 3210 against the platen
3022. The plunger 3091 retracts from the platen 3022, when the plunger cam 3083
depresses the cam—roller 3092.
[00943] Fig. 277 presents a section of the plunger 3091, platen 3022 and
infusion line 3210 at the bottom of the plunger 3091 stroke. At the top of the plunger 3091
stroke, the non compressed infusion line 3210 has a nominally round cross section that
contains a maximum volume. The pumping mechanism 3000 maximizes pumping per
stroke by allowing the infusion line 3210 to completely fill at the top of the stroke and
minimize the volume inside the infusion line 3210 at the bottom of the plunger 3091 stroke.
The amount of volume pumped may be impacted by the shape of the plunger 3091, the
length of the plunger 3091 stroke and the shape of the platen 3022. However, if the infusion
line 3210 is completely crushed, the forces on the plunger 3091 may be higher than needed,
which may necessitate larger c ts 3090, 3100, 3110 (Fig. 274) and or a larger
motor 3072 or higher power draw. The higher power draw may shorten the time the
peristaltic pump 2990 can run on a battery 3420 or may create a heavier peristaltic pump
2990 due to a large battery 3420. The design of the plunger 3091 and platen 3022 may be
selected to balance increased volume against higher loads on the plunger 3091. In one
embodiment, the plunger 3091 and platen 3022 are designed to avoid compressing infusion
line 3210 walls by providing a gap between the plunger 3091 and the platen 3022 that is
slightly larger than two times the infusion line 3210 wall thickness.
In one embodiment, the plunger cam 3083 and plunger L—shaped cam
er 3090 are designed e a minimum clearance 3022G between the tip of the
plunger 3091B and the bottom of the platen 3022D. In one example, the clearance 3022G is
2 to 3 times the infusion line 3210 wall thickness and sufficient such that the infusion line
3210 walls do not touch between the plunger tip 3091B and platen bottom 3022D. In one
example, the clearance 3022G between the plunger tip 3091B and the bottom of the platen
3022D is approximately 0.048”, which is 9% larger than twice the wall thickness of an
e infusion line 3210. In another example, the nce 3022G may be as small as
2% larger than twice the wall thickness of an example infusion line 3210. In another
example the clearance 3022G may be as large as 50% larger than twice the wall thickness of
an infusion line 3210.
[00945] In one embodiment, the dimensions of the platen 3022 and plunger tip
3091B are selected to provide a clearance 3022G that is 2 to 3 times the wall ess of a
single wall of the infusion line 3210. In one example, the clearance 3022G between the
plunger tip 3091B and the platen 3022 is 8% to 35% larger than twice the wall thickness of
an example infusion line 3210. The clearance 3022G will allow the sides of the on
line 3210 to fold without pinching the fold shut. In one embodiment, the plunger tip 3091B
has a radius of 0.05” and sides 3091C that have an angle between them of 35°. The sides
3091C may meet the plunger tip 3091B radius at a t angle. The length of the plunger
tip 3091D may be 0.116”. The platen bottom 3022D may be flat and have a radius 3022C
on each side. The length of the platen bottom 3022D and radii 3022C are selected to
maintain a clearance 3022G between the plunger tip 3091B and the platen 3022 that is more
than twice the infusion line 3210 wall thickness. In one example, the platen bottom 3022D
is 0.05 long and each radius 3022C is 006”. Side 3022B is angled away from the plunger
3091. The shorter side 3022B is nearly vertical. Side 3022F is at a less vertical angle than
the plunger walls 3091C to allow the plunger tip 3091B to enter the platen 3022 as the door
assembly 3021 is closed.
] The plunger 3091 and platen 3022 may include two flat sections 3091A and
3022A which provide a mechanical stop. The flat sections 3091A and 3022A may also be
referred to herein as stops 3091A and 3022A. The mechanical stops 3091A, 3022A may
improve the reliability and reduce the uncertainty of the volume measurement. As
described elsewhere, the volume is determined from the change in plunger 3091 position
from the beginning of the displacement stroke to the end of stroke. The stops 3091A and
3022A may remove the uncertainty or tolerance in the bottom of stroke measurement. The
profile on the plunger cam 3083 may be designed to lift off the roller 3092, when the flat
n 3091A contacts the platen 3022 at 3022A.
The plunger 3091 and platen 3022 may be formed of with a surface that
easily slides on an on line 3210 material of PVC or Non-DEHP. In one embodiment,
the plunger 3091 and platen 3022 may be formed of nylon. In another embodiment, the
plunger 3091 and platen 3022 may be metal (e.g. aluminum) that is coated with PTFE. In
other embodiments, other plastic may be used or other coatings d to a metal plunger
3091 and/or platen 3022 that provide a low friction coefficient with a PVC or Non—DEHP
infusion line 3210.
The cam shaft 3080 and the cam—follower shaft 3120 are mounted in cut—outs
3005C, 3005D, 3010C, 3010A in the lower and upper g 3005, 3010 as shown in Figs
260, 278. The accuracy of the nts of the valves 3101, 3111 and the r 3091 as
well as the usage life of the roller elements 3092, 3102, 3112 and cams 3082—3084 are
improved by better parallel alignment and correct spacing of the two shafts 3080, 3120.
The parallel alignment and spacing of the two shafts 3080, 3120 are controlled in part by the
parallel alignment and spacing of the cutouts 3005C, 3005D, 3010C, 3010A. In one
embodiment, the two parts of the housing 3005, 3010 are formed without the cutouts (Figs
278, 279). The two parts are then mechanically joined and the holes 3006, 3007 are drilled
or bored by the same e in the same setup (Fig 280) at the same time. In some
embodiments, the two housing parts 3005, 3010 include features to hold them in a fixed
alignment with one another when assembled. In one example, the housing 3005, 3010
alignment features are pins pressed in one part and matching holes in the other. In another
example, features on one part extend across the split line 3008 to engage features on the
other part. The operation of accurately boring holes is sometimes referred to as line .
Line boring may improve the parallel alignment of the cutouts 3005C, 3005D, 3010C,
3010A. The line boring of the cutouts 3005C, 3005D, 3010C, 3010A in the joined g
3005, 3010 inexpensively creates cutouts 3005C, 3005D, 3010C, 3010A that combine to
form more accurately circular holes 3006, 3007 and holes 3006, 3007 that are more parallel
one to another.
The measurement of pumped volume is based on the measured position of
the plunger 3091. In one embodiment as shown in Figs. 281, 275, the r 3091 position
is measured remotely without contacting the plunger 3091 L—shaped cam follower 3090. In
one ment, the plunger 3091 position is measured with a linear hall effect encoder IC
3002A and a simple two-pole magnet 3096A (Fig. 282). The linear encoder 3002A (Fig.
282) is d on the main PCB 3002 and reports the position of the magnet 3096A located
on the r 3091 L-shaped cam follower 3090 to the controller. The linear encoder IC
3002A is advantageously mechanically disconnected from the moving components, so the
sensor will not wear, degrade or break with use. In one embodiment, the linear encoder IC
3002A is part A85410 manufactured by Austriamicrosystems of Austria. The A85410
allows the conversion of a wide range of geometries ing curved movements, non—
linear scales, and tilted chip/magnet geometries into a linear output signal. The flexibility
of the linear encoder IC 3002A allows larger tolerances in the placement of the main PCB
3002 relative to the plunger magnet 3096A. Alternatively, the position of the plunger 3091
may be measured with a vision system that uses edges or datums located on the r
3091 L—shaped cam follower 3090. atively, the plunger 3091 position may be
measured with any of several sensors well known in the art including a linear potentiometer,
a rotary potentiometer, rotary encoder, linear encoder, or LVDT. Methods to ically
connect one of these sensors to the plunger L—shaped cam follower 3090 may be those
apparent to one skilled in the art.
The slide occluder 3200 can be seen in Fig. 261. The slide occluder 3200
serves to pinch the infusion line 3210 closed, blocking flow, when the infusion line 3210 is
in the narrow part of the opening 3200D (Fig. 261). Flow is allowed through the infusion
line 3210 when it is located in the wide end of the opening 3200C at the front of the slide
occluder 3200. The open position on the slide er 3200 refers to the infusion line 3210
being located in the wide end of the opening 3200C. The closed position of the slide
occluder 3200 refers to the infusion line 3210 being d in the narrow part of the
opening 3200D. The slide occluder 3200 includes at least one opening 3200A on the front
end of the slide occluder 3200. A tab 3200B is located at the back end of the slide occluder
3200.
The process of closing the door and inserting the slide carriage 3041 to
release the slide occluder 3200 is described with reference to Figs. 283 to 293. Fig. 283
illustrates the slide occluder 3200 fully inserted into the door split carriage 3040 and the
infusion line 3210 clipped into the clips 3062A, 3024. The door assembly 3021 will close
by ng about the hinges 3010A. The initial position of the body split carriage 3045 in
the pump body 3001 can be seen in Fig. 284. The slot 3045E in the body split carriage
3045 es the slide occluder 3200 when the door assembly 3021 is closed against the
pump body 3001. The opening 3045B in the body split carriage 3045 accommodates the
tab 3200B of the slide occluder 3200 ng the back end of the slide occluder 3200 to
enter the body split ge 3045 and allowing the door assembly 3021 to close. The body
split carriage 3045 and/or upper housing 3010 prevent the door assembly 3021 from closing
when the slide occluder 3200 has been incorrectly oriented. The side of the body split
carriage 3045 opposite the opening 3045B does not provide an opening or slot that could
accommodate the tab 3200B on the slide occluder 3200. In one embodiment, the upper
housing 3010 includes a rail 3010B that blocks the tab 3200B.
Fig. 285 illustrates the two part split—carriage assembly 3041 in the open
position. Such a position may be reached when the door assembly 3021 is open. Fig. 286
illustrates the two part split—carriage assembly 3041 in the closed position. Such a position
may be reached when the door assembly 3021 is closed against the pump body 3001. The
aXis of the hinge 3040B is approximately in line with the aXis of the upper housing 3010
hinge 3010A when the door assembly 3021 is open. The door split carriage 3040 includes
at least one slot 3040D that allows it to accommodate at least one tab 3020D on the door
3020 and rail 3010E in the upper housing 3010. In an alternative embodiment shown in
Figs 262—263, the slot 3040D may accommodate or be guided on tabs 3020D, 3020F. The
body split carriage 3045 includes at least one slot 3045D to accommodate rail 3010A on the
upper housing 3010 and/or rail 3015B on the sensor g 3015. The slots 3040D and
3045D allow the split carriage 3041 to slide within the pump body 3001 and door 3020
when the door 3020 is closed against the body 3001.
Fig. 287 illustrates the peristaltic pump 2990 having ed cam followers
3090, 3100, 3110 with the door 3020 partially closed and some elements d to reveal
the slide occluder 3200 in the closed split-carriage 3041. The door assembly 3021 is closed
and the lever 3025 has not begun to engage the body pins 3011. The on of the split
carriage 3041 comprising parts 3045 and 3040 is controlled by the position of the lever
3025. The split carriage 3041 is pushed into the pump body 3001 by a rib 3025F as the
lever 3025 is closed or rotated toward the pump body 3001. The split carriage 3041 is
pulled partially out of the pump body 3001 by the lever link 3035 as the lever 3025 is
opened or rotated away from the pump body 3001. The door split carriage 3040 is
connected to the lever 3025 via the closed end of the lever link 3035C that fits over the
ge pin 3040A and the open end 3035B holds a pin 3026 that slides in a slotted rib
3025A on the lever 3025. The split ge’s 3041 travel is limited by the length of the
slide er 3200. The slide occluder 3200 which may not provide sufficient rotation of
the lever 3025 to engage the body pins 3011 and compress the infusion line 3210 t the
inlet and/or outlet valves 3101, 3111 t inordinate manual force exerted against the
lever 3025.
The lever 3025, split ge 3021 and door assembly 3021 are designed to
in the occlusion of the infusion line 3210 at all times during the door 3020 opening
and closing processes. The infusion line 3210 is occluded by pressing the door 3020
against the body, before the slide occluder 3200 is moved by the split carriage 3041 during
closing. In the opening process, the slide occluder 3200 is moved first to block the infusion
line 3210 before the door 3020 is disengaged from the body and allows the infusion line
3210 to become decompressed.
The slotted rib 3025A and lever link 3035 allow the lever 3025 to rotate
several degrees and begin engaging the body pins 3011 with the latch hooks 3025C without
moving the split carriage 3041 when closing the lever 3025. Upon opening, the slotted rib
3025A and lever link 3035 allow the lever 3025 to retract the split ge 3041 and block
the infusion line 3201 before disengaging the body pins 3011 and releasing the infusion line
3210 from the valves 3101, 3111. The lever link 3035 mechanically connects the lever
3025 to the door split carriage 3041 such that the lever 3025 only applies a tension force on
the lever link 3035. Limiting the force on the lever link 3035 to tension force removes the
need to ensure the lever link 3035 is buckle resistant, allowing the lever link 3035 to be
lighter and smaller.
The rotation of the lever 3025 toward the door 3020 and body 3001
compresses the infusion line 3210 between the platen 3022 and the valves 3101, 3111 and
r 3091, latches the door 3020 shut and moves the slide occluder 3200 to an open
position. The lever link 3035 and the slotted rib 3025A and the geometry of the latch hook
3025C assure that the infusion line 3210is compressed against the valves 3101, 3111 before
the slide occluder 3200 is moved to the open position when the lever 3025 is closed. The
lever link 3035 and the slotted rib 3025A and the geometry of the latch hook 3025C also
assure that the slide occluder 3200 is moved into the closed position before the infusion line
3210 is uncompressed against the valves 3101, 3111 when the lever 3025 is opened. This
sequence of blocking flow through the on line 3210 with one element before releasing
the second element assures that the infusion line 3210 is never in a ow state during
the g of the infusion line 3210 in the peristaltic pump 2990.
i~fi“\ Alternatively, the door split carriage 3040 may be pulled out of the pump
body 3001 by the lever 3025 that is connected to the door split carriage 3040 by two links
3036, 3037 as shown in Fig 288. The first link 3036 fits over the split carriage pin 3040A
and connects to the second link 3037 at hinge 3036A. The second link connects the first
link 3036 to the lever 3025 at pivot point 3025G. The two links 3036, 3037 each have a flat
3036B, 3037B that limits the relative on of the links 3036, 3037 so that they never
cross a center point and always fold toward each other in the same direction. In the pictured
embodiment, the links 3036, 3037 can only fold so that their mutual pivot point 3036A
moves away from the lever pivot 3025B as the lever 3025 . The two links 3036, 3037
allows the lever 3025 to rotate several degrees and begin ng the body pins 3011 with
the latch hooks 3025C and occlude the infusion line 3210 t at least one of the valves
3101, 3111 without moving the split carriage 3041. Once the two links 3036, 3037 have
folded closed, the rib 3025F contacts the door split carriage 3040. The rib 3025F pushes the
split carriage 3041 into the pump body 3001 as the lever 3025 completes its rotation toward
the door assembly 3021.
3‘0““ Upon opening the lever 3025, or rotating the lever 3025 away from the door
assembly 3021, the two links 3036, 3037 unfold and only begin to retract the split carriage
3041 after an initial lever 3025 rotation. During the second part of the lever 3025 rotation,
the split carriage 3041 withdraws from the pump body 3001 and moves slide occluder 3200,
which blocks the infusion line 3210 before disengaging the body pins 3011 and releasing
the infusion line 3210 from the valves 3101, 3111. The infusion line 3210 is uncompressed
during the third portion of the lever 3025 rotation.
Alternatively, the two links 3036, 3037 could be replaced with a flexible
cable or wire, which pulls the split carriage 3041 out of the pump body 3001. The flexible
cable may be attached to the door split carriage 3040 and to a fixed point on the lever 3025.
The split carriage 3041 is pushed into the pump body 3001 by the rib 3025F as the lever
3025 rotates toward the pump body 3001.
Fig. 274 illustrates the peristaltic pump 2990 having ed cam followers
3090, 3100, 3110.The door 3020 is closed and the lever 3025 latched as shown in Fig. 289.
The split carriage 3041 has been partially slid through the door 3020 and into the body
3001. The movement of the split carriage 3041 moves the slide er 3200 into the
pump body 3001, while the infusion line 3210 is held in position. The movement of the
slide occluder 3200 relative to the infusion line 3210 moves the infusion line 3210 into the
wide end 3200C of the slide occluder 3200 ng flow through the infusion line 3210.
] Figs. 290-293 illustrate four steps of closing the door 3020 of the peristaltic
pump 2990 having ed cam followers 3090, 3100, 3110. In Fig. 290, the door
assembly 3021 is open and the infusion line 3210 and slide occluder 3200 are installed. In
Fig. 291, the door assembly 3021 is closed, the lever 3025 is open and the split carriage
3041 is fully retracted, so the infusion line 3210 is blocked by the slide occluder 3200 . In
Fig. 292, the lever 3025 is partially rotated toward the body 3001 to a point where the split
carriage 3041 has not moved and the slide occluder 3200 blocks the infusion line, but the
latch hooks 3025C have d the body pins 3011 and compressed the infusion line 3210
between the door assembly 3021 and at least one of the valves 3101, 3111. In Fig. 293, the
lever 3025 is fully rotated toward the pump body 3001 or closed. In Fig. 293, the slide
carriage 3041 is fully inserted into the pump body 3001, so that the on line 3210 is
unblocked by the slide occluder 3200 and the door 3021 is fully preloaded against the pump
body 3001 including at least one of the valves 3101, 3111.
Figs. 294—298 illustrate the elements of the door assembly 3021 and pump
body 3001 and lever 3025 that together latch the door 3020 closed, and position the door
assembly 3021 parallel to the face of the upper—housing 3010 and compress the infusion line
3210 n the platen 3022 and at least one of the valves 3101, 3111 and plunger 3091.
The door assembly 3021 is positioned and d against the upper housing 3010 without
placing a load on the hinge pin 3012 or requiring close tolerance on hinge pin 3012 and
pivot holes 3020], 3010F.
As described above and pictured in Figs. 283, 287 the two latch hooks
3025C engage the body pins 3011, which are mounted in the upper housing 3010 tabs
3010B, when the door ly 3021 has been d to contact the upper housing 3012
and the lever 3025 is rotated toward the door 3020. The latch hooks 3025C have tapered
openings to assure engagement for a broader range of initial positions between the door
assembly 3021 (Fig. 257) and the upper housing 3010 (Fig. 258). The opening in the latch
hook 3025C is shaped to pull the latch pin 3034 (Fig. 299) closer to the body pin 3011 as
the lever 3025 (Fig. 257) is rotated. The latch pin 3034 (Fig. 299) is free to move within the
door 3020 along slots 3020C as the latch pin 3034 moves toward the body pin 3011 (Fig.
294). The slot structure 3020C on the top of the door 3020 in Fig. 294 is repeated toward
the bottom of the door 3020 in Fig. 295, where the second latch 3025C engages the latch pin
3034.
In Fig. 298, the movement of the latch pin 3034 toward the upper housing
3010 deflects the door spring 3032 that is supported by the door 3020 at each end of the
door spring 3032A. The deflection of the door spring 3032 generates a force that is applied
to the door 3020 and directed toward the upper housing 3010 and the pump body 3001. The
pump body 3010 includes protrusions or standoffs 3025H that contact the face of the upper
housing 3010 in three or more places buted around the valves 3101, 3111 and plunger
3091 (Fig. 260). In one ment, the standoffs 3025H are also positioned within and
equal distance to the contact area between the door spring 3032 and the door 3020 so that
the spring force is equally distributed to each standoff 3025H. In one embodiment as shown
in Fig. 296, four standoffs 3020H are located around the platen 3022, near where the valves
3101, 3111 (Fig. 260) contact the infusion line 3210. The pivot holes 3020 in the door 3020
are slightly oversized for the hinge pin 3012 (Fig. 295), which allows the door 3020 to rest
on the standoffs 3025H without being ained by the hinge pin 3012.
Fig. 297 shows the cross—section through the latch pin and includes the
latches 3025C fully engaging body pins 3011. In one embodiment, the body pins 3011
include a plain bearing 3011A to reduce wear and friction. The plain bearing 3011A is tube
of hard material that can rotate on the body pin 3011 to reduce wear on the latch hooks
3025C. The latch pin 3034 passes through the lever pivot holes 3025B and is free to move
in the slots 3020C and deflect the door spring 3032. In Fig. 297, the plunger 3091 is in a
position to compress the infusion line 3210 against the platen 3022. The force of the
deflected door spring 3032 supplies the force to ss the infusion line 3210 from the
platen 3022 side, while the r elastic element 3094 (Fig. 267) supplies the force on the
plunger 3091 side.
Fig. 298 shows the cross section across the middle of the door spring 3032
and perpendicular to the latch pin 3034. The ion of the door spring 3032 is evident
between the latch pin 3034 and an edge 3020F at each end of the door spring 3032 and of
the spring cutout 3020G. 6 presents an ment where the standoffs 3020H are
d between and equal distant to the locations where the door spring 3032 contacts the
door 3020.
In one embodiment shown in Fig. 299—300, one of the latch hooks 3025C
may comprise detents 3025G, 3025] and a spring pin 3027 or ball to engage the detents
3025G, 3025]. Figs. 299 illustrates the lever 3025 fully closed against the door 3020. The
latch hook 3025C includes a first detent 3025G that is engaged by a spring pin 3027. The
spring pin 3027 is mounted in the door 3020 at such a position that it s the first
detent 3025G when lever 3025 is closed.
Fig. 300 rates the lever 3025 fully opened relative to door 3020 and the
door split carriage 3040 retracted. The spring pin 3027 engages a second detent 3025J when
the door 3020 is in the fully open position. In some embodiments, the s 3025G,
3025] in the latch hooks 3025C may allow the lever 3025 to hold one or more positions
relative to the door 3020.
Fig. 301 illustrates a detection lever 3150 displaced by the slide occluder
3200, when the door assembly 3021 and the lever 3025 (Fig. 265) are fully are closed. The
detection lever 3150 rotates on a pin 3151 that is attached to the upper g 3010 and
swings through a slot 3045F (Fig. 285) in the body split carriage 3045. If a slide occluder
3200 is present in the split carriage 3041 when the door 3020 is closed, the slide occluder
3200 will deflect the detection lever 3150 upward toward the main PCB 3002. A sensor
3152 on the main PCB 3002 will detect the neamess of a magnet 3150A on the detection
lever 3150. The detection lever 3150, magnet 3150A and sensor 3152 may be designed to
only detect a ic slide occluder 3200 geometry. Other slide occluders 3200 or slide
occluder 3200 shapes may not deflect the detection lever 3150 enough for the sensor 3152
to detect the magnet 3150A or cause the ion lever 3150 to contact the main PCB 3002
and prevent the full insertion of the split carriage 3041 and closing of the lever 3025. A
controller may only allow peristaltic pump 2990 operation when the sensor 3152 detects the
displaced detection lever 3150 indicating that the appropriate slide occluder 3200 is present.
Fig. 302 illustrates a latch hook detection slide 3160 displaced by the latch
hook 3025C, when the door assembly 3021 and the lever 3025 are fully closed. The latch
hook ion slide 3160 includes one or more slots 3160A that guide it past screws or
posts on mounted in the upper housing 3010. A spring 3164 returns latch hook detection
slide 3160 to a non—displaced position, when the latch hook 3025C is engaging the body pin
3011. The latch hook detection slide 3160 includes at least one magnet that is located so that
a sensor 3163 mounted on the main PCB 3001 will detect it presence only when the
ion slide 3160 is fully ced. In one embodiment, the latch hook detection slide
3160 may include a second magnet 3162 that is detected by the sensor 3163 only when the
latch hook ion slide 3160 is fully retracted. A ller may only allow peristaltic
pump 2990 operation when the sensor 3163 detects the displaced latch hook detection slide
3160 indicating that the lever 3025 is fully closed.
FIGS. 303-310 show various views related to a system 3200. 3
shows a system 3200 that includes several pumps 3201, 3202, and 3203. The pumps 3201,
3202, 3203 can be coupled together to form a group of pumps that are connectable to a pole
3208. The system 3200 includes two syringe pumps 3201, 3202 and a peristaltic pump
3203; however, other combinations of various medical devices may be employed.
[00972] Each of the pumps 3201, 3202, 3203 includes a touch screen 3204 which
may be used to control the pumps 3201, 3202, 3203. One of the pumps’ (e.g., 3201, 3202,
3203) touch screens 3204 may also be used to coordinate operation of all of the pumps
3201, 3202, 3203 and/or to l the one or more of the other pumps 3201, 3202, 3203.
The pumps 3201, 3202, and 3203 are daisy chained together such that they
are in electrical communication with each other. Additionally or atively, the pumps
3201, 3202, and/or 3203 may share power with each other or among each other. For
example, one of the pumps 3201, 3202, and/or 3203 may e an AC/DC converter that
converts AC ical power to DC power suitable to power the other pumps 3201, 3202,
3203.
[00974] Within the system 3200, the pumps 3201, 3202, and 3203 are stacked
together using respective Z—frames 3207. Each of the Z—frames 3207 includes a lower
portion 3206 and an upper portion 3205. A lower portion 3206 of one e 3207 (e.g.,
the lower portion 3206 of the pump 3201) can engage an upper portion 3205 of r Z—
frame 3207 (e. g., the upper portion 3205 of the Z—frame 3207 of the pump 3202).
[00975] A clamp 3209 may be coupled to one of the pumps 3201, 3202, 3203 (e. g.,
the pump 3202 as shown in 4). That is, the clamp 3209 may be coupled to any one
of the pumps 3201, 3202, and/or 3203. The clamp 3209 is attachable to the back of any one
of the pumps 3201, 3202, and/or 3203. As is easily seen in 6, each of the pumps
3201, 3202, 3203 includes an upper attachment member 3210 and a lower attachment
member 3211. A clamp adapter 3212 facilitates the attachment of the clamp 3209 to the
pump 3202 via a respective pump’s (e.g., 3201, 3202, or 3203) upper attachment member
3210 and lower attachment member 3211. In some embodiments, the clamp adapter 3212
may be integral with the clamp 3209.
7 shows a close—up view of a portion of an interface of a clamp (i.e.,
the clamp adapter 3212) that is able to the pump 3202 (or to pumps 3201 or 3203)
shown in FIGS. 304-306 in accordance with an embodiment of the present disclosure. The
clamp adapter 3212 es a hole 3213 in which a lower attachment member 3211 (see
6) may be attached. That is, the lower attachment member 3211, a curved hook—like
protrusion, may be inserted into the hole 3213 and thereafter rotated to secure the lower
attachment member 3211 therein.
As is easily seen in 8, the clamp adapter 3212 also es a latch
3214. The latch 3214 is pivotally mounted to the clamp adapter 3212 via pivots 3216. The
latch 3214 may be spring biased via springs 3218 that are coupled to the hooks 3220. The
stop members 3219 prevent the latch 3214 from pivoting beyond a predetermined amount.
After the hole 3213 is oned on the lower attachment member 3211, the clamp adapter
3212 may be rotated to bring the latch 3214 towards the upper attachment member 3210
such that the latch 3214 is compressed down by the upper attachment member 3210 until
the sion 3215 snaps into a complementary space of the upper attachment member
3210. The hooks 3220 help secure the clamp adapter 3212 to the pump 3202.
Each of the Z—frames 3207 for each of the pumps 3201, 3202, 3203 includes
a recessed portion 3223 on its upper portion 3205 (see 6) and each pump 3201,
3202, 3203 includes a protrusion 3224 (see 9). A protrusion 3224 of one pumps
(e.g., pumps 3201, 3202, or 3203) may engage a recessed portion 3223 of another Z—frame
to enable the pumps 3201, 3202, 3203 to be stacked on top of each other. Each of the
pumps 3201, 3202, 3203 includes a latch engagement member 3221 that allows another one
of the pumps 3201, 3202, 3203 to be attached thereto via a latch 3222 (see 9). The
latch 3222 may e a small spring loaded flange that can “snap” into the space formed
under the latch engagement member 3221. The latch 3222 may be pivotally coupled to the
lower portion 3206 of the Z-frame 3207 .
As is seen 4, the latch 3222 of the Z-frame of pump 3201 may be
pulled to withdraw a n of the latch 3222 out of the space under the latch engagement
member 3221 of the pump 3202. Thereafter, the pump 3201 may be rotated to pull the
protrusion 3224 of the pump 3201 out of the recessed portion 3223 of the Z—frame of pump
3202 such that the pump 3201 may be removed from the stack of pumps 3202, 3203 (see
).
Each of the pumps 3201, 3202, 3203 includes a top connector 3225 (see
0) and a bottom connector 3226 (see 9). The connectors 3225 and 3226
allow the stacked pumps 3201, 3202, and 3203 to communication between each other
and/or to e power to each other. For example, if the battery of the middle pump 3202
(see 3) fails, then the top pump 3201 and/or the bottom pump 3203 may provide
power to the middle pump 3202 as a reserve while one or more of the pumps 3201, 3202,
3203 is audibly alarming.
An example embodiment of the graphic user ace (hereafter GUI) 3300
is shown in 1. The GUI 3300 enables a user to modify the way that an agent may be
infused by izing various programming options. For purposes of example, the GUI
3300 detailed as follows uses a screen 3204 which is a touch screen as a means of
interaction with a user. In other embodiments, the means of interaction with a user may be
different. For instance, alternate embodiments may comprise user depressible buttons or
rotatable dials, audible commands, etc. In other embodiments, the screen 3204 may be any
electronic visual display such as a, liquid crystal display, LED. display, plasma display,
etc.
As detailed in the ing paragraph, the GUI 3300 is displayed on the
screen of the pumps 3203. All of the pumps 3201, 3202, 3203 may have their own
individual screen 3204 as shown in FIGS. 303-305. In arrangements where one of the
pumps 3201, 3202, 3203 is being used to control all of the pumps 3201, 3202, 3203, only
the master pump may require a screen 3204. As shown, the pump is seated in a e
3207. As shown, the GUI 3300 may display a number of interface fields 3250. The interface
fields 3250 may display various information about the pump or infusion status, the
tion, etc. In some embodiments, the interface fields 3250 on the GUI 3300 may be
touched, tapped, etc. to navigate to different menus, expand an ace field 3250, input
data, and the like. The interface fields 3250 displayed on the GUI 3300 may change from
menu to menu.
The GUI 3300 may also have a number of virtual buttons. In the non-limiting
example embodiment in 1 the display has a virtual power button 3260, a virtual start
button 3262, and a virtual stop button 3264. The l power button 3260 may turn the
pump 3201, 3202, 3203 on or off. The l start button 3262 may start an infusion. The
virtual stop button 3264 may pause or stop an infusion. The virtual buttons may be activated
by a user’s touch, tap, double tap, or the like. Different menus of the GUI 3300 may
comprise other virtual buttons. The virtual buttons may be skeuomorphic to make their
functions more immediately understandable or izable. For example, the virtual stop
button 3264 may resemble a stop sign as shown in 5. In alternate embodiments, the
names, shapes, functions, number, etc. of the virtual buttons may differ.
As shown in the example embodiment in 2, the interface fields
3250 of the GUI 3300 (see 1) may display a number of different programming
parameter input fields. For the GUI 3300 to display the ter input fields, a user may
be ed to navigate through one or a number of menus. Additionally, it may be
necessary for the user to enter a password before the user may manipulate any of the
parameter input fields.
In 2, a medication ter input field 3302, in container drug
amount ter input field 3304, total volume in container parameter input field 3306,
concentration ter input field 3308, dose ter input field 3310, volume flow rate
fter abbreviated as rate) parameter input field 3312, volume to be infused (hereafter
VTBI) parameter input field 3314, and time parameter input field 3316 are displayed. The
parameters, number of parameters, names of the parameters, etc. may differ in alternate
embodiments. In the example embodiment, the parameter input fields are cally
displayed boxes which are substantially rectangular with rounded comers. In other
embodiments, the shape and size of the parameter input fields may differ.
] In the example ment, the GUI 3300 is designed to be intuitive and
flexible. A user may choose to populate a combination of parameter input fields which are
simplest or most convenient for the user. In some embodiments, the parameter input fields
left vacant by the user may be calculated automatically and displayed by the GUI 3300 as
long as the vacant fields do not operate independent of populated parameter input fields and
enough information can be gleaned from the populated fields to calculate the vacant field or
fields. Throughout FIGS. 312-316 fields dependent upon on another are tied together by
curved double-tipped arrows.
] The medication parameter input field 3302 may be the parameter input field
in which a user sets the type of te agent to be infused. In the example embodiment, the
medication parameter input field 3302 has been populated and the infusate agent has been
defined as “0.9% NORMAL SALINE”. As shown, after the specific infusate has been set,
the GUI 3300 may populate the medication parameter input field 3302 by displaying the
name of the specific infusate in the medication parameter input field 3302.
To set the specific infusate agent to be infused, a user may touch the
medication parameter input field 3302 on the GUI 3300. In some ments, this may
cull up a list of different possible infusates. The user may browse through the list until the
desired infusate is located. In other embodiments, ng the in medication parameter
input field 3302 may cull up a virtual keyboard. The user may then type the correct infusate
on the l keyboard. In some ments, the user may only need to type only a few
letters of the infusate on the virtual keyboard before the GUI 3300 displays a number of
suggestions. For example, after typing “NORE” the GUI 3300 may suggest
“NOREPINEPHRINE”. After locating the correct infusate, the user may be required to
perform an action such as, but not limited to, tapping, double tapping, or touching and
ng the infusate. After the required action has been completed by the user, the infusate
may be displayed by the GUI 3300 in the medication parameter input field 3302. For
another detailed ption of another example means of infusate selection see 2.
In the example embodiment in 2, the parameter input fields have
been ed by a user to m a volume based infusion (for ce mL, mL/hr, etc.).
Consequentially, the in container drug amount parameter input field 3304 and total volume
in container parameter input field 3306 have been left unpopulated. The concentration
parameter input field 3308 and dose parameter input field 3310 have also been left
unpopulated. In some embodiments, the in container drug amount ter input field
3304, total volume in container parameter input field 3306, concentration parameter input
field 3308, and dose parameter input field 3310 may be locked, grayed out, or not displayed
on the GUI 3300 when such an infusion has been selected. The in container drug amount
parameter input field 3304, total volume in ner parameter input field 3306,
concentration parameter input field 3308, and dose parameter input field 3310 will be
further elaborated upon in subsequent paragraphs.
When the GUI 3300 is being used to program a volume base infusion, the
rate parameter input field 3312, VTBI parameter input field 3314, and time parameter input
field 3316 do not operate ndent of one another. A user may only be required to define
any two of the rate parameter input field 3312, VTBI parameter input field 3314, and time
parameter input field 3316. The two parameters defined by a user may be the most
convenient parameters for a user to set. The parameter left vacant by the user may be
calculated automatically and displayed by the GUI 3300. For instance, if a user populates
the rate parameter input field 3312 with a value of 125 mL/hr (as shown), and populates the
VTBI parameter input field 3314 with a value of 1000mL (as shown) the time parameter
input field 3316 value may be ated by dividing the value in the VTBI parameter input
field 3314 by the value in the rate parameter input field 3312. In the e embodiment
shown in 2, the quotient of the above calculation, 8hrs and 0 min, is correctly
populated by the GUI 3300 into the time parameter input field 3316.
For a user to populate the rate parameter input field 3312, VTBI parameter
input field 3314, and time parameter input field 3316 the user may touch or tap the desired
parameter input field on the GUI 3300. In some embodiments, this may cull up a number
pad with a range or number, such as 0-9 displayed as individual selectable virtual buttons. A
user may be required to input the parameter by individually tapping, double tapping,
touching and dragging, etc. the desired numbers. Once the desired value has been input by a
user, a user may be required to tap, double tap, etc. a l “confirm”, “enter”, etc. button
to te the field. For another detailed description of another example way of ng
cal values see 2.
[00992] 3 shows a scenario in which the infusion parameters being
programmed are not those of a volume based infusion. In 3, the infusion e is
that of a continuous volume/time dose rate. In the example embodiment shown in 3,
all of the parameter input fields have been populated. As shown, the medication parameter
input field 3302 on the GUI 3300 has been populated with “HEPARIN” as the d
infusate. As shown, the in container drug amount parameter input field 3304, total volume
in container input field 3306, and concentration parameter input field 3308 are populated in
3. Additionally, since a volume/time infusion is being programmed the dose
parameter input field 3310 shown in 2 has been ed with a dose rate parameter
input field 3318.
[00993] The in container drug amount parameter input field 3304 is a two part field
in the example embodiment shown in 3. In the example embodiment in 3
the left field of the in container drug amount parameter input field 3304 is a field which may
be populated with a numeric value. The numeric value may defined by the user in the same
manner as a user may define values in the rate parameter input field 3312, VTBI parameter
input field 3314, and time parameter input field 3316. In the example ment shown in
3, the numeric value displayed by the GUI 3300 in the in left field of the in
container drug amount parameter input field 3304 is “25,000”.
The parameter defined by the right field of the in container drug amount
parameter input field 3304 is the unit of measure. To define the right of the in container
drug amount parameter input field 3304, a user may touch the in container drug amount
parameter input field 3304 on the GUI 3300. In some embodiments, this may cull up a list
of acceptable possible units of measure. In such embodiments, the desired unit of e
may be defined by a user in the same manner as a user may define the correct infusate. In
other embodiments, ng the in container drug amount parameter input field 3304 may
cull up a virtual keyboard. The user may then type the correct unit of measure on the virtual
keyboard. In some embodiments the user may be required to tap, double tap, etc. a virtual
“confirm”, “enter”, etc. button to populate the left field of the in container drug amount
ter input field 3304.
In some embodiments, including the embodiment shown in 3, the
right field of the in container drug amount parameter input field 3304 may have one or more
acceptable values with may be dependent on the parameter input into one or more other
parameter input fields. In the example embodiment, the meaning of the unit of measure
“UNITS” may differ depending on the infusate set in the medication ter input field.
The GUI 3300 may also tically convert the value and unit of measure in tively
the left field and right field of the in ner drug amount parameter input field 3304 to a
metric equivalent if a user inputs a non—metric unit of measure in the right field of the in
container drug amount parameter input field 3304.
] The total volume in container parameter input field 3306 may be populated
by a numeric value which defines the total volume of a container. In some ments, the
GUI 3300 may automatically populate the total volume in container parameter input field
3306 based on data generated by one or more sensors. In other embodiments, the total
volume in container parameter input field 3306 may be manually input by a user. The
numeric value may defined by the user in the same manner as a user may define values in
the rate parameter input field 3312, VTBI parameter input field 3314, and time parameter
input field 3316. In the example embodiment shown in 3 the total volume in
container parameter input field 3306 has been populated with the value “250” mL. The total
volume in container parameter input field 3306 may be restricted to a unit of measure such
as mL as shown.
] The concentration parameter input field 3308 is a two part field similar to the
in container drug amount parameter input field 3304. In the example embodiment in 3 the left field of the tration parameter input field 3308 is a field which may be
populated with a numeric value. The numeric value may defined by the user in the same
manner as a user may define values in the rate parameter input field 3312, VTBI parameter
input field 3314, and time parameter input field 3316. In the example embodiment shown in
3, the numeric value displayed by the GUI 3300 in the in left field of the
concentration parameter input field 3308 is “100”.
The parameter defined by the right field of the concentration parameter
input field 3308 is a unit of measure/volume. To define the right field of the concentration
parameter input field 3308, a user may touch the concentration parameter input field 3308
on the GUI 3300. In some embodiments, this may cull up a list of acceptable possible units
of measure. In such embodiments, the desired unit of measure may be defined by a user in
the same manner as a user may define the correct infusate. In other embodiments, touching
the concentration ter input field 3308 may cull up a virtual keyboard. The user may
then type the correct unit of measure on the virtual rd. In some embodiments the user
may be required to tap, double tap, etc. a virtual “confirm”, ”, etc. button to store the
selection and move on to a list of acceptable volume measurements. The desired volume
measurement may be defined by a user in the same manner as a user may define the correct
infusate. In the example embodiment shown in 3 the right field of the concentration
parameter input field 3308 is populated with the unit of measure/volume /mL”.
[00999] The in container drug amount parameter input field 3304, total volume in
container input field 3306, and concentration parameter input field 3308 are not
independent of one another. As such, a user may only be required to define any two of the
in container drug amount parameter input field 3304, total volume in ner input field
3306, and concentration ter input field 3308. For instance, if a user were to populate
the tration parameter input field 3308 and the total volume in container ter
input field 3306, the in container drug amount parameter input field may be automatically
calculated and populated on the GUI 3300.
Since the GUI 3300 in 3 is being programmed for a continuous
volume/time dose, the dose rate ter input field 3318 has been populated. The user
may define the rate at which the infusate is infused by populating the dose rate parameter
input field 3318. In the e embodiment in 3, the dose rate parameter input
field 3318 is a two part field similar to the in container drug amount parameter input field
3304 and concentration parameter input field 3308 described above. A numeric value may
defined in the left field of the dose rate parameter input field 3318 by the user in the same
manner as a user may define values in the rate parameter input field 3312. In the example
ment in 3, the left field of the dose rate parameter input field 3318 has been
populated with the value “1000”.
The right field of the dose rate parameter input field 3318 may define a unit
of measure/time. To define the right field of the dose rate parameter input field 3318, a user
may touch the dose rate parameter input field 3318 on the GUI 3300. In some embodiments,
this may cull up a list of acceptable possible units of measure. In such embodiments, the
desired unit of measure may be defined by a user in the same manner as a user may define
the correct infusate. In other embodiments, touching the dose rate parameter input field
3304 may cull up a virtual keyboard. The user may then type the correct unit of measure on
the l keyboard. In some ments the user may be required to tap, double tap, etc.
a virtual “confirm”, “enter”, etc. button to store the selection and move on to a list of
acceptable time measurements. The d time ement may be defined by a user in
the same manner as a user may define the correct infusate. In the example embodiment
shown in 3 the right field of the dose rate parameter input field 3318 is populated
with the unit of e/time “UNITS/hr”.
In the example embodiment, the dose rate parameter input field 3318 and
the rate parameter input field 3312 are not independent of one r. After a user
populates the dose rate parameter input field 3318 or the rate parameter input field 3312, the
parameter input field left vacant by the user may be ated automatically and displayed
by the GUI 3300 as long as the concentration parameter input field 3308 has been defined.
In the example embodiment shown in 3, the rate parameter input field 3312 has
been populated with an infusate flow rate of “10 mL/hr”. The dose rate parameter input
field 3318 has been populated with “1000” “UNITS/hr”.
In the example ment shown in 3 the VTBI parameter input
field 3314 and time parameter input field 3316 have also been populated. The VTBI
parameter input field 3314 and time parameter input field 3316 may be populated by a user
in the same manner described in relation to 6. When the GUI 3300 is being
programmed to a continuous volume/time dose rate infusion, the VTBI parameter input
field 3314 and the time parameter input field 3316 are dependent on one another. A user
may only need to populate one of the VTBI parameter input field 3314 or the time
parameter input field 3316. The field left vacant by the user may be calculated automatically
and displayed on the GUI 3300.
4 shows a scenario in which the infusion parameters being
programmed are those of a drug amount based infusion herein referred to as an intermittent
on. In the example embodiment shown in 4, all of the parameter input fields
have been populated. As shown, the medication parameter input field 3302 on the GUI 3300
has been populated with the antiboitic “VANCOMYCIN” as the defined infusate.
As shown, the in container drug amount parameter input field 3304, total
volume in ner input field 3306, and concentration parameter input field 3308 are laid
out the same as in 4. In the example embodiment in 8, the left field of the in
container drug amount parameter input field 3304 has been populated with “l”. The right
field of the in container drug amount parameter input field 3304 has been populated with
“g”. Thus the total amount of Vancomycin in the ner has been defined as one gram.
The total volume in container parameter input field 3306 has been populated with “250” ml.
The left field of the concentration parameter input field 3308 has been populated with “4.0”.
The right field of the concentration parameter input field has been populated with ”.
As ned in relation to other possible types of infusions which a user
may be capable of programming through the GUI 3300, the in container drug amount
parameter input field 3304, total volume in ner input field 3306, and concentration
parameter input field 3308 are ent upon each other. As above, this is indicated by the
curved double arrows connecting the parameter input field names. By populating any two of
these parameters, the third ter may be automatically calculated and displayed on the
t parameter input field on the GUI 3300.
In the example embodiment in 4, the dose parameter input field 3310
has been populated. As shown, the dose parameter input field 3310 comprises a right and
left field. A numeric value may defined in the right field of the dose parameter input field
3310 by the user in the same manner as a user may define values for other parameter input
fields which define numeric values. In the example embodiment in 4, the left field
of the dose parameter input field 3310 has been populated with the value .
[001008] The right field of the dose parameter input field 3310 may define a unit of
mass measurement. To define the right field of the dose parameter input field 3310, a user
may touch the dose parameter input field 3310 on the GUI 3300. In some embodiments, this
may cull up a list of acceptable possible units of measure. In such embodiments, the desired
unit of measure may be defined by a user in the same manner as a user may define the
correct infusate. In other embodiments, touching the dose parameter input field 3310 may
cull up a Virtual keyboard. The user may then type the correct unit of measure on the virtual
keyboard. In some embodiments the user may be required to tap, double tap, slide, etc. a
Virtual “confirm”, ”, etc. button to store the ion and move on to a list of
acceptable mass measurements. The desired mass measurement may be defined by a user in
the same manner as a user may define the correct infusate. In the e ment
shown in 4 the right field of the dose parameter input field 3310 is populated with
the unit of measurement “mg”.
[001009] As shown, the rate parameter input field 3312, VTBI parameter input field
3314, and the time parameter input field 3316 have been populated. As shown, the rate
parameter input field 3312 has been populated with “125” mL/hr. The VTBI parameter
input field 3314 has been defined as “250” mL. The time parameter input field 3316 has
been defined as “2” hrs “00” min.
[001010] The user may not need to individually define each of the dose parameter
input field 3310, rate parameter input field 3312, VTBI parameter input field 3314, and the
time parameter input field 3316. As indicated by the curved double arrows, the dose
parameter input field 3310 and the VTBI parameter input field 3314 are dependent upon
each other. Input of one value may allow the other value to be automatically calculated and
displayed by the GUI 3300. The rate parameter input field 3312 and the time parameter
input field 3316 are also dependent upon each other. The user may need to only define one
value and then allow the non—defined value to be automatically calculated and displayed on
the GUI 3300. In some ments, the rate parameter input field 3312, VTBI parameter
input field 3314, and the time parameter input field 3316 may be locked on the GUI 3300
until the in container drug amount parameter input field 3304, total volume in container
parameter input field 3306 and concentration ter input field 3308 have been defined.
These fields may be locked because automatic calculation of the rate parameter input field
3312, VTBI parameter input field 3314, and the time parameter input field 3316 is
dependent upon values in the in container drug amount parameter input field 3304, total
volume in ner parameter input field 3306 and concentration parameter input field
3308.
In ios where an infusate may require a body weight based dosage, a
weight parameter input field 3320 may also be displayed on the GUI 3300. The example
GUI 3300 shown on 5 has been arranged such that a user may program a body
weight based dosage. The parameter input fields may be defined by a user as detailed in the
above discussion. In the example embodiment, the infusate in the medication parameter
input field 3302 has been defined as “DOPAMINE”. The left field of the in container drug
amount parameter input field 3304 has been defined as “400”. The right field of the in
container drug amount parameter input field 3304 has been defined as “mg”. The total
volume in container ter input field 3306 has been defined as “250” ml. The left field
of the concentration parameter input field 3308 has been defined as “1.6”. The right field of
the concentration parameter input field 3308 has been defined as “mg/mL”. The weight
parameter input field 3320 has been defined as “90” kg. The left field of the dose rater
parameter input field 3318 has been d as “5.0”. The right field of the dose rate
parameter input field 3318 has been defined as “mcg/kg/min”. The rate parameter input
field 3312 has been defined as “16.9” mL/hr. The VTBI parameter input field 3314 has been
defined as “250”mL. The time parameter input field 3316 has been defined as “14” hrs “48”
min.
To define the weight parameter input field 3320, a user may touch or tap the
weight parameter input field 3320 on the GUI 3300. In some ments, this may cull up
a number pad with a range of s, such as 0—9 displayed as dual selectable virtual
buttons. A user may be required to input the parameter by dually g, double
tapping, touching and dragging, etc. the desired numbers. Once the desired value has been
input by a user, a user may be required to tap, double tap, etc. a Virtual “confirm”, “enter”,
etc. button to populate the field.
As indicated by the curved double arrows, some parameter input fields
displayed on the GUI 3300 may be dependent upon each other. As in previous examples,
the in container drug amount parameter input field 3304, total volume in container
parameter input field 3306, and concentration parameter input field 3308 may be dependent
upon each other. In 5, the weight parameter input field 3320, dose rater parameter
input field 3318, rate ter input field 3312, VTBI ter input field 3314, and the
time parameter input field 3316 are all dependent upon each other. When enough
3O information has been defined by the user in these parameter input fields, the parameter input
fields not populated by the user may be automatically calculated and displayed on the GUI
3300.
In some embodiments, a user may be required to define a specific parameter
input field even if enough information has been defined to automatically calculate the field.
This may improve safety of use by presenting more opportunities for user input errors to be
caught. If a value entered by a user is not compatible with already defined values, the GUI
3300 may display an alert or alarm message soliciting the user to double check values that
the user has entered.
] In some scenarios the delivery of infusate may be informed by the body
surface area (BSA) of a patient. In 6, the GUI 3300 has been set up for a body
surface area based infusion. As shown, a BSA parameter input field 3322 may be displayed
on the GUI 3300. The parameter input fields may be defined by a user as detailed in the
above discussion. In the example embodiment, the infusate in the tion parameter
input field 3302 has been defined as “FLUOROURACIL”. The left field of the in container
drug amount parameter input field 3304 has been defined as “1700”. The right field of the in
container drug amount parameter input field 3304 has been defined as “mg”. The total
volume in container parameter input field 3306 has been defined as “500” ml. The left field
of the concentration ter input field 3308 has been defined as “3.4”. The right field of
the tration parameter input field 3308 has been defined as “mg/mL”. The BSA
parameter input field 3320 has been defined as “1.7” m2. The left field of the dose rate
parameter input field 3318 has been defined as . The right field of the dose rate
parameter input field 3318 has been defined as “mg/m2/day”. The rate parameter input field
3312 has been d as “20.8” mL/hr. The VTBI parameter input field 3314 has been
defined as L. The time parameter input field 3316 has been defined as “24” hrs “00”
min. The dependent parameter input fields are the same as in 9 with the exception
that the BSA ter input field 3322 has taken the place of the weight parameter input
field 3320.
To populate the BSA parameter input field 3322, the user may touch or tap
the BSA parameter input field 3322 on the GUI 3300. In some embodiments, this may cull
up a number pad with a range of numbers, such as 0-9 yed as individual selectable
virtual buttons. In some embodiments, the number pad and any of the number pads detailed
above may also feature symbols such as a decimal point. A user may be required to input
the parameter by individually tapping, double g, touching and dragging, etc. the
desired s. Once the desired value has been input by a user, a user may be required to
tap, double tap, etc. a virtual “confirm77 ‘6
, enter”, etc. button to populate the field.
In some embodiments, a patient’s BSA may be automatically ated and
displayed on the GUI 3300. In such embodiments, the GUI 3300 may query the user for
information about the patient when a user touches, taps, etc. the BSA parameter input field
3322. For example, the user may be asked to define a patient’s height and body weight.
After the user defines these values they may be run h a suitable formula to find the
patient’s BSA. The calculated BSA may then be used to populate the BSA parameter input
field 3322 on the GUI 3300.
In operation, the values displayed in the parameter input fields may change
hout the course of a programmed infusion to reflect the current state of the infusion.
For example, as the te is infused to a patient, the values displayed by the GUI 3300 in
the in ner drug amount parameter input field 3304 and total volume in container
parameter input field 3306 may decline to reflect the volume of the remaining contents of
the container. Additionally, the values in the VTBI parameter input field 3314 and time
parameter input field 3316 may also decline as infusate is infused to the patient.
[001019] 7 is an example rate over time graph detailing the one behavioral
configuration of a pump 3201, 3202, 3203 (see 3) over the course of an infusion.
The graph in 7 details an example behavioral configuration of a pump 3201, 3202,
3203 where the infusion is a continuous infusion (an infusion with a dose rate). As shown,
the graph in 7 begins at the initiation of infusion. As shown, the infusion is
administered at a constant rate for a period of time. As the infusion progresses, the amount
of infusate remaining is depleted. When the amount of infusate remaining reaches a pre—
determined old, an “INFUSION NEAR END ALERT” may be triggered. The
ION NEAR END ALERT” may be in the form of a message on the GUI 3300 and
may be accompanied by g lights, and audible noises such as a series of beeps. The
“INFUSION NEAR END ALERT” allows time for the care giver and pharmacy to prepare
materials to continue the infusion if necessary. As shown, the infusion rate may not change
over the “INFUSION NEAR END ALERT TIME”.
When the pump 3201, 3202, 3203 (see 3) has d the VTBI to a
patient a “VTBI ZERO ALERT” may be triggered. The “VTBI ZERO ALERT” may be in
the form of a message on the GUI 3300 and may be accompanied by g lights and
audible noises such as beeps. As shown, the “VTBI ZERO ALERT” causes the pump to
switch to a keep—vein—open (hereafter KVO) rate until a new infusate container may be put
in place. The KVO rate is a low infusion rate (for e 5—25mL/hr). The rate is set to
keep the on site patent until a new infusion may be d. The KVO rate is
configurable by the group (elaborated upon later) or medication and can be modified on the
pump 3201, 3202, 3203. The KVO rate is not allowed to exceed the continuous infusion
rate. When the KVO rate can no longer be ned and air reaches the pumping channel an
“AIR—IN—LINE ALERT” may be triggered. When the “AIR—IN—LINE—ALERT” is triggered,
all on may stop. The “AlR—IN—LINE ALERT” may be in the form of a message on the
GUI 3300 and may be accompanied by flashing lights and audible noises such as beeps.
8 shows another example rate over time graph detailing one
behavioral configuration of a pump 3201, 3202, 3203 (see 3) over the course of an
infusion. The graph in 8 details an example behavioral configuration of a pump
3201, 3202, 3203 where the infusion is a continuous infusion (an infusion with a dose rate).
The alerts in the graph shown in 8 are the same as the alerts shown in the graph in
7. The conditions which propagate the alerts are also the same. The rate, however,
remains constant throughout the entire graph until the “AIR—IN—LINE ALERT” is triggered
and the infusion is stopped. Configuring the pump to ue infusion at a constant rate
may be desirable in situations where the infusate is a drug with a short ife. By
continuing infusion at a constant rate, it is ensured that the blood plasma concentration of
the drug remains at eutically effective levels.
The pump 3201, 3202, 3203 (see 3) may also be used to deliver a
primary or secondary intermittent infusion. During an intermittent infusion, an amount of a
drug (dose) is administered to a patient as opposed to a continuous infusion where the drug
is given at a specified dose rate (amount/time). An intermittent infusion is also delivered
over a defined period of time, r, the time period and dose are ndent of one
another. The previously described 3 shows a setup of the GUI 3300 for a continuous
on. The previously described 4 shows a setup of the GUI 3300 for an
intermittent infusion.
9 is an example rate over time graph detailing the one behavioral
configuration of a pump 3201, 3202, 3203 (see 3) over the course of an intermittent
on. As shown, the intermittent infusion is given at a constant rate until all infusate
3O programmed for the intermittent infusion has been depleted. In the example behavioral
configuration, the pump 3201, 3202, 3203 has been programmed to issue a “VTBI ZERO
ALERT” and stop the infusion when all the infusate has been dispensed. In this
configuration, the user may be required to ly clear the alert before another infusion
may be started or resumed.
Other configurations may cause a pump 3201, 3202, 3203 (see 3) to
behave differently. For example, in scenarios where the ittent infusion is a secondary
infusion, the pump 3201, 3202, 3203 may be configured to communicate with its
ion pumps 3201, 3202, 3203 and automatically switch back to the primary infusion
after issuing a notification that the secondary intermittent infusion has been completed. In
alternate configurations, the pump may be configured issue a “VTBI ZERO ALERT” and
drop the infusion rate to a KVO rate after completing the intermittent on. In such
configurations, the user may be required to manually clear the alert before a primary
infusion is resumed.
A bolus may also be delivered as a primary intermittent infusion when it may
be necessary or ble to achieve a higher blood plasma drug concentration or manifest a
more immediate therapeutic effect. In such cases, the bolus may be delivered by the pump
3201, 3202, 3203 (see 3) executing the primary infusion. The bolus may be
delivered from the same container which the primary infusion is being delivery from. A
bolus may be performed at any point during an infusion providing there is enough infusate
to deliver the bolus. Any volume delivered via a bolus to a t is included in the value
displayed by the VTBI parameter input field 3314 of the primary on.
6] Depending on the infusate, a user may be forbidden from performing a bolus.
The dosage of a bolus may be pre—set depending on the specific infusate being used.
Additionally, the period of time over which the bolus occurs may be pre—defined depending
on the infusate being used. In some embodiments, a user may be capable of adjusting these
pre—sets by ing various setting on the GUI 3300. In some situations, such as those
where the drug being infused has a long ife mycin, teicoplanin, etc.), a bolus
may be given as a loading dose to more y reach a therapeutically effective blood
plasma drug concentration.
0 shows r rate over time graph in which the flow rate of the
infusate has been titrated to “ramp” the patient up on the infusate. Titration is often used
3O with drugs which register a fast therapeutic effect, but have a short half life (such as
norepinephrine). When titrating, the user may adjust the delivery rate of the infusate until
the desired therapeutic effect is manifested. Every adjustment may be checked against a
series of limits defined for the specific infusate being administered to the patient. If an
infusion is changed by more than a predefined percentage, an alert may be issued. In the
exemplary graph shown in 0, the rate has been up—titrated once. If necessary, the
rate may be up—titrated more than one time. Additionally, in cases where titration is being
used to “wean” a patient off of a drug, the rate may be down—titrated any suitable number of
times.
1 is r rate over time graph in which the infusion has been
configured as a multi-step infusion. A multi-step infusion may be programmed in a number
of ent steps. Each step may be defined by a VTBI, time, and a dose rate. Multi-step
infusions may be useful for certain types of infusates such as those used for parenteral
nutrition applications. In the example graph shown in 1, the infusion has been
configured as a five step infusion. The first step infuses a “VTBI l” for a length of time,
“Time 1”, at a constant rate, “Rate 1”. When the time interval for the first step has elapsed,
the pump moves on to the second step of the multi—step infusion. The second step s a
“VTBI 2” for a length of time, “Time 2”, at a constant rate, “Rate 2”. As shown, “Rate 2” is
higher than “Rate 1”. When the time al for the second step has d, the pump
moves on to the third step of the multi—step infusion. The third step infuses a “VTBI 3” for a
length of time, “Time 3”, at a constant rate, “Rate 3”. As shown “Rate 3” is the highest rate
of any steps in the multi—step on. “Time 3” is also the longest duration of any step of
the multi—step infusion. When the time interval for the third step has d, the pump
move on to the fourth step of the multi—step infusion. The fourth step infuses a “VTBI 4” for
a length of time, “Time 4”, at a constant rate, “Rate 4”. As shown, “Rate 4” has been down—
titrated from “Rate 3”. “Rate 4” is approximately the same as “Rate 2”. When the time
interval for the fourth step of the multi—step infusion has elapsed, the pump move on to the
fifth step. The fifth step infuses a “VTBI 5” for a length of time, “Time 5”, at a constant
rate, “Rate 5”. As shown, “Rate 5” has been down—titrated from “Rate 4” and is
approximately the same as “Rate 1”.
The “INFUSION NEAR END ALERT” is triggered during the fourth step of
the example infusion shown in 1. At the end of the fifth and final step of the multi-
step infusion, the “VTBI ZERO ALERT” is triggered. In the example configuration shown
3O in the graph in 1, the rate is dropped to a KVO rate after the multi—step infusion has
been concluded and the “VTBI ZERO ALERT” has been issued. Other configurations may
differ.
Each rate change in a multi—step infusion may be handled in a variety of
different ways. In some configurations, the pump 3201, 3202, 3203 (see 3) may
display a notification and automatically adjust the rate to move on to the next step. In other
configurations, the pump 3201, 3202, 3203 may issue an alert before changing the rate and
wait for confirmation from the user before adjusting the rate and moving on to the next step.
In such configurations, the pump 3201, 3202, 3203 may stop the infusion or drop to a KVO
rate until user confirmation has been received.
In some embodiments, the user may be capable of pre-programming
infusions. The user may pre-program an on to tically being after a fixed
interval of time has elapsed (e.g. 2 hours). The infusion may also be programmed to
automatically being at a ic time of day (e.g. 12:30 pm). In some embodiments, the
user may be capable of programming the pump 3201, 3202, 3203 (see 3) to alert the
user with a callback function when it is time to being the pre—programmed infusion. The
user may need to confirm the start of the pre—programmed infusion. The callback function
may be a series of e beeps, flashing , or the like.
2] In arrangements where there are more than one pump 3201, 3202, 3203 (see
3), the user may be able to program a relay infusion. The relay infusion may be
programmed such that after a first pump 3201, 3202, 3203 has completed its infusion, a
second pump 3201, 3202, 3203 may automatically being a second infusion and so on. The
user may also program a relay infusion such that the user is alerted via the callback function
before the relay occurs. In such a programmed arrangement, the relay infusion may not
being until confirmation from a user has been received. A pump 3201, 3202, 3203 may
continue at a KVO rate until user confirmation has been received.
2 shows an example block diagram of a “Drug stration
Library”. In the upper right hand corner there is a box which is substantially rectangular,
though its edges are rounded. The box is ated with the name al Settings”. The
“General Settings” may include settings which would be common to all devices in a facility
such as, site name (e. g. XZY Hospital), language, common passwords, and the like.
In 2, the “Drug Administration Library” has two boxes which are
associated with the names “Group Settings (ICU)” and “Group Settings”. These boxes form
the headings for their own columns. These boxes may be used to define a group within a
ty (e. g. pediatric intensive care unit, emergency room, sub—acute care, etc.) in which
the device is stationed. Groups may also be areas outside a parent facility, for example, a
patient’s home or an inter—hospital transport such as an ambulance. Each group may be used
to set specific gs for various groups within a facility (weight, titration limits, etc.).
These groups may alternatively be defined in other manners. For example, the groups may
be defined by user training level. The group may be d by a prior designated individual
or any of a number of prior designated individuals and changed if the associated patient or
device is moved from one specific group within a facility to another.
In the example embodiment, the left column is “Group Settings (ICU)”
which indicates that the peristaltic pump 2990 is stationed in the intensive care unit of the
facility. The right column is “Group Settings” and has not been further defined. In some
embodiments, this column may be used to designate a sub group, for example operator
training level. As indicated by lines extending to the box off to the left of the block diagram
from the “Group settings (ICU)” and “Group gs” columns, the settings for these
groups may include a preset number of default settings.
The group settings may include limits on patient , limits on patient
BSA, air alarm ivity, occlusion sensitivity, default KVO rates, VTBI , etc. The
group settings may also include parameters such as whether or not a review of a
programmed infusion is necessary for high risk infusates, whether the user must identify
themselves before initiating an on, whether the user must enter a text comment after a
limit has been overridden, etc. A user may also define the defaults for various utes like
screen brightness, or r volume. In some embodiments, a user may be capable of
programming the screen to tically adjust screen brightness in relation to one or more
conditions such as but not d to time of day.
As also shown to the left of the block diagram in 2, each facility may
have a “Master Medication List” ng all of the infusates which may be used in the
facility. The “Master Medication List” may comprise a number of medications which a
qualified individual may update or maintain. In the example embodiment, the “Master
Medication List” only has three medications: Heparin, 0.9% Normal Saline, and Alteplase.
Each group within a facility may have its own list of medications used in the group. In the
example embodiment, the “Group Medication List (ICU)” only includes a single
tion, Heparin.
As shown, each medication may be associated with one or a number of
clinical uses. In 2 the “Clinical Use Records” are defined for each medication in a
group medication list and appear as an expanded sub—heading for each infusate. The clinical
uses may be used to tailor limits and pre—defined settings for each clinical use of the
infusate. For Heparin, weight based dosing and non—weight based dosing are shown in
2 as possible clinical uses. In some embodiments, there may be a cal Use
Record” setting requiring the user to review or re—enter a patient’s weight (or BSA) before
beginning an infusion.
Clinical uses may also be defined for the different medical uses of each
infusate (e. g. stroke, heart attack, etc.) instead of or in addition to the infusate’s dose mode.
The clinical use may also be used to define whether the infusate is given as a primary
continuous infusion, y intermittent infusion, secondary infusion, etc. They may also
be use to provide appropriate limits on the dose, rate, VTBI, time duration, etc. Clinical uses
may also provide titration change , the availability of boluses, the availability of
g doses, and many other infusion specific parameters. In some embodiments, it may
be necessary to provide at least one al use for each infusate in the group medication
list.
[001040] Each clinical use may additionally comprise another expanded sub—heading
in which the concentration may also be defined. In some cases, there may be more than one
possible concentration of an infusate. In the example embodiment in 2, the weight
base dosing clinical use has a 400mg/250mL concentration and an 800 mg/250mL
concentration. The non—weight based dosing clinical use only has one concentration,
400mg/mL. The concentrations may also be used to define an acceptable range for instances
where the user may ize the concentration of the infusate. The tration setting
may include information on the drug concentration (as shown), the diluents volume, or other
related information.
In some embodiments, the user may navigate to the “Drug Administration
Library” to populate some of the parameter input fields shown in FIGS. 312-316. The user
may also navigate to the “Drug Administration Library” to choose from the clinical uses for
each infusate what type of infusion the peristaltic pump 2990 will administer. For example,
if a user were to select weight based Heparin dosing on 2, the GUI 3300 might
display the infusion mming screen shown on 5 with in” ted into
the medication parameter input field 3302. ing a clinical use of a drug may also
prompt a user to select a drug concentration. This concentration may then be used to
te the concentration parameter input field 3308 (see FIGS. 312-316). In some
embodiments, the “Drug Administration Library” may be updated and maintained external
to the peristaltic pump 2990 and icated to the peristaltic pump 2990 via any
suitable means. In such embodiments, the “Drug Administration Library” may not be
changeable on the altic pump 2990 but may only place limits and/or constraints on
programming options for a user populating the parameter input fields shown in 2-
316.
As ned above, by choosing a medication and clinical use from the
group medication list, a user may also be setting limits on other parameter input fields for
infusion programming s. For example, by defining a medication in the “Drug
Administration Library” a user may also be defining limits for the dose parameter input
field 3310, dose rate parameter input field 3318, rate parameter input field 3312, VTBI
parameter input field 3314, time parameter input field 3316, etc. These limits may be pre—
defined for each clinical use of an infusate prior to the mming of an infusion by a
user. In some embodiments, limits may have both a soft limit and a hard limit with the hard
limit being the ceiling for the soft limit. In some embodiments, the group settings may
include limits for all of the medications available to the group. In such cases, al use
limits may be defined to further tailor the group limits for each clinical usage of a particular
medication.
EXEMPLARY BATTERY AND SPEAKER TEST
[001043] Fig. 323 shows a circuit diagram 13420 having a speaker 3615 and a y
3420 in ance with an embodiment of the t disclosure. The battery 3420 may be
a backup battery 3450 (Fig. 325A) and/or the speaker 3615 may be a backup alarm speaker
3468 (Fig. 325B). That is, the circuit 13420 may be a backup alarm circuit, for example, a
backup alarm circuit in a medical device, such as a peristaltic pump 2900.
4] In some embodiments of the t disclosure, the battery 3420 may be
tested simultaneously with the speaker 3615. When a switch 13422 is in an open position, a
voltmeter 13425 may be used to measure the open circuit voltage of the battery 3420.
Thereafter, the switch 13422 may be closed and the closed-circuit voltage from the battery
3420 may be measured. The internal resistance of the battery 3420 may be estimated by
using the known nce, Z, of the speaker 3615. A processor may be used to estimate
the internal resistance of the battery 3420 (e.g., a processor of a peristaltic pump 2900). The
processor may correlate the internal resistance of the battery 3420 to the battery’s 3420
health. In some embodiments of the present disclosure, if the closed—circuit voltage of the
battery 3420 is not within a predetermined range (the range may be a function of the open—
circuit voltage of the battery 3420), the speaker 3615 may be determined to have .
In some additional embodiments of the present disclosure, the switch 13422
may be modulated such that the speaker 3615 is tested aneously with the battery
3420. A hone 3617 may be used to determine if the speaker 3615 is audibly
broadcasting a signal within predetermined operating parameters (e. g., volume, frequency,
spectral compositions, etc.) and/or the internal impedance of the battery 3420 may be
estimated to determine if it is within predetermined operating parameters (e. g., the complex
impedance, for example). The microphone 3617 (Fig. 325C) may be coupled to the
processor. Additionally or alternatively, a test signal may be applied to the speaker 3615
(e. g., by modulating the switch 13422) and the speaker’s 3615 current waveform may be
monitored by an current sensor 13426 to determine the total harmonic distortion of the
speaker 3615 and/or the magnitude of the current; a processor may be monitored these
values using the current sensor 13426 to determine if a fault condition exists within the
speaker 3615 (e.g., the total harmonic distortion or the magnitude of the current are not
within predetermined ranges).
s sine waves, periodic waveforms, and/or signals maybe applied to the
speaker 3615 to measure its impedance and/or to e the impedance of the battery
3420. For example, a processor of a peristaltic pump 2900 disclosed herein may modulate
the switch 13422 and measure the voltage across the battery 3420 to determine if the battery
3420 and the speaker 3615 has an nce within predetermined ranges; if the estimated
impedance of the battery 3420 is outside a first range, the processor may determine that the
battery 3420 is in a fault condition, and/or if the estimated impedance of the speaker 3615 is
outside a second range, the processor may ine that the speaker 3615 is in a fault
condition. Additionally or alternatively, if the processor cannot determine if the battery
3420 or the speaker 3615 has a fault ion, but has ined that at least one exists in
a fault condition, the sor may issue an alert or alarm that the t 13420 is in a fault
ion. The processor may alarm or alert a user or a remote server of the fault condition.
In some embodiments of the present disclosure, the peristaltic pump 2990 will not operate
until the fault is addressed, mitigated and/or corrected.
Electrical System
The electrical system 4000 of the peristaltic pump 2990 is described in a
block schematic in Figs 324, 325A—325G. The electrical system 4000 controls the ion
of the peristaltic pump 2990 based on inputs from the user interface 3700 and sensors 3501.
The electrical system 4000 may be a power system comprised of a rechargeable main
battery 3420 and battery charging 3422 that plugs into the AC mains. The electrical system
4000 may be architected to provide safe ion with redundant safety checks, and allow
the peristaltic pump 2990 to operate in fail operative modes for some errors and fail safe for
the rest.
[001048] The high level architecture of le processors is shown in Fig 324. In
one example, the electrical system 4000 is comprised of two main processors, a real time
processor 3500 and a User Interface and Safety Processor 3600. The electrical system may
also comprise a watch—dog circuit 3460, motor control elements 3431, sensors 3501 and
input/output elements. One main processor, referred to as the Real Time sor (RTP)
3500 may controls the speed and position of the motor 3072 that actuates the plunger 3091,
and valves 3101,3111. The RTP 3500 ls the motor 3072 based on input from the
sensors 3501 and commands from the User Interface & Safety processor (UIP) 3600. The
UIP 3600 may manage telecommunications, manage the user interface 3701, and provide
safety checks on the RTP 3500. The UIP 3600 estimates the volume pumped based on the
output of a motor r 3438 and may signal an alarm or alert when the estimated volume
differs by more than a specified amount from a desired volume or the volume reported by
the RTP 3500. The watch dog t 3460 monitors the functioning of the RTP 3500. If
the RTP 3500 fails to clear the watch dog 3460 on schedule, the watch dog 3460 may
disable the motor controller, sound an alarm and turn on failure lights at the user interface
3701. The sensor 3130 may measure the rotational position of the cam shaft 3080 and the
plunger 3901. The RTP 3500 may use the sensor inputs to control the motor 3072 position
and speed in a closed-loop controller as described below. The telecommunications may
include a WIFI driver and antenna to icate with a central computer or accessories, a
oth driver and antenna to communicate with accessories, tablets, cell—phones etc. and
a Near Field ication (NFC) driver and antenna for RFID tasks and a bluetooth. In
4 these components are collectively referred to with the reference number 3721.
The user interface 3701 may include a display, a touch screen and one or more buttons to
communicate with the user.
The detailed electrical connections and components of the electrical system
4000 are shown in Fig. 325A—325G. The sensors 3130, 3530, 3525, 3520and part of the
RTP 3500 are shown in Fig 325A. The sensors ring the peristaltic pump 2990 that
are connected to the RTP 3500 may comprise the rotary position sensor 3130 monitoring
the cam shaft position and two linear encoders 3520, 3525 that measure the position of the
plunger 3091 as shown. One linear encoder 3520 measures the position of the magnet
(3096A in Fig 268) upstream side of the plunger 3091. The other linear encoder 3525
measures the position of the magnet (3096A in Fig 268) on the downstream side of the
plunger 3091. In another embodiment, the position of the plunger may be measured with a
single magnet and linear encoder. Alternatively, RTP 3500 may use output of only one
linear encoder if the other fails. A thermistor 3540 provides a signal to the RTP 3500
indicative of the on line 3210 temperature. Alternatively the thermistor 3540 may
measure a ature in the peristaltic pump 2990.
As shown, the electrical system 4000 defines specific part numbers for
various components. For example, the thermistor 3540 is defined as a “2X SEMITEC
103JT—050 ADMIN Set THERMISTOR” These part numbers should not be construed as
limiting in any way whatsoever. In different ments, le replacement
components may be used in place of the ic parts listed in the FIGS. 25G. For
example the thermistor 3540 may not be a “2X SEMITEC 103JT—050 ADMIN Set
THERMISTOR”, but rather any suitable replacement thermistor 3540. In some
embodiments, the electrical system 4000 may comprise additional ents. In some
embodiments the electrical system 4000 may comprises fewer components than the number
of components shown in FIGS. 325A-325G
The two infusion line sensors located downstream of the peristaltic pump
2990, an air—in—line sensor 3545 and an occlusion sensor 3535 may be connected to the RTP
3500. An air-in-line sensor 3545 s the presence of air in the section of infusion line
3210 near the air-in-line sensor 3545. In one example, the -line sensor 3545 may
comprise an ultra-sonic sensor 3545B, a logic unit 3545A and a signal conditioning unit
3545C.
2] The occlusion sensor 3535 measures the internal pressure of fluid in the
infusion line 3535. In an example embodiment, the occlusion sensor 3535 may se a
force sensor 3535B, a current excitation IC 3535A, a signal amplifier 3535C and a data
buffer 3535D. The data buffer chip 3535D may protect the RTP 3500 from over—voltages
due to high forces form pressures applied to the force sensor 3535B.
3] The watchdog circuit 3460 is shown in Figs 25C. The watch dog
circuit is enabled by an I2C command from the RTP 3500. The watch dog circuit 3460 may
signal an error and disable the motor control 3430 if it does not e a signal from the
RTP 3500 at a specified frequency. The watch dog circuit 3460 may signal the user via an
audible alarm. The audible alarm may be issued via an amplifier 3464 and/or backup
speaker 3468. The watch dog circuit 3460 may signal the user with visual alarm LEDs
3750 (shown in Fig 325D). In one ment, the RTP 3500 must “clear” the watch dog
circuit 3460 between 10 ms and 200 ms after the watch dog Circuit’s last clear. In one
embodiment, the watch dog circuit 3460 is comprised of a window watchdog 3450A, a
logic circuit 3460B including one or more flip—flop switches and an IO expander 3460C that
communicates with the RTP 3500 over an 12C bus. A backup battery 3450 provides power
to the watchdog circuit 3460 and backup speaker system (which may comprise an audio
amplifier 3464, and a backup speaker 3468) in case the main battery 3420 fails. The backup
battery 3450 provides power to the RTP 3500 and UIP 3600 to maintain the internal
timekeeping, which may be especially desirable when the main battery 3420 is changed.
The RTP 3500 may also monitor the e of the backup battery 3450 with a switch such
as the “FAIRCHILD FPF1005 LOAD SWITCH” 3452 shown in 5A.
[001054] The RTP 3500 ly controls the speed and position of the motor 3072
which controls the position and speed of the plunger and valves. The motor 3072 may be
any of a number of types of motors including a brushed DC motor, a stepper motor or a
brushless DC motor. In the embodiment illustrated in Figs 5G, the altic pump
2990 is driven by a brushless direct current (BLDC) servo motor 3072 where the rotary
on sensor 3130 measures the position of the aft. In one example embodiment,
the RTP 3500 receives the signals from the hall-sensors 3436 of a brushless DC motor 3072
and does the calculations to commutate power to the windings of the motor 3072 to achieve
a desired speed or position. The commutation signals are sent to the motor driver 3430
which selectively connects the windings to the motor power supply 3434. The motor 3072
is monitored for damaging or dangerous operation via current sensors 3432 and a
temperature sensor 3072a.
The signals from the hall sensors 3436 may be supplied to both the RTP
3500 and to an encoder 3438. In one embodiment, three hall sensor signals are generated.
Any two of the three hall signals are sent to the encoder 3438. The encoder 3438 may use
these signals to e a position signal to the UIP 3600. The UIP 3600 estimates the total
volume of fluid dispensed by the peristaltic pump 2990 by reting the on signal of
the encoder 3438. The UIP 3600 tes the total volume by multiplying the number of
complete cam—shaft revolutions times a given stroke volume. The total volume estimate of
the UIP 3600 assumes each plunger stroke supplies the given amount of fluid. The amount
of fluid supplied per stroke is determined empirically during development and stored in
memory. Alternatively, each peristaltic pump 2990 may be ated during assembly to
establish the nominal volume / stroke that may be stored in memory. The UIP 3600
estimated volume may then be compared at regular intervals to the expected volume from
the commanded therapy. In some embodiments, the interval between comparisons may be
r for specific infusates, for example short—half life infusates. The therapy may specify,
among other parameters, a flow rate, a duration, or a total volume to be infused (VTBI). In
any case, the expected volume for a programmed therapy at a given time during that therapy
may be calculated and ed to the volume estimated by the UIP 3600. The UIP 3600
may signal an alert if the difference between UIP 3600 ted volume and the therapy
ed volume is outside a predefined threshold. The UIP 3600 may signal an alarm if
the difference between UIP 3600 estimated volume and the therapy expected volume is
e of another predefined threshold.
[001056] The UIP 3600 may also compare the estimated volume to the volume
reported by the RTP 3500. The UIP 3600 may signal an alert if the difference between UIP
3600 estimated volume and the RTP 3500 reported volume is outside a predefined
threshold. The UIP 3600 may signal an alarm if the difference between UIP 3600
estimated volume and the RTP 3500 reported volume is outside a second old.
7] In some embodiments, the UIP 3600 may e the RTP 3500 reported
volume to therapy expected volume and signal an alert if the two values differ by more than
a predefined threshold. The UIP 3600 may signal an alarm if the difference between the
RTP 3500 reported volume and the therapy expected volume differ by more than a
predefined threshold. The values of the alert and alarm thresholds may be different for
comparisons between different sets of volumes including the UIP 3600 estimated volume,
the RTP 3500 calculated volume and the therapy expected volume. The thresholds may be
stored memory. The thresholds may vary depending on a number of other parameters, such
as but not limited to, medication, medication concentration, therapy type, clinical usage,
patient or location. The thresholds may be included in the DERS database and downloaded
from the device gateway .
The slide clamp or slide occluder sensor 3152 and the door sensor 3162
communicate with both the RTP 3500 and the UIP 3600 as shown in Figs 325B, 325F. In
one embodiment the sensors are magnetic null sensors that change state when for example
the slide occluder 3200 is detected or the door latch hook 3025C engages the pump body.
The RTP 3500 or the UIP 3600 may enable the motor power supply 3434 only while the
processors receive signals indicating that the slide occluder 3200 is in place and the door
assembly 3021 is properly closed.
[001059] An RFID tag 3670 (Fig 325C) may be connected by an 12C bus to the UIP
3600 and to a near field a 3955. The RFID tag 3670 may be used by chs or
other users or personnel to acquire or store information when the peristaltic pump 2990 is in
an unpowered state. The UIP 3600 may store service logs or error codes in the RFID tag
3670 that can be accessed by an RFID reader. A ch, for example, could inspect
unpowered peristaltic pumps 2990 in storage or evaluate nctioning peristaltic pumps
2990 by using an RFID reader to interrogate the RFID tag 3670. In another e, a
med—tech may perform service on the peristaltic pump 2990 and store the related service
information in the RFID tag 3670. The UIP 3600 may then pull the latest service
information from the RFID tag 3670 and store it in memory 3605.
[001060] The main battery 3420 may supply all the power to the peristaltic pump
2990. The main battery 3420 is connected via a system power gating element 3424 to the
motor power supply 3434. All of the sensors and sors may be powered by one of the
several voltage regulators 3428. The main battery 3420 is charged from AC power Via a
battery charger 3422 and an AC/DC converter 3426. The UIP 3600 may be connected to
one or more memory chips 3605.
The UIP 3600 controls the main audio system which comprise a main
speaker 3615 and the chips 3610, 3612. The main audio system may be capable of
producing a range of sounds indicating, for e, alerts and alarms. The audio system
may also provide confirmatory sounds to facilitate and improve user interaction with the
touch screen 3755 and display 3725. The main audio system may include a microphone
3617 that may be used to confirm the operation of the main speaker 3615 as well as the
backup speaker 3468. The main audio system may produce one or more tones, tion
sequences and/or patterns of sound and the audio codec chip 3610 may compare the signal
received from the microphone 3617 to the signal sent to the main speaker 3615. The use of
one or more tones and comparison of signals may allow the system to m main speaker
3615 function independently of ambient noise. Alternatively the UIP 3600 or the audio
codec 3610 may confirm that the microphone 3617 ed a signal at the same time a
signal was sent to the speaker amplifier 3612.
The UIP 3600 may provide a range of different wireless signals for different
uses. The UIP 3600 may icate with the hospital wireless network via a dual band
wifi using chips 3621, 3620 and 3622 and as 3720, 3722. The spatially diverse dual
antenna may be desirable because it may be capable of overcoming dead spots within a
room due to multiple paths and cancellation. A hospital device gateway may communicate
DERS (Drug Error ion System), CQI (Continuous Quality Imporvement),
prescriptions, etc. to the peristaltic pump 2990 via the wifi system.
The bluetooth system, using the same chips 3621, 3620 and 3622 and
antennas 3720, 3722, es a convenient method to connect auxiliaries to the altic
pump 2990 that may include pulse—oximeters, blood pressure readers, bar—code readers,
tablets, phones, etc. The bluetooth may include version 4.0 to allow low power auxiliaries
which may communicate with the peristaltic pump 2990 periodically such as, for example, a
continuous glucose meter that sends an update once a minute.
The NFC system is comprised of an NFC controller 3624 and an antenna
3724. The controller 3624 may also be referred to as an RFID . The NFC system
may be used to read RFID chips identifying drugs or other inventory information. The
RFID tags may also be used to identify patients and caregivers. The NFC controller 3624
may also interact with a similar RFID reader on, for example, a phone or tablet computer to
input ation including prescriptions, de ation, patient, care—giver
identities, etc. The NFC controller 3624 may also provide information to the phone or
tablet computers such as the peristaltic pump 2990 history or service conditions. The RFID
antennas 3720 and 3722 or NFC antenna 3724 may preferably be located around or near the
display screen, so all interaction with the pump occurs on or near the screen face whether
reading an RFID tag or cting with the display touch screen 3725, 3735.
[001065] The UIP 3600 may include a medical grade connector 3665 so that other
medical devices may plug into the peristaltic pump 2990 and provide additional capabilities.
The tor 3665 may implement a USB interface.
The display 3700 includes the antennas 3720, 3722, 3725, the touch screen
3735, LED indicator lights 3747 and three buttons 3760, 3765, 3767. The display 3700
may include a backlight 3727 and an ambient light sensor 3740 to allow the screen
brightness to automatically respond to ambient light. The first button 3760 may be the
” button, while another button 3765 may be an infusion stop button. These buttons
3760, 3765, 3767 may not provide direct control of the peristaltic pump 2990, but rather
provide a signal to the UIP 3600to either initiate or ate infusion. The third button
3767 will e the alarm at the main speaker and at the secondary speaker. Silencing the
alarm will not clear the fault, but will end the audible alarm. The electric system 4000
described above, or an alternative embodiment of the electrical system 4000 described
above, may be used with any of peristaltic pumps with linear position sensors.
The pumping algorithms provide substantially uniform flow by varying the
rotation speed of the motor 3072 over a complete revolution. At low flows, the motor 3072
turns at a relatively high rate of speed during portions of the tion when the plunger
3091 is not moving fluid toward the patient. At higher flow rates, the motor 3072 turns at a
nearly constant speed throughout the revolution to minimize power consumption. At the
high flow rates, the motor 3072 rotation rate is proportional to the desired the flow rate.
The pump algorithm use linear encoders 3520, 3525 (Fig. 325A) above the plunger 3091 to
measure volume of fluid pumped toward the patient. The pump algorithm use linear
encoders 3520, 3525 (Fig. 325A) above the plunger 3091, the rotation encoder 3130 (Fig.
325A) near the cam—shaft 3080 and the air—in—line sensor 3545 downstream of the plunger
3091 to detect one or more of the following conditions: downstream occlusions, upstream
occlusions/empty bag, leaks and the amount of air directed toward the patient.
[001068] One embodiment of the valve 3101, 3111 openings and plunger 3091
on is plotted in Fig. 326. Three time periods are identified in Fig. 326 including a
refill 826, pressurization 835 and r 840 period. In addition, period “A” occurs
between the pressurization period 835 and Delivery period 840, and period “B” occurs
n the Delivery period 840 and Refill period 830. The inlet valve on 820, outlet
valve position 825 and r position 815 are plotted on a sensor signal over cam angle
graph over a complete cam shaft 3080 rotation.
The refill period 830 occurs while the inlet valve 820 is held off the on
line 3210 and the plunger 3091 is lifted off the infusion line 3210 by the plunger cam 3083.
The refill period 830 ends and the pressurization period 835 begins as the inlet valve 3101 is
closing. The plunger cam 3083 is full retracted during the pressurization period 835 to
allow the plunger 3091 to land on the filled infusion line 3210. The pressurization period
835 ends several cam angle s past the point where the plunger cam 3083 reaches its
minimum value. After a waiting period “A”, the plunger cam 3083 lifts until it reaches the
height where the plunger 3091 is expected to be. The delivery period 840 begins when the
outlet valve 3111 starts to open and lasts until the outlet valve 3111 closes again. The
plunger cam 3083 rotates causing the plunger 3091 to descend during the delivery period
840 pushing fluid toward the t.
[001070] The RTP 3500 may determine the volume of fluid delivered toward the
patient for each stroke based on signals from the rotary encoder 3130 ing the angle
of the camshaft 3080 and from the linear encoder 3525 3520 ements plunger 3091
position. The volume of each stroke may be measured by subtracting the height of the
plunger 3091 at the end of the delivery period 840 from the height of the plunger 3091 at
the end of pressurization period 835. The height of the plunger 3091 may be determined
from signals of one or both of the linear encoders 3020, 3025, where the height
approximates the distance of the plunger tip 3091B from the platen 3022. The end of the
delivery period 840 and the end of the rization period 835 may be determined from
the rotary encoder 3130 measuring the angle of the crank shaft. The ed height
difference 845 may be empirically associated with pumped volumes and the result stored in
a lookup table or in memory in the controller. The volume vs. stroke table may be
determined during development and be programmed into each peristaltic pump 2990 during
cture. Alternatively, the measured change in plunger 3091 height may be ated
to pumped volume for each peristaltic pump 2990 or pumping mechanism 3000 during the
manufacturing s.
In one embodiment, the pumped volume is calibrated plunger 3091 positions
Vi=A+B * (hp—hD)
where Vi is the pumped volume, A and B are fitting coefficients, hp is the plunger 3091
position at the end of the pressurization period 835 and hD is the plunger 3091 position at
the end of the delivery period 840.
The speed of the motor 3072 varies with the flow rate and it varies over a
single revolution for lower flow rates. In one example, the motor 3072 rotation is relatively
constant for commanded flow rates above approximately 750 ml/hr. The motor 3072 speed
is controlled to relatively slower speeds during intake and deliver flow rates for ded
flow rates below approximately 750 ml/hr.
The motor 3072 moves at a constant speed during the pressurization period
835 for all pumping rates. In one example the motor 3072 turns at the speed ed to
deliver fluid at the highest flow rate. In one example the motor 3072 turns at 800°/second
during the pressurization period 835, which ponds to the peristaltic pump 2990 to
delivering 1200 mL/Hr. Running the motor 3072 at a fixed high speed during the
pressurization period 835 may advantageously minimize no-flow periods which improves
uniformity of fluid flow. g the motor 3072 at a fixed high speed during the
pressurization period 835 may advantageously create a consistent measurement of the filled
infusion line 3210 height by compressing the plastic walls of the infusion line 3210 at the
same rate each time. Not being limited to a single theory, one theory holds that the plastic
infusion line 3210 continues to yield after being compressed, which would produce a lower
height for the filled infusion line 3210 the longer the time between compression and
measurement. The plastic may exhibit visco—elastic properties so that the amount of strain
in the c changes with the rate of compression, which in turn would change the
measured height of the plastic infusion line 3210.
LOW FLOW MODE
The pumping algorithm to produce a desired flow rate may control motor
3072 speed differently during the refill and delivery periods 830,840 for relatively lower
flow rates as compared to higher flow.
In the low flow mode the motor 3072 is controlled during the delivery period
840 to control the cam-shaft 3080 position in order to produce a predefined volume
trajectory. The volume trajectory is the volume of fluid delivered to the patient verses
time. The predefined volume trajectory usually occurs over many cam-shaft 3080 rotations,
so that the delivery period 840 must deliver a full revolution’s worth of fluid at the
tory speed in the shorter delivery period 840.
6] The motor 3072 speed during the refill period 830 is ed to produce a
full infusion line 3210 as measured at the plunger 3091 position at the end of the
pressurization period 835. The controller will slow the motor 3072 speed if the infusion
line 3210 is not full in the us pump cycle. The refill period 830 is selected such that
the plunger 3091 lifts off of the hard stop 3022A (Fig. 277) slowly (at lower flow rates) in
order to minimize tion and air bubble tion.
At all other times the motor 3072 spins at the Delivery Stroke Velocity. In
short, this is the velocity at which the cam shaft 3080 must te a revolution in order to
keep up with the trajectory volume, limited to values greater than 500° per second.
HIGH FLOW MODE
In high flow mode, the refill and delivery periods 830, 840 occur at the
Delivery Stroke Velocity. The pressurization period 835 continues to occur at 8000 per
second. The Delivery Stroke Speed is continuously updated based on the previous volume
measurement.
Delivery Stroke Velocity
The Delivery Stroke Velocity is the velocity at which the cam shaft 3080
needs to rotate in order for the controller to maintain the requested flow rate. This value is
limited to speeds greater than 500° per second (approx. 700 mL per Hr). This value is also
limited to less than the velocity required to maintain the requested flow rate in the case
where the peristaltic pump 2990 is only ring 80 uLs per stroke. This would be a
significant under—fill and likely the result of some issue upstream of the peristaltic pump
2990. The velocity is calculated using the current volume delivered, requested volume
delivered, previous stroke volume, and requested flow rate as pictured in Fig. 327.
A : Trajectory Volume. at end? of pTQ‘iFEDZiS stroke
8 I Meagured Delivered Voiu'me,a5 of previous stroke
D : ed Stroke Vaiuzme
C = B + D — A
T = Requested tory Flam-*Rate
C : Tm
C B + D — A
t— _
_ _
T T
, deg
6' = Cam Shaft Velocity,
3605 360° 2* T
In order to achieve a tent flow rate, particularly during low flow rate
deliveries, the rate at which the plunger 3091 descends must be controlled. The goal is to
keep the flow as continuous and as close to the trajectory volume as possible. This is
complicated by periods where the peristaltic pump 2990 does not deliver (refill, pressurize,
etc).
To achieve continuous flow, at the start of the delivery stroke the volume
red as part of the previous stroke should be equal the tory volume. This ensures
a smooth initial delivery (avoiding an l “rush” to catch up). In order to accomplish this,
by the end of the previous stroke the peristaltic pump 2990 must have over—delivered by the
volume that is accrued during the Refill and Pressurization 830, 835 phases. This Over—
Delivery volume is applied throughout the ry stroke, such that at the start none of it is
applied, but by the end the full volume is added.
An additional consideration is the fill volume. Shown in Fig. 328 is a graph
of the volume red versus the cam angle over various fill volumes for several pump
cycles. In the case of a tely full pumping chamber (approx. 150 uLs), there is a spurt
of fluid as the outlet valve 3111 first opens. Alternatively, in the case of fill volumes lower
than about 130 uLs, there is a tendency to pull fluid. Both of these occurrences negatively
affect flow uity. In to temper this, in some embodiments a target fill volume is set to
minimize these effects.
The graph in Fig. 328 shows multiple ry strokes, with the volume
delivered normalized to 135 uLs. Most of the stroke is repeatable, once adjusting for the fill
volume. The result of all of this is a third—order function that calculates a desired cam shaft
3080 angle given a requested volume. See below for the pertinent equations.
Variables
r1 : Current Delivery Stroke
1‘. = Current Motor Contra {SR cyde
f(x) : 3rd. Order Palynomiai Fit
En : Expected Pulse Veinme given. a F 1'? I Voirzm-e per current delivery stroke
Pn : Pulse Volume per f{.\') per dehvery stroke {this is a constant}
Sin : ed Volmne Shortage of current stroke
‘1’}. : Current Target Volume um Trajectory
93H : Measured Delivered Volume as of completion of previous deli very stroke
Q: : Target Volmne to be red at time 1‘.
FE : Freshen of Stroke completed at time i
2 ad Volume (Trajectory volume increase during uondelivery portions of cyst:
9i = Requested Cam Shaft Angle
80 = hutch? Cam Shaft Angle at start of deli-very stroke
EQUATIONS
Sn : Pu. _ En
Qt : Ti _ VH-i
Ff Z E—n
91' :f(Qi +3}: T 0}1F5)+50
In some embodiments, the motor 3072 velocity during the delivery stroke is
limited to no faster than the Delivery Stroke Velocity. The result of this is that at high
speeds, the requested position is always ahead of the speed—limited position. At lower flow
rates, the cam shaft 3080 on quickly s the calculated position and subsequently
follows the above algorithm.
Down-stream Occlusion Detection
The controller may determine whether a ream occlusion exists by
comparing the pressures or forces measured at the occlusion detector 3535 (3068 in Fig.
257) during the ry period 840, during the previous refill period 830 and the filtered
pressure data from previous pump cycles. Here a pump cycle is a complete revolution of
the cam—shaft 3080 producing a refill, pressurization and delivery period (830, 835, 840). A
downstream occlusion will be determined to exist by the processor if any one of several
conditions occur. The pressures or forces measured by the sensor 3545B may be low pass
filtered to reject spurious noise. In one embodiment, the low pass filter may reject noise
above 1000 Hz. A plot of filtered hypothetical pressures over time is d in Fig. 329,
where the re oscillates between lower pressures 850 when outlet valve 3111 (Fig.
259) is closed and high res 851 when the outlet valve 3111 is open and flow is being
forced through the infusion line 3210 that is pressed t the pressure sensor 3535B. A
downstream occlusion may create r flow resistance as fluid is pushed toward the
patient ing in higher peak pressures and/or higher pressures when the outlet valve
3111 is closed as the restricted fluid slowly flows past a partial occlusion.
A first example of a downstream occlusion test compares the measured
change in minimum pressure (PMIN) of the current cycle to a constant value. If the change
in PMIN is greater than a predefined value, the controller will declare an occlusion. The
change in PMINi is the difference in the minimum pressure of the current pump cycle to the
m pressure of the us pump cycle PMN_1 .
A downstream occlusion will be declared for cycle i, if P*MINi exceeds a
first given threshold.
[001088] In another embodiment, the change in PMIN is calculated as a difference
between the current change in PMIN to the filtered change in PMIN;
P*MINi =f* PMINi+ (I'D * P*MH\Ii-1
FPMINi = PMINi - P*M1Ni-1.
where f is the ing value for the newest data. In one example, the ing value for
f is 0.05. If FPMINi is greater than a second given threshold, the controller may declare an
occlusion for cycle i.
In another embodiment, a downstream occlusion is declared when the sum of
the changes in PMIN exceeds a third given threshold, where the sum of the changes in PMIN is
calculated as:
IPMIN = PMlNi - PL.
where PL is the initial pressure minus the minimum pressure. If IPMIN exceeds a third
given value, then the controller may declare an occlusion.
A forth example of a downstream occlusion test compares the maximum
pressure to a minimum pressure (PMIN) of the current pump cycle:
PPi = PMAXi - PMlN H
where PMAx 1 is the maximum pressure during the delivery period 840. The controller may
declare a downstream occlusion if the Ppi exceeds a forth given threshold.
In the event of a downstream occlusion, the controller may command the
pump to w fluid through the peristaltic pump 2990 in order to relieve the pressure on
the occlusion. It may be beneficial to relieve the pressure on the occlusion to avoid a bolus
of fluid to be directed to the patient when the occlusion is relieved. In one example, the
occlusion may be cleared by unpinching or unkinking the infusion line 3210 between the
peristaltic pump 2990 and the t.
am Occlusion / -Line Measurement
The controller may detect an am occlusion or determine the volume of
air pumped toward the patient based on the measured volume per stroke and historical
volume per stroke average. The controller calculates an under-deliver volume for each
stroke VUDi as:
VUD i = Vavgi — Vi
Vavgi = fV * Vi + (l'fV) * Vavg H
where fv is a weighting factor for the volume and Vi is the volume of fluid pumped during
cycle i. The controller maintains a buffer of several VUD values, dropping the oldest one as
the newest VUD is added. If the —line detector 3545 (3066 in Fig 257) detects a bubble,
the controller will assume the VUDi represents an air bubble. If the air—in—line or 3545
does not detect air, then the VUDi is assumed to be under—delivered volume. The controller
may declare an upstream occlusion, if VUDi is r than a given value the air—in—line
detector 3545 does not detect air. The controller may determine the volume of air pumped
toward the patient and may signal an alert if the air volume exceeds a first value over a first
time period and alarm if air volume exceeds a second value over a second time period. In
one example, the controller ates the volume of the air bubble (VBUBBLE) by summing
the under—deliver volumes (VUD i) for each stroke when the air—in—line detector 3545 signals
the presence of air and some number of VUD i before the first detection of air:
VBUBBLE = VUDi.
In one example, VBUBBLE is calculated for each stroke when the air-in-line detector 3545
signals the ce of air and the three VUD i before the first detection of air.
In an alternative embodiment, the controller calculates a under—deliver
volume for each stroke VUDi as:
VUD i = VT — Vi
where VT is the nominal volume of one pump cycle that is stored in the controller. In this
alternative embodiment, the controller calculates the total volume of the air bubble
(VBUBBLE) by summing the under—deliver volumes (VUD i) for each stroke when the air—in—
line detector 3545 signals the ce of air and some number of VUD i before the first
detection of air:
VBUBBLE = (VUD I — V*UD i)
. V*UDi = fV * V*UDi +(1‘fV) * V*UDi-1
where V*UD1 is the filtered value of VUD and fv is the weighting average. In one e, ,
VBUBBLE is calculated for each stroke when the air-in-line detector 3545 signals the presence
of air and the three VUD 1 before the first detection of air.
In one embodiment, each bubble volume VBUBBLE is added to a buffer of bubble volumes
ng a set period of time and the sum of the bubble volumes in the buffer are evaluated
t a standard. If the sum of the bubble volumes exceeds a given old, then the
controller alarms for air in line. The controller may reverse the peristaltic pump 2990 to
pull the air back from the patient. In one example, the buffer captures the most recent 15
minutes of operation and the air volume threshold is set to a value between 50 and 1000 1.
In one example, bubble volumes smaller than a given value may be counted in the
summation of the bubble volume. In one example, bubble volumes less than 10 1 may be
ignored. The air volume threshold may be user setable, or may be part of the DERS data
that is downloaded from the device server gateway. The DERS and device server gateway
are described in detail in the cross referenced non-provisional application for SYSTEM,
METHOD, AND APPARATUS FOR ONIC PATIENT CARE (ATTORNEY
DOCKET NO. J85).
Leak Test
A leak is determined at the end of the pressurization period 835 by
monitoring the r 3091 position while the plunger L-shaped cam follower 3090 is not
resting on the plunger cam 3083 and the plunger tip 3091B is resting on the infusion line
3210. If the plunger 3091 moves by more than a given value over a given time indicating
that fluid has leaked past the valves 3101, 3111. In one embodiment, the peristaltic pump
2990 is stopped for half a second every six seconds at the end of pressurization period 835
to monitor the r 3091 position to determine if a leak exists between the valves 3101,
3111.
State Diagram for Delivery of Fluid by the Peristaltic Pump
The state diagram for the software that controls the delivery of fluid is
pictured in Fig 330. The ry Top State (capitalized phases herein may refer to
les, processes, or data structures, etc. depending on context) is the SuperState for the
entire pump controller 3430 and comprises the Idle State and the Running State. The Idle
State is entered upon starting the pump controller 3430, completing a delivery, or
ng/aborting a delivery. The Running State is the tate for all states that involve
ing the motor 3072 or performing a delivery. The Running State also handles Freeze
commands.
[001096] The ry State is the SuperState for all states involving performing a
delivery. This state handles Stop commands, which had two behaviors depending on the
current state. If commanded during an active ry the peristaltic pump 2990 will finish
delivery after current stroke is completed. If the peristaltic pump 2990 is currently in the
freeze state, it will ately end the delivery.
[001097] The Start Deliver State signifies the beginning of a delivery cycle, or one
rotation of the cam shaft 3080. The peristaltic pump 2990 will transition to one of three
states depending on the current conditions. If enough time has elapsed since the previous
leak check, the Moving to Leak Check Position State is called. If the previous ry was
frozen and aborted mid-stroke, the Moving to Plunger Down State is entered in order to
resume delivering where the previous delivery ended. Otherwise, the motor controller 3430
transitions to the Moving to Pressurized Position State.
The Moving to Leak Check Position State commands the motor controller
3430 to move to and hold position at the Valves Closed Plunger Down position. The motor
3072 velocity is commanded to move at 8000 per second. Upon receiving notification that
the cam shaft 3080 has reached the desired position the Pressurized Position measurement is
taken for volume calculations and the Waiting for Leak Check State is called.
The Waiting for Leak Check State idles until a set amount of time has
elapsed, allowing the infusion line 3210 to settle and, in the case of a leak, fluid to escape
the pumping chamber. Once the time has elapsed, the plunger 3091 position is measured
again and compared to the Pressurized on in order to determine the ce of a leak
condition. The Fault Detector is told that the delivery stroke is starting in order to monitor
for air and occlusions and the Moving to Plunger Down Position State is called.
0] The Moving to Pressurized Position State commands the motor controller
3430 to move towards and send a notification upon reaching the Valves Closed Plunger
Down position. It will ue to move upon ng this position until a new command is
issued. The motor 3072 velocity is commanded to move at 8000 per second.
Upon receiving cation that the cam shaft 3080 has reached the desired
position the Pressurized Position measurement is taken for volume calculations and the
Moving to Plunger Down Position State is called. The Fault Detector is told that the
delivery stroke is starting in order to monitor for air and occlusions.
The Moving to Plunger Down Position State controls the cam shaft 3080
position hout the portion of the cam shaft 3080 rotation that the outlet valve 3111 is
open. The cam shaft 3080 position is controlled in such a way as to attempt to keep the flow
as consistent as possible. During this state, the motor 3072 velocity is again limited to no
greater than the calculated Delivery Stroke Velocity. There are two paths by which the
motor controller 3430 can exit this state. In the first case, the state is notified once the cam
shaft 3080 reaches the Outlet Open Plunger Down position. Alternatively, if the total
delivery volume reaches the commanded volume during the stroke, the cam shaft 3080
on is frozen and the state is notified that the stroke is complete.
Upon being notified that cam shaft 3080 has reached the Outlet Open
Plunger Down position, the plunger 3091 position is stored as the Post Delivery Position
measurement and the Fault Detector is told that the delivery stroke is complete. Using this
measurement, the volume delivered is ated (using the calibration in n 3). If the
peristaltic pump 2990 was d mid-stroke, the volume delivered is estimated using the
current position and the fill volume. Using the updated delivery volume information, the
updated Delivery Stroke ty is calculated. Finally, in the case where the delivery
volume has been reached, the peristaltic pump 2990 calls the End Deliver State. Otherwise
the Moving to Fill Position State is entered.
The Moving to Fill Position State commands the motor controller 3430 to
move towards and send a notification upon reaching the Inlet Valve Open r Up
on (minus the Pre—Fill Window). It will continue to move upon reaching this position
until a new command is issued. The motor 3072 velocity is ded to move at the
calculated Delivery Stroke ty. Once the desired position is reached, the Moving
Through Fill Position State is called.
The Moving to Fill Position State commands the motor controller 3430 to
move towards and send a cation upon reaching the Inlet Valve Open Plunger Up
position (plus the Post-Fill Window). It will continue to move upon reaching this position
until a new d is issued. The motor 3072 velocity is commanded to move at the
calculated Refill Stroke Velocity (see Section 8.3). The Refill Stroke Velocity is calculated
upon entering this state prior to issuing a new motor 3072 command.
[001106] Once the desired on is reached, the End Deliver State is called.
The End Deliver State checks if the delivery volume has been ed or a
stop has been requested. If so, the motor controller 3430 enters the Idle State and the cam
shaft 3080 position is commanded to go to the Inlet Valve Open Plunger Up position.
Otherwise the Start Deliver State is called, and a new delivery cycle begins.
[001108] The Freeze State is called when the Running State processes a Freeze
command. The cam shaft 3080 position is frozen at its current position and the Fault
Detector and Volume Estimator are notified that the delivery if frozen.
If a Resume Delivery d is ed while in the Freeze State, the
state machine is returned to the state which it was in prior to entering the Freeze State. The
Fault Detector and Volume tor are both informed that the delivery is resuming. If a
Stop Delivery command is received, the Idle State is called.
The Calibration State is the SuperState for the states involved in calibrating
the cam shaft 3080 and plunger 3091 positions.
The g Home State performs the cam shaft 3080 calibration. ng
this state, the IO Access class is notified that a calibration is beginning so certain sensor
protections can be turned off. The state receives a notification once the process is
completed. Upon receiving this notification, the calibration values are sent to the non-
volatile memory. Finally, the Moving to Home State is called.
2] The Moving to Home State simply commands the peristaltic pump 2990 to
move to the Inlet Valve Open Plunger Up position. Upon reaching this position the
peristaltic pump 2990 returns to the Idle State.
Fig. 331 rates a possible state chart of the code to detect to detect a fault of
the peristaltic pump 2990 and Fig. 332 illustrates a occlusion detection state chart to detect
an occlusion of the peristaltic pump 2990 in accordance with an embodiment of the present
disclosure. Fig. 33 shows a feedback control loop to l the speed the peristaltic pump
2990 motor 3072 in a peristaltic pump 2990 in accordance with an embodiment of the
t disclosure.
Software Architecture
The software architecture of the peristaltic pump 2990 is shown
schematically in Fig 334. The software architecture divides the software into cooperating
subsystems that interact to carry out the required pumping action. The software may be
equally applicable to all the embodiments bed herein. The software may also be used
for other pump embodiments which may not be bed herein. Each tem may be
composed of one or more execution streams controlled by the underlying operating system.
Useful terms used in the art include operating system, subsystem, process, thread and task.
Asynchronous messages 4130 are used to ‘push’ information to the
ation task or process. The sender s or task does not get confirmation of message
delivery. Data delivered in this manner is typically repetitive in nature. If messages are
expected on a consistent schedule, the receiver process or task can detect a failure if a
message does not arrive on time.
Synchronous messages 4120 may be used to send a command to a task or
process, or to request (pull) ation from a process or task. After sending the command
(or request), the originating task or process suspends execution while awaiting a response.
The se may contain the ted information, or may simply acknowledge the
receipt of the sent message. If a response is not received in a timely , the sending
process or task may time out. In such an event the sending s or task may resume
execution and/or may signal an error condition.
[001117] An operating system (OS) is a collection of software that manages computer
hardware resources and provides common services for computer programs. The operating
system acts as an intermediary between ms and the computer hardware. Although
some application code is executed directly by the hardware, the application code may
frequently make a system call to an OS function or be interrupted by it.
[001118] The RTP 3500 runs on a Real Time Operating System (RTOS) that has been
certified to a safety level for medical devices. An RTOS is a multitasking ing system
that aims at executing real—time applications. Real—time operating systems often use
specialized scheduling algorithms so that they can achieve a deterministic nature of
behavior. The UIP 3600 runs on a Linux operating system. The Linux operating system is
a Unix—like computer operating system.
9] A subsystem is a collection of software (and perhaps hardware) assigned a
specific set of ed) system functionality. A subsystem has clearly defined
responsibilities and a y defined interface to other subsystems. A subsystem is an
architectural division of the software that uses one or more processes, threads or tasks.
A s is an independent executable running on a Linux operating system
which runs in its own virtual address space. The memory management hardware on the
CPU may be used to enforce the integrity and isolation of this memory, by write ting
code—space, and disallowing data access e of the process’ memory region. Processes
can only pass data to other processes using process communication facilities.
In Linux, a thread is a separately scheduled, concurrent path of program
execution. On Linux, a thread is always associated with a process (which must have at least
one thread and can have le threads). Threads share the same memory space as its
‘parent’ process. Data can be directly shared among all of the threads belonging to a process
but care must be taken to properly synchronize access to shared items. Each thread has an
assigned execution priority.
A task on an RTOS (Real Time ing System) is a separately scheduled,
rent path of m execution, analogous to a Linux ‘thread’. All tasks share the
same memory address space which consists of the entire CPU memory map. When using an
RTOS that provides memory protection, each task’s ive memory map is restricted by
the Memory Protection Unit (MPU) hardware to the common code space and the task’s
private data and stack space.
The processes on the UIP 3600, communicate via IPC calls as shown by the
one—way arrows in Fig. 334. Each solid—lined arrow represents a synchronous message
4120 call and response, and dotted-line arrows are asynchronous messages 4130. The tasks
on the RTP 3500 similarly communicate with each other. The RTP 3500 and UIP 3600 are
bridged by an asynchronous serial line 3601, with one of an InterComm Process 4110 or
InterComm Task 4210 on each side. The InterComm Process 4110 presents the same
ications API (Application Programming Interface) on both sides of the bridge, so
all processes and tasks can use the same method calls to interact.
The Executive Process 4320 may be invoked by the Linux system startup
scripts after all of the operating system services have started. The Executive Process 4320
may then start the various executable files that comprise the software on the UIP 3600. If
any of the software components should exit or fail unexpectedly, the Executive Process
4320 may be notified, and may generate the appropriate alarm.
] While the system is running, the Executive Process 4320 may act as a
software ‘watchdog’ for various system ents. After registering with the Executive
process 4320, a s may be required to ‘check in’ or send a signal ically to the
executive process 4320. Failure to ‘check in’ at the required interval may be detected by the
Executive Process 4320. Upon detection of a failed subsystem, the Executive Process 4320
may take remedial action of either: do nothing, declaring an alarm, or restarting the failed
process. The remedial action taken may be predetermined by a table entry compiled into the
Executive Process 4320. The ‘check—in’ interval may vary from s to process based in
part on the importance of the process. The check—in interval may also vary during
altic pump 2990 ion to optimize the pump controller 4256 response by
minimizing computer processes. In one example embodiment, during tube loading, the
pump controller 4256 may check—in less frequently than during active pumping.
6] In response to the required check—in message, the Executive Process 4320
may return s system status items to processes that checked—in. The system status
items may be the status of one or more components on the pump and/or errors. The system
status items may include: y status, WiFi connection , device gateway connection
status, device status (Idle, Infusion g, Diagnostic Mode, Error, Etc.), technical error
indications, and engineering log levels.
A thread running in the Executive Process 4320 may be used to read the state
of the battery 3420 from an internal monitor chip in the battery 3420. This may be done at a
relatively infrequent interval such as every 10 seconds.
[001128] The UI View 4330 may implement the graphical user interface (GUI),
ing the display graphics on the display screen 3725, and responding to inputs on the
touch-screen 3735 or other data input means. The UI View 4330 design may be stateless.
The screen being displayed may be commanded by the UI Model process 4340, along with
any variable data to be displayed. The commanded display is refreshed periodically
regardless of data changes.
The style and appearance of user input s (Virtual keyboard, drop down
selection list, check box etc.) may be specified by the screen design, and implemented
entirely by the UI View 4330. User input may be collected by the UI View 4330, and sent to
the UI Model 4340 for interpretation. The UI View 4330 may provide for multi—region,
multi—lingual support with ties for the ing list including but not limited to:
l keyboards, unicode strings, loadable fonts, right to left entry, translation facility
(loadable translation files), and configurable numbers and date formats.
0] The UI Model 4340 may implement the screen flows, and so control the user
experience. The US Model 4340 may interact with the UI View 4330, specifying the screen
to display, and supply any transient values to be displayed on the screen. Here screen
refers the image displayed on the physical display screen 3725 and the defined interactive
areas or user dialogs i.e. buttons, sliders, keypads etc, on the touch screen 3735. The UI
Model 4340 may interpret any user inputs sent from the UI View 4330, and may either
update the values on the current screen, command a new screen, or pass the request to the
appropriate system service (i.e. ‘start pumping’ is passed to the RTP 3500).
When selecting a medication to infuse from the Drug Administration
Library, the UI Model 4340 may interact with the Drug Administration Library stored in the
local data base which may be part of the Database System 4350. The user’s selections may
setup the run time configurations for programming and administering the desired
medication.
While the operator may be entering an infusion program, the UI Model 4340
relays the user’s input values to the Infusion r 4360 for validation and interpretation.
Therapeutic decisions may not be made by the UI Model 4340. The ent values may
be passed from the Infusion Manager 4360 to the UI Model 4340 to the UI View 4330 to be
displayed for the user.
The UI Model 4340 may continuously monitor the device status gathered
from the Infusion Manager 4360 (current infusion progress, alerts, door sensor 3163 and
slide clamp sensor 3152, etc.) for possible display by the UI View 4330. Alerts/Alarms and
other changes in system state may provoke a screen change by the UI Model 4340.
Additional Dosage Safety Software Algorithmgs]
[001134] The Infusion Manager Process (IM) 4360 may validate and control the
infusion delivered by the peristaltic pump 2990. To start an infusion, the user may interact
with the UI odel 4330/4340 to select a specific tion and clinical use. This
ication may select one specific Drug stration Library (DAL) entry for use. The
IM 4360 may load this DAL entry from the database 4350, for use in validating and running
the infusion.
Once a Drug stration Library entry is selected, the IM 4340 may pass
the dose mode, limits for all user enterable parameters, and the default values (if set) up to
the UI Model 4340. Using this data, the UI Model 4340 may guide the user in ng the
infusion program.
As each parameter is entered by the user, the value may be sent from the UI
View/Model 340 to the IM 4360 for verification. The IM 4360 may echo the
parameters back to the UI View/Model 4330/4340, along with an tion of the
parameter’s conformance to the DAL limits. This may allow the UI odel 4330/4340
to notify the user of any values that are out of bounds.
When a complete set of valid parameters has been entered, the IM 4360 may
also return a valid infusion indicator, allowing the UI View/Model 4330/4340 to present a
‘Start’ control to the user.
[001138] The IM 4360 may simultaneously make the infusion/pump status available to
the UI View/Model 4330/4340 upon request. If the UI View/Model 4330/4340 is displaying
a ‘status’ screen, it may t this data to populate it. The data may be a composite of the
infusion state, and the pump state.
When requested to run the (valid) infusion, the IM 4360 may pass the
‘Infusion Worksheet’ containing user specified data and the ‘Infusion Template’ containing
the read—only limits from the DAL as a CRC’d binary block to the Infusion Control Task
4220 running on the RTP 3500. The on Control Task 4220 on the RTP 3500 may take
the same user inputs, conversions and DERS inputs and recalculate the Infusion eet.
The Infusion Control Task 4220 calculated results may be stored in a second CRC’d binary
block and compared to the first binary block from the UIP 3600. The on calculations
performed on the UIP 3600 may be recalculated and double checked on the RTP 3500
before the infusion is run.
0] Coefficients to convert the input values (i.e. 1, grams, %) to a standard unit
such as ml may be stored in the UIP 3600 memory or database system 4350. The
coefficients may be stored in a lookup table or at specific memory locations. The lookup
table may contain 10’s of conversion values. In order to reduce the chance that flipping a
single bit will resulting in the wrong conversion factor being used, the addresses for the
conversion values may be distributed among the values from zero to 4294967296 or 232.
The addresses may be selected so that the binary form of one address is never just one bit
different from a second address.
While an infusion is running, the IM 4360 may monitor its progress,
sequences, pauses, restarts, secondary infusions, boluses and KVO (keep vein open)
scenarios as needed. Any user alerts requested during the infusion (Infusion near complete,
KVO callback, Secondary complete callback, etc) may be tracked and red by the IM
4360.
Processes on the UIP 3600 may communicate with each other via a
proprietary messaging scheme based on a message queue library that is available with
Linux. The system may provide for both acknowledged (synchronous message 4120) and
unacknowledged (asynchronous e 4130) message passing.
Messages destined for the Real—time Processor (RTP) 3500 may be passed to
the InterComm Process 4310 which may forward the messages to the RTP 3500 over a
serial link 3601. A similar InterComm Task 4210 on the RTP 3500 may relay the message
to its intended destination via the RTP 3500 messaging system.
The messaging scheme used on this serial link 3601 may provide for error
detection and retransmission of flawed messages. This may be needed to allow the system
to be less susceptible to electrical disturbances that may occasionally ‘garble’ inter—
processor communications.
5] To maintain a consistent ace across all tasks, the message ds
used with the messaging system may be data classes derived from a common baseclass
geBase). This class adds both data identity (message type) and data integrity (CRC)
to messages.
The Audio Server Process 4370 may be used to render sounds on the system.
All user feedback sounds (key press beeps) and alarm or alert tones may be produced by
playing pre-recorded sound files. The sound system may also be used to play music or
speech if desired.
Sound ts may be symbolic (such as “Play High Priority Alarm
Sound”), with the actual sound file selection built into the Audio Server process 4370. The
ability to switch to an alternative soundscape may be ed. This ability may be used to
customize the sounds for regional or stic differences.
The Device Gateway Communication Manager Process (DGCM) 4380 may
manage ications with the Device y Server over a Wi—Fi network 3620,
3622,3720. The DGCM 4380 may be started and monitored by the ive Process 4320.
If the DGCM 4380 exits unexpectedly, it may be restarted by the Executive Process 4320
but if the failures are persistent the system may continue to function without the gateway
running.
It may be the function of the DGCM 4380 to establish and maintain the Wi—Fi
connection and to then establish a connection to the Device Gateway. All interactions
between the DGCM 4380 and the Device Gateway may system such as the system
described in the cross-referenced nonprovisional application for System, Method, and
Apparatus for onic Patient Care (Attorney Docket No. J85).
[001149] If the connection to the gateway is lable or becomes unavailable, the
DGCM 4380 may discontinue any transfers in progress, and t to reconnect the link.
Transfers may be resumed when the link is reestablished. Network and Gateway ional
states may be reported periodically to the Executive s 4320. The Executive Process
4320 may distribute this information for display to the user.
[001150] The DGCM 4380 may function as an autonomous subsystem, polling the
Device Gateway Server for updates, and downloading newer items when available. In
addition the DGCM 4380 may monitor the g tables in the database, ing new
log events as soon as they are available. Events that are successfully uploaded may be
flagged as such in the database. After a reconnection to the Device Gateway Server, the
DGCM 4380 may ‘catch up’ with the log uploads, sending all items that were entered
during the communications disruption. re and Drug Administration Library updates
received from the Gateway may be staged in the UlP’s 3600 file system for subsequent
installation. Infusion programs, clinical advisories, patient fication and other data
items destined for the device may be staged in the database.
[001151] The DGCM 4380 may report connection status and ime updates to the
Executive Process 4320. There may be no other direct connections between the DGCM
4380 and any of the other operational software. Such a design decouples the operational
software from the potentially transient availability of the Device Gateway and Wi-Fi
network.
[001152] The Motor Check 4383 software reads a hardware counter or encoder 3438
(Fig 325) that reports motor 3072 rotation. The software in this module independently
estimates the motor’s 3072 movements, and es them to the expected motion based
on the user inputs for rate of infusion. This is an independent check for proper motor
l. However, the primary motor l software may be executed on the RTP 3500.
Event ation may be written to a log Via the Logging Process 4386
during normal operation. These events may consist of internal machine status and
measurements, as well as therapy history events. Due to the volume and frequency of event
log data, these logging operations may be buffered in a FIFO queue while waiting to be
n to the database.
A SQL database (PostgreSQL) may be used to store the Drug Administration
Library, Local Machine Settings, Infusion History and Machine Log data. Stored
procedures executed by the database server may be used to insulate the application from the
internal database structures.
The database system 4350 may be used as a buffer for log data destined for
the Device y server, as well as a staging area for infusion settings and warnings sent
to the pump from the Gateway.
[001156] Upon requesting the start of an infusion, the DAL entry and all user selected
parameters may be sent to the Infusion Control Task 4220. All of the DAL validations and
a recalculation of the infusion rate and volume based upon the ted dose may be
performed. The result may be checked against the results ated by the IM 4360 on the
UIP 3600. These results may be required to match to continue.
[001157] When g an infusion, the Infusion Control Task 4220 may control the
ry of each infusion ‘segment’; i.e. one part of an infusion consisting of a volume and a
rate. Examples of segments are: a primary infusion, KVO, bolus, remainder of primary after
bolus, primary after titration, etc.
The infusion segments are sequenced by the IM Process 4360 on the UIP 3600.
[001158] The Pump Control task 4250 may incorporate the controllers that drive the
pumping mechanism. The desired pumping rate and amount (VTBI) may be specified in
commands sent from the Infusion Control Task 4220.
The Pump Control 4250 may receive periodic sensor gs from the
Sensor Task 4264. The new sensor readings may be used to determine the motor 3072 speed
and on, and to calculate the desired command to send to the Brushless Motor Control
IRQ 4262. The receipt of the sensor message may trigger a recalculation of the controller
output.
While pumping fluid, the Pump Control Task 4250 may m at least one
of the following tasks: controlling pumping speed, measuring volume delivered, ing
air detected (over a g time window), measuring fluid pressure or other indications of
occlusions, and detecting am occlusions.
Relevant measurements may be reported to the RTP Status Task 4230
periodically. The Pump Control 4250 may execute one infusion segment at a time, stopping
when the commanded delivery volume has been reached. The Sensor Task 4264 may read
and aggregate the sensor data used for the dynamic control of the pumping . The
sensor data may include the rotary encoder 3130 measuring the cam-shaft, the linear
encoders 3520, 3525 measuring the position of the plunger 3091.
The sensor task 4264 may be scheduled to run at a tent 1 kHz rate
(every 1.0 ms) via a dedicated counter/timer. After all of the relevant sensors are read, the
data may be passed to the Pump Control Task 4250 Via an asynchronous e 4120. The
periodic receipt of this message may be used as the master time base to synchronize the
peristaltic pump’s 2990 control loops.
The RTP Status Task 4230 may be the central repository for both the state
and the status of the various tasks running on the RTP 3500. The RTP Status Task 4230
may distribute this information to both the IM 4360 running on the UIP 3600, as well as to
tasks on the RTP 3500 itself.
[001164] The RTP Status Task 4230 may also be d with fluid accounting for the
ongoing infusion. Pump starts and stops, as well as pumping progress may be reported to
RTP Status 4230 by the Pump Control Task 4256. The RTP Status Task 4230 may account
for at least one of the following: total volume infused, primary volume delivered, primary
VTBI (counted down), volume delivered and VTBI of a bolus while the bolus is in progress,
and volume delivered and VTBI of a secondary infusion while the secondary infusion is in
progress.
All alerts or alarms originating on the RTP 3500 may be funneled through
the RTP Status Task 4230, and uently passed up to the UIP 3600.
While the unit is in operation, the m flash, and RAM memory may be
continually tested by the Memory Checker Task 4240. This non—destructive test may be
scheduled so that the entire memory space on the RTP 3500 is tested every few hours.
Additional periodic checks may be led under this task if needed.
Tasks running on the RTP 3500 may be required to communicate with each
other as well as to tasks that are executing on the UIP 3600.
The RTP messaging system may use a unified global addressing scheme to
allow es to be passed to any task in the system. Local messages may be passed in
memory utilizing the facilities of the RTOS’ message passing, with off—chip es
routed over the (asynchronous serial 3601) communications link by the InterComm Task
4210.
The InterComm Task 4210 may manage the RTP 3500 side of the serial link
3601 between the two processors. It is the RTP 3500 lent of the InterComm Process
4310 on the UIP 3600. Messages received from the UIP 3600 may be d to their
destination on the RTP 3500. Outbound messages may be forwarded to InterComm Process
4310 on the UIP 3600.
All es between the RTP 3500 and the UIP 3600 may be checked for
data corruption using an error—detecting code (32 bit CRC). Messages sent over the serial
link 3601 may be re—sent if corruption is detected. This provides a communications system
that may be reasonably tolerant to ESD. Corrupted messages within the processor between
processes may be handled as a hard system failure. All of the message payloads used with
the ing system may be data classes derived from a common baseclass
(MessageBase) to assure consistency across all possible message destinations.
[001171] Brushless Motor control 4262 may not run as a task; it may be implemented
as a strict foreground (interrupt t) process. Interrupts may be generated from the
commutator or hall s 3436, and the commutation thm may be run entirely in the
interrupt service routine.
Figs. 335 and 336 illustrate the geometry of two dual—band as that may
be used with the peristaltic pump 2990 in accordance with en embodiment of the present
disclosure. Figs. 335 shows a top and a bottom view of the antenna, which may be
fabricated using metallic layers on a substrate, such as is typically made when
manufacturing a printed circuit board. Fig. 336 may also be fabricated using a printed
circuit board manufacturing .
[001173] Various alternatives and modifications can be devised by those skilled in the
art without departing from the disclosure. Accordingly, the present disclosure is intended to
embrace all such alternatives, modifications and variances. Additionally, while several
ments of the present disclosure have been shown in the drawings and/or discussed
herein, it is not intended that the disclosure be limited thereto, as it is intended that the
disclosure be as broad in scope as the art will allow and that the specification be read
likewise. Therefore, the above ption should not be construed as limiting, but merely
as exemplifications of particular embodiments. And, those skilled in the art will envision
other modifications within the scope and spirit of the claims appended hereto. Other
elements, steps, methods and ques that are insubstantially different from those
described above and/or in the appended claims are also intended to be within the scope of
the disclosure.
The embodiments shown in the drawings are presented only to demonstrate
certain examples of the disclosure. And, the drawings described are only illustrative and are
non—limiting. In the drawings, for illustrative purposes, the size of some of the elements may
be exaggerated and not drawn to a particular scale. Additionally, elements shown within
the drawings that have the same s may be identical elements or may be similar
elements, depending on the context.
[001175] Where the term "comprising" is used in the present description and claims, it
does not exclude other elements or steps. Where an indefinite or definite article is used
when referring to a singular noun, e.g., "a," "an," or "the,” this includes a plural of that noun
unless something ise is specifically stated. Hence, the term "comprising" should not
be interpreted as being restricted to the items listed thereafter; it does not exclude other
elements or steps, and so the scope of the expression "a device comprising items A and B"
should not be limited to s consisting only of components A and B. This sion
signifies that, with respect to the present disclosure, the only relevant components of the
device are A and B.
Furthermore, the terms "first," "second," "third," and the like, r used
in the description or in the claims, are provided for distinguishing between similar elements
and not necessarily for describing a sequential or chronological order. It is to be understood
that the terms so used are interchangeable under appropriate circumstances s clearly
sed otherwise) and that the embodiments of the disclosure described herein are
capable of ion in other sequences and/or ements than are described or
rated herein.
Claims (11)
1. A peristaltic pump, comprising: a cam shaft having a plunger cam; a plunger-cam follower ured to engage the plunger cam to follow the plunger cam and to disengage from the plunger cam, whereby the plunger-cam er does not follow the plunger cam when disengaged from the plunger cam; a tube er configured to receive a tube; a spring-biased plunger coupled to the plunger-cam follower; a spring coupled to the spring-biased plunger, the spring configured to bias the springbiased plunger toward the tube receiver; a position sensor operatively coupled to the -biased plunger, wherein the position sensor is configured to determine a position of the spring-biased plunger when the plunger-cam er is disengaged from the plunger cam and the spring applies a force from the spring-biased plunger against the tube; and a sor coupled to the position sensor to e the position of the spring-biased plunger, wherein the processor is configured to estimate fluid flow utilizing the position of the -biased plunger as indicated by the position sensor when the plunger-cam follower is disengaged from the plunger cam and the spring applies the force from the spring-biased plunger against the tube.
2. The peristaltic pump according to claim 1, further comprising an angle sensor operatively coupled to the cam shaft configured to determine an angle of rotation of the cam shaft.
3. The peristaltic pump according to claim 2, wherein the processor es a first static region of the position sensor to a second static region of the position sensor to estimate the fluid flow.
4. The peristaltic pump according to claim 3, wherein the processor determines the first static region by identifying the first static region within a predetermined range of angles as indicated by the angle sensor.
5. The peristaltic pump according to claim 4, wherein the processor determines the second static region by identifying the second static region within a second predetermined range of angles as indicated by the angle sensor.
6. The peristaltic pump according to claim 3, wherein the processor ines the first and second static regions by measuring the position sensor at predetermined angles as indicated by the angle sensor.
7. The peristaltic pump according to claim 1, wherein the sor compares a first static region measured by the position sensor to a second static region measured by the position sensor to estimate the fluid flow.
8. The peristaltic pump ing to claim 6, wherein the processor is configured to determine the first static region by identifying a peak movement of the spring-biased plunger as measured by the position sensor and identifies the second static region to be after the peak
9. The altic pump according to claim 6, wherein the processor determines the second static region by identifying an end of the first static region.
10. The peristaltic pump according to claim 1, r comprising: a balancer cam; a balancer-cam follower; and a er spring configured to bias the balancer-cam follower against the balancer cam, wherein the balancer cam is shaped to reduce a peak torque of the cam shaft as the cam shaft rotates around its axis of rotation.
11. A peristaltic pump according to claim 1, substantially as herein described or exemplified.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ739792A NZ739792B2 (en) | 2011-12-21 | 2012-12-21 | System, method, and apparatus for infusing fluid |
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161578674P | 2011-12-21 | 2011-12-21 | |
US201161578649P | 2011-12-21 | 2011-12-21 | |
US201161578658P | 2011-12-21 | 2011-12-21 | |
US13/333,574 | 2011-12-21 | ||
US61/578,649 | 2011-12-21 | ||
US61/578,674 | 2011-12-21 | ||
US61/578,658 | 2011-12-21 | ||
USPCT/US11/66588 | 2011-12-21 | ||
US13/333,574 US10453157B2 (en) | 2010-01-22 | 2011-12-21 | System, method, and apparatus for electronic patient care |
PCT/US2011/066588 WO2013095459A1 (en) | 2011-12-21 | 2011-12-21 | System, method, and apparatus for electronic patient care |
US201261651322P | 2012-05-24 | 2012-05-24 | |
US61/651,322 | 2012-05-24 | ||
US201261679117P | 2012-08-03 | 2012-08-03 | |
US61/679,117 | 2012-08-03 | ||
NZ724959A NZ724959B2 (en) | 2011-12-21 | 2012-12-21 | System, method, and apparatus for infusing fluid |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ735908A NZ735908A (en) | 2018-03-23 |
NZ735908B2 true NZ735908B2 (en) | 2018-06-26 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11756662B2 (en) | Peristaltic pump | |
US12002561B2 (en) | System, method, and apparatus for infusing fluid | |
AU2018201251B2 (en) | Infusion system with peristaltic pump | |
AU2013266864B2 (en) | Apparatus for infusing fluid | |
NZ735908B2 (en) | System, method, and apparatus for infusing fluid | |
NZ735908A (en) | System, method, and apparatus for infusing fluid | |
NZ714766B2 (en) | System, method, and apparatus for infusing fluid | |
NZ756276B2 (en) | System, method, and apparatus for infusing fluid | |
NZ720136B2 (en) | System, method, and apparatus for infusing fluid | |
NZ739792B2 (en) | System, method, and apparatus for infusing fluid | |
NZ724959B2 (en) | System, method, and apparatus for infusing fluid | |
NZ626630B2 (en) | System, method, and apparatus for infusing fluid |